data_1fhr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fhr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.427 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 698' ' ' ASP . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.988 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.425 HG12 HG12 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.544 ' O ' ' O ' ' A' ' 583' ' ' LEU . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.988 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.9 OUTLIER -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.474 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.545 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.554 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.445 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.505 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 63.5 t60 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.662 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 3.7 mp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.405 ' O ' ' CD1' ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.438 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 672' ' ' LEU . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.439 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.419 HG22 ' CE2' ' A' ' 649' ' ' TYR . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.401 ' HA ' ' OG ' ' A' ' 657' ' ' SER . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.471 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.471 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 582' ' ' PRO . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 577' ' ' PHE . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.405 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.941 0.4 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.439 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 120.375 -0.125 . . . . 0.0 112.8 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 592' ' ' LEU . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.961 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.413 ' N ' ' C ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.961 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 580' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 598' ' ' VAL . 1.7 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.628 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.468 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.611 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.611 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.413 ' CG2' HD22 ' A' ' 618' ' ' LEU . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.407 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 46.5 t60 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 3.5 mp . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.572 ' N ' ' O ' ' A' ' 626' ' ' PHE . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.433 ' CD2' ' CE ' ' A' ' 664' ' ' MET . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.414 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.482 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.433 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.482 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.498 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.445 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.452 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 681' ' ' ILE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 586' ' ' SER . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 587' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.525 ' CE2' ' HD3' ' A' ' 582' ' ' PRO . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 577' ' ' PHE . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.062 0.458 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.403 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.435 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.554 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.449 ' CD1' ' CE2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.509 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.509 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.561 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.467 HG12 ' CG ' ' A' ' 601' ' ' PHE . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.2 mm-40 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.401 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.563 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.54 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.53 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.688 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.688 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.422 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 96.0 mt . . . . . 0 C--O 1.227 -0.111 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 670' ' ' PHE . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.537 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 661' ' ' ASN . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.405 ' HE2' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.401 ' HG3' ' HD3' ' A' ' 714' ' ' ARG . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.474 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.493 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 577' ' ' PHE . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 714' ' ' ARG . 3.1 mmm180 . . . . . 0 N--CA 1.439 -1.002 0 CA-C-O 121.07 0.462 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 722' ' ' GLU . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.969 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.487 HG13 HD13 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.969 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.449 HG12 ' CG ' ' A' ' 601' ' ' PHE . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mm-40 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.657 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.477 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.487 HD13 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.401 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.648 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.648 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.638 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 625' ' ' ILE . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 648' ' ' TRP . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.422 ' NZ ' ' CG2' ' A' ' 700' ' ' THR . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.3 mt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.541 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.1 m-20 -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.421 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.405 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.488 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.428 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.412 ' CG2' HD12 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.442 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 586' ' ' SER . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.44 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.422 ' CG2' ' NZ ' ' A' ' 627' ' ' LYS . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.984 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.483 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.428 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.483 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.984 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.536 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 601' ' ' PHE . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.507 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CG ' HG12 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.53 ' HB3' HG22 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.489 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 618' ' ' LEU . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.416 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.63 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.591 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.63 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 630' ' ' HIS . 95.8 mt . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.582 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 670' ' ' PHE . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.416 ' HG ' HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 668' ' ' THR . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.4 HG23 ' CG1' ' A' ' 665' ' ' ILE . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.582 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 577' ' ' PHE . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.976 0.417 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.441 ' O ' HD11 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.927 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.432 ' N ' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.927 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.492 HG12 ' CG ' ' A' ' 601' ' ' PHE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.503 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.45 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.654 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 692' ' ' PHE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 618' ' ' LEU . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.439 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.642 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.642 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 648' ' ' TRP . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 702' ' ' LEU . 61.1 mt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.592 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.42 ' SD ' ' CD2' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.463 HD12 HG21 ' A' ' 665' ' ' ILE . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.592 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 649' ' ' TYR . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 674' ' ' ASP . 20.3 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 673' ' ' GLN . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.462 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.48 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 582' ' ' PRO . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.419 ' CG2' ' CD1' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.402 HG23 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 2.8 mmm-85 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . 0.423 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.412 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.968 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 691' ' ' GLY . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.453 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.511 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.511 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.968 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.56 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' A' ' 601' ' ' PHE . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.495 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.8 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.608 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.548 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 618' ' ' LEU . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.664 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.664 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 77.1 mt . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.56 ' N ' ' O ' ' A' ' 626' ' ' PHE . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CB ' HD22 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 8.1 m-20 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.469 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.41 ' O ' ' CG2' ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 665' ' ' ILE . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.512 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.52 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.469 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 659' ' ' LEU . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.518 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.5 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 679' ' ' LYS . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 583' ' ' LEU . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.548 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 696' ' ' ILE . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.0 0.429 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.482 ' O ' HD11 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.216 0 CA-C-O 120.392 -0.115 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.973 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 688' ' ' PHE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 613' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.973 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.541 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.495 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.5 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.629 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.551 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.734 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.734 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.495 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 670' ' ' PHE . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.426 ' O ' HG21 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.437 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.494 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.512 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 681' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 587' ' ' ILE . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 696' ' ' ILE . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 10.3 mmm-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.403 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 723' ' ' GLU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 CA-C-O 120.385 -0.12 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.449 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 583' ' ' LEU . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.497 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.5 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.671 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.671 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.646 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.646 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 73.4 t60 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 630' ' ' HIS . 48.9 mt . . . . . 0 C--O 1.225 -0.22 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.493 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 670' ' ' PHE . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.489 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-20 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 665' ' ' ILE . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.451 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.493 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.468 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.428 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.405 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 690' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.451 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 7.0 mmm-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.41 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 722' ' ' GLU . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.005 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.408 HG12 HG12 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.005 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.526 HG12 ' CG ' ' A' ' 601' ' ' PHE . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.7 mm-40 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.407 ' HB2' ' CG2' ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.526 ' CG ' HG12 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.669 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.669 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.55 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.475 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.661 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.427 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.661 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 75.3 t60 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.613 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 702' ' ' LEU . 54.6 mt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.574 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 670' ' ' PHE . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-80 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.437 ' N ' HG23 ' A' ' 656' ' ' VAL . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.418 ' CD2' ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.574 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.435 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.438 ' CG1' ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 688' ' ' PHE . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.446 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 586' ' ' SER . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.482 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.418 ' NH2' ' CD2' ' A' ' 659' ' ' LEU . 5.1 mmm-85 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.461 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.493 ' O ' HD12 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 722' ' ' GLU . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.419 ' C ' ' NE2' ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.406 ' CG2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.522 ' O ' ' O ' ' A' ' 583' ' ' LEU . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 580' ' ' LEU . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.514 ' O ' HG11 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.514 HG11 ' O ' ' A' ' 595' ' ' GLN . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.685 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.637 ' HB2' HD22 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.593 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.506 ' CB ' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.436 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.543 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.553 ' CD2' ' CD1' ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.439 ' N ' ' O ' ' A' ' 648' ' ' TRP . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 647' ' ' ILE . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 6.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' A' ' 627' ' ' LYS . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.576 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 664' ' ' MET . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.533 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 716' ' ' VAL . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.576 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.569 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.572 ' CE2' ' HG3' ' A' ' 582' ' ' PRO . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 583' ' ' LEU . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 696' ' ' ILE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 644' ' ' LEU . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.041 0.448 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 670' ' ' PHE . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.422 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.406 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 592' ' ' LEU . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.168 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 583' ' ' LEU . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 582' ' ' PRO . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.563 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.168 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 580' ' ' LEU . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.45 HG23 ' CD1' ' A' ' 601' ' ' PHE . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.2 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 595' ' ' GLN . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 627' ' ' LYS . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.604 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.648 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.557 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . . . . . . . . . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.557 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.652 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.613 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HB3' ' OD1' ' A' ' 599' ' ' ASN . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 1.2 mp . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.441 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.51 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 m120 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.412 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.533 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.421 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.421 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 587' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.445 HD13 ' CE1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.441 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 12.0 mmm-85 . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 120.262 -0.188 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.976 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 690' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.445 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.976 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 601' ' ' PHE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.457 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.4 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.509 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.563 ' HB3' HG22 ' A' ' 603' ' ' ILE . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.616 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.616 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.3 t60 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 625' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.465 ' HB2' HG23 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 3.5 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 627' ' ' LYS . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.517 ' CH2' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.404 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 6.0 m-80 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.422 ' O ' HG21 ' A' ' 656' ' ' VAL . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.517 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.446 ' HA ' HG13 ' A' ' 696' ' ' ILE . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.44 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.462 ' CD1' HG13 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.445 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' SER . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 1.1 mmm-85 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.09 0.472 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.424 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.427 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.227 -0.311 0 CA-C-O 120.329 -0.15 . . . . 0.0 112.983 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 592' ' ' LEU . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.008 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 583' ' ' LEU . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.008 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.567 HG12 ' CG ' ' A' ' 601' ' ' PHE . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.2 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.567 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.666 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.476 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.666 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.544 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.412 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.601 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.2 t60 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 625' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.7 t60 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 93.4 mt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.45 HG23 ' CZ ' ' A' ' 577' ' ' PHE . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.676 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.452 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.57 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 6.7 m-80 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.43 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 679' ' ' LYS . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 656' ' ' VAL . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.6 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.676 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 678' ' ' ILE . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.402 HG12 HD23 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.464 ' CG2' ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.458 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.977 0.418 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.701 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.49 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 589' ' ' GLN . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.532 HG12 ' CG ' ' A' ' 601' ' ' PHE . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.518 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CG ' HG12 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.626 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.578 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.626 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.2 t60 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.407 ' CD1' HD11 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.4 mt . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.438 ' CD1' ' CD2' ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.536 ' CH2' HD21 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 670' ' ' PHE . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.557 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.405 ' O ' ' CG2' ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.408 ' HA ' HG12 ' A' ' 716' ' ' VAL . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 652' ' ' THR . 7.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.536 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 680' ' ' ILE . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 586' ' ' SER . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.539 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.419 HG23 ' CD2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.739 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 4.7 mmm180 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.466 HG23 ' CE2' ' A' ' 670' ' ' PHE . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.917 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.643 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.424 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.917 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.519 HG12 ' CG ' ' A' ' 601' ' ' PHE . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.6 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.642 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.452 ' O ' HD12 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 613' ' ' ILE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.479 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.533 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.57 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 648' ' ' TRP . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.411 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 2.8 mp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.351 0.12 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.528 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 670' ' ' PHE . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.597 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.546 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.0 m-80 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.438 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE1' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.528 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.465 ' CG2' HD23 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.451 ' CD1' HG11 ' A' ' 689' ' ' VAL . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.407 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.407 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 682' ' ' TRP . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.466 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.429 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.463 HD12 HG22 ' A' ' 696' ' ' ILE . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.639 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 5.0 mmm180 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.401 ' HA ' ' OD1' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 670' ' ' PHE . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.444 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.916 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.434 ' CD2' ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.437 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.438 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.916 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.56 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 582' ' ' PRO . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.444 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.541 HG12 ' CG ' ' A' ' 601' ' ' PHE . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.3 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.667 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.45 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.667 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.45 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.2 t60 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 628' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.496 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.462 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.417 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.432 ' CD1' HD21 ' A' ' 672' ' ' LEU . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.406 ' HG2' HG23 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.496 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 659' ' ' LEU . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.454 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.429 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.435 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 582' ' ' PRO . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.705 0.764 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 664' ' ' MET . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.402 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 592' ' ' LEU . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.416 HG12 ' CG1' ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.544 ' O ' ' O ' ' A' ' 583' ' ' LEU . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.981 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.449 ' O ' HG12 ' A' ' 598' ' ' VAL . 4.6 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.528 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.446 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.668 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.434 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.656 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 73.3 t60 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.627 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 1.6 t60 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 91.7 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 628' ' ' LYS . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.559 ' CH2' HD21 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.422 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.559 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.465 HG23 HG21 ' A' ' 680' ' ' ILE . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.441 ' CD1' HG13 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.441 HG13 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 582' ' ' PRO . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 696' ' ' ILE . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.424 ' C ' HD11 ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.468 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 6.0 mmm-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.953 0.406 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.422 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.463 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.524 HG12 ' CG ' ' A' ' 601' ' ' PHE . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.4 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.545 ' HB3' HG22 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.567 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 609' ' ' CYS . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.567 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.43 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.1 mp . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.647 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.3 m-80 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.46 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.647 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CD2' ' CD1' ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.456 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.536 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.497 HG21 HD13 ' A' ' 690' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.507 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 16.0 mmm-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.402 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.42 0 CA-C-O 119.879 -0.401 . . . . 1.32 113.64 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 2.16 110.677 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 1.18 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 1.56 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 1.19 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 592' ' ' LEU . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 1.53 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 2.14 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 0.959 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.37 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.84 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.69 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.67 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.3 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.495 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 2.47 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.457 ' O ' ' O ' ' A' ' 583' ' ' LEU . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 2.01 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.64 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 0.959 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.11 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 1.06 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 580' ' ' LEU . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 2.59 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 601' ' ' PHE . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 1.09 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.66 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.27 113.177 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 1.56 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.88 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.35 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.491 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.32 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.28 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.661 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 1.19 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.3 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.54 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.72 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.37 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.88 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.94 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.9 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 1.44 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.58 113.095 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.523 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.72 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.61 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.89 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . 0.42 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 1.22 112.001 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.626 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 1.33 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.56 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.456 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 1.08 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 1.11 109.105 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.626 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.3 t60 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.43 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 1.26 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.42 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 1.38 107.794 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.33 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 647' ' ' ILE . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 1.55 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 2.38 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.93 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 1.24 111.302 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.0 mt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.253 -0.277 . . . . 1.88 110.253 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 628' ' ' LYS . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.36 109.621 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 1.11 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.559 ' CH2' HD23 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.49 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 670' ' ' PHE . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.93 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.54 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.417 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.26 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 1.12 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 1.07 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.8 m-20 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.83 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.547 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 1.62 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.63 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.54 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.421 HD13 ' CG2' ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.89 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.15 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 3.05 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.9 111.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 3.2 110.324 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 1.3 111.24 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 1.25 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.82 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 1.16 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 1.45 109.157 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 1.28 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 2.2 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 1.1 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.68 110.987 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.41 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.43 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.31 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.43 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 678' ' ' ILE . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.96 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.56 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 622' ' ' HIS . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 2.27 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 681' ' ' ILE . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 1.38 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 1.02 111.14 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.85 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.67 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.92 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.54 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.495 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.99 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 2.03 111.307 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.508 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 1.52 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.42 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.94 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 2.38 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.17 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 1.1 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 1.56 110.765 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 2.7 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 2.12 111.054 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 112.856 0.687 . . . . 3.17 112.856 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 1.24 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 1.33 111.113 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.408 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 2.21 110.693 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.91 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.11 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 1.4 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 1.31 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.26 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.65 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 3.19 111.155 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.61 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.87 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 1.35 111.063 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 3.29 110.993 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -90.11 10.25 25.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.657 0.265 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -132.45 -25.83 0.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.683 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.427 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 698' ' ' ASP . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.459 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.988 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.425 HG12 HG12 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.544 ' O ' ' O ' ' A' ' 583' ' ' LEU . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.988 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.9 OUTLIER -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.474 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.477 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.545 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.554 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.445 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.505 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.608 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 63.5 t60 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.662 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 -67.41 126.09 28.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -101.51 140.23 36.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.396 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.05 161.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.965 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -91.03 54.57 3.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mttp 58.45 172.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.703 0.287 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.189 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.32 44.49 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.3 -153.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.424 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.58 100.12 8.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.464 0.649 . . . . 0.0 109.768 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.2 p -138.27 156.63 73.58 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.721 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 641' ' ' ALA . 73.3 Cg_endo -71.35 -153.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.648 2.232 . . . . 0.0 111.743 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 640' ' ' PRO . . . 80.02 -71.01 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 42.14 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -113.46 121.22 5.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.332 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 3.7 mp -146.53 -151.16 0.37 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.492 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.405 ' O ' ' CD1' ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.453 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.441 ' HB2' HD23 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.482 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.438 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.436 HD22 ' CD2' ' A' ' 672' ' ' LEU . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.41 ' O ' HG22 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.439 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 707' ' ' LEU . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.419 HG22 ' CE2' ' A' ' 649' ' ' TYR . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.401 ' HA ' ' OG ' ' A' ' 657' ' ' SER . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.471 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.471 ' CG1' ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 582' ' ' PRO . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.447 HG22 ' CD1' ' A' ' 577' ' ' PHE . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.405 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -82.86 134.86 35.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.422 ' CE2' ' HA2' ' A' ' 708' ' ' GLY . 1.9 p90 -45.58 -31.77 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.537 0.684 . . . . 0.0 110.188 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 4.2 t30 -148.7 -51.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 4.0 pt-20 152.19 -28.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.209 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.17 -11.91 2.07 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.552 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 673' ' ' GLN . 0.1 OUTLIER -86.04 9.1 18.14 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.011 0.434 . . . . 0.0 111.863 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 703' ' ' PHE . . . 66.95 -166.64 40.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.803 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.448 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -156.57 123.55 5.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.718 0.294 . . . . 0.0 110.398 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 67.14 129.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.829 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 42.93 90.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -63.83 126.38 27.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.741 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -115.5 97.51 6.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 110.383 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -106.03 77.47 1.24 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.439 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 9.26 15.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.993 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.882 0.372 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.1 41.71 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' P' ' 828' ' ' ILE . 0.0 OUTLIER -114.5 33.13 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -162.11 133.24 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 63.0 mt -123.31 151.28 42.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.864 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -22.16 63.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 129.77 -6.83 6.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.8 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.488 ' CD1' ' CD1' ' A' ' 647' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 592' ' ' LEU . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.961 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.426 HG12 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.413 ' N ' ' C ' ' A' ' 586' ' ' SER . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.961 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 580' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.472 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 598' ' ' VAL . 1.7 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.563 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.671 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.628 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.468 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.611 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.628 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.611 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.413 ' CG2' HD22 ' A' ' 618' ' ' LEU . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.407 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.49 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 46.5 t60 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.671 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.486 ' CE1' ' CE2' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -61.13 135.38 57.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -81.69 76.75 8.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.611 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.54 -175.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 114.43 -25.11 10.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.603 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -80.28 66.95 5.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.955 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.48 105.5 7.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 5.3 ttm -72.09 61.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.44 . . . . 0.0 110.411 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 175.23 -157.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 100.56 8.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.6 p -136.78 156.43 76.04 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.39 -151.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.665 2.243 . . . . 0.0 111.438 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 73.84 -68.49 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.786 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 46.61 -171.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -104.39 119.62 6.34 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.263 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 3.5 mp -146.95 -154.42 0.55 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.606 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.572 ' N ' ' O ' ' A' ' 626' ' ' PHE . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.433 ' CD2' ' CE ' ' A' ' 664' ' ' MET . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.414 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.482 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.433 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.482 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.429 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.498 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.527 ' HB ' ' CD2' ' A' ' 622' ' ' HIS . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.456 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.445 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.452 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 681' ' ' ILE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 586' ' ' SER . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 587' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.525 ' CE2' ' HD3' ' A' ' 582' ' ' PRO . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 577' ' ' PHE . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -75.23 139.62 42.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.486 ' CE2' ' CE1' ' A' ' 630' ' ' HIS . 1.0 OUTLIER -46.72 -29.88 2.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.222 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.426 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 4.8 t30 -154.95 -65.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.885 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.426 ' HG2' ' C ' ' A' ' 704' ' ' ASN . 4.8 pt-20 169.98 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.424 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.17 17.32 0.26 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.01 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.436 ' HA ' ' CG ' ' A' ' 673' ' ' GLN . 0.8 OUTLIER -82.79 8.52 12.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 38.46 72.65 0.18 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.333 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.75 100.75 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.435 ' CG ' ' HG2' ' A' ' 712' ' ' GLU . 2.7 pt? -166.79 -162.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -66.67 -51.51 55.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.806 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.435 ' HG2' ' CG ' ' A' ' 710' ' ' LEU . 8.9 pt-20 -63.4 140.38 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 97.71 6.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.301 0.572 . . . . 0.0 110.37 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 44.57 79.01 0.05 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.832 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . 0.429 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -58.19 -38.56 76.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -104.59 -25.77 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.324 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CE1' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.726 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.852 0.358 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -104.55 133.42 49.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.0 pp -123.57 40.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.069 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.6 160.29 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 90.8 mt -123.55 101.16 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -103.56 -13.38 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.261 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.91 54.4 0.76 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.328 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.403 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.435 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.554 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.449 ' CD1' ' CE2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.509 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.509 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.561 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.467 HG12 ' CG ' ' A' ' 601' ' ' PHE . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.2 mm-40 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.401 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.534 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.563 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.537 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.54 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.53 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.688 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.688 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.422 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -75.42 130.79 39.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -121.56 118.27 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.16 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.67 159.8 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -63.52 177.89 7.24 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.396 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 111.97 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.62 99.15 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 mtm -88.18 49.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 110.179 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.05 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.9 100.45 8.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.383 0.611 . . . . 0.0 109.884 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 60.8 p -138.23 148.6 60.36 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.84 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.51 -140.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.946 2.431 . . . . 0.0 112.195 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 68.36 -69.95 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.925 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 39.19 32.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.64 124.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.699 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 96.0 mt -153.51 -144.43 0.15 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 670' ' ' PHE . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.537 ' O ' ' O ' ' A' ' 656' ' ' VAL . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 661' ' ' ASN . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.405 ' HE2' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 707' ' ' LEU . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.474 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.493 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 681' ' ' ILE . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 577' ' ' PHE . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.54 128.14 33.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.603 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 3.7 p90 -45.13 -32.63 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.559 0.695 . . . . 0.0 110.123 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 5.3 t30 -145.24 -60.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.438 ' HG2' ' C ' ' A' ' 704' ' ' ASN . 10.3 pt-20 157.33 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.556 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.1 -15.98 1.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.689 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.417 ' CG ' ' HB3' ' A' ' 673' ' ' GLN . 0.2 OUTLIER -83.09 8.81 11.89 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 72.59 -133.11 18.98 Favored Glycine 0 C--N 1.32 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.642 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.11 34.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.3 -167.98 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -60.88 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.337 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -114.96 98.05 6.59 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.746 0.308 . . . . 0.0 111.049 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.484 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -117.99 97.65 5.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 714' ' ' ARG . 3.1 mmm180 -141.83 98.19 3.29 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.409 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 722' ' ' GLU . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.404 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -24.58 22.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -110.01 -31.1 7.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.031 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.809 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 128.92 39.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.8 pt -101.62 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.95 -171.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.75 158.88 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.781 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.008 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -81.65 -22.37 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.56 0.219 . . . . 0.0 111.151 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -148.36 59.19 0.46 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.69 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.969 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.585 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.487 HG13 HD13 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.969 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.546 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.449 HG12 ' CG ' ' A' ' 601' ' ' PHE . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.6 mm-40 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.638 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.657 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.477 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.657 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.487 HD13 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.401 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.648 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.648 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.638 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 625' ' ' ILE . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.466 ' O ' ' N ' ' A' ' 648' ' ' TRP . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.422 ' NZ ' ' CG2' ' A' ' 700' ' ' THR . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -61.36 124.46 20.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -59.84 125.12 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.377 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.77 -175.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.744 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 109.57 25.42 5.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.704 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.0 73.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.761 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.31 108.36 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.05 35.01 1.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.144 0.497 . . . . 0.0 110.302 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.34 -151.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.306 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.25 99.89 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.656 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 156.86 73.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.087 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.422 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 73.9 Cg_endo -70.74 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.703 2.269 . . . . 0.0 111.703 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 640' ' ' PRO . . . 82.62 -71.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 38.06 34.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.469 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 61.06 115.97 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.484 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.3 mt -152.85 -152.58 0.43 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.713 -0.744 . . . . 0.0 110.081 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.428 ' HB2' ' CG ' ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.541 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.1 m-20 -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.421 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.405 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.488 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.428 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.412 ' CG2' HD12 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.442 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 586' ' ' SER . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.44 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.422 ' CG2' ' NZ ' ' A' ' 627' ' ' LYS . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.84 140.96 42.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.498 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 48.8 p90 -50.1 -32.27 15.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 7.2 t30 -149.8 -59.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.547 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 14.8 pt-20 160.02 -28.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.23 -10.46 1.15 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.738 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 673' ' ' GLN . 0.1 OUTLIER -82.94 8.82 11.53 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.01 0.433 . . . . 0.0 111.882 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 67.44 -130.15 28.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.989 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.87 -137.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 4.2 pp -37.85 131.77 1.0 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.542 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 46.27 89.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.62 128.45 35.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.689 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -115.41 97.37 6.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.335 0.588 . . . . 0.0 110.494 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -102.83 71.75 1.17 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -29.14 68.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -105.57 23.24 14.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.662 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.817 0.342 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.07 74.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 36.5 mt -111.62 140.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.51 119.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 9.6 mt -135.67 113.34 10.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.874 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.212 0 N-CA-C 112.728 -0.149 . . . . 0.0 112.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.2 10.24 22.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.575 0.226 . . . . 0.0 111.492 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 114.01 1.9 23.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.821 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.984 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.483 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.428 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.483 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.984 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.536 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 601' ' ' PHE . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.507 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.555 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CG ' HG12 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.53 ' HB3' HG22 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.489 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 618' ' ' LEU . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.416 ' CB ' ' CD1' ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.63 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.591 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.63 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 -78.2 133.77 37.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -138.64 132.68 31.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.4 171.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -57.88 171.2 3.7 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.562 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -59.45 88.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.754 0.312 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.03 103.43 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.33 27.18 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 639' ' ' SER . 1.3 p90 -139.67 -148.95 0.27 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.164 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 100.64 8.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.096 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' SER . . . . . 0.464 ' HB3' ' CE2' ' A' ' 637' ' ' TYR . 4.6 p -138.06 156.58 73.94 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.4 -153.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.701 2.267 . . . . 0.0 111.405 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 70.15 -66.32 0.28 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 40.62 32.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.223 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . 63.48 117.86 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.785 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 95.8 mt -154.68 -150.81 0.33 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.38 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.427 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.582 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 670' ' ' PHE . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.416 ' HG ' HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 668' ' ' THR . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.4 HG23 ' CG1' ' A' ' 665' ' ' ILE . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.582 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.424 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.455 ' CG2' ' CG1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.469 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 586' ' ' SER . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.523 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -77.15 149.15 35.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.599 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -54.76 -17.48 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.028 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.557 ' OD1' ' CG ' ' A' ' 703' ' ' PHE . 1.4 p-10 -175.6 -48.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.611 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 696' ' ' ILE . 4.8 pt-20 162.38 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.688 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.24 19.64 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.541 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 0.2 OUTLIER -81.17 8.62 8.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 671' ' ' LEU . . . 31.54 90.81 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.098 -0.501 . . . . 0.0 114.181 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.412 ' HE3' ' ND2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -106.53 75.35 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.867 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.46 -166.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -55.15 -53.92 49.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -64.06 133.03 52.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.67 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -116.67 97.57 6.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.293 0.568 . . . . 0.0 110.44 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 45.25 74.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.681 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.441 ' O ' HD11 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.466 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 61.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.74 -46.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.911 -179.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.947 0.404 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -174.76 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.86 172.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 61.8 170.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.8 151.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.804 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -103.79 10.49 36.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.93 -40.97 1.58 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.698 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.927 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.432 ' N ' HD22 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.927 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.492 HG12 ' CG ' ' A' ' 601' ' ' PHE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.6 OUTLIER -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.492 ' CG ' HG12 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.654 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.503 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.443 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.45 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.654 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 692' ' ' PHE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 618' ' ' LEU . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.439 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.642 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.642 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.484 ' N ' ' O ' ' A' ' 648' ' ' TRP . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.459 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 -61.29 127.4 31.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.35 107.0 6.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.218 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.4 p -97.16 159.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -105.93 -168.96 23.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.627 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -71.52 145.71 48.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 110.792 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.3 108.02 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -96.82 31.34 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.335 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.86 -151.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.523 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -114.49 100.32 8.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.342 0.591 . . . . 0.0 109.87 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 23.7 p -136.96 156.48 75.79 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.757 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.91 -154.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.695 2.264 . . . . 0.0 111.778 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 67.27 -72.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.69 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 32.47 38.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.836 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 63.28 113.67 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.646 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 61.1 mt -152.48 -170.92 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.839 -0.68 . . . . 0.0 110.562 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.43 ' CG ' ' CE1' ' A' ' 703' ' ' PHE . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . . . . . . . . . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.592 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.413 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.42 ' SD ' ' CD2' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.463 HD12 HG21 ' A' ' 665' ' ' ILE . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.406 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.592 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' A' ' 649' ' ' TYR . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 20.3 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 706' ' ' GLY . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.462 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.48 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 582' ' ' PRO . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.475 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.402 HG23 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.5 OUTLIER -89.08 124.43 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.558 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 4.5 p90 -29.37 -42.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.386 0.612 . . . . 0.0 111.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.9 OUTLIER -121.57 -44.78 2.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.444 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 12.0 pt-20 144.21 -22.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.097 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 112.64 11.74 14.24 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 707' ' ' LEU . 4.3 tt -98.87 8.65 44.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.431 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 126.72 -134.18 8.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.079 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 3.7 ttm -174.74 -133.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.284 . . . . 0.0 110.511 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 2.4 pp -50.76 -173.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.738 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -33.94 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.408 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -114.38 99.6 7.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 111.672 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 50.7 tp60 -117.14 97.84 6.14 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 713' ' ' GLN . 2.8 mmm-85 -168.92 64.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.686 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . 0.423 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.412 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -57.59 -31.86 66.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 25.64 11.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.643 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -160.03 160.8 33.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.85 155.29 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -125.92 134.46 51.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 53.8 mt -126.48 115.54 19.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.779 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.95 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -72.05 -8.46 54.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.505 0.193 . . . . 0.0 111.398 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -125.65 -28.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.478 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.968 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 691' ' ' GLY . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.453 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.446 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.511 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.511 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.968 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.56 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' A' ' 601' ' ' PHE . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.495 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.8 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.495 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.608 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.608 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.548 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 618' ' ' LEU . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.664 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.568 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.664 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.458 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 -66.58 122.56 17.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.23 134.61 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.04 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.65 170.45 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -124.45 46.83 1.06 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.522 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt 61.42 152.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.54 114.31 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.04 30.43 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.01 -159.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.771 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -113.25 100.3 8.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.443 0.639 . . . . 0.0 109.754 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.4 p -137.08 156.79 75.46 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.15 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.57 2.18 . . . . 0.0 111.665 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 703' ' ' PHE . . . 72.3 -71.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 35.45 35.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.63 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 60.47 115.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.282 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 77.1 mt -151.63 -154.51 0.55 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.271 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.476 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.56 ' N ' ' O ' ' A' ' 626' ' ' PHE . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.436 ' CB ' HD22 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.445 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 8.1 m-20 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.469 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.41 ' O ' ' CG2' ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 665' ' ' ILE . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.512 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.467 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.416 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.52 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.469 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 707' ' ' LEU . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 659' ' ' LEU . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.518 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.5 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.446 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 679' ' ' LYS . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 583' ' ' LEU . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.548 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 696' ' ' ILE . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.0 133.71 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.462 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 19.1 p90 -40.92 -35.43 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.489 0.661 . . . . 0.0 110.246 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 5.1 t30 -143.68 -56.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.054 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 10.1 pt-20 155.27 -26.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.246 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.55 -9.72 3.18 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.445 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 673' ' ' GLN . 0.1 OUTLIER -88.03 9.32 22.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.976 0.417 . . . . 0.0 112.095 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 62.01 -171.41 9.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.666 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.43 31.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 -165.96 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.57 -96.94 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.814 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.92 99.21 7.3 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 0.0 111.168 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -117.18 97.46 5.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 109.946 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -156.65 72.94 0.76 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.013 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.482 ' O ' HD11 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -65.55 -36.46 83.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -101.35 22.92 11.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.961 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.603 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.87 0.367 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -130.72 134.43 46.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.1 mt -108.01 141.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -133.42 83.28 2.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.0 83.67 7.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.647 -0.181 . . . . 0.0 112.647 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -70.04 -22.11 63.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.702 0.287 . . . . 0.0 110.931 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 127.98 0.57 6.49 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.005 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.973 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.457 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 688' ' ' PHE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.483 HG13 HG23 ' A' ' 613' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.973 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.541 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.495 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.478 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.5 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.595 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.629 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.551 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.629 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.51 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.734 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.482 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.734 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.595 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.495 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.419 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -81.56 132.12 35.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -126.53 98.36 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.905 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.68 -178.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -69.33 -72.61 0.82 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.572 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.24 174.04 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 110.941 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.14 118.56 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 18.7 mtm -95.1 29.33 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.059 0.457 . . . . 0.0 110.496 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.69 -162.82 1.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -114.44 99.75 7.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.456 0.646 . . . . 0.0 109.634 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.49 157.04 72.99 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.39 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.567 2.178 . . . . 0.0 111.336 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 72.53 -64.89 0.38 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -84.45 83.63 7.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 138.08 -1.32 2.77 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.493 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -96.57 -168.05 1.66 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.28 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.414 ' O ' ' CD1' ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.525 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 670' ' ' PHE . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.41 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.426 ' O ' HG21 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.437 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.525 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 649' ' ' TYR . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 8.1 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.494 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.512 HG22 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 681' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 587' ' ' ILE . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.633 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 696' ' ' ILE . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -83.41 128.64 34.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.59 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 0.7 OUTLIER -45.93 -30.46 1.77 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.289 0.566 . . . . 0.0 110.281 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 6.4 t30 -150.42 -60.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.072 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.451 ' HG2' ' C ' ' A' ' 704' ' ' ASN . 8.5 pt-20 165.17 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.448 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.3 30.93 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.394 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.484 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 9.0 mp -91.25 9.03 33.0 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.441 ' CA ' ' CD1' ' A' ' 671' ' ' LEU . . . 42.4 81.06 0.03 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.205 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.422 ' HE3' ' CE2' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -84.69 92.27 8.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.97 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.49 -177.06 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.71 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -63.93 140.05 58.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.37 97.47 6.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.21 0.528 . . . . 0.0 110.245 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 10.3 mmm-85 41.09 80.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.797 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.403 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 723' ' ' GLU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -30.98 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -126.04 -0.22 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.112 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -135.33 145.16 47.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.2 mp -89.91 49.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -59.09 -174.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 17.9 mt 68.04 97.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.923 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -96.08 -10.92 27.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.33 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.68 -0.48 6.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.857 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.449 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.496 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' A' ' 583' ' ' LEU . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.449 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 601' ' ' PHE . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.497 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.5 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.497 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.633 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.671 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.671 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.524 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.514 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.646 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.486 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.646 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 73.4 t60 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.633 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 -75.69 129.51 37.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.18 125.02 43.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.22 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.7 p -88.01 162.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -52.3 -95.8 0.01 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.644 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.2 165.68 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.325 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 99.44 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.3 ttp -85.67 54.55 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.042 0.448 . . . . 0.0 110.222 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.75 -153.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.469 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.9 100.48 8.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.35 0.595 . . . . 0.0 109.943 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 50.8 p -137.51 156.37 74.95 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.17 -153.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.577 2.185 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 74.51 -71.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 39.18 -159.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.223 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -106.94 122.95 7.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.048 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 48.9 mt -150.84 -150.76 0.36 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.212 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.445 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.493 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 670' ' ' PHE . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.489 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-20 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.468 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 665' ' ' ILE . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.451 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.493 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CD2' HD13 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.427 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.468 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.428 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.405 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.405 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 690' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -114.68 169.26 9.2 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.585 ' O ' ' C ' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -59.05 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 703' ' ' PHE . 10.5 t30 -16.65 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.991 0.424 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 2.5 pt-20 157.96 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.763 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 157.28 -21.35 0.42 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.427 ' HA ' ' CG ' ' A' ' 673' ' ' GLN . 0.1 OUTLIER -87.13 9.75 18.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 703' ' ' PHE . . . -90.54 131.81 10.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.647 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -159.06 123.71 4.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.821 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.508 ' O ' ' C ' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -79.23 -162.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . 0.508 ' C ' ' O ' ' A' ' 710' ' ' LEU . 16.0 mt-30 -7.02 -66.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 710' ' ' LEU . 4.8 pt-20 -63.15 129.16 39.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.93 97.89 6.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.359 0.599 . . . . 0.0 110.45 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.451 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 7.0 mmm-85 50.97 79.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.824 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.41 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.504 ' O ' HD12 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 722' ' ' GLU . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -64.84 -30.38 71.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -100.47 10.11 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.612 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -152.6 108.92 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.01 152.72 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -163.51 99.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 76.8 mt -93.76 116.07 28.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -91.06 -22.36 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -159.21 65.21 0.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.005 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.468 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.408 HG12 HG12 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.463 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.005 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.526 HG12 ' CG ' ' A' ' 601' ' ' PHE . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 1.7 mm-40 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.407 ' HB2' ' CG2' ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.662 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.526 ' CG ' HG12 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.662 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.669 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.669 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.55 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.539 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.475 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.661 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.427 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.661 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 75.3 t60 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.613 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.58 133.86 56.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.65 36.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.948 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.412 HG23 ' CA ' ' A' ' 643' ' ' GLY . 0.5 OUTLIER -106.46 175.17 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.256 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -134.61 -177.67 15.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.146 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -70.05 106.52 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.76 0.314 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.69 101.17 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mmm -91.82 47.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.115 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.43 -151.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.481 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.56 100.49 8.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.386 0.612 . . . . 0.0 109.831 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 156.84 78.37 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.68 -153.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.672 2.248 . . . . 0.0 111.641 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 69.48 -70.12 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 34.14 36.51 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.754 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.421 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 61.73 110.04 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.753 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.909 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.574 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 54.6 mt -151.81 -173.61 4.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.342 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.574 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 670' ' ' PHE . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.45 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-80 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.437 ' N ' HG23 ' A' ' 656' ' ' VAL . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.418 ' CD2' ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.574 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 706' ' ' GLY . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.435 ' CG2' ' CE2' ' A' ' 649' ' ' TYR . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.438 ' CG1' ' CD2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 688' ' ' PHE . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.446 ' CD1' ' CG1' ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.454 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 586' ' ' SER . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.482 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -91.82 132.21 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.574 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -30.17 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.971 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -169.78 29.76 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.521 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.15 -57.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 155.58 39.99 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.262 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 2.9 tp -94.62 8.26 42.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.057 0.428 . . . . 0.0 111.695 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.401 ' C ' ' HG3' ' A' ' 709' ' ' MET . . . 79.37 -6.17 58.07 Favored Glycine 0 C--N 1.321 -0.256 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.642 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.411 ' HB3' ' OD1' ' A' ' 704' ' ' ASN . 0.0 OUTLIER 36.72 -145.29 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.08 0.44 . . . . 0.0 111.206 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.33 129.67 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.835 0.35 . . . . 0.0 111.35 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 45.65 95.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.34 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.55 129.58 40.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 97.26 6.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.418 ' NH2' ' CD2' ' A' ' 659' ' ' LEU . 5.1 mmm-85 -111.66 72.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.074 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.461 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.493 ' O ' HD12 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 722' ' ' GLU . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -59.84 -25.18 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -109.4 -29.89 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 2.5 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.649 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.06 136.74 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.2 pt -106.67 141.87 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -164.18 141.86 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 27.6 mt -144.59 119.27 9.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.88 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.09 -22.29 58.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.419 ' C ' ' NE2' ' A' ' 596' ' ' GLN . . . -167.25 48.18 0.25 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.07 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 592' ' ' LEU . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.406 ' CG2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.522 ' O ' ' O ' ' A' ' 583' ' ' LEU . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.469 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.577 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' A' ' 580' ' ' LEU . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.514 ' O ' HG11 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.514 HG11 ' O ' ' A' ' 595' ' ' GLN . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.685 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.637 ' HB2' HD22 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.544 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.593 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.506 ' CB ' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.436 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 605' ' ' ARG . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.543 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.553 ' CD2' ' CD1' ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.439 ' N ' ' O ' ' A' ' 648' ' ' TRP . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 647' ' ' ILE . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.425 ' CE1' ' HE3' ' A' ' 709' ' ' MET . 6.9 t60 -80.14 132.13 35.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.22 105.59 8.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.406 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.19 165.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.081 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -109.84 -168.5 19.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.674 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 67.87 89.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.882 0.372 . . . . 0.0 111.207 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.29 98.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.3 mtt -88.32 50.64 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.113 0.483 . . . . 0.0 110.113 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -153.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.401 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -115.25 100.57 8.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 109.67 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.8 p -133.56 156.6 79.44 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.52 -150.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.526 2.15 . . . . 0.0 111.183 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.413 ' HA ' ' CB ' ' A' ' 703' ' ' PHE . . . 72.78 -63.7 0.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.718 0.294 . . . . 0.0 111.083 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -81.09 98.81 8.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 119.41 5.65 11.2 Favored Glycine 0 CA--C 1.508 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.144 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.2 OUTLIER -86.44 -162.95 0.82 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.18 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' A' ' 627' ' ' LYS . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.576 ' CH2' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.468 ' CD2' ' CE ' ' A' ' 664' ' ' MET . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.421 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.533 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.465 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 716' ' ' VAL . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.576 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.478 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.569 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.572 ' CE2' ' HG3' ' A' ' 582' ' ' PRO . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 583' ' ' LEU . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.497 HG22 HD12 ' A' ' 696' ' ' ILE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.407 ' O ' HD13 ' A' ' 644' ' ' LEU . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.89 152.21 19.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.454 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 45.9 p90 -58.59 -29.21 66.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.762 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 4.2 t30 -157.9 -55.41 0.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.823 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 9.5 pt-20 162.47 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.446 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.43 28.32 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.714 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.523 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 3.0 mm? -82.94 9.66 9.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.422 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 84.33 -85.42 1.55 Allowed Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.425 ' HE3' ' CE1' ' A' ' 630' ' ' HIS . 1.3 ttp 60.95 78.32 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.51 -177.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -47.06 83.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.275 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 130.96 46.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.066 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.65 97.55 6.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.095 0.474 . . . . 0.0 110.147 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 44.12 64.43 1.31 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.463 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 670' ' ' PHE . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.422 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.406 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 30.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 -37.71 3.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.239 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.412 ' CD1' ' C ' ' A' ' 730' ' ' LEU . 2.3 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -100.81 101.69 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 31.4 mt -85.45 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -178.02 116.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 3.1 mt -115.89 74.58 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.918 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -93.47 6.34 48.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.558 0.218 . . . . 0.0 111.393 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 133.17 51.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.139 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 592' ' ' LEU . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.168 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 583' ' ' LEU . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.457 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 582' ' ' PRO . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.563 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.168 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 580' ' ' LEU . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.45 HG23 ' CD1' ' A' ' 601' ' ' PHE . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.2 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 595' ' ' GLN . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 627' ' ' LYS . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.604 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.648 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.557 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.648 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . . . . . . . . . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.557 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.652 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.613 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HB3' ' OD1' ' A' ' 599' ' ' ASN . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 -62.21 136.31 57.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.06 122.19 40.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.034 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 12.1 p -105.96 160.66 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 111.242 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -100.62 35.36 4.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.403 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.9 tttt 56.21 -172.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.784 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.59 122.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.7 mmm -78.18 60.0 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.966 0.412 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 176.57 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.74 99.72 7.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.358 0.599 . . . . 0.0 109.677 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 19.6 p -138.73 156.12 73.05 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.55 -153.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.697 2.265 . . . . 0.0 111.728 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 78.85 -71.98 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.755 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.428 ' HB3' HD11 ' A' ' 644' ' ' LEU . 1.0 OUTLIER 38.76 -157.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.126 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -113.99 114.11 3.23 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.364 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 1.2 mp -148.18 -161.84 1.42 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.819 -0.69 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.441 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.533 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.51 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.465 HD22 HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 m120 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.412 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.533 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 706' ' ' GLY . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.465 HG21 HD22 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.421 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.421 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.448 ' CD1' HG12 ' A' ' 587' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 582' ' ' PRO . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.445 HD13 ' CE1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -93.42 146.35 23.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.484 ' CD2' ' OD1' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -41.55 -31.94 0.31 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.064 179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.484 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -179.41 31.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.088 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.4 OUTLIER 68.54 -57.38 0.5 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.963 -178.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 147.91 63.13 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.02 8.67 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 110.92 -68.38 0.22 Allowed Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.962 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.404 ' CE ' ' NE2' ' A' ' 630' ' ' HIS . 0.0 OUTLIER 67.91 119.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 0.0 110.569 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -51.82 -172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.497 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . 0.474 ' N ' ' CD2' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 77.05 -62.99 0.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.026 0.441 . . . . 0.0 110.072 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.11 121.57 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.464 ' O ' ' C ' ' A' ' 714' ' ' ARG . 0.0 OUTLIER -115.06 97.5 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.289 0.566 . . . . 0.0 110.264 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 713' ' ' GLN . 12.0 mmm-85 16.13 79.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.11 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.411 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.65 9.98 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.176 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.609 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 59.66 83.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.822 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.2 pt -60.47 172.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.93 162.12 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.42 152.61 50.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 39.9 t0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -84.89 -22.2 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.656 0.265 . . . . 0.0 111.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 124.22 2.14 8.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.943 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.976 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 690' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.445 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.976 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 601' ' ' PHE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.457 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.4 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.509 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.604 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.522 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.563 ' HB3' HG22 ' A' ' 603' ' ' ILE . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.488 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.616 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.616 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.3 t60 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 625' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.465 ' HB2' HG23 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 -71.35 123.71 22.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.371 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.8 -176.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.833 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -58.81 -92.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -156.98 178.15 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 110.711 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.1 92.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.221 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 31.7 mmt -87.93 51.82 2.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 110.088 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.91 -149.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.479 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.22 97.45 6.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.594 0.711 . . . . 0.0 109.562 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.3 p -140.75 156.86 68.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.461 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.04 -157.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.196 1.93 . . . . 0.0 111.135 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.54 22.58 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.02 61.7 5.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.584 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.47 107.18 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.53 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.63 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -144.96 -155.76 0.64 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.509 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.403 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 627' ' ' LYS . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.517 ' CH2' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.433 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.404 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.49 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 6.0 m-80 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.418 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.422 ' O ' HG21 ' A' ' 656' ' ' VAL . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.517 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.446 ' HA ' HG13 ' A' ' 696' ' ' ILE . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.44 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.462 ' CD1' HG13 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.445 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' SER . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.488 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.44 150.19 21.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.505 ' CG ' ' OD1' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -50.92 -23.08 2.59 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 707' ' ' LEU . 1.1 p-10 -172.42 -43.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.554 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 0.3 OUTLIER 158.15 -29.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.5 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.34 15.98 0.49 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.345 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.527 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 0.4 OUTLIER -80.97 9.59 6.3 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 42.31 81.74 0.03 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.502 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -75.36 92.26 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 0.0 110.727 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.12 171.08 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.099 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -28.61 68.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.029 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.59 140.23 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.649 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -116.15 97.52 6.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 1.1 mmm-85 41.8 89.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.424 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.427 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.427 ' HA ' ' CE1' ' A' ' 602' ' ' PHE . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm -87.34 51.2 2.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.112 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -67.86 168.43 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' P' ' 828' ' ' ILE . 0.1 OUTLIER -124.67 136.56 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 101.52 4.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 13.5 mt -123.1 82.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -86.28 -14.28 44.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 111.238 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.08 11.92 3.03 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.983 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 592' ' ' LEU . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.008 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 583' ' ' LEU . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.008 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.567 HG12 ' CG ' ' A' ' 601' ' ' PHE . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.2 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.567 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.666 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.476 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.666 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.544 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.412 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.601 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.601 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.2 t60 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 625' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.7 t60 -76.21 131.44 39.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.04 119.13 38.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.238 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.74 -171.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -88.42 49.12 3.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.736 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.96 172.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.2 106.95 3.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.017 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.4 ttt -93.41 26.96 2.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.512 . . . . 0.0 110.444 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.24 -159.58 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.067 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.3 96.92 7.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.723 0.773 . . . . 0.0 109.408 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -140.88 156.51 68.61 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.276 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.95 -158.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.15 1.9 . . . . 0.0 111.27 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.48 23.46 0.23 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.235 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.82 63.28 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.555 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 58.32 116.15 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.603 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 93.4 mt -154.14 -144.39 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.71 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.45 HG23 ' CZ ' ' A' ' 577' ' ' PHE . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.676 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.452 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.57 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 6.7 m-80 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.43 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 679' ' ' LYS . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.413 ' O ' HG23 ' A' ' 656' ' ' VAL . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.6 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.417 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.676 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 678' ' ' ILE . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.402 HG12 HD23 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 622' ' ' HIS . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.464 ' CG2' ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.458 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.435 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.07 155.42 30.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.527 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -58.04 -15.7 10.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.109 179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 4.6 t30 -177.43 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 2.0 pt-20 163.71 -37.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.765 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 152.16 34.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.212 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 673' ' ' GLN . 2.9 mm? -86.19 9.23 18.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.028 0.414 . . . . 0.0 112.004 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 60.46 -84.24 0.02 OUTLIER Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.569 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 29.5 mtm 59.89 83.83 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.27 -176.68 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 -55.21 -34.97 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.15 139.93 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.59 97.31 5.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.172 0.511 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 37.96 79.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.736 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.79 -29.29 39.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -111.58 -23.95 10.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.221 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.6 127.48 53.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.4 mt -100.98 129.88 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 4.2 p90 -143.65 118.57 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.13 103.27 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.914 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.72 -14.59 62.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.654 0.264 . . . . 0.0 111.263 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 116.35 -42.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.467 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.701 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.489 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.49 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 589' ' ' GLN . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.532 HG12 ' CG ' ' A' ' 601' ' ' PHE . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.701 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.518 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CG ' HG12 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' HG21 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.626 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.578 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.626 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.2 t60 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.407 ' CD1' HD11 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -76.24 129.66 37.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.26 129.04 52.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.41 159.96 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -74.52 170.01 53.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 90.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.38 109.93 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.02 35.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 -152.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.423 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -114.51 100.31 8.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.751 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 p -137.28 156.68 75.18 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.753 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.64 -153.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.687 2.258 . . . . 0.0 111.737 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 77.98 -70.38 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 37.61 35.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.0 125.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.743 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.614 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 92.4 mt -155.88 -147.0 0.19 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.123 -0.538 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.438 ' CD1' ' CD2' ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.536 ' CH2' HD21 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.458 ' N ' ' O ' ' A' ' 670' ' ' PHE . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.557 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.434 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.405 ' O ' ' CG2' ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.408 ' HA ' HG12 ' A' ' 716' ' ' VAL . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 652' ' ' THR . 7.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.536 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 5.5 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.461 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 680' ' ' ILE . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.432 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 586' ' ' SER . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.539 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 705' ' ' GLU . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.419 HG23 ' CD2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.25 136.14 39.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.614 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.21 -24.81 3.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 9.1 t30 -160.24 -56.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.465 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 5.6 pt-20 161.67 -30.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.13 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 142.49 33.11 0.11 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.662 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 8.4 mp -88.29 8.37 27.72 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 33.16 71.16 0.11 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.571 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.43 ' HE3' ' CE2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -79.13 118.95 21.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.102 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.74 170.23 0.85 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.756 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -31.05 66.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.68 141.16 58.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -113.77 97.17 6.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.291 0.567 . . . . 0.0 110.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.739 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 4.7 mmm180 28.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.946 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.466 HG23 ' CE2' ' A' ' 670' ' ' PHE . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.407 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -60.38 -26.74 66.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -91.47 -16.83 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.075 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.961 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -161.82 126.63 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 13.8 pt -73.68 148.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.51 116.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.92 89.1 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.978 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -92.42 8.82 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -137.64 -36.98 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.657 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.917 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.643 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.424 ' CD1' ' CE1' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.917 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.519 HG12 ' CG ' ' A' ' 601' ' ' PHE . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.6 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.551 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.642 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.591 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.642 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.452 ' O ' HD12 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.474 HG21 HD13 ' A' ' 613' ' ' ILE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.518 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.479 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.533 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.57 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 648' ' ' TRP . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.411 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.479 ' CE1' ' CE2' ' A' ' 703' ' ' PHE . 1.7 t60 -61.98 134.39 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -134.52 126.05 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -114.69 -175.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -56.92 -168.17 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -74.25 133.9 42.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.41 119.58 35.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.7 mmm -94.38 28.4 2.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.121 0.486 . . . . 0.0 110.568 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -163.86 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.6 99.49 7.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.398 0.618 . . . . 0.0 109.676 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 92.0 p -138.88 156.36 72.7 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.797 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.46 -151.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.534 2.156 . . . . 0.0 111.178 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 75.39 -62.18 0.45 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.721 0.296 . . . . 0.0 111.2 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -98.61 93.16 5.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 111.38 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 146.47 -6.36 1.24 Allowed Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.828 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 2.8 mp -106.54 -164.87 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.219 -0.49 . . . . 0.0 110.76 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.528 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' A' ' 670' ' ' PHE . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.597 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.546 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.0 m-80 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.438 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE1' ' O ' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.429 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.528 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.462 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.465 ' CG2' HD23 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.451 HG23 HG23 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.451 ' CD1' HG11 ' A' ' 689' ' ' VAL . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.407 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.407 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 682' ' ' TRP . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.466 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.429 ' CG2' ' CD2' ' A' ' 580' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.463 HD12 HG22 ' A' ' 696' ' ' ILE . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.418 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.28 130.48 37.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 1.2 p90 -44.3 -31.3 0.99 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 110.486 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 5.8 t30 -149.06 -55.9 0.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.065 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 11.5 pt-20 156.51 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.402 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 141.24 -9.36 2.71 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.462 ' HA ' ' CG ' ' A' ' 673' ' ' GLN . 3.0 tt -94.58 9.84 37.08 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.904 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.44 126.98 7.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 5.8 mmt -148.66 134.28 18.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 110.96 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -140.51 138.41 34.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 140.67 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.706 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -115.78 97.5 6.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.397 0.617 . . . . 0.0 110.078 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.639 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 5.0 mmm180 35.89 89.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.12 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.401 ' HA ' ' OD1' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.444 HG22 ' CE1' ' A' ' 670' ' ' PHE . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.403 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -57.66 -25.42 60.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -100.17 -43.26 6.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.754 -179.857 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -147.6 80.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -113.26 80.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' P' ' 830' ' ' TYR . 2.7 m-85 -113.0 -163.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 18.3 mt 69.51 63.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.8 10.15 41.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.282 . . . . 0.0 111.403 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 116.55 -4.85 19.37 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.948 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.444 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 592' ' ' LEU . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.916 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.434 ' CD2' ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.437 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.422 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.438 ' C ' ' HG2' ' A' ' 589' ' ' GLN . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.916 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.56 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 582' ' ' PRO . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.444 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.541 HG12 ' CG ' ' A' ' 601' ' ' PHE . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.3 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.667 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.494 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.45 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.667 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.45 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 605' ' ' ARG . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.641 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.2 t60 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.649 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.3 134.26 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.27 116.51 29.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.545 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.87 161.24 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.983 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -82.25 148.55 26.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.447 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.94 91.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.16 115.74 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.99 29.44 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.104 0.478 . . . . 0.0 110.25 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.09 -159.81 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.885 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.77 99.78 7.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.593 0.711 . . . . 0.0 109.732 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 p -138.7 156.58 72.9 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 641' ' ' ALA . 57.5 Cg_endo -67.67 -153.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.414 2.076 . . . . 0.0 111.394 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 640' ' ' PRO . . . 71.91 -68.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.822 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 43.99 -164.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.964 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -123.31 119.46 3.86 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.647 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.6 OUTLIER -150.24 -162.04 1.47 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.97 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 628' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.496 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.411 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.462 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.417 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.432 ' CD1' HD21 ' A' ' 672' ' ' LEU . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.406 ' HG2' HG23 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.496 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 659' ' ' LEU . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.655 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.454 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.435 HG22 ' HB ' ' A' ' 690' ' ' ILE . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . 0.502 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.429 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.435 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 582' ' ' PRO . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -81.06 137.52 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 3.8 p90 -45.1 -32.91 1.94 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.489 0.661 . . . . 0.0 110.328 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -141.75 -44.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.59 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 17.1 pt-20 137.31 -22.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.302 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.655 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 100.71 20.75 13.8 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.414 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.83 8.02 13.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.14 97.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.206 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.431 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -41.83 97.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.304 . . . . 0.0 111.642 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.5 OUTLIER 35.95 82.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.163 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 40.77 88.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 141.31 36.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.49 . . . . 0.0 111.7 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -113.4 99.61 7.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -73.33 -151.45 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.15 -178.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.406 HG23 ' HG2' ' A' ' 664' ' ' MET . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.402 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -90.34 42.84 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.07 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.536 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.32 -0.847 . . . . 0.0 110.943 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.873 0.368 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.32 165.27 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 10.9 pt -96.05 176.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -92.78 133.31 36.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.12 122.49 39.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -83.46 -22.56 32.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.82 50.75 0.85 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.642 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 592' ' ' LEU . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.416 HG12 ' CG1' ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.544 ' O ' ' O ' ' A' ' 583' ' ' LEU . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.981 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.449 ' O ' HG12 ' A' ' 598' ' ' VAL . 4.6 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.627 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.528 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.446 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.668 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' A' ' 618' ' ' LEU . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.536 ' HB3' ' CD1' ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.434 ' O ' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.528 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 730' ' ' LEU . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.656 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 73.3 t60 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.627 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.445 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.415 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 1.6 t60 -61.07 140.54 57.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -56.0 -162.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.334 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 633' ' ' GLY . 0.4 OUTLIER 65.13 179.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.639 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 632' ' ' VAL . . . 140.22 163.68 9.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.406 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp 56.67 83.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.2 p -119.44 133.08 55.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.8 tpt -97.24 27.27 4.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -145.0 -159.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.617 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -114.44 98.99 7.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.417 0.627 . . . . 0.0 109.898 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.8 p -139.47 156.54 71.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.504 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.82 -156.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.384 2.056 . . . . 0.0 111.482 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 67.65 -67.76 0.17 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 34.4 36.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.77 114.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.726 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.588 HD12 ' HA ' ' A' ' 703' ' ' PHE . 91.7 mt -155.31 -166.07 2.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.287 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.559 ' CH2' HD21 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.422 ' HE1' ' N ' ' A' ' 715' ' ' VAL . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.559 HD21 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . . . . . . . . . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.465 HG21 HG23 ' A' ' 681' ' ' ILE . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.465 HG23 HG21 ' A' ' 680' ' ' ILE . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.441 ' CD1' HG13 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.441 HG13 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.513 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 582' ' ' PRO . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 696' ' ' ILE . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 704' ' ' ASN . 0.3 OUTLIER -87.23 136.94 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.588 ' HA ' HD12 ' A' ' 644' ' ' LEU . 4.4 p90 -28.34 -42.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.412 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.583 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -133.29 -47.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.518 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 17.0 pt-20 133.14 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.349 1.031 . . . . 0.0 109.359 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.36 10.74 4.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.111 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 9.73 8.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.19 -135.55 11.98 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.9 ttm 179.06 -140.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.407 . . . . 0.0 109.999 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -163.46 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -44.61 -93.26 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.605 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -115.02 99.47 7.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.716 0.293 . . . . 0.0 111.569 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 43.8 tp60 -117.16 96.93 5.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 713' ' ' GLN . 6.0 mmm-85 -162.93 69.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.71 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.422 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -62.3 -21.05 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -56.87 16.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.03 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 621' ' ' VAL . 3.4 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -68.42 74.38 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.4 pt -107.27 98.58 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.89 132.97 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 63.7 mt -103.3 156.79 17.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -70.47 -19.39 62.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.656 0.265 . . . . 0.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 123.67 11.48 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.797 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.485 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.975 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.463 ' CG2' ' CB ' ' A' ' 582' ' ' PRO . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.975 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.524 HG12 ' CG ' ' A' ' 601' ' ' PHE . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' HB2' ' CG2' ' A' ' 598' ' ' VAL . 1.4 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.61 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 623' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.458 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.458 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.545 ' HB3' HG22 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.514 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.47 ' HB3' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.567 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 609' ' ' CYS . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.567 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.427 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.43 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 -61.19 136.33 58.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 632' ' ' VAL . . . -50.58 -176.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.762 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 631' ' ' ALA . 0.4 OUTLIER 57.77 -179.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.511 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 632' ' ' VAL . . . 119.65 32.37 1.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.582 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -131.53 60.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 20.1 p -102.47 141.59 35.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.086 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.44 31.83 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.483 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.93 -153.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.4 99.72 7.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.511 0.672 . . . . 0.0 109.891 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.7 p -138.72 156.63 72.86 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 642' ' ' GLN . 74.0 Cg_endo -71.55 -156.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.562 2.174 . . . . 0.0 111.74 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 65.04 -71.87 0.07 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 640' ' ' PRO . 0.2 OUTLIER 41.12 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -112.51 118.26 4.59 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.083 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.1 mp -143.88 -154.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.766 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.647 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.41 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.3 m-80 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.46 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.647 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.415 ' CD2' ' CD1' ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 707' ' ' LEU . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.456 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.536 HG13 ' CZ ' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . 0.437 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.497 HG21 HD13 ' A' ' 690' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.507 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 675' ' ' GLY . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' A' ' 705' ' ' GLU . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.414 ' CD1' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.24 139.58 30.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.44 ' HA ' HD22 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -49.06 -29.44 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.395 0.617 . . . . 0.0 110.103 178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 3.6 t30 -150.96 -58.29 0.17 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.906 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.407 ' HB2' HD12 ' A' ' 696' ' ' ILE . 5.8 pt-20 159.59 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.36 -10.9 2.0 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.661 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 673' ' ' GLN . 0.1 OUTLIER -87.94 9.34 22.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 703' ' ' PHE . . . 65.78 -167.08 34.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.757 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.77 30.85 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 3.4 pp -127.89 -169.7 2.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -63.96 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.046 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.8 102.58 10.14 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.55 97.51 6.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.48 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 16.0 mmm-85 -157.07 77.02 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.036 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.402 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.62 -29.45 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -114.3 -24.38 8.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.93 91.69 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.4 pt -86.54 169.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -61.9 157.49 18.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 15.5 mt -124.76 119.6 29.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.016 -0.434 . . . . 4.79 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -69.48 -19.41 63.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.284 . . . . 4.27 111.277 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -144.42 -17.09 0.21 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.454 -0.879 . . . . 1.32 113.64 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 2.16 110.677 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 1.18 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.516 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 1.56 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 1.19 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 592' ' ' LEU . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 1.53 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 2.14 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.959 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.37 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.84 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.468 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.69 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.67 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.3 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.495 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 2.47 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.457 ' O ' ' O ' ' A' ' 583' ' ' LEU . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 2.01 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.64 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.959 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.11 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 1.06 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 580' ' ' LEU . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 2.59 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.491 HG12 ' CG ' ' A' ' 601' ' ' PHE . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 1.09 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.1 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.66 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.27 113.177 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 1.56 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.88 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.35 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.491 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.32 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.28 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.661 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 1.19 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.3 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.54 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.72 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.37 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.88 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.94 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.9 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.661 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 1.44 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.58 113.095 -178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.523 ' CD1' ' CZ ' ' A' ' 692' ' ' PHE . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.72 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.61 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.89 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . 0.42 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 1.22 112.001 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.626 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 1.33 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.56 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.456 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 1.08 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 1.11 109.105 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.626 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.3 t60 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.43 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 1.26 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.42 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . . . . . . . . . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 1.38 107.794 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.33 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 647' ' ' ILE . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 1.55 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 2.38 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.93 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -64.02 126.34 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 1.24 111.302 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.87 31.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.8 111.298 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.55 160.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 2.8 111.103 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -66.1 165.47 38.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 3.41 112.422 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -58.51 130.22 45.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 5.1 110.831 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.44 112.93 20.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 2.67 111.142 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 20.1 mtp -97.9 30.86 2.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 5.1 110.337 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.29 -153.69 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 6.57 110.506 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 100.22 8.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.375 0.607 . . . . 4.04 109.733 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 11.5 p -138.24 156.9 73.51 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.003 -0.999 . . . . 2.52 110.704 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.97 -153.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.567 2.178 . . . . 2.62 111.514 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 703' ' ' PHE . . . 68.62 -70.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.278 -0.419 . . . . 1.66 110.758 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 34.37 37.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.906 -0.588 . . . . 4.64 111.531 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.56 115.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.081 -0.58 . . . . 1.43 112.303 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.0 mt -151.63 -152.45 0.43 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.814 -0.693 . . . . 1.88 110.253 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 628' ' ' LYS . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.36 109.621 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.466 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 1.11 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.559 ' CH2' HD23 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.49 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 670' ' ' PHE . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.93 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.444 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.54 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.417 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.26 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 1.12 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 1.07 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.8 m-20 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.83 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.547 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 1.62 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.63 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.54 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.421 HD13 ' CG2' ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.89 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.15 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 3.05 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.9 111.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 3.2 110.324 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 1.3 111.24 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 1.25 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.82 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 1.16 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 1.45 109.157 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 1.28 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 2.2 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.418 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 1.1 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 707' ' ' LEU . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.68 110.987 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.41 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.43 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.31 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.43 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 678' ' ' ILE . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.96 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.56 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 622' ' ' HIS . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 2.27 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.412 ' O ' HG21 ' A' ' 681' ' ' ILE . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 1.38 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 1.02 111.14 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.85 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.67 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.92 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.54 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.495 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.99 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 2.03 111.307 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.508 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 1.52 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.42 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.94 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 2.38 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 675' ' ' GLY . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 1.15 111.17 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 1.1 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 1.56 110.765 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 645' ' ' ASP . 2.7 mt -78.42 138.96 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 2.12 111.054 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.467 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . 39.4 p90 -43.25 -34.72 1.23 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.654 0.74 . . . . 1.32 109.862 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.447 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 3.9 t30 -145.63 -59.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.504 -1.225 . . . . 1.86 108.865 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 161.24 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.684 -1.144 . . . . 1.94 109.593 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.02 -9.11 2.0 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.745 -0.661 . . . . 1.6 112.765 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.482 ' HA ' ' CB ' ' A' ' 673' ' ' GLN . 1.0 OUTLIER -86.57 9.15 19.37 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.293 0.479 . . . . 2.44 112.293 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 50.2 -160.76 1.19 Allowed Glycine 0 C--N 1.319 -0.362 0 C-N-CA 120.805 -0.712 . . . . 2.51 112.662 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.05 40.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.271 . . . . 3.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -172.8 3.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.864 0.364 . . . . 4.59 111.306 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -62.81 -17.95 62.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 6.65 112.047 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 120.82 12.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 6.04 110.773 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -116.45 97.18 5.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.152 0.501 . . . . 5.08 110.605 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.3 OUTLIER 30.75 89.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.028 -0.987 . . . . 3.17 112.856 179.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 1.24 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 1.33 111.113 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.408 HD11 ' CZ3' ' A' ' 648' ' ' TRP . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 2.21 110.693 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.91 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.11 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 1.4 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 1.31 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.26 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.65 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 3.19 111.155 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.61 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.87 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 1.35 111.063 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -25.83 53.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 3.29 110.993 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -106.15 -35.51 7.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 3.2 110.988 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.184 -0.912 . . . . 2.69 110.879 -179.891 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.795 0.331 . . . . 7.03 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -88.9 106.14 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 5.4 110.924 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -108.51 93.43 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 3.5 110.961 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.27 153.96 23.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 6.22 110.945 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 22.0 mt -154.75 148.04 24.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 2.56 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.195 -0.907 . . . . 4.87 110.91 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.454 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 696' ' ' ILE . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 578' ' ' LEU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.79 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.706 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.971 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.841 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.971 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.454 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.691 HG23 ' CD1' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.738 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.47 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.691 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.904 ' C ' HD13 ' A' ' 603' ' ' ILE . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.991 ' HB3' HG23 ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.932 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.932 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.626 ' CB ' HD13 ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 13.9 t-80 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.79 ' CD1' HD11 ' A' ' 580' ' ' LEU . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HZ1' HG21 ' A' ' 700' ' ' THR . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.7 mp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.88 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.993 ' CH2' HD22 ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 656' ' ' VAL . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.891 ' O ' HG21 ' A' ' 716' ' ' VAL . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.425 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.541 ' HE2' HD11 ' A' ' 717' ' ' LEU . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.634 ' HD2' HD23 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.993 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.738 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 688' ' ' PHE . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.837 ' CD1' HG12 ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 686' ' ' ASN . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 587' ' ' ILE . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.756 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 577' ' ' PHE . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 700' ' ' THR . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 660' ' ' ASN . 16.0 mmm-85 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.941 0.4 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.891 HG21 ' O ' ' A' ' 663' ' ' ARG . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.541 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.403 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 120.375 -0.125 . . . . 0.0 112.8 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.93 HD22 ' CD1' ' A' ' 594' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.724 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 583' ' ' LEU . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.937 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.485 HD11 ' OD1' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.829 HD12 HD13 ' A' ' 613' ' ' ILE . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.937 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 592' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.93 ' CD1' HD22 ' A' ' 578' ' ' LEU . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.772 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 1.8 pt20 -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.772 HG23 ' HB2' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.723 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.613 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.896 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.613 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 588' ' ' ILE . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.876 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 681' ' ' ILE . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.876 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.908 HG11 HG23 ' A' ' 727' ' ' VAL . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 680' ' ' ILE . 9.4 t-80 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.456 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 603' ' ' ILE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 580' ' ' LEU . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.5 mp . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.88 HD13 HD12 ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CB ' HD21 ' A' ' 672' ' ' LEU . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.493 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.3 OUTLIER -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.691 HD13 HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.923 ' O ' HG21 ' A' ' 716' ' ' VAL . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.493 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.677 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.943 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 694' ' ' VAL . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 583' ' ' LEU . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.703 HD11 HG21 ' A' ' 690' ' ' ILE . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 655' ' ' ASN . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.802 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.452 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.802 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.703 HG21 HD11 ' A' ' 680' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 580' ' ' LEU . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.841 HG22 HD21 ' A' ' 578' ' ' LEU . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 700' ' ' THR . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.675 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.062 0.458 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.923 HG21 ' O ' ' A' ' 663' ' ' ARG . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 727' ' ' VAL . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 626' ' ' PHE . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.908 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.769 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.613 ' O ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.977 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 613' ' ' ILE . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.522 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.977 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 578' ' ' LEU . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mm100 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.709 ' HG3' HD23 ' A' ' 726' ' ' LEU . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.859 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 588' ' ' ILE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.759 ' HB3' HD13 ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.843 HG11 ' CG2' ' A' ' 727' ' ' VAL . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.703 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.628 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.695 ' CD1' HD11 ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 700' ' ' THR . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 96.0 mt . . . . . 0 C--O 1.227 -0.111 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.793 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 672' ' ' LEU . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.551 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.782 HD12 ' HE1' ' A' ' 670' ' ' PHE . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.725 ' N ' HD13 ' A' ' 659' ' ' LEU . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m-20 -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.445 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.782 ' HE1' HD12 ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 649' ' ' TYR . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.432 ' HG3' ' HD3' ' A' ' 714' ' ' ARG . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.629 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.716 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.725 ' HD1' HG12 ' A' ' 689' ' ' VAL . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.725 HG12 ' HD1' ' A' ' 682' ' ' TRP . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 587' ' ' ILE . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' A' ' 577' ' ' PHE . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.554 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.756 ' HA ' ' CZ ' ' A' ' 714' ' ' ARG . 3.1 mmm180 . . . . . 0 N--CA 1.439 -1.002 0 CA-C-O 121.07 0.462 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.421 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.843 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 1.015 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.035 HD21 HG22 ' A' ' 694' ' ' VAL . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 581' ' ' LYS . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.647 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 583' ' ' LEU . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.949 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.738 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 690' ' ' ILE . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.804 HG13 HD12 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.949 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.54 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.726 HD23 ' HE2' ' A' ' 692' ' ' PHE . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.004 HD12 HD22 ' A' ' 578' ' ' LEU . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.871 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mm100 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.485 ' HB2' HG21 ' A' ' 700' ' ' THR . 4.4 pm0 -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.804 HD12 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.81 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.81 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.944 HG11 HG23 ' A' ' 727' ' ' VAL . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.647 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.667 ' HB2' HG22 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 701' ' ' GLY . 92.3 mt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.015 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.577 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.541 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.1 OUTLIER -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.979 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.839 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.578 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.615 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.979 HG22 HD13 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.753 HG21 ' OD2' ' A' ' 615' ' ' ASP . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.628 ' HA ' HG23 ' A' ' 689' ' ' VAL . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 682' ' ' TRP . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 587' ' ' ILE . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.726 ' HE2' HD23 ' A' ' 592' ' ' LEU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.035 HG22 HD21 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.719 HG12 HD12 ' A' ' 578' ' ' LEU . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 700' ' ' THR . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.679 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.452 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.839 HG21 ' O ' ' A' ' 663' ' ' ARG . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 727' ' ' VAL . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.944 HG23 HG11 ' A' ' 621' ' ' VAL . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.821 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.862 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.006 HD12 HD13 ' A' ' 647' ' ' ILE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.79 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.646 ' O ' HD13 ' A' ' 583' ' ' LEU . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.466 ' HB2' HD23 ' A' ' 583' ' ' LEU . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.504 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 580' ' ' LEU . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 1.6 pt20 -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.858 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.858 ' HB3' HG23 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.585 HD11 HD21 ' A' ' 592' ' ' LEU . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.895 ' OD2' HG21 ' A' ' 681' ' ' ILE . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.685 ' HB2' HD13 ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.968 HG11 HG13 ' A' ' 727' ' ' VAL . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.653 ' CD2' HG21 ' A' ' 680' ' ' ILE . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.477 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 95.8 mt . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CB ' HD21 ' A' ' 672' ' ' LEU . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.535 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 665' ' ' ILE . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.749 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.577 ' HA ' HG13 ' A' ' 656' ' ' VAL . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 694' ' ' VAL . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.749 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.895 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.587 ' HA ' HG23 ' A' ' 689' ' ' VAL . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 682' ' ' TRP . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.737 ' HB ' HG22 ' A' ' 681' ' ' ILE . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.726 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 577' ' ' PHE . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.976 0.417 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 663' ' ' ARG . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 722' ' ' GLU . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.968 HG13 HG11 ' A' ' 621' ' ' VAL . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.096 HD12 HG23 ' A' ' 696' ' ' ILE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 581' ' ' LYS . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 694' ' ' VAL . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.619 ' HG2' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.903 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.621 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 1.018 HD11 HG23 ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.903 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.785 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.867 HD12 ' SG ' ' A' ' 611' ' ' CYS . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 625' ' ' ILE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.032 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CG ' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.032 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 1.018 HG23 HD11 ' A' ' 588' ' ' ILE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 727' ' ' VAL . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.657 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 701' ' ' GLY . 61.1 mt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.856 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.534 ' OD2' HD11 ' A' ' 671' ' ' LEU . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.747 HD13 HD22 ' A' ' 578' ' ' LEU . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.627 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.919 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.2 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.627 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.624 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.786 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.483 ' HE3' ' O ' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.627 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 694' ' ' VAL . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 674' ' ' ASP . 20.3 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 673' ' ' GLN . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.919 HG21 ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.561 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.621 ' CD1' HG22 ' A' ' 587' ' ' ILE . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 580' ' ' LEU . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 1.096 HG23 HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 2.8 mmm-85 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 663' ' ' ARG . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.434 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.553 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 621' ' ' VAL . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.863 HD12 HD13 ' A' ' 647' ' ' ILE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.693 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 583' ' ' LEU . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.693 HG22 ' HB2' ' A' ' 582' ' ' PRO . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.517 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.879 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 578' ' ' LEU . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.0 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 1.5 pt20 -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG3' HD23 ' A' ' 726' ' ' LEU . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.879 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.925 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.732 ' OD2' HG21 ' A' ' 681' ' ' ILE . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.674 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 727' ' ' VAL . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.674 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.631 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.687 ' CD1' HD11 ' A' ' 580' ' ' LEU . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.647 HD22 ' O ' ' A' ' 701' ' ' GLY . 77.1 mt . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.863 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.648 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.6 m120 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.554 ' N ' HD12 ' A' ' 659' ' ' LEU . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.955 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.407 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.512 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 717' ' ' LEU . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD22 HD21 ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.401 ' HG3' ' NH1' ' A' ' 714' ' ' ARG . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 649' ' ' TYR . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.609 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.909 HG22 ' CG2' ' A' ' 690' ' ' ILE . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 684' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ASN . . . . . 0.514 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.909 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.762 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.647 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.436 HH22 HD11 ' A' ' 659' ' ' LEU . 7.9 mmm180 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.0 0.429 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.216 0 CA-C-O 120.392 -0.115 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 594' ' ' ILE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.636 ' N ' HD23 ' A' ' 578' ' ' LEU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 625' ' ' ILE . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 583' ' ' LEU . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.95 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.662 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 588' ' ' ILE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.557 HD13 HG23 ' A' ' 587' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.95 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.008 HD12 HD22 ' A' ' 578' ' ' LEU . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.725 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 4.7 pm0 -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.725 HG23 ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.912 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.912 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.969 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.821 ' CG ' HD13 ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.821 HD13 ' CG ' ' A' ' 615' ' ' ASP . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.965 HG11 HG23 ' A' ' 727' ' ' VAL . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 580' ' ' LEU . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.888 HG21 ' HZ ' ' A' ' 577' ' ' PHE . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.555 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.537 ' CD2' ' HE1' ' A' ' 664' ' ' MET . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.1 OUTLIER -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.941 ' O ' HG21 ' A' ' 716' ' ' VAL . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.537 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.445 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.555 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 659' ' ' LEU . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 690' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.415 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.969 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 581' ' ' LYS . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.877 HG22 HD21 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 659' ' ' LEU . 10.3 mmm-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.407 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.941 HG21 ' O ' ' A' ' 663' ' ' ARG . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.631 ' O ' HD22 ' A' ' 726' ' ' LEU . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 726' ' ' LEU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.965 HG23 HG11 ' A' ' 621' ' ' VAL . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 CA-C-O 120.385 -0.12 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.955 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.736 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.442 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 690' ' ' ILE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 613' ' ' ILE . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.955 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.705 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.023 HD12 HD22 ' A' ' 578' ' ' LEU . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.768 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.9 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 1.3 pt20 -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 726' ' ' LEU . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.038 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.038 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.941 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.41 ' CA ' ' NE ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.823 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.959 HG11 HG23 ' A' ' 727' ' ' VAL . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.665 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 18.7 t-80 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.681 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t-80 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 48.9 mt . . . . . 0 C--O 1.225 -0.22 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.953 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.599 ' HD2' HD12 ' A' ' 659' ' ' LEU . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.478 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.8 m120 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.474 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.827 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.863 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.478 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.953 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.763 HG23 HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.847 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.767 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.415 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.815 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.767 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 587' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.755 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.794 HG22 HD21 ' A' ' 578' ' ' LEU . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.827 ' NH2' HD22 ' A' ' 659' ' ' LEU . 7.0 mmm-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.415 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 663' ' ' ARG . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.524 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 600' ' ' PRO . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.959 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.829 ' N ' HD23 ' A' ' 578' ' ' LEU . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.757 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.994 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.75 ' CD1' HG23 ' A' ' 613' ' ' ILE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.994 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 578' ' ' LEU . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.924 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mm100 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB2' HG21 ' A' ' 700' ' ' THR . 5.6 pm0 -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.924 HG23 ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.689 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.055 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.513 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.055 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.928 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.928 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.752 ' CB ' HD13 ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.458 ' HB2' ' OD1' ' A' ' 615' ' ' ASP . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.752 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 1.034 HG11 HG23 ' A' ' 727' ' ' VAL . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.648 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 19.1 t-80 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 580' ' ' LEU . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.803 HD22 ' O ' ' A' ' 701' ' ' GLY . 54.6 mt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.794 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.011 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.598 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.699 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.539 ' HB3' HD12 ' A' ' 681' ' ' ILE . 2.1 m120 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.48 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.862 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.564 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.598 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 649' ' ' TYR . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.677 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.71 HG23 HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 655' ' ' ASN . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.858 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.858 HG12 ' CD1' ' A' ' 682' ' ' TRP . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 587' ' ' ILE . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.734 HG22 HD21 ' A' ' 578' ' ' LEU . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.803 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.862 ' NH2' HD22 ' A' ' 659' ' ' LEU . 5.1 mmm-85 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.469 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 1.034 HG23 HG11 ' A' ' 621' ' ' VAL . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.497 ' HA2' ' NE2' ' A' ' 596' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.455 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.69 ' N ' HD23 ' A' ' 578' ' ' LEU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.724 HD21 HG23 ' A' ' 694' ' ' VAL . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 583' ' ' LEU . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.942 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.656 HD11 HG23 ' A' ' 613' ' ' ILE . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.49 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.942 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.838 HD12 ' SG ' ' A' ' 611' ' ' CYS . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.455 ' CB ' ' HD3' ' A' ' 576' ' ' ARG . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.995 HD12 HD22 ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.497 ' NE2' ' HA2' ' A' ' 575' ' ' GLY . 4.8 pm0 -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 598' ' ' VAL . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.738 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.844 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.78 ' N ' HD21 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.422 ' H ' ' HA ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.844 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 612' ' ' LYS . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.73 ' HB2' HD11 ' A' ' 681' ' ' ILE . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.954 HD12 ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.796 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.954 ' CD2' HD12 ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.605 ' CD1' HD11 ' A' ' 580' ' ' LEU . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HZ3' HG21 ' A' ' 700' ' ' THR . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 6.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.792 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.41 ' CG ' HD11 ' A' ' 671' ' ' LEU . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.021 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.919 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.437 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.92 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CD1' HD23 ' A' ' 659' ' ' LEU . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.919 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.776 HG12 HD13 ' A' ' 659' ' ' LEU . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.567 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.697 ' CG1' HG22 ' A' ' 681' ' ' ILE . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.8 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.551 HG23 ' CD1' ' A' ' 577' ' ' PHE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.041 0.448 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 663' ' ' ARG . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.4 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.444 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.796 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.712 ' CE1' HD11 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.783 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.635 ' O ' HD23 ' A' ' 583' ' ' LEU . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.165 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 689' ' ' VAL . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.619 HG21 ' CE1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 690' ' ' ILE . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.627 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.8 pm0 -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.165 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 611' ' ' CYS . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.622 ' HG3' HG23 ' A' ' 579' ' ' THR . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.931 HD12 HD22 ' A' ' 578' ' ' LEU . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.488 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.5 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 598' ' ' VAL . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.003 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.557 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.003 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.825 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.589 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.885 HG11 HG23 ' A' ' 727' ' ' VAL . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.667 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' A' ' 700' ' ' THR . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 644' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.514 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.086 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.565 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.446 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.474 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.829 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 41.0 m-80 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.927 ' O ' HG21 ' A' ' 716' ' ' VAL . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 656' ' ' VAL . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.78 HG22 HD21 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.848 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.706 HG21 ' OD2' ' A' ' 615' ' ' ASP . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.73 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.619 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 588' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.72 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.48 HG23 ' CD1' ' A' ' 577' ' ' PHE . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.479 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.829 ' NH2' HD22 ' A' ' 659' ' ' LEU . 12.0 mmm-85 . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.927 HG21 ' O ' ' A' ' 663' ' ' ARG . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.885 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 120.262 -0.188 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.839 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 594' ' ' ILE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.75 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.945 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.572 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.572 HG13 HD13 ' A' ' 588' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.945 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.91 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 625' ' ' ILE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 2.5 pt20 -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.862 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.91 ' SG ' HD13 ' A' ' 592' ' ' LEU . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.936 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.746 ' HB3' HD13 ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 680' ' ' ILE . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.86 HG11 ' CG2' ' A' ' 727' ' ' VAL . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 653' ' ' GLY . 22.4 t-80 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.845 HD12 HD11 ' A' ' 594' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 702' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.839 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.944 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CB ' HD21 ' A' ' 672' ' ' LEU . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.466 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.6 m120 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.476 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.784 HD22 HH21 ' A' ' 714' ' ' ARG . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.753 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.466 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.944 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.702 ' CD2' HD11 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.463 ' HA ' HG13 ' A' ' 696' ' ' ILE . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.649 HG22 ' CD2' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.731 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.607 HG23 HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 596' ' ' GLN . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.64 ' C ' HD22 ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.784 HH21 HD22 ' A' ' 659' ' ' LEU . 1.1 mmm-85 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.09 0.472 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.753 HG21 ' O ' ' A' ' 663' ' ' ARG . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 724' ' ' LYS . 31.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.45 ' O ' HG12 ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.86 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.227 -0.311 0 CA-C-O 120.329 -0.15 . . . . 0.0 112.983 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.809 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.038 HD22 HD13 ' A' ' 647' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.565 ' H ' HD12 ' A' ' 578' ' ' LEU . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.616 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 613' ' ' ILE . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.458 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 578' ' ' LEU . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.774 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.94 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.773 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.853 HG11 HG23 ' A' ' 727' ' ' VAL . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.704 ' CE1' HG23 ' A' ' 680' ' ' ILE . 22.7 t-80 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.605 HD12 HD11 ' A' ' 594' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 647' ' ' ILE . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t-80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 93.4 mt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.038 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.706 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 1.9 m120 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 656' ' ' VAL . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.758 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 652' ' ' THR . 35.5 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.706 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 694' ' ' VAL . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 613' ' ' ILE . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.634 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 587' ' ' ILE . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.883 HG13 HD11 ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.698 ' CG1' HD13 ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.977 0.418 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 663' ' ' ARG . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 727' ' ' VAL . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.853 HG23 HG11 ' A' ' 621' ' ' VAL . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 647' ' ' ILE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.447 ' H ' HD12 ' A' ' 578' ' ' LEU . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.024 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.55 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.652 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 613' ' ' ILE . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.785 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.476 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.024 HD11 HD11 ' A' ' 580' ' ' LEU . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.893 HG23 HG13 ' A' ' 588' ' ' ILE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.895 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.895 HD13 ' CB ' ' A' ' 615' ' ' ASP . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.608 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.913 HG11 HG23 ' A' ' 727' ' ' VAL . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.646 ' CE1' ' HB ' ' A' ' 680' ' ' ILE . 16.4 t-80 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.602 HD11 HD21 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t-80 . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.4 mt . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.853 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.575 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.859 HD12 ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 659' ' ' LEU . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.668 ' HB3' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.894 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.455 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 653' ' ' GLY . 30.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.859 ' CE1' HD12 ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.596 HD13 HG21 ' A' ' 694' ' ' VAL . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.754 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.646 ' HB ' ' CE1' ' A' ' 622' ' ' HIS . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.697 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.697 HG12 ' CD1' ' A' ' 682' ' ' TRP . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.652 ' CD1' HG22 ' A' ' 587' ' ' ILE . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 1.006 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.896 HG12 HD13 ' A' ' 578' ' ' LEU . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.746 HG22 ' CE2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.736 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 4.7 mmm180 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.894 HG21 ' O ' ' A' ' 663' ' ' ARG . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.405 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.913 HG23 HG11 ' A' ' 621' ' ' VAL . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.015 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.809 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.901 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.901 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.614 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.95 HD11 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 3.7 pt20 -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.723 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.011 ' HB3' HG23 ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.536 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.802 ' HB3' HD13 ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.992 HD11 ' CG2' ' A' ' 680' ' ' ILE . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.871 HG11 ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.59 ' NE2' HG23 ' A' ' 680' ' ' ILE . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.598 ' CD1' HD21 ' A' ' 580' ' ' LEU . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.503 ' NZ ' HG21 ' A' ' 700' ' ' THR . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 2.8 mp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.351 0.12 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.872 ' O ' HD13 ' A' ' 702' ' ' LEU . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.557 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.646 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' OE1' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.546 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m120 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.507 ' N ' HD12 ' A' ' 659' ' ' LEU . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.617 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.6 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.89 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE3' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 652' ' ' THR . 37.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.557 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.93 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.434 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.608 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.811 HG22 HD13 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.992 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.678 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 689' ' ' VAL . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.93 HG21 HD13 ' A' ' 672' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.503 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.651 ' HA ' ' NE ' ' A' ' 714' ' ' ARG . 5.0 mmm180 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.559 ' HA ' ' ND2' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 663' ' ' ARG . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.871 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.023 HD12 HD13 ' A' ' 647' ' ' ILE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.82 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 579' ' ' THR . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.885 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.542 HD13 HG23 ' A' ' 587' ' ' ILE . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.885 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 592' ' ' LEU . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.482 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.964 HD12 HD22 ' A' ' 578' ' ' LEU . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.841 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.666 ' HB2' HG21 ' A' ' 700' ' ' THR . 4.7 pm0 -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.008 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.47 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.008 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.846 ' C ' HD13 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 1.008 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.901 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.824 HD13 ' CG ' ' A' ' 615' ' ' ASP . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.607 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 21.1 t-80 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.722 ' CD1' HD11 ' A' ' 580' ' ' LEU . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 644' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.418 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.859 ' HG ' HG22 ' A' ' 678' ' ' ILE . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.905 ' O ' HG21 ' A' ' 716' ' ' VAL . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.447 ' HA ' HG11 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 649' ' ' TYR . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.859 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.682 HG23 HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.901 HG21 ' OD2' ' A' ' 615' ' ' ASP . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.698 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ASN . . . . . 0.517 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 1.008 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.78 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 674' ' ' ASP . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.705 0.764 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.905 HG21 ' O ' ' A' ' 663' ' ' ARG . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.062 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.805 ' N ' HD23 ' A' ' 578' ' ' LEU . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.814 HD11 HD12 ' A' ' 625' ' ' ILE . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.726 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.444 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.459 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.88 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.044 HD12 HD22 ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.488 ' N ' HG12 ' A' ' 598' ' ' VAL . 4.6 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.036 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.899 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.871 ' HB3' HD13 ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.871 HD13 ' HB3' ' A' ' 615' ' ' ASP . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.844 HG11 ' CG2' ' A' ' 727' ' ' VAL . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.651 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 17.7 t-80 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 680' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.814 HD12 HD11 ' A' ' 580' ' ' LEU . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.6 t60 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 701' ' ' GLY . 91.7 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.848 ' O ' HD23 ' A' ' 702' ' ' LEU . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 628' ' ' LYS . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.062 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.932 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.62 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.054 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.589 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.733 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.932 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.701 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 659' ' ' LEU . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 657' ' ' SER . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 680' ' ' ILE . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.873 ' CD1' HG12 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.873 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 587' ' ' ILE . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 700' ' ' THR . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.832 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 6.0 mmm-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.953 0.406 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.427 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 663' ' ' ARG . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.844 ' CG2' HG11 ' A' ' 621' ' ' VAL . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.987 HD12 HD13 ' A' ' 647' ' ' ILE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.799 ' N ' HD23 ' A' ' 578' ' ' LEU . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.619 ' O ' HD13 ' A' ' 583' ' ' LEU . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.954 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.717 HG22 HG12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.674 ' CD1' HG23 ' A' ' 613' ' ' ILE . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.954 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.79 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.488 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 580' ' ' LEU . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.785 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.9 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 1.2 pt20 -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.529 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 588' ' ' ILE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.85 HG11 ' CG2' ' A' ' 727' ' ' VAL . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.71 ' CD1' HD11 ' A' ' 580' ' ' LEU . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.431 ' NZ ' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 702' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.833 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.987 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.67 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.931 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 12.3 m120 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.928 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.67 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.831 ' CD2' HD11 ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.901 HG22 HD21 ' A' ' 659' ' ' LEU . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 587' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.581 ' CE2' HD11 ' A' ' 680' ' ' ILE . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.7 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 577' ' ' PHE . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 700' ' ' THR . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.931 ' NH2' HD22 ' A' ' 659' ' ' LEU . 16.0 mmm-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.928 HG21 ' O ' ' A' ' 663' ' ' ARG . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.85 ' CG2' HG11 ' A' ' 621' ' ' VAL . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.42 0 CA-C-O 119.879 -0.401 . . . . 0.66 113.64 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 1.67 110.677 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.65 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.92 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.952 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 0.93 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 0.4 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.754 ' CD2' HG23 ' A' ' 694' ' ' VAL . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 0.84 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 1.67 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.3 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.17 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.62 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.67 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 690' ' ' ILE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 1.92 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.597 ' CD1' HG23 ' A' ' 613' ' ' ILE . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 1.39 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.452 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.11 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 0.54 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.792 HD12 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 1.98 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.721 HD12 HD22 ' A' ' 578' ' ' LEU . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 0.32 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.3 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.66 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 3.0 pt20 -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.26 113.177 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 0.82 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.88 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.3 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.26 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.24 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 1.014 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 0.45 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.3 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.02 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.32 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.37 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.88 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.27 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.24 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 1.014 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 0.5 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.852 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.07 113.095 -178.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 612' ' ' LYS . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.11 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.97 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.61 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.89 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.68 112.001 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 615' ' ' ASP . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 0.72 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.09 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 0.91 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.854 HG11 ' CG2' ' A' ' 727' ' ' VAL . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 0.26 109.105 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.614 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 17.4 t-80 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.28 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 0.24 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.3 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 580' ' ' LEU . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 0.76 107.794 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.3 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.455 ' NZ ' HG21 ' A' ' 700' ' ' THR . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 0.91 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.8 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.29 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.99 111.302 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.0 mt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.253 -0.277 . . . . 1.25 110.253 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' O ' HD22 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.36 109.621 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.952 HD13 HD12 ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 0.35 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.965 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.43 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.58 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.34 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.44 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.25 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 0.26 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 0.33 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.8 m120 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.83 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 0.98 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.16 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.22 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.104 HD13 HG22 ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.29 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.15 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 2.42 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 714' ' ' ARG . 5.7 m-80 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.9 111.096 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 2.64 110.324 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 656' ' ' VAL . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.98 111.24 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 0.64 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.82 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 0.44 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 0.82 109.157 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.783 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 0.8 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.965 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 1.5 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.58 HD21 ' CB ' ' A' ' 649' ' ' TYR . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 0.63 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.54 110.987 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.41 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.43 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.31 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.676 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.43 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.104 HG22 HD13 ' A' ' 659' ' ' LEU . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.34 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.04 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.57 ' CG2' ' CE1' ' A' ' 622' ' ' HIS . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 1.7 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.537 HG21 ' OD2' ' A' ' 615' ' ' ASP . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 0.62 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' TRP . . . . . 0.652 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.91 111.14 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.44 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.14 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.84 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.14 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.18 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.652 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.38 111.307 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 615' ' ' ASP . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.83 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.33 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.35 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 1.87 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.754 HG23 ' CD2' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.31 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.17 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 0.55 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 700' ' ' THR . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 0.99 110.765 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 645' ' ' ASP . 2.7 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 1.42 111.054 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.471 ' HB3' ' ND2' ' A' ' 662' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 112.856 0.687 . . . . 2.5 112.856 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.59 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.886 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 0.72 111.113 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.693 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.47 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.01 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 0.82 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.7 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.26 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.65 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 2.68 111.155 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.61 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.23 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 621' ' ' VAL . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.66 111.063 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 2.75 110.993 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -90.11 10.25 25.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.657 0.265 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -132.45 -25.83 0.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.683 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.454 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 696' ' ' ILE . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 578' ' ' LEU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.79 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.706 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.971 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.841 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.971 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.454 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.691 HG23 ' CD1' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.738 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.47 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.691 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.904 ' C ' HD13 ' A' ' 603' ' ' ILE . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.991 ' HB3' HG23 ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.932 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.932 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.626 ' CB ' HD13 ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.613 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 13.9 t-80 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.79 ' CD1' HD11 ' A' ' 580' ' ' LEU . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HZ1' HG21 ' A' ' 700' ' ' THR . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 -67.41 126.09 28.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -101.51 140.23 36.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.396 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.2 p -103.05 161.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.965 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.538 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -91.03 54.57 3.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mttp 58.45 172.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.703 0.287 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.189 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.32 44.49 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.3 -153.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.424 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.58 100.12 8.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.464 0.649 . . . . 0.0 109.768 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.2 p -138.27 156.63 73.58 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.721 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.3 Cg_endo -71.35 -153.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.648 2.232 . . . . 0.0 111.743 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 80.02 -71.01 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 42.14 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.54 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.46 121.22 5.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.332 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.651 HD13 ' CB ' ' A' ' 703' ' ' PHE . 3.7 mp -146.53 -151.16 0.37 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.492 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.88 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.993 ' CH2' HD22 ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 656' ' ' VAL . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.891 ' O ' HG21 ' A' ' 716' ' ' VAL . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.425 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.541 ' HE2' HD11 ' A' ' 717' ' ' LEU . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.634 ' HD2' HD23 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.993 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.738 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 688' ' ' PHE . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.837 ' CD1' HG12 ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 686' ' ' ASN . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 587' ' ' ILE . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.756 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 705' ' ' GLU . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 700' ' ' THR . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -82.86 134.86 35.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.651 ' CB ' HD13 ' A' ' 644' ' ' LEU . 1.9 p90 -45.58 -31.77 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.537 0.684 . . . . 0.0 110.188 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.7 t-20 -148.7 -51.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.0 pt-20 152.19 -28.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.209 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.17 -11.91 2.07 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.552 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -86.04 9.1 18.14 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.011 0.434 . . . . 0.0 111.863 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 703' ' ' PHE . . . 66.95 -166.64 40.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.803 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.464 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -156.57 123.55 5.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.718 0.294 . . . . 0.0 110.398 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 67.14 129.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.829 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 42.93 90.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -63.83 126.38 27.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.741 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -115.5 97.51 6.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 110.383 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 660' ' ' ASN . 16.0 mmm-85 -106.03 77.47 1.24 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.808 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.891 HG21 ' O ' ' A' ' 663' ' ' ARG . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.541 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.403 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 9.26 15.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.611 ' C ' HD12 ' A' ' 730' ' ' LEU . 3.3 pp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.882 0.372 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 827' ' ' ASP . . . . . 0.544 ' C ' HD13 ' P' ' 828' ' ' ILE . 0.4 OUTLIER -99.1 41.71 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.785 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.558 ' N ' HD13 ' P' ' 828' ' ' ILE . 0.0 OUTLIER -114.5 33.13 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -162.11 133.24 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 63.0 mt -123.31 151.28 42.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.864 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -22.16 63.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 129.77 -6.83 6.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.8 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.93 HD22 ' CD1' ' A' ' 594' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.724 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 583' ' ' LEU . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.937 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.485 HD11 ' OD1' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.829 HD12 HD13 ' A' ' 613' ' ' ILE . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.937 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 592' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.468 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.93 ' CD1' HD22 ' A' ' 578' ' ' LEU . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.772 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 1.8 pt20 -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.772 HG23 ' HB2' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.723 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.613 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.896 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.613 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 588' ' ' ILE . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.876 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 681' ' ' ILE . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.876 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.95 HG22 HD21 ' A' ' 730' ' ' LEU . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 680' ' ' ILE . 9.4 t-80 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.456 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 603' ' ' ILE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 580' ' ' LEU . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -61.13 135.38 57.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -81.69 76.75 8.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.611 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -134.54 -175.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 632' ' ' VAL . . . 114.43 -25.11 10.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.603 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -80.28 66.95 5.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.955 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.48 105.5 7.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 5.3 ttm -72.09 61.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.44 . . . . 0.0 110.411 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 175.23 -157.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 100.56 8.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.6 p -136.78 156.43 76.04 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 67.7 Cg_endo -69.39 -151.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.665 2.243 . . . . 0.0 111.438 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 73.84 -68.49 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.786 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.52 ' HB2' HD11 ' A' ' 644' ' ' LEU . 2.0 mp0 46.61 -171.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -104.39 119.62 6.34 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.263 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.5 mp -146.95 -154.42 0.55 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.606 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.88 HD13 HD12 ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CB ' HD21 ' A' ' 672' ' ' LEU . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.493 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.691 HD13 HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.923 ' O ' HG21 ' A' ' 716' ' ' VAL . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.493 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.677 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.943 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 694' ' ' VAL . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.766 ' OE1' HD23 ' A' ' 707' ' ' LEU . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.561 ' OD1' HD11 ' A' ' 707' ' ' LEU . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 583' ' ' LEU . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.703 HD11 HG21 ' A' ' 690' ' ' ILE . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 655' ' ' ASN . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.802 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.747 ' HB2' HD13 ' P' ' 831' ' ' LEU . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.802 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.703 HG21 HD11 ' A' ' 680' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 580' ' ' LEU . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.841 HG22 HD21 ' A' ' 578' ' ' LEU . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 705' ' ' GLU . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 700' ' ' THR . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.675 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -75.23 139.62 42.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.652 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -46.72 -29.88 2.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.222 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.494 ' HB3' ' HE3' ' A' ' 709' ' ' MET . 5.1 t-20 -154.95 -65.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.885 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.8 pt-20 169.98 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.424 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.17 17.32 0.26 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.01 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.766 HD23 ' OE1' ' A' ' 673' ' ' GLN . 0.8 OUTLIER -82.79 8.52 12.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 38.46 72.65 0.18 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.333 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.494 ' HE3' ' HB3' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -84.75 100.75 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 710' ' ' LEU . 2.7 pt? -166.79 -162.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -66.67 -51.51 55.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.806 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.448 ' HG2' ' CG ' ' A' ' 710' ' ' LEU . 8.9 pt-20 -63.4 140.38 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 97.71 6.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.301 0.572 . . . . 0.0 110.37 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 44.57 79.01 0.05 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.832 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.923 HG21 ' O ' ' A' ' 663' ' ' ARG . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 727' ' ' VAL . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 626' ' ' PHE . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.908 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -58.19 -38.56 76.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -104.59 -25.77 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.324 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.95 HD21 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.726 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.852 0.358 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -104.55 133.42 49.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.403 ' C ' HD12 ' P' ' 828' ' ' ILE . 2.0 pp -123.57 40.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.069 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.6 160.29 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' A' ' 683' ' ' ASP . 90.8 mt -123.55 101.16 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -103.56 -13.38 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.261 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.91 54.4 0.76 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.328 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.769 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.613 ' O ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.977 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 613' ' ' ILE . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.522 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.977 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 578' ' ' LEU . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mm100 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.709 ' HG3' HD23 ' A' ' 726' ' ' LEU . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.859 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 588' ' ' ILE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.759 ' HB3' HD13 ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 730' ' ' LEU . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.703 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.628 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.695 ' CD1' HD11 ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 700' ' ' THR . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -75.42 130.79 39.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -121.56 118.27 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.16 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -88.67 159.8 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -63.52 177.89 7.24 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.396 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 111.97 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.62 99.15 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 mtm -88.18 49.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 110.179 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.05 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.9 100.45 8.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.383 0.611 . . . . 0.0 109.884 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 640' ' ' PRO . 60.8 p -138.23 148.6 60.36 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.84 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 639' ' ' SER . 32.2 Cg_exo -57.51 -140.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.946 2.431 . . . . 0.0 112.195 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.36 -69.95 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 39.19 32.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.64 124.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.699 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 703' ' ' PHE . 96.0 mt -153.51 -144.43 0.15 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.793 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 672' ' ' LEU . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.736 ' OD1' HD23 ' P' ' 831' ' ' LEU . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.782 HD12 ' HE1' ' A' ' 670' ' ' PHE . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.725 ' N ' HD13 ' A' ' 659' ' ' LEU . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m-20 -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.445 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.782 ' HE1' HD12 ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 649' ' ' TYR . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 707' ' ' LEU . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.629 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.716 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.725 ' HD1' HG12 ' A' ' 689' ' ' VAL . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.725 HG12 ' HD1' ' A' ' 682' ' ' TRP . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 587' ' ' ILE . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 705' ' ' GLU . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.554 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -79.54 128.14 33.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.847 ' HA ' HD12 ' A' ' 644' ' ' LEU . 3.7 p90 -45.13 -32.63 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.559 0.695 . . . . 0.0 110.123 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 3.5 t-20 -145.24 -60.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.522 ' C ' HD12 ' A' ' 702' ' ' LEU . 10.3 pt-20 157.33 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.556 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.1 -15.98 1.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.689 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 673' ' ' GLN . 0.2 OUTLIER -83.09 8.81 11.89 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 72.59 -133.11 18.98 Favored Glycine 0 C--N 1.32 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.642 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.11 34.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.3 -167.98 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -60.88 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.337 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -114.96 98.05 6.59 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.746 0.308 . . . . 0.0 111.049 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -117.99 97.65 5.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.756 ' CZ ' ' HA ' ' A' ' 714' ' ' ARG . 3.1 mmm180 -141.83 98.19 3.29 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.409 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.421 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.843 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -24.58 22.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -110.01 -31.1 7.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.031 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 621' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.809 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 128.92 39.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.8 pt -101.62 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.95 -171.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.736 HD23 ' OD1' ' A' ' 655' ' ' ASN . 0.3 OUTLIER -160.75 158.88 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.781 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.008 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -81.65 -22.37 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.56 0.219 . . . . 0.0 111.151 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -148.36 59.19 0.46 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.69 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 1.015 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.035 HD21 HG22 ' A' ' 694' ' ' VAL . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 581' ' ' LYS . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.647 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 583' ' ' LEU . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.949 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.738 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 690' ' ' ILE . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.804 HG13 HD12 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.949 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.54 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.726 HD23 ' HE2' ' A' ' 692' ' ' PHE . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.004 HD12 HD22 ' A' ' 578' ' ' LEU . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.871 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mm100 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.485 ' HB2' HG21 ' A' ' 700' ' ' THR . 4.4 pm0 -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.804 HD12 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.81 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.409 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.81 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.944 HG11 HG23 ' A' ' 727' ' ' VAL . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.647 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.667 ' HB2' HG22 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -61.36 124.46 20.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -59.84 125.12 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.377 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -135.77 -175.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.744 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.569 ' H ' HG22 ' A' ' 632' ' ' VAL . . . 109.57 25.42 5.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.704 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.0 73.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.761 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.31 108.36 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.05 35.01 1.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.144 0.497 . . . . 0.0 110.302 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.34 -151.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.306 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.25 99.89 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.656 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 156.86 73.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.087 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.9 Cg_endo -70.74 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.703 2.269 . . . . 0.0 111.703 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 82.62 -71.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 38.06 34.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.469 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 61.06 115.97 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.484 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.3 mt -152.85 -152.58 0.43 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.713 -0.744 . . . . 0.0 110.081 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.015 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.577 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.696 ' OD1' HD12 ' P' ' 831' ' ' LEU . 1.1 m-20 -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.979 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.839 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.578 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.615 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.979 HG22 HD13 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.753 HG21 ' OD2' ' A' ' 615' ' ' ASP . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.628 ' HA ' HG23 ' A' ' 689' ' ' VAL . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 682' ' ' TRP . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 587' ' ' ILE . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.726 ' HE2' HD23 ' A' ' 592' ' ' LEU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.035 HG22 HD21 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.719 HG12 HD12 ' A' ' 578' ' ' LEU . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.562 ' O ' HG23 ' A' ' 700' ' ' THR . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.679 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.544 HD22 ' CA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -75.84 140.96 42.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.917 ' HA ' HD12 ' A' ' 644' ' ' LEU . 48.8 p90 -50.1 -32.27 15.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.447 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 3.8 t-20 -149.8 -59.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.547 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.708 ' HB2' HD13 ' A' ' 696' ' ' ILE . 14.8 pt-20 160.02 -28.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.23 -10.46 1.15 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.738 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -82.94 8.82 11.53 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.01 0.433 . . . . 0.0 111.882 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 67.44 -130.15 28.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.989 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.87 -137.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 710' ' ' LEU . 4.2 pp -37.85 131.77 1.0 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.542 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 46.27 89.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.62 128.45 35.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.689 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -115.41 97.37 6.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.335 0.588 . . . . 0.0 110.494 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -102.83 71.75 1.17 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.452 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.839 HG21 ' O ' ' A' ' 663' ' ' ARG . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 727' ' ' VAL . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.944 HG23 HG11 ' A' ' 621' ' ' VAL . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -29.14 68.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -105.57 23.24 14.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.919 HD13 HG22 ' A' ' 621' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.662 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.817 0.342 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.07 74.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 36.5 mt -111.62 140.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.51 119.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.696 HD12 ' OD1' ' A' ' 655' ' ' ASN . 9.6 mt -135.67 113.34 10.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.874 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.212 0 N-CA-C 112.728 -0.149 . . . . 0.0 112.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.2 10.24 22.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.575 0.226 . . . . 0.0 111.492 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 114.01 1.9 23.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.821 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.862 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.006 HD12 HD13 ' A' ' 647' ' ' ILE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.79 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.646 ' O ' HD13 ' A' ' 583' ' ' LEU . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.466 ' HB2' HD23 ' A' ' 583' ' ' LEU . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.504 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 580' ' ' LEU . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 1.6 pt20 -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.858 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.858 ' HB3' HG23 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.585 HD11 HD21 ' A' ' 592' ' ' LEU . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.895 ' OD2' HG21 ' A' ' 681' ' ' ILE . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.685 ' HB2' HD13 ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 730' ' ' LEU . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.653 ' CD2' HG21 ' A' ' 680' ' ' ILE . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.477 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 -78.2 133.77 37.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -138.64 132.68 31.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.6 OUTLIER -99.4 171.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -57.88 171.2 3.7 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -59.45 88.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.754 0.312 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.03 103.43 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.33 27.18 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 639' ' ' SER . 1.3 p90 -139.67 -148.95 0.27 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.164 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 100.64 8.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.096 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.485 ' HB3' ' CE2' ' A' ' 637' ' ' TYR . 4.6 p -138.06 156.58 73.94 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 72.6 Cg_endo -71.4 -153.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.701 2.267 . . . . 0.0 111.405 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.15 -66.32 0.28 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 40.62 32.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.223 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . 63.48 117.86 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.785 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 703' ' ' PHE . 95.8 mt -154.68 -150.81 0.33 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.38 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.427 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CB ' HD21 ' A' ' 672' ' ' LEU . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.535 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 665' ' ' ILE . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.749 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.577 ' HA ' HG13 ' A' ' 656' ' ' VAL . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 694' ' ' VAL . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.749 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.895 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.587 ' HA ' HG23 ' A' ' 689' ' ' VAL . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 682' ' ' TRP . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.737 ' HB ' HG22 ' A' ' 681' ' ' ILE . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.726 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 705' ' ' GLU . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 700' ' ' THR . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.51 HD22 ' C ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -77.15 149.15 35.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.871 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -54.76 -17.48 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.028 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.705 ' ND2' ' CG ' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -175.6 -48.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.611 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.629 ' HB2' HD12 ' A' ' 696' ' ' ILE . 4.8 pt-20 162.38 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.688 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.24 19.64 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.472 ' HA ' ' CB ' ' A' ' 673' ' ' GLN . 0.2 OUTLIER -81.17 8.62 8.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 671' ' ' LEU . . . 31.54 90.81 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.098 -0.501 . . . . 0.0 114.181 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.457 ' SD ' ' ND2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -106.53 75.35 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.867 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.46 -166.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -55.15 -53.92 49.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.47 ' HG2' HG21 ' A' ' 715' ' ' VAL . 12.2 mt-10 -64.06 133.03 52.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.67 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -116.67 97.57 6.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.293 0.568 . . . . 0.0 110.44 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 45.25 74.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.681 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 712' ' ' GLU . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 663' ' ' ARG . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 722' ' ' GLU . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.968 HG13 HG11 ' A' ' 621' ' ' VAL . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 61.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.74 -46.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 621' ' ' VAL . 2.8 pp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.911 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.947 0.404 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -174.76 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.86 172.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 61.8 170.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.8 151.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.804 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -103.79 10.49 36.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.93 -40.97 1.58 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.698 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.096 HD12 HG23 ' A' ' 696' ' ' ILE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 581' ' ' LYS . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 694' ' ' VAL . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.619 ' HG2' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.903 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.621 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 1.018 HD11 HG23 ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.903 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.785 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.867 HD12 ' SG ' ' A' ' 611' ' ' CYS . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 625' ' ' ILE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.032 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CG ' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.032 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 1.018 HG23 HD11 ' A' ' 588' ' ' ILE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.451 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.93 HG22 HD13 ' A' ' 730' ' ' LEU . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.657 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 -61.29 127.4 31.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.35 107.0 6.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.218 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.4 p -97.16 159.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -105.93 -168.96 23.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.627 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -71.52 145.71 48.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 110.792 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.3 108.02 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -96.82 31.34 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.335 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.86 -151.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.523 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -114.49 100.32 8.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.342 0.591 . . . . 0.0 109.87 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 23.7 p -136.96 156.48 75.79 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.757 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.91 -154.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.695 2.264 . . . . 0.0 111.778 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 67.27 -72.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.69 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 32.47 38.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.836 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 63.28 113.67 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.646 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 703' ' ' PHE . 61.1 mt -152.48 -170.92 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.839 -0.68 . . . . 0.0 110.562 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.856 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.534 ' OD2' HD11 ' A' ' 671' ' ' LEU . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.747 HD13 HD22 ' A' ' 578' ' ' LEU . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.627 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.919 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.627 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.624 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.786 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.483 ' HE3' ' O ' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.627 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 694' ' ' VAL . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 5.7 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.906 ' OD2' HD12 ' A' ' 707' ' ' LEU . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.919 HG21 ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.561 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.686 ' OD1' HD13 ' P' ' 831' ' ' LEU . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.621 ' CD1' HG22 ' A' ' 587' ' ' ILE . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 580' ' ' LEU . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 1.096 HG23 HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -89.08 124.43 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.909 ' HA ' HD12 ' A' ' 644' ' ' LEU . 4.5 p90 -29.37 -42.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.386 0.612 . . . . 0.0 111.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -121.57 -44.78 2.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.444 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 12.0 pt-20 144.21 -22.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.097 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 112.64 11.74 14.24 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.906 HD12 ' OD2' ' A' ' 674' ' ' ASP . 4.3 tt -98.87 8.65 44.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 126.72 -134.18 8.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.079 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.466 ' HE3' ' HG2' ' A' ' 713' ' ' GLN . 3.7 ttm -174.74 -133.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.284 . . . . 0.0 110.511 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 2.4 pp -50.76 -173.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.738 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -33.94 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.408 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -114.38 99.6 7.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 111.672 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 50.7 tp60 -117.14 97.84 6.14 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 2.8 mmm-85 -168.92 64.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.686 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 663' ' ' ARG . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.434 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.553 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 621' ' ' VAL . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -57.59 -31.86 66.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 25.64 11.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 621' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -160.03 160.8 33.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.85 155.29 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -125.92 134.46 51.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.686 HD13 ' OD1' ' A' ' 683' ' ' ASP . 53.8 mt -126.48 115.54 19.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.779 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.95 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -72.05 -8.46 54.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.505 0.193 . . . . 0.0 111.398 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -125.65 -28.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.863 HD12 HD13 ' A' ' 647' ' ' ILE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.693 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 583' ' ' LEU . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.693 HG22 ' HB2' ' A' ' 582' ' ' PRO . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.517 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.879 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 578' ' ' LEU . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.0 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG3' HD23 ' A' ' 726' ' ' LEU . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.879 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.925 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.732 ' OD2' HG21 ' A' ' 681' ' ' ILE . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.674 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 727' ' ' VAL . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.674 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.631 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.687 ' CD1' HD11 ' A' ' 580' ' ' LEU . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 -66.58 122.56 17.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.23 134.61 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.04 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.8 OUTLIER -95.65 170.45 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -124.45 46.83 1.06 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.522 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt 61.42 152.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.54 114.31 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.04 30.43 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.01 -159.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.771 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -113.25 100.3 8.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.443 0.639 . . . . 0.0 109.754 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.4 p -137.08 156.79 75.46 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 57.0 Cg_endo -67.15 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.57 2.18 . . . . 0.0 111.665 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.3 -71.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 35.45 35.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.63 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 60.47 115.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.282 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 703' ' ' PHE . 77.1 mt -151.63 -154.51 0.55 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.271 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.863 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.648 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.6 m120 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.554 ' N ' HD12 ' A' ' 659' ' ' LEU . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.955 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.407 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.512 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 717' ' ' LEU . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD22 HD21 ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.462 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.439 ' OD1' HD22 ' A' ' 707' ' ' LEU . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 649' ' ' TYR . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.609 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.909 HG22 ' CG2' ' A' ' 690' ' ' ILE . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 684' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ASN . . . . . 0.514 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.909 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.762 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 705' ' ' GLU . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.647 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -81.0 133.71 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.937 ' HA ' HD12 ' A' ' 644' ' ' LEU . 19.1 p90 -40.92 -35.43 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.489 0.661 . . . . 0.0 110.246 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 3.2 t-20 -143.68 -56.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.054 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.1 pt-20 155.27 -26.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.246 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.55 -9.72 3.18 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.445 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -88.03 9.32 22.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.976 0.417 . . . . 0.0 112.095 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 62.01 -171.41 9.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.666 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.43 31.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 -165.96 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.57 -96.94 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.814 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.92 99.21 7.3 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 0.0 111.168 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -117.18 97.46 5.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 109.946 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.436 HH22 HD11 ' A' ' 659' ' ' LEU . 7.9 mmm180 -156.65 72.94 0.76 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.013 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -65.55 -36.46 83.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -101.35 22.92 11.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.961 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.926 HD13 HG22 ' A' ' 621' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.603 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.87 0.367 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -130.72 134.43 46.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.1 mt -108.01 141.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -133.42 83.28 2.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.0 83.67 7.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.647 -0.181 . . . . 0.0 112.647 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -70.04 -22.11 63.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.702 0.287 . . . . 0.0 110.931 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 127.98 0.57 6.49 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.005 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 594' ' ' ILE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.636 ' N ' HD23 ' A' ' 578' ' ' LEU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 625' ' ' ILE . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 583' ' ' LEU . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.95 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.662 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 588' ' ' ILE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.557 HD13 HG23 ' A' ' 587' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.95 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 592' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.47 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.008 HD12 HD22 ' A' ' 578' ' ' LEU . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.725 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 4.7 pm0 -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.725 HG23 ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.912 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.912 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.969 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.821 ' CG ' HD13 ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.821 HD13 ' CG ' ' A' ' 615' ' ' ASP . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.087 HG22 HD21 ' A' ' 730' ' ' LEU . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 580' ' ' LEU . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -81.56 132.12 35.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -126.53 98.36 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.905 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 642' ' ' GLN . 0.6 OUTLIER -56.68 -178.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -69.33 -72.61 0.82 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.572 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.24 174.04 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 110.941 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.14 118.56 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 18.7 mtm -95.1 29.33 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.059 0.457 . . . . 0.0 110.496 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.69 -162.82 1.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -114.44 99.75 7.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.456 0.646 . . . . 0.0 109.634 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.49 157.04 72.99 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 44.3 Cg_endo -64.39 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.567 2.178 . . . . 0.0 111.336 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.53 -64.89 0.38 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.776 ' HB2' HG12 ' A' ' 632' ' ' VAL . 4.4 tm0? -84.45 83.63 7.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 138.08 -1.32 2.77 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.493 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -96.57 -168.05 1.66 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.28 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.888 HG21 ' HZ ' ' A' ' 577' ' ' PHE . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.555 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.537 ' CE2' HG21 ' A' ' 678' ' ' ILE . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.676 ' OD1' HD12 ' P' ' 831' ' ' LEU . 1.3 m-20 -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.941 ' O ' HG21 ' A' ' 716' ' ' VAL . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.537 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.445 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.582 HD12 ' HA3' ' A' ' 708' ' ' GLY . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 659' ' ' LEU . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 2.2 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.741 ' OD1' HD11 ' A' ' 707' ' ' LEU . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 690' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.415 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.969 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 581' ' ' LYS . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.877 HG22 HD21 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.57 HD12 ' HB2' ' A' ' 705' ' ' GLU . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -83.41 128.64 34.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 0.7 OUTLIER -45.93 -30.46 1.77 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.289 0.566 . . . . 0.0 110.281 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.459 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 8.4 t-20 -150.42 -60.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.072 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.5 pt-20 165.17 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.448 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.3 30.93 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.394 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.741 HD11 ' OD1' ' A' ' 674' ' ' ASP . 9.0 mp -91.25 9.03 33.0 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 671' ' ' LEU . . . 42.4 81.06 0.03 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.205 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.45 ' HE2' ' CB ' ' A' ' 707' ' ' LEU . 0.3 OUTLIER -84.69 92.27 8.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.97 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.49 -177.06 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.71 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -63.93 140.05 58.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.37 97.47 6.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.21 0.528 . . . . 0.0 110.245 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 659' ' ' LEU . 10.3 mmm-85 41.09 80.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.797 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.407 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.941 HG21 ' O ' ' A' ' 663' ' ' ARG . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.631 ' O ' HD22 ' A' ' 726' ' ' LEU . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 726' ' ' LEU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.965 HG23 HG11 ' A' ' 621' ' ' VAL . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -30.98 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -126.04 -0.22 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 1.087 HD21 HG22 ' A' ' 621' ' ' VAL . 2.1 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.112 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -135.33 145.16 47.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.575 HD12 ' H ' ' P' ' 828' ' ' ILE . 1.2 mp -89.91 49.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -59.09 -174.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.676 HD12 ' OD1' ' A' ' 655' ' ' ASN . 17.9 mt 68.04 97.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.923 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -96.08 -10.92 27.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.33 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.68 -0.48 6.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.857 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.955 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.736 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.442 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 690' ' ' ILE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 613' ' ' ILE . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.955 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.705 ' N ' HD22 ' A' ' 592' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.023 HD12 HD22 ' A' ' 578' ' ' LEU . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.768 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.9 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 1.3 pt20 -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 726' ' ' LEU . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.038 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.038 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.941 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.41 ' CA ' ' NE ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.823 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.959 HG11 HG23 ' A' ' 727' ' ' VAL . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.665 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 18.7 t-80 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.681 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t-80 -75.69 129.51 37.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.18 125.02 43.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.22 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.551 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -88.01 162.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -52.3 -95.8 0.01 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.644 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.2 165.68 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.325 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 99.44 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.3 ttp -85.67 54.55 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.042 0.448 . . . . 0.0 110.222 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.75 -153.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.469 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.9 100.48 8.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.35 0.595 . . . . 0.0 109.943 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 50.8 p -137.51 156.37 74.95 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 67.5 Cg_endo -70.17 -153.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.577 2.185 . . . . 0.0 111.749 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 74.51 -71.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 39.18 -159.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.223 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -106.94 122.95 7.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.048 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 48.9 mt -150.84 -150.76 0.36 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.212 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.953 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.599 ' HD2' HD12 ' A' ' 659' ' ' LEU . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.478 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-20 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.474 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.827 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.863 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.478 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.953 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.763 HG23 HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.847 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.767 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.415 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.815 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.767 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 587' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.755 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.794 HG22 HD21 ' A' ' 578' ' ' LEU . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 705' ' ' GLU . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -114.68 169.26 9.2 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.585 ' O ' ' C ' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -59.05 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 703' ' ' PHE . 6.0 t-20 -16.65 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.991 0.424 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.704 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.5 pt-20 157.96 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.763 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 157.28 -21.35 0.42 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -87.13 9.75 18.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 703' ' ' PHE . . . -90.54 131.81 10.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.647 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.568 ' SD ' HD23 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -159.06 123.71 4.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.821 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.639 ' H ' HD13 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -79.23 -162.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.508 ' C ' ' O ' ' A' ' 710' ' ' LEU . 16.0 mt-30 -7.02 -66.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 710' ' ' LEU . 4.8 pt-20 -63.15 129.16 39.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.93 97.89 6.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.359 0.599 . . . . 0.0 110.45 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.827 ' NH2' HD22 ' A' ' 659' ' ' LEU . 7.0 mmm-85 50.97 79.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.824 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.415 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 663' ' ' ARG . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.524 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 600' ' ' PRO . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.959 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -64.84 -30.38 71.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -100.47 10.11 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.905 HD13 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -152.6 108.92 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.01 152.72 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -163.51 99.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 76.8 mt -93.76 116.07 28.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -91.06 -22.36 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -159.21 65.21 0.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.829 ' N ' HD23 ' A' ' 578' ' ' LEU . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.757 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.994 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.75 ' CD1' HG23 ' A' ' 613' ' ' ILE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.994 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.712 ' N ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 578' ' ' LEU . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.924 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mm-40 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB2' HG21 ' A' ' 700' ' ' THR . 5.6 pm0 -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.924 HG23 ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.689 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.055 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.513 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.055 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.928 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.928 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.752 ' CB ' HD13 ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.49 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.752 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 730' ' ' LEU . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.648 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 19.1 t-80 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 580' ' ' LEU . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.58 133.86 56.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.65 36.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.948 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -106.46 175.17 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.256 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -134.61 -177.67 15.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.146 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -70.05 106.52 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.76 0.314 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.69 101.17 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mmm -91.82 47.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.115 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.43 -151.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.481 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.56 100.49 8.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.386 0.612 . . . . 0.0 109.831 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 156.84 78.37 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 64.4 Cg_endo -69.68 -153.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.672 2.248 . . . . 0.0 111.641 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 69.48 -70.12 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 34.14 36.51 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.754 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.466 ' CA ' HG21 ' A' ' 632' ' ' VAL . . . 61.73 110.04 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.753 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.909 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 703' ' ' PHE . 54.6 mt -151.81 -173.61 4.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.342 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.794 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.011 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.598 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.699 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.698 ' OD1' HD11 ' P' ' 831' ' ' LEU . 7.0 m-80 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.48 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.862 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.564 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.598 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 649' ' ' TYR . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.615 ' OD1' HD12 ' A' ' 707' ' ' LEU . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.677 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.71 HG23 HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 655' ' ' ASN . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.858 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.858 HG12 ' CD1' ' A' ' 682' ' ' TRP . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 587' ' ' ILE . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.734 HG22 HD21 ' A' ' 578' ' ' LEU . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.803 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -91.82 132.21 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -30.17 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.971 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -169.78 29.76 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.521 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.15 -57.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 155.58 39.99 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.262 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.615 HD12 ' OD1' ' A' ' 674' ' ' ASP . 2.9 tp -94.62 8.26 42.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.057 0.428 . . . . 0.0 111.695 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.17 58.07 Favored Glycine 0 C--N 1.321 -0.256 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.642 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.441 ' HB2' ' H ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 36.72 -145.29 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.08 0.44 . . . . 0.0 111.206 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 710' ' ' LEU . 3.7 pp -66.33 129.67 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.835 0.35 . . . . 0.0 111.35 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 45.65 95.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.34 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.55 129.58 40.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 97.26 6.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.862 ' NH2' HD22 ' A' ' 659' ' ' LEU . 5.1 mmm-85 -111.66 72.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.074 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.469 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 1.034 HG23 HG11 ' A' ' 621' ' ' VAL . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -59.84 -25.18 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -109.4 -29.89 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 621' ' ' VAL . 2.5 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.649 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.06 136.74 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.2 pt -106.67 141.87 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.713 ' O ' HD23 ' P' ' 831' ' ' LEU . 18.8 p90 -164.18 141.86 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.713 HD23 ' O ' ' P' ' 830' ' ' TYR . 27.6 mt -144.59 119.27 9.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.88 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.09 -22.29 58.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.497 ' HA2' ' NE2' ' A' ' 596' ' ' GLN . . . -167.25 48.18 0.25 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.07 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.455 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.69 ' N ' HD23 ' A' ' 578' ' ' LEU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.724 HD21 HG23 ' A' ' 694' ' ' VAL . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 583' ' ' LEU . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.942 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.656 HD11 HG23 ' A' ' 613' ' ' ILE . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.49 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.942 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.838 HD12 ' SG ' ' A' ' 611' ' ' CYS . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.455 ' CB ' ' HD3' ' A' ' 576' ' ' ARG . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.995 HD12 HD22 ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.497 ' NE2' ' HA2' ' A' ' 575' ' ' GLY . 4.8 pm0 -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 598' ' ' VAL . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.738 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.844 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.78 ' N ' HD21 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.422 ' H ' ' HA ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.844 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 612' ' ' LYS . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.73 ' HB2' HD11 ' A' ' 681' ' ' ILE . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.954 HD12 ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.796 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.954 ' CD2' HD12 ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.605 ' CD1' HD11 ' A' ' 580' ' ' LEU . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HZ3' HG21 ' A' ' 700' ' ' THR . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' NE2' ' HE3' ' A' ' 709' ' ' MET . 6.9 t60 -80.14 132.13 35.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.22 105.59 8.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.406 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 633' ' ' GLY . 12.6 p -114.19 165.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -109.84 -168.5 19.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.674 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 67.87 89.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.882 0.372 . . . . 0.0 111.207 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.29 98.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.3 mtt -88.32 50.64 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.113 0.483 . . . . 0.0 110.113 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -153.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.401 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -115.25 100.57 8.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 109.67 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.8 p -133.56 156.6 79.44 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 43.5 Cg_endo -64.52 -150.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.526 2.15 . . . . 0.0 111.183 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.78 -63.7 0.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.718 0.294 . . . . 0.0 111.083 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -81.09 98.81 8.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 119.41 5.65 11.2 Favored Glycine 0 CA--C 1.508 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.144 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.792 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -86.44 -162.95 0.82 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.18 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.41 ' CG ' HD11 ' A' ' 671' ' ' LEU . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.021 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.919 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.437 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.425 HG22 ' O ' ' P' ' 829' ' ' PTR . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.92 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CD1' HD23 ' A' ' 659' ' ' LEU . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.919 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 707' ' ' LEU . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.58 ' OD2' HD21 ' A' ' 707' ' ' LEU . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.776 HG12 HD13 ' A' ' 659' ' ' LEU . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.567 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.661 ' OD1' HD22 ' P' ' 831' ' ' LEU . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.697 ' CG1' HG22 ' A' ' 681' ' ' ILE . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.8 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.551 HG23 ' CD1' ' A' ' 577' ' ' PHE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 700' ' ' THR . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -93.89 152.21 19.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.473 ' N ' HD12 ' A' ' 644' ' ' LEU . 45.9 p90 -58.59 -29.21 66.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.762 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -157.9 -55.41 0.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.823 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.616 ' HA ' HD22 ' A' ' 702' ' ' LEU . 9.5 pt-20 162.47 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.446 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.43 28.32 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.714 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 673' ' ' GLN . 3.0 mm? -82.94 9.66 9.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 84.33 -85.42 1.55 Allowed Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.455 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 1.3 ttp 60.95 78.32 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.51 -177.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -47.06 83.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.275 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 715' ' ' VAL . 39.0 mt-10 -63.91 130.96 46.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.066 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.65 97.55 6.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.095 0.474 . . . . 0.0 110.147 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 44.12 64.43 1.31 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.463 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.534 HG23 ' OE1' ' A' ' 712' ' ' GLU . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 663' ' ' ARG . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.413 HD21 ' OE2' ' A' ' 712' ' ' GLU . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.4 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.444 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.796 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 30.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 -37.71 3.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.239 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 730' ' ' LEU . 2.3 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -100.81 101.69 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 31.4 mt -85.45 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 829' ' ' PTR . . . . . 0.425 ' O ' HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -178.02 116.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.661 HD22 ' OD1' ' A' ' 683' ' ' ASP . 3.1 mt -115.89 74.58 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.918 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -93.47 6.34 48.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.558 0.218 . . . . 0.0 111.393 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 133.17 51.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.139 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.712 ' CE1' HD11 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.783 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.635 ' O ' HD23 ' A' ' 583' ' ' LEU . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.165 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 689' ' ' VAL . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.619 HG21 ' CE1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 690' ' ' ILE . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.627 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.8 pm0 -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.165 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 611' ' ' CYS . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.622 ' HG3' HG23 ' A' ' 579' ' ' THR . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.931 HD12 HD22 ' A' ' 578' ' ' LEU . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.488 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.2 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 598' ' ' VAL . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.003 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.557 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.003 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.825 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.589 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.925 HG22 HD13 ' A' ' 730' ' ' LEU . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.667 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' A' ' 700' ' ' THR . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 -62.21 136.31 57.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.06 122.19 40.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.034 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 633' ' ' GLY . 12.1 p -105.96 160.66 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 111.242 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -100.62 35.36 4.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.403 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.9 tttt 56.21 -172.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.784 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.59 122.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.7 mmm -78.18 60.0 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.966 0.412 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 176.57 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.74 99.72 7.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.358 0.599 . . . . 0.0 109.677 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 19.6 p -138.73 156.12 73.05 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 76.1 Cg_endo -72.55 -153.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.697 2.265 . . . . 0.0 111.728 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 78.85 -71.98 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.755 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 38.76 -157.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.126 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.691 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.99 114.11 3.23 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.364 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.938 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.2 mp -148.18 -161.84 1.42 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.819 -0.69 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.514 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.086 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.565 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.446 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.474 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.829 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 41.0 m-80 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.927 ' O ' HG21 ' A' ' 716' ' ' VAL . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 656' ' ' VAL . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 706' ' ' GLY . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.78 HG22 HD21 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.848 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.706 HG21 ' OD2' ' A' ' 615' ' ' ASP . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.73 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.832 ' OD2' HD22 ' P' ' 831' ' ' LEU . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.619 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 588' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.72 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.48 HG23 ' CD1' ' A' ' 577' ' ' PHE . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.479 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -93.42 146.35 23.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.938 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -41.55 -31.94 0.31 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.064 179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.633 ' ND2' ' CD2' ' A' ' 703' ' ' PHE . 13.5 p30 -179.41 31.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.088 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.4 OUTLIER 68.54 -57.38 0.5 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.963 -178.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 147.91 63.13 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.02 8.67 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 110.92 -68.38 0.22 Allowed Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.962 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.404 ' CE ' ' NE2' ' A' ' 630' ' ' HIS . 0.0 OUTLIER 67.91 119.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 0.0 110.569 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.871 HD22 ' N ' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -51.82 -172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.497 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.871 ' N ' HD22 ' A' ' 710' ' ' LEU . 0.0 OUTLIER 77.05 -62.99 0.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.026 0.441 . . . . 0.0 110.072 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.11 121.57 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.603 ' O ' HG13 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -115.06 97.5 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.289 0.566 . . . . 0.0 110.264 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.829 ' NH2' HD22 ' A' ' 659' ' ' LEU . 12.0 mmm-85 16.13 79.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.11 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.927 HG21 ' O ' ' A' ' 663' ' ' ARG . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.885 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.65 9.98 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.176 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.925 HD13 HG22 ' A' ' 621' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.609 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 59.66 83.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.822 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.2 pt -60.47 172.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.93 162.12 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.832 HD22 ' OD2' ' A' ' 683' ' ' ASP . 0.4 OUTLIER -131.42 152.61 50.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 39.9 t0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -84.89 -22.2 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.656 0.265 . . . . 0.0 111.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 124.22 2.14 8.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.943 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.839 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 594' ' ' ILE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.75 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.945 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.572 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.572 HG13 HD13 ' A' ' 588' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.945 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.91 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 625' ' ' ILE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 2.5 pt20 -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.862 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.91 ' SG ' HD13 ' A' ' 592' ' ' LEU . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.936 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.746 ' HB3' HD13 ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 680' ' ' ILE . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.993 HG22 HD21 ' A' ' 730' ' ' LEU . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.585 ' O ' ' N ' ' A' ' 653' ' ' GLY . 22.4 t-80 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.845 HD12 HD11 ' A' ' 594' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 -71.35 123.71 22.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.371 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -136.8 -176.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.833 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.578 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -58.81 -92.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -156.98 178.15 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 110.711 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.1 92.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.221 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 31.7 mmt -87.93 51.82 2.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 110.088 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.91 -149.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.479 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.22 97.45 6.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.594 0.711 . . . . 0.0 109.562 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.3 p -140.75 156.86 68.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.461 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.04 -157.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.196 1.93 . . . . 0.0 111.135 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.54 22.58 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.02 61.7 5.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.584 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.47 107.18 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.53 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.63 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -144.96 -155.76 0.64 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.509 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.403 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.839 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.944 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CB ' HD21 ' A' ' 672' ' ' LEU . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.466 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 6.0 m-80 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.476 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.784 HD22 HH21 ' A' ' 714' ' ' ARG . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.753 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.466 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.944 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.702 ' CD2' HD11 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.63 ' OE1' HD23 ' A' ' 707' ' ' LEU . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.607 ' OD1' HD11 ' A' ' 707' ' ' LEU . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.649 HG22 ' CD2' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.515 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.731 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 596' ' ' GLN . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.64 ' C ' HD22 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -90.44 150.19 21.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.764 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -50.92 -23.08 2.59 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.655 ' ND2' ' CG ' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -172.42 -43.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.554 178.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER 158.15 -29.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.5 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.34 15.98 0.49 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.345 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -80.97 9.59 6.3 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 42.31 81.74 0.03 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.502 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.402 ' HE1' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -75.36 92.26 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 0.0 110.727 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -162.12 171.08 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.099 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -28.61 68.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.029 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.699 ' HB2' HD13 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -63.59 140.23 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.649 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -116.15 97.52 6.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.784 HH21 HD22 ' A' ' 659' ' ' LEU . 1.1 mmm-85 41.8 89.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.424 HG21 ' HG2' ' A' ' 712' ' ' GLU . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.753 HG21 ' O ' ' A' ' 663' ' ' ARG . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' A' ' 724' ' ' LYS . 31.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.45 ' O ' HG12 ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.86 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm -87.34 51.2 2.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.993 HD21 HG22 ' A' ' 621' ' ' VAL . 3.3 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -67.86 168.43 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.656 ' N ' HD13 ' P' ' 828' ' ' ILE . 0.1 OUTLIER -124.67 136.56 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 101.52 4.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' P' ' 831' ' ' LEU . 13.5 mt -123.1 82.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -86.28 -14.28 44.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 111.238 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.08 11.92 3.03 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.983 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.809 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.038 HD22 HD13 ' A' ' 647' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.565 ' H ' HD12 ' A' ' 578' ' ' LEU . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.616 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 613' ' ' ILE . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.687 ' N ' HD22 ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.458 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 578' ' ' LEU . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.774 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.8 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.94 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.773 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.965 HG22 HD21 ' A' ' 730' ' ' LEU . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.704 ' CE1' HG23 ' A' ' 680' ' ' ILE . 22.7 t-80 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.605 HD12 HD11 ' A' ' 594' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 647' ' ' ILE . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t-80 -76.21 131.44 39.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -111.04 119.13 38.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.238 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -94.74 -171.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.781 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.602 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -88.42 49.12 3.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.736 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.96 172.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.2 106.95 3.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.017 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.4 ttt -93.41 26.96 2.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.512 . . . . 0.0 110.444 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.24 -159.58 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.067 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.3 96.92 7.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.723 0.773 . . . . 0.0 109.408 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -140.88 156.51 68.61 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.276 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.95 -158.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.15 1.9 . . . . 0.0 111.27 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.48 23.46 0.23 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.235 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.82 63.28 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.555 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.453 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 58.32 116.15 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.603 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 703' ' ' PHE . 93.4 mt -154.14 -144.39 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.71 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.038 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.706 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 6.7 m-80 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 656' ' ' VAL . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.758 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 652' ' ' THR . 35.5 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.706 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 694' ' ' VAL . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.662 ' HB3' HD22 ' A' ' 707' ' ' LEU . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.876 ' OD1' HD21 ' A' ' 707' ' ' LEU . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 613' ' ' ILE . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.634 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.691 ' OD2' HD22 ' P' ' 831' ' ' LEU . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 587' ' ' ILE . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.883 HG13 HD11 ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.698 ' CG1' HD13 ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -78.07 155.42 30.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -58.04 -15.7 10.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.109 179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 4.9 t-20 -177.43 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.631 ' HB2' HD13 ' A' ' 696' ' ' ILE . 2.0 pt-20 163.71 -37.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.765 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 152.16 34.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.212 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.876 HD21 ' OD1' ' A' ' 674' ' ' ASP . 2.9 mm? -86.19 9.23 18.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.028 0.414 . . . . 0.0 112.004 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 60.46 -84.24 0.02 OUTLIER Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.569 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 29.5 mtm 59.89 83.83 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 710' ' ' LEU . 0.2 OUTLIER -165.27 -176.68 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 -55.21 -34.97 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.15 139.93 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.59 97.31 5.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.172 0.511 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 37.96 79.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.736 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 663' ' ' ARG . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 727' ' ' VAL . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.853 HG23 HG11 ' A' ' 621' ' ' VAL . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.79 -29.29 39.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -111.58 -23.95 10.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.221 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.965 HD21 HG22 ' A' ' 621' ' ' VAL . 1.3 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.6 127.48 53.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.4 mt -100.98 129.88 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 4.2 p90 -143.65 118.57 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.691 HD22 ' OD2' ' A' ' 683' ' ' ASP . 12.8 mt -104.13 103.27 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.914 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.72 -14.59 62.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.654 0.264 . . . . 0.0 111.263 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 116.35 -42.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.467 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 647' ' ' ILE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.447 ' H ' HD12 ' A' ' 578' ' ' LEU . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.024 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.55 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.652 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 613' ' ' ILE . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.785 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.476 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.024 HD11 HD11 ' A' ' 580' ' ' LEU . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.893 HG23 HG13 ' A' ' 588' ' ' ILE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.895 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.895 HD13 ' CB ' ' A' ' 615' ' ' ASP . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.608 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.913 HG11 HG23 ' A' ' 727' ' ' VAL . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.646 ' CE1' ' HB ' ' A' ' 680' ' ' ILE . 16.4 t-80 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.602 HD11 HD21 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 5.5 t-80 -76.24 129.66 37.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.26 129.04 52.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -97.41 159.96 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -74.52 170.01 53.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.498 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 90.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.38 109.93 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.02 35.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 -152.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.423 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -114.51 100.31 8.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.751 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 p -137.28 156.68 75.18 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.753 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 65.2 Cg_endo -69.64 -153.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.687 2.258 . . . . 0.0 111.737 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 77.98 -70.38 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 37.61 35.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.0 125.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.743 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.4 mt -155.88 -147.0 0.19 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.123 -0.538 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.853 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 623' ' ' CYS . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.575 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.859 HD12 ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 659' ' ' LEU . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.668 ' HB3' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.894 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.455 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 653' ' ' GLY . 30.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.859 ' CE1' HD12 ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.596 HD13 HG21 ' A' ' 694' ' ' VAL . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 1.4 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.698 ' OD1' HD11 ' A' ' 707' ' ' LEU . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.754 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.646 ' HB ' ' CE1' ' A' ' 622' ' ' HIS . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.697 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.688 ' OD1' HD13 ' P' ' 831' ' ' LEU . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.697 HG12 ' CD1' ' A' ' 682' ' ' TRP . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.652 ' CD1' HG22 ' A' ' 587' ' ' ILE . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 1.006 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.896 HG12 HD13 ' A' ' 578' ' ' LEU . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.746 HG22 ' CE2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.25 136.14 39.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.859 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.21 -24.81 3.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 707' ' ' LEU . 6.7 t-20 -160.24 -56.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 696' ' ' ILE . 5.6 pt-20 161.67 -30.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.13 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 142.49 33.11 0.11 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.662 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.698 HD11 ' OD1' ' A' ' 674' ' ' ASP . 8.4 mp -88.29 8.37 27.72 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 33.16 71.16 0.11 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.571 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.426 ' HE3' ' H ' ' A' ' 709' ' ' MET . 0.0 OUTLIER -79.13 118.95 21.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.102 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 712' ' ' GLU . 0.3 OUTLIER 178.74 170.23 0.85 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.756 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -31.05 66.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 710' ' ' LEU . 1.3 mt-10 -63.68 141.16 58.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -113.77 97.17 6.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.291 0.567 . . . . 0.0 110.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.736 ' HA ' ' NE ' ' A' ' 714' ' ' ARG . 4.7 mmm180 28.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.946 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.894 HG21 ' O ' ' A' ' 663' ' ' ARG . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.405 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.913 HG23 HG11 ' A' ' 621' ' ' VAL . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -60.38 -26.74 66.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -91.47 -16.83 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.075 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.884 HD13 HG22 ' A' ' 621' ' ' VAL . 5.2 tt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -161.82 126.63 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 13.8 pt -73.68 148.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.51 116.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.718 ' O ' HD12 ' P' ' 831' ' ' LEU . 0.6 OUTLIER -147.92 89.1 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.978 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -92.42 8.82 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -137.64 -36.98 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.657 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.015 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.809 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.901 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 587' ' ' ILE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.901 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.614 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.95 HD11 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.723 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.011 ' HB3' HG23 ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.536 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.802 ' HB3' HD13 ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.487 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.992 HD11 ' CG2' ' A' ' 680' ' ' ILE . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.871 HG11 ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.59 ' NE2' HG23 ' A' ' 680' ' ' ILE . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.598 ' CD1' HD21 ' A' ' 580' ' ' LEU . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.503 ' NZ ' HG21 ' A' ' 700' ' ' THR . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.479 ' CE1' ' CE2' ' A' ' 703' ' ' PHE . 1.7 t60 -61.98 134.39 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -134.52 126.05 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 642' ' ' GLN . 0.4 OUTLIER -114.69 -175.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.574 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -56.92 -168.17 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.563 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -74.25 133.9 42.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.41 119.58 35.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.7 mmm -94.38 28.4 2.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.121 0.486 . . . . 0.0 110.568 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -163.86 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.6 99.49 7.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.398 0.618 . . . . 0.0 109.676 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.402 ' HB2' ' HD2' ' A' ' 640' ' ' PRO . 92.0 p -138.88 156.36 72.7 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.797 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.547 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.6 Cg_endo -67.46 -151.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.534 2.156 . . . . 0.0 111.178 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 75.39 -62.18 0.45 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.721 0.296 . . . . 0.0 111.2 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.789 ' HB2' HG12 ' A' ' 632' ' ' VAL . 63.5 tt0 -98.61 93.16 5.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 111.38 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 146.47 -6.36 1.24 Allowed Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.828 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.8 mp -106.54 -164.87 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.219 -0.49 . . . . 0.0 110.76 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.872 ' O ' HD13 ' A' ' 702' ' ' LEU . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.557 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.646 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.447 ' O ' ' OE1' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.81 ' OD1' HD12 ' P' ' 831' ' ' LEU . 5.0 m-80 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.507 ' N ' HD12 ' A' ' 659' ' ' LEU . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.617 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.6 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.89 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE3' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 652' ' ' THR . 37.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.557 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.93 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.588 ' HB3' HD12 ' A' ' 707' ' ' LEU . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.457 ' OD2' HD13 ' A' ' 707' ' ' LEU . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.434 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.608 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.811 HG22 HD13 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.992 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.678 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 689' ' ' VAL . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.93 HG21 HD13 ' A' ' 672' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 705' ' ' GLU . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.503 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.28 130.48 37.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.2 p90 -44.3 -31.3 0.99 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 110.486 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 3.9 t-20 -149.06 -55.9 0.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.065 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 696' ' ' ILE . 11.5 pt-20 156.51 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.402 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 141.24 -9.36 2.71 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 673' ' ' GLN . 3.0 tt -94.58 9.84 37.08 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.904 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.44 126.98 7.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 5.8 mmt -148.66 134.28 18.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 110.96 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -140.51 138.41 34.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 140.67 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.706 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -115.78 97.5 6.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.397 0.617 . . . . 0.0 110.078 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.651 ' HA ' ' NE ' ' A' ' 714' ' ' ARG . 5.0 mmm180 35.89 89.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.12 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.559 ' HA ' ' ND2' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 663' ' ' ARG . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.871 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -57.66 -25.42 60.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -100.17 -43.26 6.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.726 HD21 HG22 ' A' ' 621' ' ' VAL . 2.0 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 827' ' ' ASP . . . . . 0.543 ' C ' HD13 ' P' ' 828' ' ' ILE . 47.7 m-20 -147.6 80.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.543 HD13 ' C ' ' P' ' 827' ' ' ASP . 0.7 OUTLIER -113.26 80.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 2.7 m-85 -113.0 -163.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.81 HD12 ' OD1' ' A' ' 655' ' ' ASN . 18.3 mt 69.51 63.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.8 10.15 41.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.282 . . . . 0.0 111.403 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 116.55 -4.85 19.37 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.948 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.023 HD12 HD13 ' A' ' 647' ' ' ILE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.82 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 579' ' ' THR . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.885 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.542 HD13 HG23 ' A' ' 587' ' ' ILE . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.885 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 592' ' ' LEU . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.482 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.964 HD12 HD22 ' A' ' 578' ' ' LEU . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.841 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.666 ' HB2' HG21 ' A' ' 700' ' ' THR . 4.7 pm0 -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.008 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.47 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.008 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.846 ' C ' HD13 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 1.008 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.901 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.824 HD13 ' CG ' ' A' ' 615' ' ' ASP . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 730' ' ' LEU . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.607 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 21.1 t-80 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.722 ' CD1' HD11 ' A' ' 580' ' ' LEU . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.3 134.26 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.27 116.51 29.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.545 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 633' ' ' GLY . 8.1 p -107.87 161.24 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.983 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -82.25 148.55 26.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.94 91.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.16 115.74 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.99 29.44 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.104 0.478 . . . . 0.0 110.25 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.09 -159.81 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.885 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.77 99.78 7.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.593 0.711 . . . . 0.0 109.732 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 p -138.7 156.58 72.9 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 57.5 Cg_endo -67.67 -153.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.414 2.076 . . . . 0.0 111.394 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 71.91 -68.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.822 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.433 ' HB2' HD11 ' A' ' 644' ' ' LEU . 7.1 mm-40 43.99 -164.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.964 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.612 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -123.31 119.46 3.86 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.647 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -150.24 -162.04 1.47 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.97 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.418 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.859 ' HG ' HG22 ' A' ' 678' ' ' ILE . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.905 ' O ' HG21 ' A' ' 716' ' ' VAL . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.447 ' HA ' HG11 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 649' ' ' TYR . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.655 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.859 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.682 HG23 HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.901 HG21 ' OD2' ' A' ' 615' ' ' ASP . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.698 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ASN . . . . . 0.517 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 1.008 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.78 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 674' ' ' ASP . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -81.06 137.52 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.693 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.8 p90 -45.1 -32.91 1.94 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.489 0.661 . . . . 0.0 110.328 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -141.75 -44.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.59 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 17.1 pt-20 137.31 -22.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.302 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.655 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 100.71 20.75 13.8 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.414 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.554 HD22 ' OD2' ' A' ' 674' ' ' ASP . 0.1 OUTLIER -82.83 8.02 13.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.14 97.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.206 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.448 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -41.83 97.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.304 . . . . 0.0 111.642 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.5 OUTLIER 35.95 82.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.163 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 40.77 88.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 141.31 36.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.49 . . . . 0.0 111.7 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -113.4 99.61 7.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -73.33 -151.45 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.15 -178.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.905 HG21 ' O ' ' A' ' 663' ' ' ARG . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -90.34 42.84 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.07 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.536 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 621' ' ' VAL . 4.9 mt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.32 -0.847 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.873 0.368 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.32 165.27 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 828' ' ' ILE . . . . . 0.619 HD12 ' CB ' ' P' ' 830' ' ' TYR . 10.9 pt -96.05 176.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' P' P ' 830' ' ' TYR . . . . . 0.619 ' CB ' HD12 ' P' ' 828' ' ' ILE . 4.0 t80 -92.78 133.31 36.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.12 122.49 39.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -83.46 -22.56 32.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.82 50.75 0.85 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.642 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.062 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.805 ' N ' HD23 ' A' ' 578' ' ' LEU . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.814 HD11 HD12 ' A' ' 625' ' ' ILE . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.726 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.444 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.459 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.88 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.044 HD12 HD22 ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.488 ' N ' HG12 ' A' ' 598' ' ' VAL . 13.3 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.036 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.899 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.871 ' HB3' HD13 ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.871 HD13 ' HB3' ' A' ' 615' ' ' ASP . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.951 ' CG2' HD11 ' A' ' 730' ' ' LEU . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.651 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 17.7 t-80 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 680' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.814 HD12 HD11 ' A' ' 580' ' ' LEU . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.6 t60 -61.07 140.54 57.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.449 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -56.0 -162.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.334 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.4 OUTLIER 65.13 179.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.639 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.64 ' N ' HG13 ' A' ' 632' ' ' VAL . . . 140.22 163.68 9.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.406 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp 56.67 83.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.2 p -119.44 133.08 55.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.8 tpt -97.24 27.27 4.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -145.0 -159.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.617 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -114.44 98.99 7.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.417 0.627 . . . . 0.0 109.898 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.8 p -139.47 156.54 71.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.504 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 72.1 Cg_endo -72.82 -156.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.384 2.056 . . . . 0.0 111.482 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 67.65 -67.76 0.17 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 34.4 36.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.77 114.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.726 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 701' ' ' GLY . 91.7 mt -155.31 -166.07 2.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.287 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.848 ' O ' HD23 ' A' ' 702' ' ' LEU . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.062 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.932 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.62 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.054 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.589 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.733 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.932 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.701 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 659' ' ' LEU . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 657' ' ' SER . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.558 HD11 HD21 ' P' ' 831' ' ' LEU . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.873 ' CD1' HG12 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.873 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 587' ' ' ILE . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 705' ' ' GLU . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 700' ' ' THR . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.832 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -87.23 136.94 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.632 ' HA ' HD12 ' A' ' 644' ' ' LEU . 4.4 p90 -28.34 -42.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.412 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.6 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -133.29 -47.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.518 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 17.0 pt-20 133.14 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.349 1.031 . . . . 0.0 109.359 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.36 10.74 4.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.111 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 9.73 8.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.19 -135.55 11.98 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.9 ttm 179.06 -140.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.407 . . . . 0.0 109.999 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -163.46 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -44.61 -93.26 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.605 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -115.02 99.47 7.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.716 0.293 . . . . 0.0 111.569 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 43.8 tp60 -117.16 96.93 5.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 713' ' ' GLN . 6.0 mmm-85 -162.93 69.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.71 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.427 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 663' ' ' ARG . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.844 ' CG2' HG11 ' A' ' 621' ' ' VAL . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -62.3 -21.05 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -56.87 16.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.03 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.951 HD11 ' CG2' ' A' ' 621' ' ' VAL . 3.4 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -68.42 74.38 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.4 pt -107.27 98.58 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.89 132.97 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.558 HD21 HD11 ' A' ' 681' ' ' ILE . 63.7 mt -103.3 156.79 17.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -70.47 -19.39 62.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.656 0.265 . . . . 0.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 123.67 11.48 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.797 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.987 HD12 HD13 ' A' ' 647' ' ' ILE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.799 ' N ' HD23 ' A' ' 578' ' ' LEU . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.619 ' O ' HD13 ' A' ' 583' ' ' LEU . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.954 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.717 HG22 HG12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.674 ' CD1' HG23 ' A' ' 613' ' ' ILE . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.954 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.79 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.488 ' O ' ' NE2' ' A' ' 595' ' ' GLN . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 580' ' ' LEU . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.785 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.9 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 1.2 pt20 -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.529 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 588' ' ' ILE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.908 HG22 HD21 ' A' ' 730' ' ' LEU . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.71 ' CD1' HD11 ' A' ' 580' ' ' LEU . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.431 ' NZ ' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 -61.19 136.33 58.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.452 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -50.58 -176.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.762 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.4 OUTLIER 57.77 -179.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.511 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.632 ' N ' HG13 ' A' ' 632' ' ' VAL . . . 119.65 32.37 1.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.582 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -131.53 60.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 20.1 p -102.47 141.59 35.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.086 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.44 31.83 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.483 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.93 -153.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.4 99.72 7.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.511 0.672 . . . . 0.0 109.891 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.7 p -138.72 156.63 72.86 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 642' ' ' GLN . 74.0 Cg_endo -71.55 -156.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.562 2.174 . . . . 0.0 111.74 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 65.04 -71.87 0.07 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 640' ' ' PRO . 2.7 mt-30 41.12 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -112.51 118.26 4.59 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.083 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.728 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.1 mp -143.88 -154.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.766 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.833 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.987 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.67 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.931 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 12.3 m120 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.928 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.67 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.831 ' CD2' HD11 ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.469 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.511 ' OD1' HD22 ' A' ' 707' ' ' LEU . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.901 HG22 HD21 ' A' ' 659' ' ' LEU . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 587' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.581 ' CE2' HD11 ' A' ' 680' ' ' ILE . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.7 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 705' ' ' GLU . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 700' ' ' THR . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.24 139.58 30.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.728 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -49.06 -29.44 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.395 0.617 . . . . 0.0 110.103 178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 2.4 t-20 -150.96 -58.29 0.17 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.906 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 696' ' ' ILE . 5.8 pt-20 159.59 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.36 -10.9 2.0 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.661 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -87.94 9.34 22.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 703' ' ' PHE . . . 65.78 -167.08 34.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.757 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.77 30.85 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 711' ' ' GLN . 3.4 pp -127.89 -169.7 2.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.698 ' N ' HD12 ' A' ' 710' ' ' LEU . 1.1 mp0 -63.96 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.046 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.8 102.58 10.14 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.684 ' CD ' HD21 ' A' ' 710' ' ' LEU . 38.6 tt0 -116.55 97.51 6.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.931 ' NH2' HD22 ' A' ' 659' ' ' LEU . 16.0 mmm-85 -157.07 77.02 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.036 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.928 HG21 ' O ' ' A' ' 663' ' ' ARG . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.85 ' CG2' HG11 ' A' ' 621' ' ' VAL . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.62 -29.45 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -114.3 -24.38 8.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.908 HD21 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.93 91.69 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.4 pt -86.54 169.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -61.9 157.49 18.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 15.5 mt -124.76 119.6 29.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.016 -0.434 . . . . 4.52 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -69.48 -19.41 63.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.284 . . . . 3.76 111.277 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -144.42 -17.09 0.21 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.454 -0.879 . . . . 0.66 113.64 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 1.67 110.677 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.65 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.92 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.952 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 0.93 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 0.4 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.754 ' CD2' HG23 ' A' ' 694' ' ' VAL . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 0.84 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 1.67 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.3 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.17 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.62 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.67 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.07 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 690' ' ' ILE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 1.92 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.597 ' CD1' HG23 ' A' ' 613' ' ' ILE . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 1.39 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.452 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.11 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 0.54 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.792 HD12 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 1.98 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.721 HD12 HD22 ' A' ' 578' ' ' LEU . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 0.32 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.3 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.66 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 3.0 pt20 -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.11 109.084 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.26 113.177 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 0.82 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.88 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.3 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.26 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.24 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 1.014 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 0.45 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.3 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.02 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.32 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.37 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.88 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.27 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.24 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 1.014 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 0.5 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.852 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.07 113.095 -178.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 612' ' ' LYS . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.11 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.97 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.61 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.89 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.68 112.001 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 615' ' ' ASP . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 0.72 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.09 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 0.91 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.854 HG11 ' CG2' ' A' ' 727' ' ' VAL . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 0.26 109.105 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.614 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 17.4 t-80 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.28 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 0.24 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.3 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 580' ' ' LEU . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 0.76 107.794 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.3 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.455 ' NZ ' HG21 ' A' ' 700' ' ' THR . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 0.91 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.8 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.29 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -64.02 126.34 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.99 111.302 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.87 31.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.18 111.298 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.1 p -102.55 160.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 2.34 111.103 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -66.1 165.47 38.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 2.86 112.422 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -58.51 130.22 45.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 4.8 110.831 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.44 112.93 20.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 2.46 111.142 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 20.1 mtp -97.9 30.86 2.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 4.7 110.337 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.29 -153.69 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 6.29 110.506 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 100.22 8.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.375 0.607 . . . . 3.86 109.733 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 11.5 p -138.24 156.9 73.51 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.003 -0.999 . . . . 2.36 110.704 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.6 Cg_endo -67.97 -153.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.567 2.178 . . . . 2.3 111.514 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 703' ' ' PHE . . . 68.62 -70.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.278 -0.419 . . . . 1.49 110.758 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 34.37 37.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.906 -0.588 . . . . 4.12 111.531 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.56 115.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.081 -0.58 . . . . 0.91 112.303 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.0 mt -151.63 -152.45 0.43 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.814 -0.693 . . . . 1.25 110.253 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' O ' HD22 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.36 109.621 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.952 HD13 HD12 ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 0.35 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.965 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.43 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.58 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.34 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.44 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.25 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 0.26 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 0.33 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.8 m-20 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.83 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 0.98 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.16 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.22 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.104 HD13 HG22 ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.29 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.15 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 2.42 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 714' ' ' ARG . 5.7 m-80 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.9 111.096 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 2.64 110.324 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 656' ' ' VAL . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.98 111.24 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 0.64 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.82 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 0.44 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 0.82 109.157 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.783 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 0.8 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.965 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 1.5 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.58 HD21 ' CB ' ' A' ' 649' ' ' TYR . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 0.63 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.498 ' CB ' ' HA ' ' A' ' 707' ' ' LEU . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.54 110.987 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 707' ' ' LEU . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.41 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.43 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.31 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.676 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.43 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.104 HG22 HD13 ' A' ' 659' ' ' LEU . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.34 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.04 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.57 ' CG2' ' CE1' ' A' ' 622' ' ' HIS . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 1.7 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.537 HG21 ' OD2' ' A' ' 615' ' ' ASP . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 0.62 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' TRP . . . . . 0.652 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.91 111.14 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.44 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.14 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.84 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.14 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.18 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.652 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.38 111.307 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 615' ' ' ASP . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.83 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.33 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.35 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 1.87 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.754 HG23 ' CD2' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.31 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.92 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 705' ' ' GLU . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.47 111.17 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 0.55 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 700' ' ' THR . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 0.99 110.765 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 645' ' ' ASP . 2.7 mt -78.42 138.96 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 1.42 111.054 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.925 ' HA ' HD12 ' A' ' 644' ' ' LEU . 39.4 p90 -43.25 -34.72 1.23 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.654 0.74 . . . . 1.32 109.862 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 2.8 t-20 -145.63 -59.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.504 -1.225 . . . . 1.86 108.865 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 696' ' ' ILE . 5.8 pt-20 161.24 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.684 -1.144 . . . . 1.94 109.593 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.02 -9.11 2.0 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.745 -0.661 . . . . 1.6 112.765 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.672 HD13 ' OD2' ' A' ' 674' ' ' ASP . 1.0 OUTLIER -86.57 9.15 19.37 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.293 0.479 . . . . 1.94 112.293 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 50.2 -160.76 1.19 Allowed Glycine 0 C--N 1.319 -0.362 0 C-N-CA 120.805 -0.712 . . . . 2.51 112.662 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.05 40.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.271 . . . . 3.2 110.933 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.417 HD13 ' CB ' ' A' ' 712' ' ' GLU . 0.2 OUTLIER -132.72 -172.8 3.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.864 0.364 . . . . 4.19 111.306 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -62.81 -17.95 62.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 6.06 112.047 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.417 ' CB ' HD13 ' A' ' 710' ' ' LEU . 1.1 tm-20 -63.39 120.82 12.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 6.04 110.773 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -116.45 97.18 5.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.152 0.501 . . . . 4.64 110.605 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.471 ' HB3' ' ND2' ' A' ' 662' ' ' ASN . 0.3 OUTLIER 30.75 89.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.028 -0.987 . . . . 2.5 112.856 179.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.59 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.886 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 0.72 111.113 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.693 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.47 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.01 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 0.82 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.7 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.26 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.65 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 2.68 111.155 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.61 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.23 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 621' ' ' VAL . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.66 111.063 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -25.83 53.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 2.75 110.993 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -106.15 -35.51 7.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 2.83 110.988 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.752 HD21 HG22 ' A' ' 621' ' ' VAL . 1.8 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.184 -0.912 . . . . 2.69 110.879 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.795 0.331 . . . . 7.03 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -88.9 106.14 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 5.4 110.924 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -108.51 93.43 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 2.95 110.961 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.27 153.96 23.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 5.79 110.945 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 831' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' P' ' 831' ' ' LEU . 22.0 mt -154.75 148.04 24.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 2.56 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.195 -0.907 . . . . 4.87 110.91 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.454 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 696' ' ' ILE . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 578' ' ' LEU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.79 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.706 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.971 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.841 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.971 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.454 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.691 HG23 ' CD1' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.738 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.9 OUTLIER -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.47 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.691 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.904 ' C ' HD13 ' A' ' 603' ' ' ILE . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.991 ' HB3' HG23 ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.932 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.932 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.626 ' CB ' HD13 ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 63.5 t60 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.79 ' CD1' HD11 ' A' ' 580' ' ' LEU . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HZ1' HG21 ' A' ' 700' ' ' THR . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.7 mp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.88 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.993 ' CH2' HD22 ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 656' ' ' VAL . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.891 ' O ' HG21 ' A' ' 716' ' ' VAL . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.425 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.541 ' HE2' HD11 ' A' ' 717' ' ' LEU . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.634 ' HD2' HD23 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.993 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.738 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 688' ' ' PHE . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.837 ' CD1' HG12 ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 686' ' ' ASN . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 587' ' ' ILE . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.756 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 577' ' ' PHE . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 700' ' ' THR . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 660' ' ' ASN . 16.0 mmm-85 . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 120.941 0.4 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.891 HG21 ' O ' ' A' ' 663' ' ' ARG . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.541 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.403 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 120.375 -0.125 . . . . 0.0 112.8 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.93 HD22 ' CD1' ' A' ' 594' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.724 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 583' ' ' LEU . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.937 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.485 HD11 ' OD1' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.829 HD12 HD13 ' A' ' 613' ' ' ILE . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.937 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 592' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.93 ' CD1' HD22 ' A' ' 578' ' ' LEU . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.772 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.772 HG23 ' HB2' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.723 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.613 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.896 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.613 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 588' ' ' ILE . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.876 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 681' ' ' ILE . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.876 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.908 HG11 HG23 ' A' ' 727' ' ' VAL . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.623 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 46.5 t60 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.456 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 603' ' ' ILE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 580' ' ' LEU . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 629' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.5 mp . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.88 HD13 HD12 ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CB ' HD21 ' A' ' 672' ' ' LEU . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.493 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.691 HD13 HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.923 ' O ' HG21 ' A' ' 716' ' ' VAL . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.493 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.677 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.943 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 694' ' ' VAL . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 583' ' ' LEU . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.703 HD11 HG21 ' A' ' 690' ' ' ILE . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 655' ' ' ASN . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.802 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.452 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.802 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.703 HG21 HD11 ' A' ' 680' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 580' ' ' LEU . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.841 HG22 HD21 ' A' ' 578' ' ' LEU . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 700' ' ' THR . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.675 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 121.062 0.458 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.923 HG21 ' O ' ' A' ' 663' ' ' ARG . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 727' ' ' VAL . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 626' ' ' PHE . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.908 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.769 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.613 ' O ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.977 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 613' ' ' ILE . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.522 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.977 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 578' ' ' LEU . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.2 mm-40 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.401 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.709 ' HG3' HD23 ' A' ' 726' ' ' LEU . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.859 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 588' ' ' ILE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.759 ' HB3' HD13 ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.843 HG11 ' CG2' ' A' ' 727' ' ' VAL . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.703 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.628 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.695 ' CD1' HD11 ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 700' ' ' THR . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 96.0 mt . . . . . 0 C--O 1.227 -0.111 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.793 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 672' ' ' LEU . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.551 ' O ' HG13 ' A' ' 656' ' ' VAL . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.782 HD12 ' HE1' ' A' ' 670' ' ' PHE . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.725 ' N ' HD13 ' A' ' 659' ' ' LEU . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.445 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.782 ' HE1' HD12 ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 649' ' ' TYR . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.432 ' HG3' ' HD3' ' A' ' 714' ' ' ARG . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.629 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.716 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.725 ' HD1' HG12 ' A' ' 689' ' ' VAL . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.725 HG12 ' HD1' ' A' ' 682' ' ' TRP . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 587' ' ' ILE . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' A' ' 577' ' ' PHE . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.554 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.756 ' HA ' ' CZ ' ' A' ' 714' ' ' ARG . 3.1 mmm180 . . . . . 0 N--CA 1.439 -1.002 0 CA-C-O 121.07 0.462 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.421 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.843 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 1.015 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.035 HD21 HG22 ' A' ' 694' ' ' VAL . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 581' ' ' LYS . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.647 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 583' ' ' LEU . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.949 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.738 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 690' ' ' ILE . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.804 HG13 HD12 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.949 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.54 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.726 HD23 ' HE2' ' A' ' 692' ' ' PHE . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.004 HD12 HD22 ' A' ' 578' ' ' LEU . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.871 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mm-40 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.485 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.804 HD12 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.81 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.409 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.81 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.944 HG11 HG23 ' A' ' 727' ' ' VAL . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.647 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.667 ' HB2' HG22 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 701' ' ' GLY . 92.3 mt . . . . . 0 C--O 1.226 -0.183 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.015 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.577 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.541 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.1 m-20 -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.979 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.839 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.578 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.615 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.979 HG22 HD13 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.753 HG21 ' OD2' ' A' ' 615' ' ' ASP . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.628 ' HA ' HG23 ' A' ' 689' ' ' VAL . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 682' ' ' TRP . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 587' ' ' ILE . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.726 ' HE2' HD23 ' A' ' 592' ' ' LEU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.035 HG22 HD21 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.719 HG12 HD12 ' A' ' 578' ' ' LEU . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 700' ' ' THR . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.679 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.452 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.839 HG21 ' O ' ' A' ' 663' ' ' ARG . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 727' ' ' VAL . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.944 HG23 HG11 ' A' ' 621' ' ' VAL . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 120.388 -0.118 . . . . 0.0 112.821 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.862 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.006 HD12 HD13 ' A' ' 647' ' ' ILE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.79 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.646 ' O ' HD13 ' A' ' 583' ' ' LEU . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.466 ' HB2' HD23 ' A' ' 583' ' ' LEU . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.504 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 580' ' ' LEU . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.858 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.858 ' HB3' HG23 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.585 HD11 HD21 ' A' ' 592' ' ' LEU . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.895 ' OD2' HG21 ' A' ' 681' ' ' ILE . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.685 ' HB2' HD13 ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.968 HG11 HG13 ' A' ' 727' ' ' VAL . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.653 ' CD2' HG21 ' A' ' 680' ' ' ILE . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.477 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 95.8 mt . . . . . 0 CA--C 1.528 0.132 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CB ' HD21 ' A' ' 672' ' ' LEU . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.535 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 665' ' ' ILE . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.749 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.577 ' HA ' HG13 ' A' ' 656' ' ' VAL . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 694' ' ' VAL . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.749 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.895 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.587 ' HA ' HG23 ' A' ' 689' ' ' VAL . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 682' ' ' TRP . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.737 ' HB ' HG22 ' A' ' 681' ' ' ILE . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.726 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.508 HG23 ' CD1' ' A' ' 577' ' ' PHE . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.976 0.417 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 663' ' ' ARG . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 722' ' ' GLU . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.968 HG13 HG11 ' A' ' 621' ' ' VAL . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.096 HD12 HG23 ' A' ' 696' ' ' ILE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 581' ' ' LYS . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 694' ' ' VAL . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.619 ' HG2' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.903 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.621 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 1.018 HD11 HG23 ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.903 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.785 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.867 HD12 ' SG ' ' A' ' 611' ' ' CYS . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 625' ' ' ILE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.032 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CG ' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.032 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 1.018 HG23 HD11 ' A' ' 588' ' ' ILE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.451 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.659 HG11 HG23 ' A' ' 727' ' ' VAL . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.657 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 701' ' ' GLY . 61.1 mt . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.856 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.534 ' OD2' HD11 ' A' ' 671' ' ' LEU . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.747 HD13 HD22 ' A' ' 578' ' ' LEU . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.627 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.919 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.627 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.624 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.786 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.483 ' HE3' ' O ' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.627 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 694' ' ' VAL . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 674' ' ' ASP . 20.3 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 673' ' ' GLN . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.919 HG21 ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.561 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.621 ' CD1' HG22 ' A' ' 587' ' ' ILE . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 580' ' ' LEU . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 1.096 HG23 HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.516 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 2.8 mmm-85 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.072 0.463 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 663' ' ' ARG . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.434 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.553 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 621' ' ' VAL . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.773 -0.131 . . . . 0.0 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.863 HD12 HD13 ' A' ' 647' ' ' ILE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.693 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 583' ' ' LEU . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.693 HG22 ' HB2' ' A' ' 582' ' ' PRO . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.517 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.879 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 578' ' ' LEU . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG3' HD23 ' A' ' 726' ' ' LEU . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.879 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.925 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.732 ' OD2' HG21 ' A' ' 681' ' ' ILE . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.674 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 727' ' ' VAL . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.674 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.631 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.687 ' CD1' HD11 ' A' ' 580' ' ' LEU . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.647 HD22 ' O ' ' A' ' 701' ' ' GLY . 77.1 mt . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.863 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.648 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 8.1 m-20 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.554 ' N ' HD12 ' A' ' 659' ' ' LEU . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.467 HD22 HG23 ' A' ' 716' ' ' VAL . 2.6 m120 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.955 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.407 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.512 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 717' ' ' LEU . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD22 HD21 ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.401 ' HG3' ' NH1' ' A' ' 714' ' ' ARG . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 649' ' ' TYR . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.609 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.909 HG22 ' CG2' ' A' ' 690' ' ' ILE . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.514 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.909 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.762 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.647 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.436 HH22 HD11 ' A' ' 659' ' ' LEU . 7.9 mmm180 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.0 0.429 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.216 0 CA-C-O 120.392 -0.115 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 594' ' ' ILE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.636 ' N ' HD23 ' A' ' 578' ' ' LEU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 625' ' ' ILE . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 583' ' ' LEU . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.95 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.662 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 588' ' ' ILE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.557 HD13 HG23 ' A' ' 587' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.95 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.008 HD12 HD22 ' A' ' 578' ' ' LEU . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.725 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.5 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.725 HG23 ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.912 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.912 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.969 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.821 ' CG ' HD13 ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.821 HD13 ' CG ' ' A' ' 615' ' ' ASP . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.965 HG11 HG23 ' A' ' 727' ' ' VAL . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 580' ' ' LEU . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.604 ' CD2' ' N ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.888 HG21 ' HZ ' ' A' ' 577' ' ' PHE . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.555 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.537 ' CD2' ' HE1' ' A' ' 664' ' ' MET . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.3 m-20 -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.941 ' O ' HG21 ' A' ' 716' ' ' VAL . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.537 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.445 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.555 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 659' ' ' LEU . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 690' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.415 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.969 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 581' ' ' LYS . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.877 HG22 HD21 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 659' ' ' LEU . 10.3 mmm-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.407 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.941 HG21 ' O ' ' A' ' 663' ' ' ARG . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.631 ' O ' HD22 ' A' ' 726' ' ' LEU . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 726' ' ' LEU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.965 HG23 HG11 ' A' ' 621' ' ' VAL . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.285 0 CA-C-O 120.385 -0.12 . . . . 0.0 112.857 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.955 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.736 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.442 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 690' ' ' ILE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 613' ' ' ILE . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.955 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.705 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.023 HD12 HD22 ' A' ' 578' ' ' LEU . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.768 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.5 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 726' ' ' LEU . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.038 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.038 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.941 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.41 ' CA ' ' NE ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.823 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.959 HG11 HG23 ' A' ' 727' ' ' VAL . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.665 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 73.4 t60 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.681 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 48.9 mt . . . . . 0 C--O 1.225 -0.22 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.953 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.599 ' HD2' HD12 ' A' ' 659' ' ' LEU . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.489 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-20 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.474 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.827 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.863 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.953 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.763 HG23 HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.847 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.767 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.415 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.815 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.767 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 587' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.755 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.794 HG22 HD21 ' A' ' 578' ' ' LEU . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 644' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.827 ' NH2' HD22 ' A' ' 659' ' ' LEU . 7.0 mmm-85 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.973 0.416 . . . . 0.0 111.824 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.415 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 663' ' ' ARG . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.524 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 600' ' ' PRO . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.959 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.829 ' N ' HD23 ' A' ' 578' ' ' LEU . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.757 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.994 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.75 ' CD1' HG23 ' A' ' 613' ' ' ILE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.994 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 578' ' ' LEU . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.924 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mm-40 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.924 HG23 ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.689 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.055 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.513 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.055 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.928 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.928 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.752 ' CB ' HD13 ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.49 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.752 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 1.034 HG11 HG23 ' A' ' 727' ' ' VAL . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.671 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 75.3 t60 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 580' ' ' LEU . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.803 HD22 ' O ' ' A' ' 701' ' ' GLY . 54.6 mt . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.794 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.011 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.598 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.699 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.539 ' HB3' HD12 ' A' ' 681' ' ' ILE . 7.0 m-80 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.48 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.862 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.564 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.598 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 649' ' ' TYR . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.677 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.71 HG23 HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 655' ' ' ASN . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.858 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.858 HG12 ' CD1' ' A' ' 682' ' ' TRP . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 587' ' ' ILE . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.734 HG22 HD21 ' A' ' 578' ' ' LEU . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.803 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.862 ' NH2' HD22 ' A' ' 659' ' ' LEU . 5.1 mmm-85 . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 120.991 0.424 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.469 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 1.034 HG23 HG11 ' A' ' 621' ' ' VAL . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.455 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.69 ' N ' HD23 ' A' ' 578' ' ' LEU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.724 HD21 HG23 ' A' ' 694' ' ' VAL . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 583' ' ' LEU . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.942 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.656 HD11 HG23 ' A' ' 613' ' ' ILE . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.49 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.942 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.838 HD12 ' SG ' ' A' ' 611' ' ' CYS . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.455 ' CB ' ' HD3' ' A' ' 576' ' ' ARG . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.995 HD12 HD22 ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 598' ' ' VAL . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.738 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.844 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.78 ' N ' HD21 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.422 ' H ' ' HA ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.844 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 612' ' ' LYS . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.73 ' HB2' HD11 ' A' ' 681' ' ' ILE . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.954 HD12 ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.796 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.954 ' CD2' HD12 ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.605 ' CD1' HD11 ' A' ' 580' ' ' LEU . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HZ3' HG21 ' A' ' 700' ' ' THR . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 6.9 t60 . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.792 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.41 ' CG ' HD11 ' A' ' 671' ' ' LEU . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.021 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.919 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.437 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.92 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CD1' HD23 ' A' ' 659' ' ' LEU . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.919 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.776 HG12 HD13 ' A' ' 659' ' ' LEU . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.567 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.697 ' CG1' HG22 ' A' ' 681' ' ' ILE . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.8 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.551 HG23 ' CD1' ' A' ' 577' ' ' PHE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.041 0.448 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 663' ' ' ARG . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.4 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.444 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.796 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 112.139 -0.385 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.712 ' CE1' HD11 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.783 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.635 ' O ' HD23 ' A' ' 583' ' ' LEU . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.165 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 689' ' ' VAL . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.619 HG21 ' CE1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 690' ' ' ILE . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.627 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.165 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 611' ' ' CYS . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.622 ' HG3' HG23 ' A' ' 579' ' ' THR . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.931 HD12 HD22 ' A' ' 578' ' ' LEU . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.488 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.2 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 598' ' ' VAL . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.003 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.557 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.003 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.825 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.589 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.885 HG11 HG23 ' A' ' 727' ' ' VAL . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.667 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' A' ' 700' ' ' THR . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 644' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.514 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.086 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.565 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.446 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.474 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.829 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 m120 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.927 ' O ' HG21 ' A' ' 716' ' ' VAL . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 656' ' ' VAL . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.78 HG22 HD21 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.848 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.706 HG21 ' OD2' ' A' ' 615' ' ' ASP . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.73 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.619 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 588' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.72 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.48 HG23 ' CD1' ' A' ' 577' ' ' PHE . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.479 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.829 ' NH2' HD22 ' A' ' 659' ' ' LEU . 12.0 mmm-85 . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.927 HG21 ' O ' ' A' ' 663' ' ' ARG . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.885 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 120.262 -0.188 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.839 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 594' ' ' ILE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.75 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.945 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.572 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.572 HG13 HD13 ' A' ' 588' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.945 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.91 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 625' ' ' ILE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.862 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.91 ' SG ' HD13 ' A' ' 592' ' ' LEU . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.936 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.746 ' HB3' HD13 ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 680' ' ' ILE . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.86 HG11 ' CG2' ' A' ' 727' ' ' VAL . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.628 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.3 t60 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.845 HD12 HD11 ' A' ' 594' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.64 HD22 ' C ' ' A' ' 702' ' ' LEU . 3.5 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.839 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.944 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CB ' HD21 ' A' ' 672' ' ' LEU . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.559 HG23 HE22 ' A' ' 719' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 6.0 m-80 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.476 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.784 HD22 HH21 ' A' ' 714' ' ' ARG . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.753 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.944 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.702 ' CD2' HD11 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.463 ' HA ' HG13 ' A' ' 696' ' ' ILE . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.649 HG22 ' CD2' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.731 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.607 HG23 HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 596' ' ' GLN . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.64 ' C ' HD22 ' A' ' 644' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.784 HH21 HD22 ' A' ' 659' ' ' LEU . 1.1 mmm-85 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 121.09 0.472 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.753 HG21 ' O ' ' A' ' 663' ' ' ARG . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.559 HE22 HG23 ' A' ' 652' ' ' THR . 13.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.45 ' O ' HG12 ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.86 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.227 -0.311 0 CA-C-O 120.329 -0.15 . . . . 0.0 112.983 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.809 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.038 HD22 HD13 ' A' ' 647' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.565 ' H ' HD12 ' A' ' 578' ' ' LEU . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.616 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 613' ' ' ILE . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 578' ' ' LEU . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.774 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.2 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.94 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.773 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.853 HG11 HG23 ' A' ' 727' ' ' VAL . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.612 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.2 t60 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.605 HD12 HD11 ' A' ' 594' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 647' ' ' ILE . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.7 t60 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 93.4 mt . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.784 -0.151 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.038 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.706 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.57 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 6.7 m-80 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 656' ' ' VAL . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.758 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.6 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.706 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 694' ' ' VAL . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 613' ' ' ILE . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.634 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 587' ' ' ILE . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.883 HG13 HD11 ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.698 ' CG1' HD13 ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.977 0.418 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 663' ' ' ARG . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 727' ' ' VAL . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.853 HG23 HG11 ' A' ' 621' ' ' VAL . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 647' ' ' ILE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.447 ' H ' HD12 ' A' ' 578' ' ' LEU . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.024 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.55 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.652 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 613' ' ' ILE . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.785 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.024 HD11 HD11 ' A' ' 580' ' ' LEU . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.8 OUTLIER -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.893 HG23 HG13 ' A' ' 588' ' ' ILE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.895 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.895 HD13 ' CB ' ' A' ' 615' ' ' ASP . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.608 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.913 HG11 HG23 ' A' ' 727' ' ' VAL . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HD12 ' A' ' 680' ' ' ILE . 70.2 t60 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.602 HD11 HD21 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 . . . . . 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.4 mt . . . . . 0 C--O 1.226 -0.162 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.853 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.557 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.575 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.859 HD12 ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 659' ' ' LEU . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.668 ' HB3' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.894 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.455 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 652' ' ' THR . 7.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.859 ' CE1' HD12 ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.596 HD13 HG21 ' A' ' 694' ' ' VAL . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.754 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 622' ' ' HIS . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.697 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.697 HG12 ' CD1' ' A' ' 682' ' ' TRP . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.652 ' CD1' HG22 ' A' ' 587' ' ' ILE . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 1.006 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.896 HG12 HD13 ' A' ' 578' ' ' LEU . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.746 HG22 ' CE2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.736 ' HA ' ' NE ' ' A' ' 714' ' ' ARG . 4.7 mmm180 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.894 HG21 ' O ' ' A' ' 663' ' ' ARG . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.405 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.913 HG23 HG11 ' A' ' 621' ' ' VAL . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.015 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.809 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.901 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.901 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.614 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.95 HD11 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.723 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.011 ' HB3' HG23 ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.536 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.802 ' HB3' HD13 ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.487 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.992 HD11 ' CG2' ' A' ' 680' ' ' ILE . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.871 HG11 ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.59 ' NE2' HG23 ' A' ' 680' ' ' ILE . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.598 ' CD1' HD21 ' A' ' 580' ' ' LEU . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.503 ' NZ ' HG21 ' A' ' 700' ' ' THR . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 701' ' ' GLY . 2.8 mp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.351 0.12 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.872 ' O ' HD13 ' A' ' 702' ' ' LEU . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.557 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.646 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.597 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.546 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.0 m-80 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.507 ' N ' HD12 ' A' ' 659' ' ' LEU . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.632 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.89 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE3' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.557 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.93 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.434 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.608 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.811 HG22 HD13 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.992 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.678 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 689' ' ' VAL . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.93 HG21 HD13 ' A' ' 672' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.503 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.651 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 5.0 mmm180 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 663' ' ' ARG . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.871 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.948 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.023 HD12 HD13 ' A' ' 647' ' ' ILE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.82 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 579' ' ' THR . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.885 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.542 HD13 HG23 ' A' ' 587' ' ' ILE . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.885 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.964 HD12 HD22 ' A' ' 578' ' ' LEU . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.841 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.666 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.008 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.47 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.008 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.846 ' C ' HD13 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 1.008 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.901 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.824 HD13 ' CG ' ' A' ' 615' ' ' ASP . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.2 t60 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.722 ' CD1' HD11 ' A' ' 580' ' ' LEU . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.418 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.859 ' HG ' HG22 ' A' ' 678' ' ' ILE . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.905 ' O ' HG21 ' A' ' 716' ' ' VAL . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.447 ' HA ' HG11 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 649' ' ' TYR . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.859 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.682 HG23 HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.901 HG21 ' OD2' ' A' ' 615' ' ' ASP . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.698 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . 0.517 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 1.008 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.78 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 674' ' ' ASP . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.705 0.764 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.905 HG21 ' O ' ' A' ' 663' ' ' ARG . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.062 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.805 ' N ' HD23 ' A' ' 578' ' ' LEU . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.814 HD11 HD12 ' A' ' 625' ' ' ILE . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.726 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.459 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.88 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.044 HD12 HD22 ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.488 ' N ' HG12 ' A' ' 598' ' ' VAL . 4.6 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.036 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.899 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.871 ' HB3' HD13 ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.871 HD13 ' HB3' ' A' ' 615' ' ' ASP . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.844 HG11 ' CG2' ' A' ' 727' ' ' VAL . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.663 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 73.3 t60 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 680' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.814 HD12 HD11 ' A' ' 580' ' ' LEU . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.6 t60 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 701' ' ' GLY . 91.7 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.848 ' O ' HD23 ' A' ' 702' ' ' LEU . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 628' ' ' LYS . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.062 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.932 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.62 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.054 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.589 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.733 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.932 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.701 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 659' ' ' LEU . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 657' ' ' SER . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.453 HG22 HG22 ' A' ' 680' ' ' ILE . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.873 ' CD1' HG12 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.873 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 587' ' ' ILE . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 700' ' ' THR . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.832 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 6.0 mmm-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.953 0.406 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.427 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 663' ' ' ARG . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.844 ' CG2' HG11 ' A' ' 621' ' ' VAL . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.987 HD12 HD13 ' A' ' 647' ' ' ILE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.799 ' N ' HD23 ' A' ' 578' ' ' LEU . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.619 ' O ' HD13 ' A' ' 583' ' ' LEU . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.954 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.717 HG22 HG12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.674 ' CD1' HG23 ' A' ' 613' ' ' ILE . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.954 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.79 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.454 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 580' ' ' LEU . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.785 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.529 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 588' ' ' ILE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.847 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.85 HG11 ' CG2' ' A' ' 727' ' ' VAL . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.71 ' CD1' HD11 ' A' ' 580' ' ' LEU . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.431 ' NZ ' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.54 HD22 ' C ' ' A' ' 702' ' ' LEU . 4.1 mp . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.833 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.987 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.67 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.931 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.3 m-80 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.418 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.928 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.67 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.831 ' CD2' HD11 ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.901 HG22 HD21 ' A' ' 659' ' ' LEU . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 587' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.581 ' CE2' HD11 ' A' ' 680' ' ' ILE . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.7 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 577' ' ' PHE . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 700' ' ' THR . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.931 ' NH2' HD22 ' A' ' 659' ' ' LEU . 16.0 mmm-85 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.928 HG21 ' O ' ' A' ' 663' ' ' ARG . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.85 ' CG2' HG11 ' A' ' 621' ' ' VAL . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.42 0 CA-C-O 119.879 -0.401 . . . . 0.66000000000000003 113.64 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 1.6699999999999999 110.677 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.65 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.92000000000000004 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.952 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 0.93000000000000005 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 0.40000000000000002 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.754 ' CD2' HG23 ' A' ' 694' ' ' VAL . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 0.83999999999999997 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 1.6699999999999999 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.29999999999999999 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.1699999999999999 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.62 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.6699999999999999 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.0700000000000001 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 690' ' ' ILE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 1.9199999999999999 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.597 ' CD1' HG23 ' A' ' 613' ' ' ILE . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 1.3899999999999999 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.452 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.1099999999999999 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 0.54000000000000004 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.792 HD12 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 1.98 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.721 HD12 HD22 ' A' ' 578' ' ' LEU . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 0.32000000000000001 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.1 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.6599999999999999 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.1100000000000001 109.084 178.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 113.177 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 0.81999999999999995 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.8799999999999999 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.29999999999999999 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.26000000000000001 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.23999999999999999 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 1.014 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 0.45000000000000001 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.29999999999999999 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.02 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.3200000000000001 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.3700000000000001 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.8799999999999999 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.24 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 1.014 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 0.5 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.852 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.0699999999999998 113.095 -178.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 612' ' ' LYS . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.1100000000000001 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.97 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.6100000000000001 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.8899999999999999 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.68000000000000005 112.001 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 615' ' ' ASP . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 0.71999999999999997 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 0.91000000000000003 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.854 HG11 ' CG2' ' A' ' 727' ' ' VAL . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 0.26000000000000001 109.105 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.3 t60 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.28000000000000003 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 0.23999999999999999 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.29999999999999999 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 580' ' ' LEU . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 0.76000000000000001 107.794 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.29999999999999999 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.455 ' NZ ' HG21 ' A' ' 700' ' ' THR . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 0.91000000000000003 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.8 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.29 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.98999999999999999 111.302 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 92.0 mt . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.253 -0.277 . . . . 1.25 110.253 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' O ' HD22 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.3600000000000001 109.621 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.952 HD13 HD12 ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 0.34999999999999998 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.965 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.42999999999999999 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.58 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.34000000000000002 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.44 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.25 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26000000000000001 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 0.33000000000000002 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.8 m-20 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.8300000000000001 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 0.97999999999999998 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.1599999999999999 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.22 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.104 HD13 HG22 ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.29 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.1499999999999999 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 2.4199999999999999 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.561 HD22 HG23 ' A' ' 716' ' ' VAL . 2.2 m120 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.8999999999999999 111.096 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 2.6400000000000001 110.324 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 656' ' ' VAL . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.97999999999999998 111.24 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 0.64000000000000001 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.81999999999999995 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 0.44 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 0.81999999999999995 109.157 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.783 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 0.80000000000000004 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.965 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 1.5 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.58 HD21 ' CB ' ' A' ' 649' ' ' TYR . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 0.63 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.54000000000000004 110.987 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.4099999999999999 110.844 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.42999999999999999 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.3100000000000001 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.676 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.4300000000000002 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.104 HG22 HD13 ' A' ' 659' ' ' LEU . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.3400000000000001 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.04 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 618' ' ' LEU . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 1.7 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.537 HG21 ' OD2' ' A' ' 615' ' ' ASP . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 0.62 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . 0.652 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.91000000000000003 111.14 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.4399999999999999 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.1400000000000001 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.8400000000000001 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.1400000000000001 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.1800000000000002 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.652 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.3799999999999999 111.307 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 615' ' ' ASP . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.82999999999999996 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.33000000000000002 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.3500000000000001 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.754 HG23 ' CD2' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.31 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.9199999999999999 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.17 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 0.55000000000000004 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 700' ' ' THR . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 0.98999999999999999 110.765 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 645' ' ' ASP . 2.7 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 1.4199999999999999 111.054 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.3 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 112.856 0.687 . . . . 2.5 112.856 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.58999999999999997 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.886 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 0.71999999999999997 111.113 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 1.6899999999999999 110.693 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.4700000000000002 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.01 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 0.81999999999999995 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.69999999999999996 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.6499999999999999 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 2.6800000000000002 111.155 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.6100000000000001 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.23 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 621' ' ' VAL . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.66000000000000003 111.063 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 2.75 110.993 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.622 -0.191 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -90.11 10.25 25.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.657 0.265 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . -132.45 -25.83 0.69 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.683 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.454 ' HG3' ' CB ' ' A' ' 593' ' ' GLU . 7.9 tmm_? -110.07 134.34 52.25 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.384 0.611 . . . . 0.0 111.339 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 696' ' ' ILE . 0.0 OUTLIER -122.49 -46.87 2.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.942 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.051 HD12 HD13 ' A' ' 647' ' ' ILE . 7.7 tt -115.55 142.99 45.98 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.116 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 578' ' ' LEU . 22.9 m -122.04 114.97 21.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.791 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.79 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.5 OUTLIER -104.76 109.84 21.95 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.706 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.5 ptpt -114.52 105.06 54.11 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.971 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -57.05 123.32 13.57 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.62 1.547 . . . . 0.0 109.341 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.743 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.03 153.89 67.01 Favored Pre-proline 0 N--CA 1.469 0.509 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.6 Cg_exo -57.35 -27.73 76.87 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.405 2.737 . . . . 0.0 112.738 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.98 -26.19 68.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.062 0.458 . . . . 0.0 110.418 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.1 p -96.01 154.28 17.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.337 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 690' ' ' ILE . 14.3 pt -44.95 -26.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.328 0.585 . . . . 0.0 109.857 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.841 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.5 mt -96.87 149.74 4.75 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.316 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.53 58.41 0.63 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.971 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.2 mt-10 -126.98 176.36 7.39 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.629 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -132.02 116.31 16.93 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.642 177.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -113.31 138.4 50.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.454 ' CB ' ' HG3' ' A' ' 576' ' ' ARG . 0.4 OUTLIER -123.89 124.21 42.13 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.072 -178.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.691 HG23 ' CD1' ' A' ' 601' ' ' PHE . 40.7 mt -76.63 136.05 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.738 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.9 OUTLIER -82.85 136.2 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.692 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.47 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.2 OUTLIER -47.59 -24.24 0.84 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.41 . . . . 0.0 110.023 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -92.54 -19.21 38.74 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.449 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.738 HG23 ' HB2' ' A' ' 595' ' ' GLN . 97.3 t -86.58 113.45 24.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 CA-C-N 118.231 1.015 . . . . 0.0 111.138 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.465 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -146.78 124.76 6.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.245 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.526 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.2 Cg_endo -92.8 160.6 23.15 Favored 'Cis proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.92 -0.867 . . . . 0.0 110.697 -0.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.691 ' CD1' HG23 ' A' ' 594' ' ' ILE . 1.4 t80 -90.45 120.25 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.904 ' C ' HD13 ' A' ' 603' ' ' ILE . 77.9 m-85 -91.53 138.23 31.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.327 0.584 . . . . 0.0 111.969 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.991 HG23 ' HB3' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -127.8 140.51 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.847 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 618' ' ' LEU . . . 161.03 166.72 20.32 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.639 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.3 ttp85 -49.52 -32.62 12.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.782 0.325 . . . . 0.0 110.939 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 1.4 p -75.31 118.07 17.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.83 -18.76 9.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.518 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -49.78 -29.2 7.37 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 89.2 m -65.15 113.37 3.91 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 114.513 -1.222 . . . . 0.0 109.511 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -35.86 -36.77 0.09 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.255 0.55 . . . . 0.0 110.638 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.991 ' HB3' HG23 ' A' ' 603' ' ' ILE . 0.0 OUTLIER -100.62 143.04 31.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.932 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.11 124.26 51.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.932 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.5 mm -138.59 110.91 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.73 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 99.4 9.21 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 122.077 0.941 . . . . 0.0 110.278 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.626 ' CB ' HD13 ' A' ' 618' ' ' LEU . 6.0 t70 -133.03 111.04 10.66 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.251 177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -36.0 -34.98 0.06 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.44 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.62 -34.12 53.47 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.64 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -59.11 158.35 8.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.941 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 89.9 p -110.22 175.0 5.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.675 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.68 -73.17 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.883 HG11 HG23 ' A' ' 727' ' ' VAL . 40.1 t -94.97 61.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' A' ' 618' ' ' LEU . 63.5 t60 -45.69 -47.56 15.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.842 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.672 ' O ' HG12 ' A' ' 603' ' ' ILE . 3.6 p -173.34 162.74 4.41 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 2.7 p90 -147.2 149.75 33.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.85 0.357 . . . . 0.0 110.541 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.79 ' CD1' HD11 ' A' ' 580' ' ' LEU . 62.3 mt -101.44 119.6 49.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.1 t80 -109.06 152.69 24.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.031 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HZ1' HG21 ' A' ' 700' ' ' THR . 8.7 ttmt -115.29 136.33 53.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.01 156.93 48.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.836 -179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -78.57 113.0 16.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.425 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.7 t60 -67.41 126.09 28.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.988 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -101.51 140.23 36.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.396 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.2 p -103.05 161.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.965 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.538 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -91.03 54.57 3.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mttp 58.45 172.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.703 0.287 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.64 113.93 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.189 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.32 44.49 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.3 -153.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.424 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.58 100.12 8.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.464 0.649 . . . . 0.0 109.768 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.2 p -138.27 156.63 73.58 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.721 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.3 Cg_endo -71.35 -153.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.648 2.232 . . . . 0.0 111.743 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 80.02 -71.01 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.981 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 42.14 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.54 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.46 121.22 5.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.332 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.651 HD13 ' CB ' ' A' ' 703' ' ' PHE . 3.7 mp -146.53 -151.16 0.37 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.85 -0.675 . . . . 0.0 110.492 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.88 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -115.03 147.23 40.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.251 0.548 . . . . 0.0 112.282 -179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 1.1 t0 -131.68 147.98 52.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.051 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -104.66 116.47 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.493 0.663 . . . . 0.0 112.319 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.993 ' CH2' HD22 ' A' ' 671' ' ' LEU . 74.2 m95 -103.23 136.16 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.178 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' HB2' HD21 ' A' ' 672' ' ' LEU . 11.3 t80 -90.08 117.32 28.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.6 t -108.9 105.7 15.37 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.438 ' CE1' ' OG ' ' A' ' 657' ' ' SER . 41.6 t60 -77.43 130.57 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.471 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.98 5.09 7.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.703 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -95.86 151.85 20.1 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.797 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 92.2 m -78.0 -24.38 47.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.077 0.465 . . . . 0.0 110.823 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.9 m120 -72.97 4.04 4.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.632 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.9 p 49.85 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.264 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 656' ' ' VAL . 16.0 m -125.22 161.31 27.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.563 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -122.58 120.85 35.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -116.38 100.86 8.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.869 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 25.3 t-20 63.92 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.689 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m-20 -152.26 22.2 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.03 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.802 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -121.54 130.63 53.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.845 0.355 . . . . 0.0 111.008 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.891 ' O ' HG21 ' A' ' 716' ' ' VAL . 35.5 ttt180 -88.59 141.28 28.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.437 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.425 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -137.95 115.08 10.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.883 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.98 156.5 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.997 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -50.62 104.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.086 0.47 . . . . 0.0 110.652 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.4 23.0 2.71 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -123.0 160.38 26.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.428 0.632 . . . . 0.0 111.368 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.541 ' HE2' HD11 ' A' ' 717' ' ' LEU . 1.4 ttpm? -123.53 148.75 46.0 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.051 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.634 ' HD2' HD23 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.37 144.22 28.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.993 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.59 129.69 38.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.747 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -104.3 114.73 29.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.935 0.398 . . . . 0.0 111.183 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.9 mt-30 -91.88 151.14 20.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -55.05 118.65 4.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 110.686 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.23 37.58 9.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.273 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.29 120.09 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.731 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.738 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -96.21 109.58 22.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 3.6 mt -105.3 132.52 51.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.175 0.512 . . . . 0.0 112.207 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -100.7 125.78 47.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.21 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 613' ' ' ILE . 0.1 OUTLIER -93.97 -26.65 4.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.839 -178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.403 HG12 ' CE1' ' A' ' 688' ' ' PHE . 3.8 tp -154.79 130.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.941 0.4 . . . . 0.0 111.296 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.837 ' CD1' HG12 ' A' ' 689' ' ' VAL . 9.5 t90 -137.13 116.01 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.226 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -124.1 116.36 22.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.485 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -46.51 71.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.521 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.73 -40.22 91.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.761 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 26.6 m120 -85.71 -16.12 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.609 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 686' ' ' ASN . 3.3 mppt? 64.53 14.31 8.84 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -102.14 120.65 40.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.951 0.405 . . . . 0.0 110.004 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 682' ' ' TRP . 34.4 m -126.01 138.31 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.17 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.992 HD11 HD11 ' A' ' 587' ' ' ILE . 12.0 mt -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 111.281 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -150.47 135.11 5.06 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.342 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.756 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.7 m-85 -114.68 141.56 47.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.652 0.263 . . . . 0.0 110.816 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -101.79 117.01 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.161 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 2.0 t -81.79 116.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -125.26 111.16 14.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.512 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 705' ' ' GLU . 10.3 mt -87.25 114.77 26.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -91.67 -43.04 9.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.198 0.523 . . . . 0.0 109.742 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -110.8 141.2 44.46 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.151 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.2 p -113.07 96.47 5.95 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 700' ' ' THR . 10.1 t -69.37 66.96 0.19 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.565 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.49 38.19 95.92 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.45 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -82.86 134.86 35.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.814 -179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.651 ' CB ' HD13 ' A' ' 644' ' ' LEU . 1.9 p90 -45.58 -31.77 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.537 0.684 . . . . 0.0 110.188 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 4.2 t30 -148.7 -51.87 0.17 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.0 pt-20 152.19 -28.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.209 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.17 -11.91 2.07 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.552 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -86.04 9.1 18.14 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.011 0.434 . . . . 0.0 111.863 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 703' ' ' PHE . . . 66.95 -166.64 40.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.803 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.464 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -156.57 123.55 5.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.718 0.294 . . . . 0.0 110.398 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 67.14 129.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.829 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 42.93 90.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -63.83 126.38 27.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.741 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -115.5 97.51 6.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 110.383 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.402 ' NH2' ' HB2' ' A' ' 660' ' ' ASN . 16.0 mmm-85 -106.03 77.47 1.24 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.808 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.446 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 4.6 m -123.15 140.49 46.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.962 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.891 HG21 ' O ' ' A' ' 663' ' ' ARG . 99.2 t -80.87 130.13 36.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.478 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.541 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -113.74 167.0 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.422 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.09 154.38 18.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.165 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -94.37 160.21 14.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.4 p -121.94 -173.9 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.219 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.82 46.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -60.97 -47.35 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.403 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -66.98 -49.14 66.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.05 -32.75 64.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.018 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -36.57 79.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.8 mt -59.17 -45.0 92.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 3.4 p -69.6 -12.8 16.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.303 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 9.26 15.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.987 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 730' ' ' LEU . 3.3 pp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.882 0.372 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . 0.544 ' C ' HD13 ' P' ' 828' ' ' ILE . 0.4 OUTLIER -99.1 41.71 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.785 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.558 ' N ' HD13 ' P' ' 828' ' ' ILE . 0.0 OUTLIER -114.5 33.13 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -162.11 133.24 5.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.833 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 63.0 mt -123.31 151.28 42.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.864 -179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -22.16 63.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 129.77 -6.83 6.17 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.8 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 19.4 ttp-105 -99.7 118.46 36.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.299 0.571 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -106.83 -47.08 3.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.122 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.93 HD22 ' CD1' ' A' ' 594' ' ' ILE . 8.5 tt -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.724 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.7 m -117.7 116.16 26.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.764 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.744 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.5 mt -100.62 110.3 22.43 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 583' ' ' LEU . 35.1 mtmt -115.68 104.89 52.52 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.937 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.2 Cg_endo -61.37 121.79 10.14 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 121.759 1.639 . . . . 0.0 109.54 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -78.84 154.6 78.11 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -176.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 31.4 Cg_exo -57.16 -26.68 70.68 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.415 2.743 . . . . 0.0 112.68 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 109.949 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 1.7 t -96.5 154.83 17.05 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.788 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.485 HD11 ' OD1' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -46.19 -25.31 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 121.357 0.599 . . . . 0.0 109.444 178.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.829 HD12 HD13 ' A' ' 613' ' ' ILE . 0.7 OUTLIER -106.66 152.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.027 178.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -148.73 64.99 1.06 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.937 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -125.82 175.54 7.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.128 -1.851 . . . . 0.0 110.264 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.75 121.91 23.75 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.298 178.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 592' ' ' LEU . 2.3 mm? -112.78 153.69 27.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.0 123.12 39.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.93 ' CD1' HD22 ' A' ' 578' ' ' LEU . 18.6 mt -88.03 114.47 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.772 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mp0 -72.68 138.75 46.83 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.432 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -48.1 -29.44 3.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -81.44 -26.89 50.02 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.772 HG23 ' HB2' ' A' ' 595' ' ' GLN . 92.8 t -82.09 112.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.108 0.954 . . . . 0.0 110.697 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.15 122.12 5.24 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.299 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 37.8 Cg_endo -91.37 160.79 28.31 Favored 'Cis proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.53 -1.029 . . . . 0.0 109.92 -1.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.483 ' CG ' HG12 ' A' ' 594' ' ' ILE . 6.8 t80 -87.9 114.59 24.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.723 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 78.1 m-85 -88.79 135.33 33.58 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.765 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.896 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.2 mp -132.77 136.54 55.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.218 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.33 -178.98 41.18 Favored Glycine 0 C--N 1.316 -0.536 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.512 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -58.76 -33.3 70.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.75 0.31 . . . . 0.0 111.531 -179.448 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 15.5 p -79.9 118.86 22.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.694 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.613 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -50.91 -21.76 1.89 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.88 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -47.92 -28.46 2.7 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 3.9 m -72.92 120.1 18.08 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.108 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -38.68 -34.73 0.15 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.256 0.551 . . . . 0.0 110.731 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.896 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.3 t -97.08 144.6 26.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.613 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.12 118.07 29.61 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.829 HD13 HD12 ' A' ' 588' ' ' ILE . 20.3 mm -139.67 116.9 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.129 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.086 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.88 100.22 11.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 122.265 1.031 . . . . 0.0 109.15 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.876 ' HB2' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -130.76 108.17 9.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.537 179.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -37.28 -40.25 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.91 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.421 ' HB3' HD11 ' A' ' 681' ' ' ILE . 6.3 mmp_? -78.16 -28.13 48.23 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.876 HD13 ' HB2' ' A' ' 615' ' ' ASP . 0.4 OUTLIER -59.83 158.8 9.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.53 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 13.2 m -112.34 171.42 7.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.462 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.57 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.95 HG22 HD21 ' A' ' 730' ' ' LEU . 44.9 t -91.97 58.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.009 0.909 . . . . 0.0 108.878 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.623 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 46.5 t60 -44.81 -41.97 7.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.018 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.456 ' O ' HD12 ' A' ' 603' ' ' ILE . 1.1 p 177.56 146.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 603' ' ' ILE . 37.9 p90 -139.42 153.09 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 111.371 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.744 ' CD1' HD11 ' A' ' 580' ' ' LEU . 31.0 mt -102.62 120.5 52.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 648' ' ' TRP . 7.1 t80 -110.2 152.67 25.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.456 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.0 OUTLIER -119.23 136.53 54.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.194 0.521 . . . . 0.0 111.009 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -136.2 158.68 43.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.796 -178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.9 OUTLIER -76.98 128.93 35.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.469 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.486 ' CE1' ' CE2' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -61.13 135.38 57.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.364 -179.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -81.69 76.75 8.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.611 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -134.54 -175.94 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.589 ' H ' HG12 ' A' ' 632' ' ' VAL . . . 114.43 -25.11 10.7 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.603 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -80.28 66.95 5.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.955 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.48 105.5 7.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 5.3 ttm -72.09 61.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.023 0.44 . . . . 0.0 110.411 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 175.23 -157.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.628 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 100.56 8.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.6 p -136.78 156.43 76.04 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.047 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 67.7 Cg_endo -69.39 -151.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.665 2.243 . . . . 0.0 111.438 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 73.84 -68.49 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.751 0.31 . . . . 0.0 110.786 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.52 ' HB2' HD11 ' A' ' 644' ' ' LEU . 2.0 mp0 46.61 -171.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.208 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.456 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -104.39 119.62 6.34 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.263 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 701' ' ' GLY . 3.5 mp -146.95 -154.42 0.55 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.606 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.424 ' O ' ' CD2' ' A' ' 702' ' ' LEU . 0.0 OUTLIER -108.19 146.99 31.96 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.218 0.533 . . . . 0.0 112.104 -179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 628' ' ' LYS . 6.4 t0 -132.73 130.52 40.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.88 HD13 HD12 ' A' ' 578' ' ' LEU . 2.0 pt -93.75 115.81 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.436 0.636 . . . . 0.0 111.935 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.943 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 73.9 m95 -103.03 136.96 41.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.586 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.564 ' CB ' HD21 ' A' ' 672' ' ' LEU . 16.4 t80 -90.0 117.13 28.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -112.74 105.66 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 46.6 t60 -74.29 129.76 38.42 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.805 0.336 . . . . 0.0 110.76 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.493 ' C ' ' HB2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.8 -1.07 8.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.643 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.54 150.63 25.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.521 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.5 m -77.04 -24.77 52.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.93 0.395 . . . . 0.0 111.168 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.9 m-20 -74.82 4.84 5.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.549 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.6 p 49.3 148.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.546 0.688 . . . . 0.0 112.4 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 680' ' ' ILE . 50.5 p -118.24 165.46 13.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.819 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -127.48 120.75 29.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.608 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.691 HD13 HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -109.59 104.21 13.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.0 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 63.35 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 t30 -148.5 19.5 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.211 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -120.23 140.0 51.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.832 0.348 . . . . 0.0 111.086 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.923 ' O ' HG21 ' A' ' 716' ' ' VAL . 43.7 ttt180 -96.41 140.91 30.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.562 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.453 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -142.03 118.61 10.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.733 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 22.7 pt -87.29 165.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.894 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.493 ' HB2' ' C ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -55.96 107.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.23 21.44 3.09 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 81.9 p -121.77 158.44 28.82 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.383 0.611 . . . . 0.0 111.319 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.01 144.27 49.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.845 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.677 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.13 143.9 28.61 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.943 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -73.43 140.56 46.61 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.635 HD13 HG21 ' A' ' 694' ' ' VAL . 4.1 mt -113.24 108.1 16.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.766 ' OE1' HD23 ' A' ' 707' ' ' LEU . 6.0 mt-30 -87.33 142.11 28.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.554 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.561 ' OD1' HD11 ' A' ' 707' ' ' LEU . 13.6 p-10 -44.57 116.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.92 0.39 . . . . 0.0 110.961 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.87 37.27 7.97 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.25 119.01 31.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.829 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 583' ' ' LEU . 2.6 tt0 -96.34 108.8 21.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.691 HG23 HD13 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -111.67 137.56 43.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.27 0.557 . . . . 0.0 111.892 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -106.62 116.24 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.321 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.703 HD11 HG21 ' A' ' 690' ' ' ILE . 19.5 pt -78.83 -28.9 14.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 655' ' ' ASN . 6.1 tt -154.94 130.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.888 0.375 . . . . 0.0 111.846 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.802 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -137.1 118.27 14.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.747 ' HB2' HD13 ' P' ' 831' ' ' LEU . 34.3 t0 -127.39 115.99 19.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.958 0.408 . . . . 0.0 110.535 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -46.1 71.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.109 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -58.35 -40.48 82.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.939 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -89.99 -10.64 44.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.621 0.248 . . . . 0.0 111.424 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt 61.89 18.18 9.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.432 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 688' ' ' PHE . 1.8 p90 -103.38 116.27 32.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.802 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.1 m -125.9 138.98 52.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.318 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.703 HG21 HD11 ' A' ' 680' ' ' ILE . 43.3 mm -119.56 128.14 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -148.86 135.04 5.25 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.667 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.665 ' HB3' HD22 ' A' ' 580' ' ' LEU . 9.5 m-85 -114.85 166.67 11.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 111.011 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.72 116.4 21.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.777 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.841 HG22 HD21 ' A' ' 578' ' ' LEU . 1.3 t -85.61 114.72 25.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.561 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -123.12 111.18 16.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.74 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 705' ' ' GLU . 17.1 mt -89.43 106.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -87.25 -46.2 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.502 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.81 139.88 45.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.181 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.1 p -114.24 96.9 6.03 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 700' ' ' THR . 42.2 m -68.74 65.44 0.12 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.144 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.675 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 67.12 31.25 77.15 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.51 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -75.23 139.62 42.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.666 0.269 . . . . 0.0 110.75 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.652 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -46.72 -29.88 2.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.273 0.559 . . . . 0.0 110.222 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.639 HD21 HD12 ' A' ' 707' ' ' LEU . 4.8 t30 -154.95 -65.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.885 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.529 ' O ' HD13 ' A' ' 696' ' ' ILE . 4.8 pt-20 169.98 -30.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.424 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.17 17.32 0.26 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.44 -0.886 . . . . 0.0 114.01 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.766 HD23 ' OE1' ' A' ' 673' ' ' GLN . 0.8 OUTLIER -82.79 8.52 12.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 38.46 72.65 0.18 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.333 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.481 ' HE3' ' HB3' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -84.75 100.75 11.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 111.047 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 710' ' ' LEU . 2.7 pt? -166.79 -162.6 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -66.67 -51.51 55.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.806 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.448 ' HG2' ' CG ' ' A' ' 710' ' ' LEU . 8.9 pt-20 -63.4 140.38 58.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.846 0.355 . . . . 0.0 111.006 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 97.71 6.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.301 0.572 . . . . 0.0 110.37 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 5.7 mmm-85 44.57 79.01 0.05 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.832 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.3 m -124.27 142.27 41.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.92 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.923 HG21 ' O ' ' A' ' 663' ' ' ARG . 73.1 t -77.77 115.81 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.64 172.23 8.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -103.15 143.98 31.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.446 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 13.7 pt20 -77.57 160.3 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.996 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.4 p -120.11 -177.73 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.63 -28.95 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -50.16 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.88 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.82 -47.08 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.966 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 727' ' ' VAL . 6.3 tttm -57.26 -33.24 67.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.215 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -68.11 -36.67 80.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.435 HD11 ' CD1' ' A' ' 626' ' ' PHE . 3.3 mt -59.48 -44.86 92.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 111.083 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.908 HG23 HG11 ' A' ' 621' ' ' VAL . 8.3 p -70.88 -21.38 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.47 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -58.19 -38.56 76.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.722 0.296 . . . . 0.0 111.201 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -104.59 -25.77 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.324 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.95 HD21 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.726 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.852 0.358 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -104.55 133.42 49.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.403 ' C ' HD12 ' P' ' 828' ' ' ILE . 2.0 pp -123.57 40.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.069 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.6 160.29 20.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.747 HD13 ' HB2' ' A' ' 683' ' ' ASP . 90.8 mt -123.55 101.16 7.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.888 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -103.56 -13.38 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.649 0.261 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.91 54.4 0.76 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.328 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -85.65 105.46 16.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.075 0.465 . . . . 0.0 110.297 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -92.98 -47.98 6.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.587 0.708 . . . . 0.0 110.05 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.004 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -115.45 142.53 46.57 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.769 ' N ' HD23 ' A' ' 578' ' ' LEU . 26.5 m -126.95 114.79 18.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.035 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -101.22 109.09 20.91 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.613 ' O ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -107.01 99.16 24.8 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.977 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -58.49 109.49 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.312 1.342 . . . . 0.0 108.938 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.645 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -80.19 157.68 72.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.463 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 66.7 Cg_exo -52.31 -30.74 43.91 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 124.123 3.216 . . . . 0.0 113.565 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.17 -23.16 67.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.2 0.524 . . . . 0.0 110.075 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 24.6 p -96.05 153.58 17.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.54 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.72 HD13 ' CD2' ' A' ' 688' ' ' PHE . 0.2 OUTLIER -49.5 -23.88 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.293 0.568 . . . . 0.0 109.688 178.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.724 HG13 HG23 ' A' ' 613' ' ' ILE . 10.8 mm -96.57 149.68 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.694 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.522 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -153.3 52.78 0.73 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.668 1.223 . . . . 0.0 108.494 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.977 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -125.26 177.52 6.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 112.655 -2.066 . . . . 0.0 108.614 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.59 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.27 116.39 19.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.029 0.442 . . . . 0.0 110.395 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.765 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -113.47 130.76 56.25 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.565 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.1 mp0 -122.96 128.03 49.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.736 HD12 HD22 ' A' ' 578' ' ' LEU . 11.8 mt -85.26 127.5 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.864 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.2 mm-40 -82.68 140.08 33.33 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.271 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.401 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -48.45 -29.92 4.58 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.12 -23.52 56.98 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.823 -1.081 . . . . 0.0 113.296 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 595' ' ' GLN . 53.2 t -86.93 112.95 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.151 0.975 . . . . 0.0 111.234 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.45 122.92 5.29 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.062 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.709 ' HG3' HD23 ' A' ' 726' ' ' LEU . 48.0 Cg_endo -92.09 160.54 25.65 Favored 'Cis proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.765 -0.931 . . . . 0.0 110.379 -1.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.8 t80 -90.03 117.43 28.82 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 74.4 m-85 -90.24 137.66 32.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.923 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.859 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -132.86 135.9 56.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.95 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.66 173.1 36.17 Favored Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.48 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.91 -35.58 58.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.908 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.551 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 9.7 p -75.96 118.9 19.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.998 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -19.71 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.57 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.57 -29.62 3.0 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -72.39 123.32 22.83 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.611 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.43 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.262 0.553 . . . . 0.0 110.685 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.859 ' HB3' HG23 ' A' ' 603' ' ' ILE . 49.9 t -96.02 144.6 26.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.799 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 113.15 19.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.724 HG23 HG13 ' A' ' 588' ' ' ILE . 10.3 mm -138.61 111.25 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.255 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -92.23 99.85 12.56 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 122.216 1.008 . . . . 0.0 109.793 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.759 ' HB3' HD13 ' A' ' 618' ' ' LEU . 54.9 t0 -132.31 108.51 9.25 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.427 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -36.47 -36.56 0.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.875 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.8 mmp_? -78.04 -30.35 49.82 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.706 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.39 158.61 9.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.5 172.72 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.086 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.551 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.87 -66.29 0.41 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.007 HG22 HD21 ' A' ' 730' ' ' LEU . 40.1 t -99.49 52.36 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.982 0.896 . . . . 0.0 109.057 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.703 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 65.9 t60 -42.24 -40.41 2.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.852 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 7.0 p 178.61 155.3 0.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.628 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.63 147.53 34.47 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.146 0.498 . . . . 0.0 110.847 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.695 ' CD1' HD11 ' A' ' 580' ' ' LEU . 71.3 mt -101.07 119.25 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.3 t80 -109.52 152.62 25.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.522 -178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.554 ' NZ ' HG21 ' A' ' 700' ' ' THR . 15.9 ttmt -115.24 132.46 56.6 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.85 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.48 158.64 43.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.609 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.43 120.9 23.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.629 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.8 t60 -75.42 130.79 39.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -121.56 118.27 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.16 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -88.67 159.8 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -63.52 177.89 7.24 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.396 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 111.97 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.62 99.15 12.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.0 mtm -88.18 49.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 110.179 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.05 -153.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.3 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -114.9 100.45 8.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.383 0.611 . . . . 0.0 109.884 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 640' ' ' PRO . 60.8 p -138.23 148.6 60.36 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.84 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 639' ' ' SER . 32.2 Cg_exo -57.51 -140.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.946 2.431 . . . . 0.0 112.195 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.36 -69.95 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 39.19 32.36 0.07 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.64 124.65 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.699 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.847 HD12 ' HA ' ' A' ' 703' ' ' PHE . 96.0 mt -153.51 -144.43 0.15 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.414 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.793 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -119.73 147.57 44.44 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.06 156.27 48.97 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.61 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.004 HD13 HD12 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -108.47 115.92 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.497 0.665 . . . . 0.0 112.253 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 68.4 m95 -100.61 128.28 46.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.355 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 672' ' ' LEU . 9.0 t80 -89.27 117.35 28.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.477 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -106.46 110.65 22.93 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.408 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 35.9 t60 -83.89 125.99 32.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.513 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.52 2.67 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.617 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.2 147.35 18.81 Favored Glycine 0 C--N 1.319 -0.402 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.579 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.6 m -71.09 -23.69 62.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.736 ' OD1' HD23 ' P' ' 831' ' ' LEU . 3.7 m-80 -74.06 4.13 5.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 49.38 155.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.272 0.558 . . . . 0.0 111.998 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.428 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 7.9 t -127.46 165.57 19.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.027 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -127.81 120.61 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.109 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.782 HD12 ' HE1' ' A' ' 670' ' ' PHE . 1.0 OUTLIER -114.19 128.47 56.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.097 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.725 ' N ' HD13 ' A' ' 659' ' ' LEU . 16.4 t-20 48.55 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.31 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.1 OUTLIER -136.86 -2.54 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -117.47 140.98 48.89 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.779 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.15 142.35 27.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.458 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.445 ' HE3' ' HB2' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -123.38 133.48 54.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 -179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 156.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.408 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.69 107.6 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.094 0.473 . . . . 0.0 110.74 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.33 24.29 3.25 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 31.3 p -126.5 162.5 25.49 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.487 0.66 . . . . 0.0 111.162 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.8 ttpt -123.04 129.77 51.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.274 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.782 ' HE1' HD12 ' A' ' 659' ' ' LEU . 30.4 t80 -133.26 133.29 42.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.601 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -68.85 143.72 54.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 112.191 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 649' ' ' TYR . 6.3 mt -112.7 145.71 40.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.892 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.53 ' HB3' HD12 ' A' ' 707' ' ' LEU . 24.0 mt-30 -119.11 157.17 28.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.11 130.37 45.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.746 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.13 40.85 82.36 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.577 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -107.65 133.95 51.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.863 0.363 . . . . 0.0 111.136 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 6.0 tt0 -96.34 117.57 31.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.786 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.688 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.83 121.44 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 0.0 111.309 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -101.28 117.03 34.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.075 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.629 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -90.49 -25.89 5.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.574 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.716 HG21 ' OD2' ' A' ' 615' ' ' ASP . 0.5 OUTLIER -150.24 130.18 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 110.94 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.725 ' HD1' HG12 ' A' ' 689' ' ' VAL . 12.3 t90 -137.57 124.68 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.364 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.46 116.54 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -46.74 72.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.206 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.8 -40.46 20.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.75 0.31 . . . . 0.0 111.638 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -8.88 57.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.415 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.56 23.92 4.99 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.915 0.388 . . . . 0.0 110.756 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.72 ' CD2' HD13 ' A' ' 587' ' ' ILE . 4.4 t80 -103.22 105.28 15.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.383 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.725 HG12 ' HD1' ' A' ' 682' ' ' TRP . 5.1 m -126.07 131.57 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.699 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.652 HG12 HG22 ' A' ' 587' ' ' ILE . 5.1 mt -116.48 142.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.956 178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.71 136.96 3.52 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.191 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.2 OUTLIER -121.94 151.0 41.21 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.46 117.74 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.368 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.679 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -75.53 120.47 25.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.666 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 579' ' ' THR . 0.8 OUTLIER -126.97 110.93 13.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.009 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 705' ' ' GLU . 46.9 mt -92.55 106.79 18.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.38 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.4 -43.35 13.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.876 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -109.72 141.05 42.88 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.808 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 4.0 p -113.13 96.42 5.92 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.768 0.794 . . . . 0.0 109.106 178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.554 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.5 t -67.75 72.6 0.16 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.63 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.83 71.61 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.713 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.2 OUTLIER -79.54 128.14 33.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.723 0.296 . . . . 0.0 111.231 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.847 ' HA ' HD12 ' A' ' 644' ' ' LEU . 3.7 p90 -45.13 -32.63 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.559 0.695 . . . . 0.0 110.123 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.438 ' C ' ' HG2' ' A' ' 705' ' ' GLU . 5.3 t30 -145.24 -60.24 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.522 ' C ' HD12 ' A' ' 702' ' ' LEU . 10.3 pt-20 157.33 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.556 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.1 -15.98 1.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.689 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 673' ' ' GLN . 0.2 OUTLIER -83.09 8.81 11.89 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 72.59 -133.11 18.98 Favored Glycine 0 C--N 1.32 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.642 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.11 34.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.3 -167.98 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -60.88 -106.42 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.337 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -114.96 98.05 6.59 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.746 0.308 . . . . 0.0 111.049 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.478 ' O ' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -117.99 97.65 5.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.756 ' CZ ' ' HA ' ' A' ' 714' ' ' ARG . 3.1 mmm180 -141.83 98.19 3.29 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.409 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.24 146.28 30.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.239 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.421 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 9.9 p -89.97 130.45 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.946 0.403 . . . . 0.0 111.893 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -110.63 171.28 7.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.688 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -103.59 149.35 24.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.438 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -97.23 160.61 14.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.787 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 42.2 p -121.45 -173.69 2.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.486 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -52.85 -28.99 25.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.02 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.6 OUTLIER -58.66 -52.37 65.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.191 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.09 -44.41 95.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.247 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -52.58 -32.4 40.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -38.67 81.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.085 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.16 -46.79 75.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.0 111.337 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.843 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.5 p -69.57 -24.89 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.277 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -24.58 22.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -110.01 -31.1 7.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.031 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 1.007 HD21 HG22 ' A' ' 621' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.809 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.815 0.34 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 128.92 39.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.8 pt -101.62 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.073 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -111.95 -171.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.736 HD23 ' OD1' ' A' ' 655' ' ' ASN . 0.3 OUTLIER -160.75 158.88 29.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.781 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.008 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.339 -0.304 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -81.65 -22.37 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.56 0.219 . . . . 0.0 111.151 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -148.36 59.19 0.46 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.69 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -83.63 109.2 17.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 1.015 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.2 OUTLIER -97.15 -45.82 6.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.688 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.035 HD21 HG22 ' A' ' 694' ' ' VAL . 1.3 tt -123.21 143.13 50.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.474 HG22 ' HG2' ' A' ' 581' ' ' LYS . 7.4 m -114.57 114.88 26.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.182 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.647 HD11 ' CD1' ' A' ' 625' ' ' ILE . 4.4 mt -101.23 110.48 22.5 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 583' ' ' LEU . 4.8 mtpp -116.86 104.33 51.17 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.949 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 9.6 Cg_endo -62.02 123.1 11.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.648 1.565 . . . . 0.0 109.227 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.738 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -79.14 151.66 75.88 Favored Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 35.7 Cg_exo -58.16 -25.6 72.24 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.459 2.773 . . . . 0.0 112.727 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.09 -20.5 65.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.21 0.529 . . . . 0.0 109.803 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.532 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.55 154.68 17.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.758 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 690' ' ' ILE . 6.6 pt -45.53 -25.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.45 0.643 . . . . 0.0 109.589 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.804 HG13 HD12 ' A' ' 613' ' ' ILE . 28.6 mm -101.26 151.65 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.071 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -152.27 63.34 0.82 Allowed 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.949 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.6 mt-10 -126.37 174.04 8.89 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 113.446 -1.707 . . . . 0.0 110.412 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.54 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -133.97 117.86 17.19 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.952 177.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.726 HD23 ' HE2' ' A' ' 692' ' ' PHE . 1.3 mm? -112.9 148.24 35.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.95 117.27 23.67 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.004 HD12 HD22 ' A' ' 578' ' ' LEU . 20.7 mt -76.16 123.93 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.871 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mm-40 -81.66 139.9 34.68 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.474 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.485 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.51 -29.62 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -80.84 -25.49 55.92 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.724 -1.125 . . . . 0.0 113.183 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 595' ' ' GLN . 46.7 t -84.54 112.69 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 118.054 0.927 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.74 121.96 4.98 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.189 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.0 Cg_endo -91.58 160.74 27.55 Favored 'Cis proline' 0 N--CA 1.45 -1.046 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.245 -1.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.6 t80 -88.67 116.09 26.66 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.687 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 91.2 m-85 -89.27 137.72 32.07 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.311 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.4 mt -133.15 135.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.921 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.525 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 175.57 36.49 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.578 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.67 -48.43 58.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.704 0.288 . . . . 0.0 111.439 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -66.61 118.93 10.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -17.72 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.168 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.54 -28.66 3.54 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.09 122.04 19.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.991 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.33 -34.74 0.14 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.617 -179.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.5 t -97.7 143.91 27.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.16 115.64 25.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.804 HD12 HG13 ' A' ' 588' ' ' ILE . 20.5 mm -139.91 111.05 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.76 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -95.22 100.38 12.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.158 0.98 . . . . 0.0 109.819 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.81 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.1 t0 -131.62 108.55 9.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.409 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -35.61 -38.34 0.11 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.963 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.409 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.4 mmp_? -77.78 -31.19 51.78 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.775 0.322 . . . . 0.0 111.629 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.81 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.1 158.38 8.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.775 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.82 172.65 6.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.774 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.63 -68.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 110.311 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.944 HG11 HG23 ' A' ' 727' ' ' VAL . 13.8 t -97.13 52.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.022 0.915 . . . . 0.0 109.124 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 50.8 t60 -40.43 -39.38 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.718 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.8 p 176.76 153.01 0.2 Allowed 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.687 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.4 p90 -143.7 151.77 40.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.512 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.647 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.4 mt -101.57 119.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.506 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.2 t80 -109.31 152.62 25.02 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.654 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.667 ' HB2' HG22 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -116.73 135.06 54.07 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.899 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -136.44 158.46 44.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.625 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt85 -77.45 120.17 22.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.0 110.316 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.445 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -61.36 124.46 20.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.889 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -59.84 125.12 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.377 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -135.77 -175.67 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.744 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.569 ' H ' HG22 ' A' ' 632' ' ' VAL . . . 109.57 25.42 5.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.704 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -143.0 73.23 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.761 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.31 108.36 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.05 35.01 1.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.144 0.497 . . . . 0.0 110.302 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.34 -151.76 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.306 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -114.25 99.89 7.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.458 0.647 . . . . 0.0 109.656 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.4 156.86 73.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.087 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 73.9 Cg_endo -70.74 -152.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.703 2.269 . . . . 0.0 111.703 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 82.62 -71.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 38.06 34.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.469 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 61.06 115.97 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.484 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.917 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.3 mt -152.85 -152.58 0.43 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.713 -0.744 . . . . 0.0 110.081 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 147.4 26.73 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 628' ' ' LYS . 11.6 t0 -134.69 131.14 37.33 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.351 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.015 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.0 pt -96.67 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.458 0.647 . . . . 0.0 112.227 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 61.6 m95 -102.05 137.31 40.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.515 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.577 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.0 t80 -89.75 117.34 28.53 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.451 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 1.2 t -110.59 107.05 16.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.412 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 46.5 t60 -77.8 128.06 33.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.623 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.478 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.24 2.87 9.21 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.659 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.97 149.81 21.08 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.471 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 63.4 m -76.34 -24.03 54.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.696 ' OD1' HD12 ' P' ' 831' ' ' LEU . 1.1 m-20 -74.99 4.93 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.541 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.8 p 49.7 152.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.38 0.61 . . . . 0.0 112.05 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 13.3 t -123.6 165.18 17.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -123.63 130.39 52.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.61 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.979 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -122.03 99.8 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.898 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 64.57 -75.65 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.906 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.93 22.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.432 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 14.8 m120 -123.24 140.15 53.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.924 0.392 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.839 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -97.04 141.49 30.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.502 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.7 ptm -141.88 117.26 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.843 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 30.6 pt -87.03 160.57 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.062 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -52.43 108.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.72 18.8 4.27 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.9 p -118.86 156.2 29.89 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.434 0.635 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.424 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 3.2 ttpt -122.82 131.78 53.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.137 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.578 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.0 OUTLIER -131.2 143.99 51.01 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.34 134.31 45.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.615 ' CD2' HD21 ' A' ' 659' ' ' LEU . 2.9 mt -108.65 116.52 32.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.031 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 9.6 mt-30 -93.24 166.77 12.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.827 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -63.22 120.8 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 80.86 38.97 14.38 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.435 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -90.75 116.95 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.11 111.01 23.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.979 HG22 HD13 ' A' ' 659' ' ' LEU . 29.0 pt -105.49 133.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.246 0.546 . . . . 0.0 112.331 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.64 116.7 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.89 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.467 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -84.74 -28.78 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.753 HG21 ' OD2' ' A' ' 615' ' ' ASP . 6.8 tt -154.34 130.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.783 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.628 ' HA ' HG23 ' A' ' 689' ' ' VAL . 10.3 t90 -137.09 122.05 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.026 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.459 ' HB2' ' CE2' ' A' ' 688' ' ' PHE . 9.0 t0 -127.04 116.69 21.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 110.391 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -67.42 -44.56 78.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.994 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.54 -40.36 82.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.028 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.6 -14.29 18.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.636 0.255 . . . . 0.0 111.432 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 683' ' ' ASP . 0.6 OUTLIER 63.42 16.16 9.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.276 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 3.1 p90 -89.11 105.7 17.96 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 682' ' ' TRP . 0.8 OUTLIER -123.44 138.04 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.612 -178.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.579 HD11 HD11 ' A' ' 587' ' ' ILE . 17.9 mt -118.3 119.83 62.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.898 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -136.08 142.23 13.45 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.405 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.726 ' HE2' HD23 ' A' ' 592' ' ' LEU . 8.7 m-85 -114.66 166.87 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.357 . . . . 0.0 111.01 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 116.65 22.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.654 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.035 HG22 HD21 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -90.1 117.64 33.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.54 111.15 12.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.77 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.719 HG12 HD12 ' A' ' 578' ' ' LEU . 3.8 mt -86.54 105.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.84 -47.67 8.85 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.535 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.26 139.55 46.55 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.275 179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 699' ' ' THR . 0.1 OUTLIER -114.95 97.18 6.08 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 700' ' ' THR . 6.5 t -66.43 74.29 0.09 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.679 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 63.82 24.23 68.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.188 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.544 HD22 ' CA ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -75.84 140.96 42.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 111.184 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.917 ' HA ' HD12 ' A' ' 644' ' ' LEU . 48.8 p90 -50.1 -32.27 15.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.447 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 7.2 t30 -149.8 -59.75 0.2 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.547 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.708 ' HB2' HD13 ' A' ' 696' ' ' ILE . 14.8 pt-20 160.02 -28.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 148.23 -10.46 1.15 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.738 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -82.94 8.82 11.53 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.01 0.433 . . . . 0.0 111.882 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 67.44 -130.15 28.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.989 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.87 -137.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 710' ' ' LEU . 4.2 pp -37.85 131.77 1.0 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.542 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 46.27 89.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.62 128.45 35.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.689 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -115.41 97.37 6.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.335 0.588 . . . . 0.0 110.494 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -102.83 71.75 1.17 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.452 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 10.0 m -123.41 141.15 44.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.126 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.839 HG21 ' O ' ' A' ' 663' ' ' ARG . 85.1 t -77.71 130.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.43 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.24 172.07 7.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.496 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -99.18 145.51 27.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 111.311 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 7.9 pt20 -86.84 159.4 19.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.35 -174.66 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.091 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.35 -28.92 31.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.094 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -59.98 -51.26 70.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.583 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -67.3 -44.21 79.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 727' ' ' VAL . 10.1 mtmm -58.68 -33.77 70.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.39 -36.7 81.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.9 mt -58.8 -45.21 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.8 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.944 HG23 HG11 ' A' ' 621' ' ' VAL . 7.1 p -74.07 -30.22 27.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.667 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -29.14 68.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.582 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -105.57 23.24 14.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.919 HD13 HG22 ' A' ' 621' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.662 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.817 0.342 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.07 74.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 36.5 mt -111.62 140.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.51 119.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.696 HD12 ' OD1' ' A' ' 655' ' ' ASN . 9.6 mt -135.67 113.34 10.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.874 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.212 0 N-CA-C 112.728 -0.149 . . . . 0.0 112.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.2 10.24 22.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.575 0.226 . . . . 0.0 111.492 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 114.01 1.9 23.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.821 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -102.32 120.49 40.57 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.303 0.573 . . . . 0.0 110.705 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.862 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -107.42 -47.32 3.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.842 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.006 HD12 HD13 ' A' ' 647' ' ' ILE . 7.4 tt -117.74 142.35 47.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.045 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.79 ' N ' HD23 ' A' ' 578' ' ' LEU . 19.9 m -127.28 114.33 17.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.223 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.742 HD11 HD11 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -99.33 109.07 21.73 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.646 ' O ' HD13 ' A' ' 583' ' ' LEU . 3.2 ptpt -113.09 100.28 50.95 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.963 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -56.49 109.65 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.569 1.513 . . . . 0.0 109.56 176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.713 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.61 161.06 52.12 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.504 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 78.3 Cg_exo -49.05 -25.97 9.77 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 124.233 3.289 . . . . 0.0 112.926 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.466 ' HB2' HD23 ' A' ' 583' ' ' LEU . 26.1 m-20 -62.96 -24.88 68.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 35.0 p -95.61 153.35 17.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -54.98 -19.61 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.049 0.452 . . . . 0.0 110.537 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.789 HG23 ' HB2' ' A' ' 582' ' ' PRO . 6.3 tt -106.46 153.18 7.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.669 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.504 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 23.6 mp0 -143.02 63.66 1.37 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.963 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.5 mt-10 -123.86 174.08 7.77 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.199 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.814 ' C ' HD13 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -133.18 116.44 16.25 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.691 178.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.814 HD13 ' C ' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.78 134.4 54.8 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 579' ' ' THR . 2.5 mp0 -123.45 130.88 53.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 580' ' ' LEU . 15.7 mt -87.62 119.01 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.756 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.1 mp0 -73.78 136.18 43.58 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -45.08 -28.9 0.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 109.782 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.404 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -89.34 -18.31 53.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.877 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.756 HG23 ' HB2' ' A' ' 595' ' ' GLN . 74.7 t -82.72 114.59 23.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.428 1.114 . . . . 0.0 110.981 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -146.76 124.07 5.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.017 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 71.6 Cg_endo -92.64 160.59 23.73 Favored 'Cis proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.855 -0.894 . . . . 0.0 110.384 -1.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.594 ' CD1' HG23 ' A' ' 594' ' ' ILE . 3.4 t80 -90.33 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 609' ' ' CYS . 67.6 m-85 -89.75 138.22 31.66 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.597 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.858 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -133.06 135.89 56.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.964 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.37 175.36 37.91 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.391 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -41.75 68.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.581 0.229 . . . . 0.0 111.07 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.633 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -72.6 119.23 16.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.6 OUTLIER -51.93 -19.04 1.57 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.939 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -45.92 -30.24 1.69 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.634 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 2.1 m -72.77 122.75 22.04 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.792 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.525 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -39.81 -33.36 0.19 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.311 0.577 . . . . 0.0 110.624 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.858 ' HB3' HG23 ' A' ' 603' ' ' ILE . 28.8 t -94.0 143.31 26.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.85 115.75 23.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.585 HD11 HD21 ' A' ' 592' ' ' LEU . 7.6 mm -139.28 116.92 11.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.02 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -95.58 98.98 10.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.215 1.007 . . . . 0.0 109.87 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.895 ' OD2' HG21 ' A' ' 681' ' ' ILE . 53.8 t0 -132.27 108.29 9.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.493 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -38.24 -36.31 0.21 Allowed 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.685 ' HB2' HD13 ' A' ' 681' ' ' ILE . 6.2 mmp_? -78.05 -27.41 48.71 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.641 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -59.04 158.39 8.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.234 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.5 m -113.69 174.93 5.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.934 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.633 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.67 -67.92 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 730' ' ' LEU . 14.7 t -98.77 51.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.095 0.95 . . . . 0.0 109.093 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.653 ' CD2' HG21 ' A' ' 680' ' ' ILE . 41.5 t60 -40.1 -37.99 0.68 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.744 -1.571 . . . . 0.0 112.741 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.9 p 176.33 154.69 0.21 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.604 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.7 p90 -143.38 146.67 33.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.203 0.525 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 580' ' ' LEU . 72.3 mt -101.95 117.85 47.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.4 t80 -110.15 152.34 26.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.545 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.477 ' HB2' HG22 ' A' ' 647' ' ' ILE . 33.1 ttmt -115.88 135.91 53.54 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.977 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.7 158.85 43.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.442 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.803 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -76.84 115.18 16.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 644' ' ' LEU . 3.3 t60 -78.2 133.77 37.7 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.62 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.803 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -138.64 132.68 31.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.304 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.6 OUTLIER -99.4 171.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.937 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -57.88 171.2 3.7 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.562 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -59.45 88.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.754 0.312 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.03 103.43 4.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.01 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.33 27.18 3.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 639' ' ' SER . 1.3 p90 -139.67 -148.95 0.27 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.164 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 100.64 8.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.096 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.485 ' HB3' ' CE2' ' A' ' 637' ' ' TYR . 4.6 p -138.06 156.58 73.94 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.881 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 72.6 Cg_endo -71.4 -153.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.701 2.267 . . . . 0.0 111.405 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 70.15 -66.32 0.28 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 40.62 32.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.223 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 630' ' ' HIS . . . 63.48 117.86 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.785 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.871 HD12 ' HA ' ' A' ' 703' ' ' PHE . 95.8 mt -154.68 -150.81 0.33 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.38 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -113.07 147.72 36.69 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.427 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 0.2 OUTLIER -131.14 157.0 44.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.634 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.006 HD13 HD12 ' A' ' 578' ' ' LEU . 4.6 pt -115.09 113.67 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 121.718 0.77 . . . . 0.0 112.127 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.608 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 84.5 m95 -99.11 127.88 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.861 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.598 ' CB ' HD21 ' A' ' 672' ' ' LEU . 14.6 t80 -89.53 116.37 27.64 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.422 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 6.0 t -110.2 110.18 20.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.492 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 47.3 t60 -81.53 127.79 33.22 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.862 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.544 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.12 -1.59 8.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.736 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.16 147.26 23.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.689 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 36.4 m -73.1 -23.45 60.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.001 0.429 . . . . 0.0 111.086 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.535 ' C ' HG23 ' A' ' 656' ' ' VAL . 1.9 m120 -71.34 3.63 3.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.696 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' A' ' 665' ' ' ILE . 0.1 OUTLIER 56.67 157.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.71 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.492 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 2.6 t -133.35 159.62 39.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.013 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -137.26 120.1 16.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.0 110.717 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.749 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -108.63 108.96 20.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.6 m120 62.56 -79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.646 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 659' ' ' LEU . 28.6 m120 -145.43 13.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.472 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -109.06 141.76 40.75 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.841 0.353 . . . . 0.0 111.234 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.668 ' O ' HG21 ' A' ' 716' ' ' VAL . 16.0 ttm105 -80.43 141.37 35.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 657' ' ' SER . 52.0 mmm -130.01 88.14 2.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.054 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.577 ' HA ' HG13 ' A' ' 656' ' ' VAL . 39.1 pt -87.77 143.56 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -46.96 107.37 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.145 0.498 . . . . 0.0 111.145 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.21 23.74 3.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.356 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.5 p -124.76 158.05 34.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.541 0.686 . . . . 0.0 111.368 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -122.92 141.36 51.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.075 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 649' ' ' TYR . 5.3 t80 -147.02 144.45 29.15 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.608 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -77.64 140.87 39.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.024 0.44 . . . . 0.0 111.501 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.709 HD13 HG21 ' A' ' 694' ' ' VAL . 3.7 mt -107.94 111.34 23.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.338 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 11.9 mt-30 -90.83 145.26 24.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.3 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -47.44 123.26 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.946 0.403 . . . . 0.0 110.981 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 82.12 39.1 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.37 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.76 120.29 37.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.312 . . . . 0.0 111.008 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.1 mp0 -96.07 112.98 24.55 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.749 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.5 mt -104.98 120.18 55.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.14 0.495 . . . . 0.0 112.005 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -95.48 116.79 29.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.707 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -92.52 -20.44 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.895 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.0 OUTLIER -154.33 131.95 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.52 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.587 ' HA ' HG23 ' A' ' 689' ' ' VAL . 6.6 t90 -136.3 124.82 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.48 116.94 31.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.256 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -46.63 73.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.125 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -79.19 -40.2 31.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.758 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.96 -20.08 33.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.472 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 12.1 tttt 61.79 16.46 7.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.47 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.0 OUTLIER -88.91 105.62 17.87 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 682' ' ' TRP . 1.0 OUTLIER -122.05 138.38 52.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.228 -177.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.737 ' HB ' HG22 ' A' ' 681' ' ' ILE . 36.5 mm -109.27 144.68 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.814 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.48 136.94 2.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.372 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.707 ' CZ ' HD11 ' A' ' 680' ' ' ILE . 0.0 OUTLIER -124.72 153.01 43.04 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -101.59 117.42 34.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.726 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -72.99 115.02 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -117.15 110.78 18.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.419 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 705' ' ' GLU . 33.8 mt -94.46 105.72 17.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.426 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -87.94 -44.14 11.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.124 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.23 139.64 45.19 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.896 179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 701' ' ' GLY . 3.3 p -114.28 96.8 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -64.48 72.9 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.643 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 59.42 27.95 64.05 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.044 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.51 HD22 ' C ' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -77.15 149.15 35.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.008 0.433 . . . . 0.0 111.321 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.871 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -54.76 -17.48 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.028 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 707' ' ' LEU . 1.4 p-10 -175.6 -48.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.611 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.629 ' HB2' HD12 ' A' ' 696' ' ' ILE . 4.8 pt-20 162.38 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.688 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.24 19.64 0.19 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.605 ' H ' ' ND2' ' A' ' 704' ' ' ASN . 0.2 OUTLIER -81.17 8.62 8.38 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 671' ' ' LEU . . . 31.54 90.81 0.01 OUTLIER Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.098 -0.501 . . . . 0.0 114.181 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.431 ' HE2' ' N ' ' A' ' 709' ' ' MET . 0.0 OUTLIER -106.53 75.35 1.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.884 0.373 . . . . 0.0 110.867 179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.46 -166.43 1.99 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -55.15 -53.92 49.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.47 ' HG2' HG21 ' A' ' 715' ' ' VAL . 12.2 mt-10 -64.06 133.03 52.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.67 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -116.67 97.57 6.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.293 0.568 . . . . 0.0 110.44 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 45.25 74.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.681 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.47 HG21 ' HG2' ' A' ' 712' ' ' GLU . 3.7 m -124.68 143.1 39.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.595 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 663' ' ' ARG . 32.5 t -80.62 129.05 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.937 0.398 . . . . 0.0 111.325 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.08 168.5 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.863 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -103.12 140.39 37.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.806 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -78.42 157.36 29.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.771 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.15 -174.37 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.268 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -31.27 46.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.538 ' O ' HD13 ' A' ' 726' ' ' LEU . 5.1 pt-20 -62.11 -49.29 76.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.553 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.27 -45.25 92.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.542 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -32.6 51.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.66 -38.04 80.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.268 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 722' ' ' GLU . 9.8 mp -54.94 -46.95 75.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.054 0.454 . . . . 0.0 111.192 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.968 HG13 HG11 ' A' ' 621' ' ' VAL . 16.4 t -68.6 -22.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.394 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 61.38 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.507 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -151.74 -46.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.174 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 621' ' ' VAL . 2.8 pp . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.911 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.947 0.404 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -174.76 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 3.2 pt -103.86 172.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 61.8 170.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 1.2 mt 62.8 151.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.036 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.804 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -103.79 10.49 36.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.509 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 130.93 -40.97 1.58 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.698 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.401 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 61.6 ttp180 -111.75 136.35 51.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.381 0.61 . . . . 0.0 111.94 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.689 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -122.27 -45.66 2.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.326 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.096 HD12 HG23 ' A' ' 696' ' ' ILE . 6.1 tp -121.77 142.64 50.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.592 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 581' ' ' LYS . 22.4 m -121.02 116.26 24.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.021 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.886 HD22 HG22 ' A' ' 694' ' ' VAL . 1.5 mt -103.79 109.19 20.81 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.619 ' HG2' HG22 ' A' ' 579' ' ' THR . 0.1 OUTLIER -110.75 102.21 51.57 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -176.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.903 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -55.74 102.58 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.389 1.393 . . . . 0.0 109.463 177.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.699 ' H ' HD13 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -79.56 159.82 71.16 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.479 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 81.4 Cg_exo -49.82 -27.42 15.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 124.164 3.243 . . . . 0.0 112.981 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.403 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 4.7 t0 -62.99 -27.09 69.17 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 56.6 p -95.86 154.07 17.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.718 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.621 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.3 OUTLIER -52.85 -20.85 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.102 0.477 . . . . 0.0 110.457 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 1.018 HD11 HG23 ' A' ' 613' ' ' ILE . 6.5 mt -98.44 152.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.802 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 582' ' ' PRO . 12.3 mp0 -146.24 53.49 1.13 Allowed 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.527 1.155 . . . . 0.0 108.546 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.903 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 4.8 mm-40 -124.63 175.19 7.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.854 -1.975 . . . . 0.0 108.612 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.785 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.87 116.48 17.25 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.904 0.383 . . . . 0.0 111.226 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.867 HD12 ' SG ' ' A' ' 611' ' ' CYS . 0.7 OUTLIER -114.78 139.44 49.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 579' ' ' THR . 1.0 OUTLIER -124.54 126.35 45.68 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.256 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 625' ' ' ILE . 12.1 mt -74.64 124.9 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.855 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -72.39 140.57 48.48 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -48.9 -23.87 1.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 109.984 179.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -95.17 -9.26 58.27 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.777 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.855 HG23 ' HB2' ' A' ' 595' ' ' GLN . 72.5 t -89.82 112.85 25.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.684 1.242 . . . . 0.0 110.722 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.43 122.34 5.17 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.302 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.4 Cg_endo -91.88 160.82 26.54 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.629 -0.988 . . . . 0.0 110.181 -1.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.653 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -88.28 115.24 25.64 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.0 m-85 -89.02 137.88 31.91 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.883 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.032 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.5 mt -133.28 136.14 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.135 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.86 176.51 37.29 Favored Glycine 0 C--N 1.319 -0.373 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.635 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.48 -47.21 63.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -67.54 118.94 11.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.251 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 pp20? -53.72 -17.78 2.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.099 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -48.45 -28.9 3.58 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.9 m -71.0 122.29 19.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.095 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CG ' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.26 -34.53 0.13 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.324 0.583 . . . . 0.0 110.691 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.032 ' HB3' HG23 ' A' ' 603' ' ' ILE . 6.7 t -97.98 143.65 28.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -119.11 120.8 38.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 1.018 HG23 HD11 ' A' ' 588' ' ' ILE . 6.2 mt -139.27 125.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.166 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -101.0 98.22 8.7 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 122.127 0.965 . . . . 0.0 109.127 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.498 ' OD2' HG21 ' A' ' 681' ' ' ILE . 1.3 m-20 -132.9 108.5 8.97 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.704 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -41.39 -38.22 1.19 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.585 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.451 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -77.89 -25.72 48.7 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.572 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.657 ' HG ' ' CG ' ' A' ' 622' ' ' HIS . 1.1 tp -59.23 158.96 8.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.266 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 75.3 m -114.67 171.27 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.332 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.24 -68.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.647 0.261 . . . . 0.0 110.421 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.93 HG22 HD13 ' A' ' 730' ' ' LEU . 11.2 t -97.31 52.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.054 0.931 . . . . 0.0 109.21 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.657 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 44.3 t60 -40.66 -37.06 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.789 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.4 p 176.09 150.02 0.12 Allowed 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 23.0 p90 -144.01 148.93 35.92 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.89 HD13 HD13 ' A' ' 594' ' ' ILE . 0.2 OUTLIER -102.3 124.52 56.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 2.6 t80 -110.16 152.17 26.38 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.703 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.448 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 19.3 ttmt -111.32 132.12 54.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.944 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.66 156.5 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.7 tpt180 -79.38 117.66 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.135 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.1 t60 -61.29 127.4 31.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.141 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.35 107.0 6.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.218 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.4 p -97.16 159.2 3.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.907 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -105.93 -168.96 23.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.627 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -71.52 145.71 48.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 110.792 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.3 108.02 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -96.82 31.34 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.335 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.86 -151.87 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.523 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -114.49 100.32 8.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.342 0.591 . . . . 0.0 109.87 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 23.7 p -136.96 156.48 75.79 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.757 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.91 -154.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.695 2.264 . . . . 0.0 111.778 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 67.27 -72.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.69 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 32.47 38.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.836 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 63.28 113.67 0.01 OUTLIER Glycine 0 CA--C 1.504 -0.646 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.842 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 703' ' ' PHE . 61.1 mt -152.48 -170.92 3.77 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.839 -0.68 . . . . 0.0 110.562 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.856 ' O ' HD13 ' A' ' 702' ' ' LEU . 5.7 p-10 -103.46 146.16 28.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.242 0.544 . . . . 0.0 112.378 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.534 ' OD2' HD11 ' A' ' 671' ' ' LEU . 5.4 t0 -130.32 139.53 50.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.137 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.747 HD13 HD22 ' A' ' 578' ' ' LEU . 3.7 pt -96.43 123.59 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.455 0.645 . . . . 0.0 110.898 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.627 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 90.5 m95 -110.2 132.96 53.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.74 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.919 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.8 t80 -90.09 117.33 28.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -113.55 109.48 18.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.458 ' ND1' ' CB ' ' A' ' 657' ' ' SER . 48.1 t60 -78.97 127.73 32.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.46 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.02 2.61 8.67 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.643 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -84.8 143.0 20.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.467 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 79.9 m -68.89 -24.77 64.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.526 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -74.52 5.12 5.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.25 152.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.448 0.642 . . . . 0.0 111.996 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.458 ' CB ' ' ND1' ' A' ' 651' ' ' HIS . 8.6 t -124.79 165.63 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.889 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -130.78 120.46 23.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.627 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -106.83 103.95 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.924 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 714' ' ' ARG . 24.7 t-20 63.3 -79.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.2 13.49 2.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.531 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.624 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -117.5 137.29 52.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.825 0.345 . . . . 0.0 110.938 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.786 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.1 ttt-85 -82.93 141.55 32.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.633 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.483 ' HE3' ' O ' ' A' ' 649' ' ' TYR . 33.5 mtp -128.32 103.32 7.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.142 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.5 pt -87.05 144.38 9.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.376 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.77 107.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.106 0.479 . . . . 0.0 110.93 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 120.41 20.64 3.55 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 60.7 p -124.55 159.94 29.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.413 0.625 . . . . 0.0 111.274 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.421 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.8 ttpm? -123.32 143.67 49.93 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.861 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -147.18 132.09 18.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.627 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.2 OUTLIER -69.38 141.88 54.06 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.128 0.49 . . . . 0.0 111.785 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 694' ' ' VAL . 11.8 mt -109.33 115.77 30.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.656 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 20.3 mt-30 -95.37 130.89 42.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.616 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.906 ' OD2' HD12 ' A' ' 707' ' ' LEU . 11.8 p-10 -31.0 122.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.892 0.377 . . . . 0.0 111.519 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.84 39.85 9.2 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -98.81 114.79 27.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.523 -0.339 . . . . 0.0 111.517 -179.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -96.37 108.79 21.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.919 HG21 ' CE2' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -105.33 122.61 58.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.096 0.475 . . . . 0.0 112.061 -178.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -89.26 116.95 27.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.248 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.561 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.29 -27.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.967 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.519 HG22 ' CG1' ' A' ' 690' ' ' ILE . 1.2 tt -152.66 131.3 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.937 0.399 . . . . 0.0 111.514 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 8.6 t90 -135.98 119.29 16.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.739 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.686 ' OD1' HD13 ' P' ' 831' ' ' LEU . 3.1 m-20 -118.93 117.16 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.372 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -67.14 -46.1 75.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.809 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.42 -40.4 57.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.893 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 23.1 m-20 -90.45 -6.99 54.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.564 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm 56.81 22.12 6.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.731 0.3 . . . . 0.0 111.013 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 682' ' ' TRP . 0.1 OUTLIER -78.81 105.06 9.86 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 585' ' ' ASP . 0.8 OUTLIER -126.46 130.51 71.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.935 0.397 . . . . 0.0 111.982 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.621 ' CD1' HG22 ' A' ' 587' ' ' ILE . 33.1 mm -119.26 156.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.053 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.458 ' N ' HG22 ' A' ' 690' ' ' ILE . . . 177.51 125.98 0.95 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.706 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.52 148.3 38.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.667 0.27 . . . . 0.0 110.657 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 583' ' ' LEU . 6.9 ttmt -101.58 116.53 32.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.484 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.886 HG22 HD22 ' A' ' 580' ' ' LEU . 1.3 t -84.88 114.89 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.507 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.53 111.49 14.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 1.096 HG23 HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -83.84 112.8 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.843 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -88.6 -44.12 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.6 OUTLIER -110.67 141.69 43.57 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.177 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 65.1 p -113.17 96.13 5.76 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 577' ' ' PHE . 4.7 t -75.59 65.22 1.76 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.607 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 58.71 58.09 16.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.882 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.856 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -89.08 124.43 34.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.572 0.225 . . . . 0.0 111.215 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.909 ' HA ' HD12 ' A' ' 644' ' ' LEU . 4.5 p90 -29.37 -42.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.386 0.612 . . . . 0.0 111.514 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 705' ' ' GLU . 0.9 OUTLIER -121.57 -44.78 2.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.444 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 12.0 pt-20 144.21 -22.18 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.097 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 112.64 11.74 14.24 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.906 HD12 ' OD2' ' A' ' 674' ' ' ASP . 4.3 tt -98.87 8.65 44.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.049 0.452 . . . . 0.0 111.488 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.453 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 126.72 -134.18 8.36 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.079 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.466 ' HE3' ' HG2' ' A' ' 713' ' ' GLN . 3.7 ttm -174.74 -133.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.284 . . . . 0.0 110.511 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 2.4 pp -50.76 -173.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.738 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -33.94 -87.28 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.408 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -114.38 99.6 7.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.799 0.333 . . . . 0.0 111.672 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 50.7 tp60 -117.14 97.84 6.14 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 2.8 mmm-85 -168.92 64.94 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.686 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.376 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.786 HG21 ' O ' ' A' ' 663' ' ' ARG . 77.8 t -77.62 123.53 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.906 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.43 172.08 7.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.785 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.14 135.79 41.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.214 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.434 ' NE2' ' HA2' ' A' ' 667' ' ' GLY . 22.2 pt20 -78.86 160.29 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.816 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 28.4 p -119.37 -173.39 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.37 -28.71 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.02 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.36 -51.64 68.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 39.6 mp0 -67.59 -49.23 64.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.92 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.553 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.2 mtmt -56.69 -32.74 65.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.56 -36.52 81.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.122 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.427 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -60.32 -45.17 94.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.107 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.659 HG23 HG11 ' A' ' 621' ' ' VAL . 9.3 p -69.73 -28.06 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.096 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -57.59 -31.86 66.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.777 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 25.64 11.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.93 HD13 HG22 ' A' ' 621' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.643 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.932 0.396 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -160.03 160.8 33.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.85 155.29 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -125.92 134.46 51.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.686 HD13 ' OD1' ' A' ' 683' ' ' ASP . 53.8 mt -126.48 115.54 19.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.779 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.95 180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.687 -0.165 . . . . 0.0 112.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -72.05 -8.46 54.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.505 0.193 . . . . 0.0 111.398 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -125.65 -28.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -99.39 124.94 44.95 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.254 0.55 . . . . 0.0 110.642 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -112.64 -46.93 3.11 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.885 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.863 HD12 HD13 ' A' ' 647' ' ' ILE . 8.8 tt -117.36 142.89 46.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.693 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.4 m -122.79 114.54 20.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.112 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' A' ' 625' ' ' ILE . 0.4 OUTLIER -100.6 108.69 20.67 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.599 ' O ' HD13 ' A' ' 583' ' ' LEU . 15.0 ptpt -108.96 99.3 34.49 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -57.29 109.82 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.28 1.32 . . . . 0.0 108.828 176.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.672 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -76.08 157.37 83.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.466 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.1 Cg_exo -55.06 -25.47 45.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 124.009 3.139 . . . . 0.0 113.005 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -62.35 -26.73 68.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.136 0.493 . . . . 0.0 109.841 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.4 OUTLIER -95.88 153.16 17.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.391 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' A' ' 688' ' ' PHE . 0.0 OUTLIER -47.53 -25.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.358 0.599 . . . . 0.0 109.592 178.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.693 HG22 ' HB2' ' A' ' 582' ' ' PRO . 9.7 mm -93.67 149.12 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.179 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.517 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.6 56.23 0.62 Allowed 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 122.627 1.204 . . . . 0.0 108.283 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.7 mt-10 -124.87 175.34 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.674 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.31 115.42 16.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.024 178.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.879 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.2 OUTLIER -115.03 139.2 50.06 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -123.96 128.96 50.17 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.649 HD12 HD22 ' A' ' 578' ' ' LEU . 37.9 mt -78.35 125.6 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.71 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.8 mp0 -78.08 135.73 37.77 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.336 -0.545 . . . . 0.0 110.023 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.409 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -46.54 -29.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.399 0.619 . . . . 0.0 109.517 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.31 -20.5 52.08 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.177 -0.92 . . . . 0.0 113.483 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.71 HG23 ' HB2' ' A' ' 595' ' ' GLN . 62.6 t -82.58 114.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 118.171 0.985 . . . . 0.0 110.976 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.1 t30 -146.59 122.53 5.59 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.674 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG3' HD23 ' A' ' 726' ' ' LEU . 44.1 Cg_endo -92.85 160.89 23.16 Favored 'Cis proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.831 -0.904 . . . . 0.0 110.371 -2.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.7 t80 -89.39 114.31 25.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.635 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 87.2 m-85 -89.29 137.91 31.9 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.86 135.48 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.847 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.94 174.66 37.71 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.348 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 1.6 tpp85 -52.82 -41.47 64.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.632 0.253 . . . . 0.0 111.305 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -72.4 118.83 15.78 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.5 OUTLIER -52.64 -19.01 2.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.0 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.48 -29.75 2.95 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.74 124.42 24.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.506 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -39.47 -32.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.29 0.567 . . . . 0.0 110.427 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.879 ' SG ' HD13 ' A' ' 592' ' ' LEU . 38.1 t -96.35 144.53 26.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.577 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.925 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -118.64 110.73 17.66 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.426 -178.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -137.81 110.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.202 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -94.85 100.54 12.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.247 1.022 . . . . 0.0 110.014 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.732 ' OD2' HG21 ' A' ' 681' ' ' ILE . 62.8 t0 -131.11 108.73 9.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.231 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -33.1 -42.46 0.09 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.72 -25.69 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.674 ' HG ' ' CD2' ' A' ' 622' ' ' HIS . 1.2 mp -59.25 158.64 8.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 24.9 m -114.6 175.45 5.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.199 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.606 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.47 -66.46 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 727' ' ' VAL . 15.9 t -98.71 51.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.011 0.91 . . . . 0.0 109.073 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.674 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 53.1 t60 -40.68 -39.01 0.98 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 113.87 -1.513 . . . . 0.0 112.844 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.567 ' O ' ' N ' ' A' ' 603' ' ' ILE . 5.1 p 177.01 154.41 0.24 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.631 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 12.4 p90 -143.36 147.56 34.87 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.102 0.477 . . . . 0.0 110.772 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.687 ' CD1' HD11 ' A' ' 580' ' ' LEU . 58.6 mt -101.36 117.18 46.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.2 t80 -110.17 152.59 25.87 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.732 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.1 OUTLIER -116.35 136.87 52.62 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.061 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.447 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.92 158.47 44.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.641 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.13 118.09 19.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.285 0.564 . . . . 0.0 110.632 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 2.1 t60 -66.58 122.56 17.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.754 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -74.23 134.61 42.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.04 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.8 OUTLIER -95.65 170.45 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.485 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -124.45 46.83 1.06 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.522 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt 61.42 152.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.54 114.31 4.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.012 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.04 30.43 2.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.272 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.01 -159.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.771 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -113.25 100.3 8.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.443 0.639 . . . . 0.0 109.754 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.4 p -137.08 156.79 75.46 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.611 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 57.0 Cg_endo -67.15 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.57 2.18 . . . . 0.0 111.665 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.3 -71.96 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 35.45 35.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.63 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 60.47 115.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.282 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 703' ' ' PHE . 77.1 mt -151.63 -154.51 0.55 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.271 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.1 OUTLIER -107.51 147.0 31.08 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 5.8 t0 -127.46 157.5 39.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.329 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.863 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -115.03 113.77 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.246 0.546 . . . . 0.0 111.628 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.964 ' CH2' HD22 ' A' ' 671' ' ' LEU . 54.7 m95 -100.73 137.21 39.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.369 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.648 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.8 t80 -90.39 117.54 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 624' ' ' PHE . 0.7 OUTLIER -107.76 105.6 15.52 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 44.4 t60 -79.25 127.61 32.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.677 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.63 2.9 8.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.759 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -88.86 146.51 19.26 Favored Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.575 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 39.8 m -72.16 -23.79 61.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.943 0.401 . . . . 0.0 111.001 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.55 ' O ' ' O ' ' A' ' 656' ' ' VAL . 8.1 m-20 -73.5 4.59 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 49.0 154.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.401 0.62 . . . . 0.0 112.134 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.438 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 13.1 t -126.61 164.72 20.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.802 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -127.31 120.83 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.651 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -112.97 111.05 21.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.978 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.554 ' N ' HD12 ' A' ' 659' ' ' LEU . 34.2 m-20 60.13 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.731 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.6 m-20 -148.12 18.68 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.091 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.467 HD22 HG23 ' A' ' 716' ' ' VAL . 2.6 m120 -119.04 141.23 48.9 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.833 0.349 . . . . 0.0 111.224 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.955 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -91.79 141.09 29.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.223 179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.407 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 12.6 mtp -129.23 116.43 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.403 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 37.5 pt -87.53 142.97 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.512 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -46.18 104.14 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.194 0.521 . . . . 0.0 110.875 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 719' ' ' GLN . . . 121.55 26.34 1.99 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 28.3 p -125.83 162.89 24.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.436 0.636 . . . . 0.0 111.292 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' A' ' 717' ' ' LEU . 2.1 ttpt -122.73 146.41 47.52 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.443 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.9 OUTLIER -147.25 144.02 28.56 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.964 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -70.37 135.89 49.2 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.924 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD22 HD21 ' A' ' 659' ' ' LEU . 1.9 mt -112.24 115.75 29.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.265 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.462 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.7 mt-30 -91.26 159.53 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.737 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.439 ' OD1' HD22 ' A' ' 707' ' ' LEU . 8.8 p-10 -60.88 120.33 9.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.487 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 83.72 40.53 8.81 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.104 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.44 114.97 26.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 21.9 tt0 -96.41 108.55 21.1 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 649' ' ' TYR . 2.6 mt -105.46 124.53 60.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.119 0.485 . . . . 0.0 112.171 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -94.57 116.32 28.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.209 178.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.609 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -87.61 -16.88 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.909 HG22 ' CG2' ' A' ' 690' ' ' ILE . 2.1 tt -154.36 130.46 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 111.317 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -136.88 126.79 25.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.185 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.4 116.55 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.811 0.338 . . . . 0.0 110.305 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.0 OUTLIER -67.53 -43.49 80.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.784 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.514 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 18.6 m120 -83.29 -40.51 19.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.718 0.294 . . . . 0.0 111.552 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -86.03 -11.0 54.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.428 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 58.63 21.11 8.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.687 0.279 . . . . 0.0 110.876 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' A' ' 587' ' ' ILE . 1.0 OUTLIER -76.68 104.74 7.34 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.48 124.32 65.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.484 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.909 ' CG2' HG22 ' A' ' 681' ' ' ILE . 1.9 tt -128.17 125.12 63.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.573 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -161.78 146.27 11.9 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.284 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 582' ' ' PRO . 0.4 OUTLIER -122.91 148.26 45.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -101.11 117.29 34.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.922 0.392 . . . . 0.0 110.631 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.762 HG22 HD21 ' A' ' 578' ' ' LEU . 2.3 t -75.94 117.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.945 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.79 110.92 15.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.226 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.501 HD13 ' O ' ' A' ' 705' ' ' GLU . 13.6 mt -86.14 109.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.208 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -90.0 -45.93 8.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -110.94 140.96 44.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.165 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.1 p -113.4 96.69 6.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.587 0.708 . . . . 0.0 109.103 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.9 t -68.24 67.79 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.919 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.647 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 59.89 36.61 90.65 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.267 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -81.0 133.71 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.666 0.27 . . . . 0.0 110.874 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.937 ' HA ' HD12 ' A' ' 644' ' ' LEU . 19.1 p90 -40.92 -35.43 0.52 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.489 0.661 . . . . 0.0 110.246 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 5.1 t30 -143.68 -56.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.054 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.501 ' O ' HD13 ' A' ' 696' ' ' ILE . 10.1 pt-20 155.27 -26.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.246 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 139.55 -9.72 3.18 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.445 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -88.03 9.32 22.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.976 0.417 . . . . 0.0 112.095 -179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 62.01 -171.41 9.82 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.666 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.43 31.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.758 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.04 -165.96 1.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -72.57 -96.94 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.814 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -114.92 99.21 7.3 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.748 0.309 . . . . 0.0 111.168 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -117.18 97.46 5.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 109.946 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.436 HH22 HD11 ' A' ' 659' ' ' LEU . 7.9 mmm180 -156.65 72.94 0.76 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.013 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.46 140.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.817 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.1 t -80.78 125.88 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.326 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.2 OUTLIER -114.16 141.95 46.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.672 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.17 156.19 38.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 21.0 pt20 -96.0 160.27 14.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.734 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -176.5 2.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.24 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.42 -28.78 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 726' ' ' LEU . 27.8 tt0 -62.0 -52.63 63.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.658 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 19.4 mm-40 -63.3 -46.61 85.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.453 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -52.85 -32.32 44.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.311 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -39.48 88.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 600' ' ' PRO . 7.7 mp -55.37 -47.32 75.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.173 0.511 . . . . 0.0 110.924 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.93 -26.75 23.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -65.55 -36.46 83.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.62 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -101.35 22.92 11.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.961 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.926 HD13 HG22 ' A' ' 621' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.603 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.87 0.367 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -130.72 134.43 46.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.1 mt -108.01 141.32 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -133.42 83.28 2.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.0 83.67 7.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 44.2 t0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.647 -0.181 . . . . 0.0 112.647 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 -70.04 -22.11 63.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.702 0.287 . . . . 0.0 110.931 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 127.98 0.57 6.49 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.005 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -96.24 124.86 40.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.245 0.545 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.888 ' HZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -114.2 -46.1 3.01 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.108 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.008 HD22 HD12 ' A' ' 594' ' ' ILE . 8.7 tt -120.79 143.1 49.01 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.734 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.636 ' N ' HD23 ' A' ' 578' ' ' LEU . 27.2 m -122.38 121.57 36.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.744 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 625' ' ' ILE . 7.8 mt -102.87 108.67 19.97 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 583' ' ' LEU . 13.1 ptpt -111.27 101.01 49.38 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.95 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 10.0 Cg_endo -62.08 103.66 0.31 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.415 1.41 . . . . 0.0 109.047 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -81.0 160.43 66.07 Favored Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.476 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 70.9 Cg_exo -49.54 -27.52 14.53 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 124.221 3.281 . . . . 0.0 113.087 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.62 -27.4 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.662 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -95.86 153.26 17.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.175 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 588' ' ' ILE . 1.1 tp -52.77 -21.83 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.281 0.562 . . . . 0.0 109.965 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.557 HD13 HG23 ' A' ' 587' ' ' ILE . 12.6 mm -91.09 151.57 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.685 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 586' ' ' SER . 9.6 mp0 -150.0 51.99 0.91 Allowed 'General case' 0 CA--C 1.504 -0.807 0 CA-C-O 122.508 1.146 . . . . 0.0 108.574 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.95 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mt-10 -124.73 174.93 7.57 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.965 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.579 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -132.97 116.8 16.87 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.297 178.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.5 OUTLIER -112.85 143.86 43.39 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -124.6 129.17 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.008 HD12 HD22 ' A' ' 578' ' ' LEU . 18.7 mt -86.22 118.3 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.725 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.5 mp0 -73.75 139.02 44.97 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.529 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.07 -28.75 1.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -87.98 -23.3 38.8 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.625 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.725 HG23 ' HB2' ' A' ' 595' ' ' GLN . 69.5 t -82.49 113.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.409 1.105 . . . . 0.0 111.146 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.34 122.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.17 178.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.3 Cg_endo -91.49 160.7 27.85 Favored 'Cis proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.635 -0.986 . . . . 0.0 110.301 -1.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -89.09 115.48 26.66 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 89.3 m-85 -89.63 134.45 34.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.674 -177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.912 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.46 135.82 57.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.302 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.11 -179.19 41.94 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.55 -49.99 69.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -66.68 119.23 11.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.718 0.294 . . . . 0.0 110.519 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 9.6 tm-20 -53.31 -16.79 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.429 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 609' ' ' CYS . 11.1 p30 -51.04 -25.94 5.56 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -71.82 121.37 18.86 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.319 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.9 OUTLIER -38.21 -34.41 0.12 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.302 0.572 . . . . 0.0 110.636 -179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.912 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.4 t -97.67 144.29 27.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.784 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -116.64 118.57 32.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.969 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -138.19 111.31 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.992 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.71 99.57 11.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.216 1.008 . . . . 0.0 109.823 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.821 ' CG ' HD13 ' A' ' 618' ' ' LEU . 3.0 t70 -132.47 108.12 8.93 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.291 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.98 -39.65 0.4 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.146 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -77.82 -27.99 50.14 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.821 HD13 ' CG ' ' A' ' 615' ' ' ASP . 4.8 mp -59.64 158.74 9.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.859 0.361 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.4 m -110.9 176.27 5.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.35 -72.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.087 HG22 HD21 ' A' ' 730' ' ' LEU . 13.2 t -93.18 55.08 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 122.028 0.918 . . . . 0.0 108.943 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.745 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 60.6 t60 -41.95 -43.31 3.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.855 -1.521 . . . . 0.0 112.691 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 603' ' ' ILE . 4.2 p -177.48 150.33 0.69 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.867 ' HA ' HD12 ' A' ' 603' ' ' ILE . 43.1 p90 -143.18 149.1 37.55 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.234 0.54 . . . . 0.0 111.082 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 580' ' ' LEU . 20.6 mt -101.77 120.49 51.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 6.4 t80 -109.09 152.76 24.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.859 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 647' ' ' ILE . 6.2 ttmt -115.71 133.88 55.59 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.57 158.39 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.908 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.92 122.53 24.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.738 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -81.56 132.12 35.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.312 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -126.53 98.36 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.905 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 642' ' ' GLN . 0.6 OUTLIER -56.68 -178.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.591 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -69.33 -72.61 0.82 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.572 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.24 174.04 11.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 110.941 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.14 118.56 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.003 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 18.7 mtm -95.1 29.33 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.059 0.457 . . . . 0.0 110.496 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.69 -162.82 1.52 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -114.44 99.75 7.8 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.456 0.646 . . . . 0.0 109.634 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.49 157.04 72.99 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.732 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 44.3 Cg_endo -64.39 -150.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.567 2.178 . . . . 0.0 111.336 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.53 -64.89 0.38 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.776 ' HB2' HG12 ' A' ' 632' ' ' VAL . 4.4 tm0? -84.45 83.63 7.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 138.08 -1.32 2.77 Favored Glycine 0 CA--C 1.506 -0.498 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.493 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 0.1 OUTLIER -96.57 -168.05 1.66 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.194 -0.503 . . . . 0.0 110.28 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.785 ' O ' HD13 ' A' ' 702' ' ' LEU . 2.9 m-20 -122.3 147.0 46.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.178 0.513 . . . . 0.0 111.688 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.454 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 1.2 m-20 -127.52 147.06 50.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.807 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.888 HG21 ' HZ ' ' A' ' 577' ' ' PHE . 4.0 pt -104.89 115.47 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.409 0.624 . . . . 0.0 111.805 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.555 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.0 m95 -99.59 131.64 45.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.803 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.537 ' CD2' ' HE1' ' A' ' 664' ' ' MET . 6.8 t80 -89.89 117.04 28.42 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 4.7 t -112.99 105.93 14.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 33.7 t60 -76.66 124.19 27.27 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.468 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -119.45 3.42 11.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.663 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -90.42 146.26 18.48 Favored Glycine 0 C--N 1.318 -0.452 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.513 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 55.3 m -72.12 -23.53 61.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.951 0.405 . . . . 0.0 111.241 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.676 ' OD1' HD12 ' P' ' 831' ' ' LEU . 1.3 m-20 -74.11 4.48 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.9 p 48.8 156.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.416 0.627 . . . . 0.0 112.335 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 34.9 p -129.56 165.54 21.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.686 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -133.51 125.99 30.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -115.09 111.87 21.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.5 m120 63.35 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 659' ' ' LEU . 6.1 p30 -150.41 21.44 0.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.181 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.757 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.5 OUTLIER -118.21 140.65 49.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.941 ' O ' HG21 ' A' ' 716' ' ' VAL . 48.5 ttp180 -97.29 141.11 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.616 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.537 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -144.86 110.6 5.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.708 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 20.2 pt -87.28 164.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.084 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -51.03 110.82 0.47 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.006 0.432 . . . . 0.0 110.612 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 118.9 14.4 6.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 14.3 p -118.28 154.73 31.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.346 0.593 . . . . 0.0 110.958 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.445 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpm? -122.67 143.13 49.98 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.528 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.15 134.55 20.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.582 HD12 ' HA3' ' A' ' 708' ' ' GLY . 0.3 OUTLIER -69.28 141.1 54.43 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.959 0.409 . . . . 0.0 111.619 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 659' ' ' LEU . 15.2 mt -110.64 117.76 34.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.449 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 8.1 mt-30 -97.35 138.75 34.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.949 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.741 ' OD1' HD11 ' A' ' 707' ' ' LEU . 6.6 p-10 -42.47 113.79 0.5 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.096 0.474 . . . . 0.0 111.123 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 97.03 36.27 5.03 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.72 119.29 36.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 111.149 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -95.91 108.98 21.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.6 mt -105.23 119.72 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -96.91 117.03 30.22 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -89.56 -20.45 7.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -177.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 690' ' ' ILE . 18.1 tt -154.07 131.14 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.914 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -136.63 125.51 24.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.73 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.14 117.12 26.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.904 0.383 . . . . 0.0 110.515 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -46.48 74.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.871 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.79 -40.18 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.37 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -81.83 -14.34 56.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.282 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 8.2 tptt 61.01 18.83 9.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.736 0.303 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.415 ' CE1' ' OD2' ' A' ' 615' ' ' ASP . 1.6 t80 -82.79 105.19 13.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.39 131.73 71.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.792 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 3.8 mt -118.78 157.18 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.49 134.63 2.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.232 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.969 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 2.0 m-85 -125.84 141.25 52.08 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.406 ' HB3' ' HG3' ' A' ' 581' ' ' LYS . 1.8 tptt -102.85 116.47 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.877 HG22 HD21 ' A' ' 578' ' ' LEU . 1.0 OUTLIER -80.25 115.02 22.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.574 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -118.1 110.99 18.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.614 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.57 HD12 ' HB2' ' A' ' 705' ' ' GLU . 26.2 mt -90.32 105.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -87.39 -44.15 11.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.199 0.523 . . . . 0.0 109.824 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.45 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -110.05 140.18 44.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.823 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.5 p -112.82 96.5 5.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.857 0.837 . . . . 0.0 108.799 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 1.8 t -73.11 70.5 1.09 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 70.67 29.93 69.07 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.785 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -83.41 128.64 34.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 0.0 110.681 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.608 ' HB3' ' HB2' ' A' ' 644' ' ' LEU . 0.7 OUTLIER -45.93 -30.46 1.77 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.289 0.566 . . . . 0.0 110.281 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.686 HD21 HD13 ' A' ' 707' ' ' LEU . 6.4 t30 -150.42 -60.4 0.19 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.072 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.5 pt-20 165.17 -29.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.448 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 143.3 30.93 0.11 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.394 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.741 HD11 ' OD1' ' A' ' 674' ' ' ASP . 9.0 mp -91.25 9.03 33.0 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.582 ' HA3' HD12 ' A' ' 671' ' ' LEU . . . 42.4 81.06 0.03 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.125 -0.56 . . . . 0.0 113.205 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.527 ' HE2' ' CB ' ' A' ' 707' ' ' LEU . 0.3 OUTLIER -84.69 92.27 8.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.97 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.49 -177.06 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -41.71 96.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -63.93 140.05 58.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.824 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -116.37 97.47 6.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.21 0.528 . . . . 0.0 110.245 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 659' ' ' LEU . 10.3 mmm-85 41.09 80.1 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.797 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.407 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.6 m -123.69 141.21 44.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.941 HG21 ' O ' ' A' ' 663' ' ' ARG . 58.8 t -82.03 130.44 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.621 -179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.34 160.61 21.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.64 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.45 144.22 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.014 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -78.34 160.18 27.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 44.7 p -123.0 -175.69 3.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.288 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.66 -29.28 37.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.631 ' O ' HD22 ' A' ' 726' ' ' LEU . 3.0 tp10 -61.02 -51.53 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.44 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 726' ' ' LEU . 10.0 mm-40 -63.78 -47.73 79.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.498 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -60.11 -32.15 70.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.824 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.88 -49.33 78.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.757 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.643 HD13 ' N ' ' A' ' 726' ' ' LEU . 0.1 OUTLIER -58.94 -44.5 91.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.572 0.225 . . . . 0.0 111.432 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.965 HG23 HG11 ' A' ' 621' ' ' VAL . 7.3 p -69.72 -25.81 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.333 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -30.98 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.875 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -126.04 -0.22 7.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 1.087 HD21 HG22 ' A' ' 621' ' ' VAL . 2.1 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.169 -0.919 . . . . 0.0 111.112 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.8 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 32.5 p-10 -135.33 145.16 47.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.575 HD12 ' H ' ' P' ' 828' ' ' ILE . 1.2 mp -89.91 49.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -59.09 -174.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.676 HD12 ' OD1' ' A' ' 655' ' ' ASN . 17.9 mt 68.04 97.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.923 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -96.08 -10.92 27.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.33 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.68 -0.48 6.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.857 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 5.4 ttm180 -102.53 130.45 49.37 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.239 0.542 . . . . 0.0 110.565 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -121.95 -45.67 2.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.062 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.024 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -119.8 142.76 48.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.748 ' N ' HD23 ' A' ' 578' ' ' LEU . 28.2 m -121.6 118.41 29.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.6 mt -103.37 109.78 21.54 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -115.44 101.58 54.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -176.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.955 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.3 Cg_endo -57.51 122.92 12.6 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.618 1.546 . . . . 0.0 109.69 176.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.736 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -86.08 156.48 57.54 Favored Pre-proline 0 N--CA 1.468 0.445 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.442 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.8 Cg_exo -54.92 -30.52 69.32 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.647 2.898 . . . . 0.0 112.986 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -63.27 -22.48 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.148 0.499 . . . . 0.0 110.15 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.466 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 4.2 t -95.91 153.73 17.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 690' ' ' ILE . 10.0 pt -48.7 -24.53 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 613' ' ' ILE . 8.5 mt -99.01 150.01 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.232 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -154.09 57.93 0.72 Allowed 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.955 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 11.9 mt-10 -126.66 175.8 7.7 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 112.828 -1.987 . . . . 0.0 109.594 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.0 116.37 16.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 178.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.705 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.4 OUTLIER -113.54 145.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 2.3 mp0 -124.65 128.38 48.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.023 HD12 HD22 ' A' ' 578' ' ' LEU . 18.0 mt -81.04 122.14 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.768 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.5 mp0 -75.54 137.22 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.895 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.9 -28.79 2.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.357 0.598 . . . . 0.0 109.458 179.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.01 -19.03 58.43 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.135 -0.938 . . . . 0.0 113.33 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.0 t -83.44 114.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.124 0.962 . . . . 0.0 110.719 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 5.5 t30 -146.8 121.95 5.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.021 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.711 ' HG3' HD23 ' A' ' 726' ' ' LEU . 41.3 Cg_endo -91.74 161.5 27.27 Favored 'Cis proline' 0 N--CA 1.452 -0.927 0 C-N-CA 124.718 -0.951 . . . . 0.0 109.86 -2.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.619 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -87.9 114.76 24.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.681 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 87.6 m-85 -88.95 137.82 31.97 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.193 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.038 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.09 135.93 56.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.554 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.61 176.76 38.56 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.753 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.95 -46.79 61.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.678 0.275 . . . . 0.0 111.456 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.517 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -69.63 118.91 13.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.34 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.49 -19.24 2.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.816 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -47.48 -29.67 2.9 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -69.64 122.19 18.62 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.645 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.94 -34.03 0.1 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 110.818 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.038 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.8 t -100.87 143.81 30.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.941 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.57 120.89 43.62 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.941 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.3 mm -137.92 110.67 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.63 98.9 10.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.107 0.956 . . . . 0.0 109.773 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.5 t70 -133.43 108.51 8.71 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.167 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -36.08 -40.53 0.21 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.41 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.26 -27.1 47.43 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.823 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.3 mp -59.09 158.86 8.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.862 0.363 . . . . 0.0 111.19 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.16 174.79 5.71 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.481 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.28 -67.99 0.22 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.959 HG11 HG23 ' A' ' 727' ' ' VAL . 7.4 t -95.89 54.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 122.037 0.923 . . . . 0.0 109.171 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.665 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 73.4 t60 -42.45 -41.56 2.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.813 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.544 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.4 p 179.67 152.23 0.42 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.681 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 45.3 p90 -143.29 150.5 39.33 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.27 0.557 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 35.6 mt -102.37 120.9 52.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' O ' ' N ' ' A' ' 648' ' ' TRP . 8.4 t80 -110.56 152.43 26.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.705 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.437 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 10.1 ttmt -116.56 135.75 53.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.46 159.35 42.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.773 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt180 -76.53 114.01 14.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.399 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.7 t60 -75.69 129.51 37.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.801 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.18 125.02 43.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.22 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.551 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -88.01 162.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -52.3 -95.8 0.01 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.644 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.2 165.68 26.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.325 . . . . 0.0 110.876 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 99.44 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.3 ttp -85.67 54.55 3.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.042 0.448 . . . . 0.0 110.222 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.75 -153.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.469 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.9 100.48 8.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.35 0.595 . . . . 0.0 109.943 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 50.8 p -137.51 156.37 74.95 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 67.5 Cg_endo -70.17 -153.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.577 2.185 . . . . 0.0 111.749 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 74.51 -71.46 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 39.18 -159.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.223 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -106.94 122.95 7.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.048 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 48.9 mt -150.84 -150.76 0.36 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.212 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -111.83 147.16 36.33 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.406 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -136.15 149.41 48.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.43 178.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.024 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -103.01 124.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.561 0.696 . . . . 0.0 112.249 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.953 ' CH2' HD22 ' A' ' 671' ' ' LEU . 88.6 m95 -107.46 128.5 54.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.987 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.599 ' HD2' HD12 ' A' ' 659' ' ' LEU . 7.6 t80 -88.88 116.95 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t -111.28 105.86 14.66 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 22.7 t60 -76.24 127.05 32.12 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.751 178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.489 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.11 -1.07 9.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.611 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -85.5 150.85 24.85 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.558 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -78.19 -24.75 47.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.883 0.373 . . . . 0.0 111.191 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.521 ' O ' ' O ' ' A' ' 656' ' ' VAL . 7.0 m-20 -75.33 4.28 7.48 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.521 ' O ' ' O ' ' A' ' 655' ' ' ASN . 5.0 p 49.15 156.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.564 0.697 . . . . 0.0 112.535 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.474 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.5 p -129.21 165.56 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.309 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -126.99 120.69 29.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.751 0.31 . . . . 0.0 111.441 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.827 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -111.35 104.4 12.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.583 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.27 -78.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.02 20.05 0.88 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.354 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -119.4 141.38 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.863 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -96.42 141.54 29.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.421 ' CE ' ' CD2' ' A' ' 649' ' ' TYR . 8.2 mtp -137.87 106.92 6.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 32.5 pt -87.01 153.45 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.662 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.18 105.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.0 110.62 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.86 17.23 3.84 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 13.9 p -118.75 154.71 32.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.257 0.551 . . . . 0.0 111.353 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -122.84 143.6 49.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.143 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.8 OUTLIER -147.14 144.24 28.85 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.953 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.99 139.73 46.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.709 ' CD2' HD11 ' A' ' 659' ' ' LEU . 3.3 mt -109.55 106.9 16.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 6.8 mt-30 -83.99 146.0 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.493 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -47.9 120.85 3.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 82.96 38.84 10.8 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.443 -0.885 . . . . 0.0 110.986 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.93 119.23 31.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.813 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.6 OUTLIER -96.01 110.98 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.644 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -105.18 125.61 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.029 0.442 . . . . 0.0 112.058 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -91.61 116.66 29.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.982 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.763 HG23 HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -79.54 -34.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.379 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.847 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.3 tt -154.54 130.58 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 111.498 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.767 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.5 t90 -136.86 118.44 14.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.415 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 0.4 OUTLIER -127.43 116.81 21.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.19 178.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -46.04 76.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.63 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.1 -40.46 27.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.439 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.415 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 2.1 t30 -75.26 -12.67 60.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.363 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 61.15 27.12 16.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.706 0.289 . . . . 0.0 111.034 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.815 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -105.71 104.6 14.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.207 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.767 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.9 m -126.16 131.76 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.307 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.925 HD11 HD11 ' A' ' 587' ' ' ILE . 8.8 mt -128.22 154.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.865 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -172.22 129.32 1.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.922 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.755 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.71 141.21 48.13 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -102.12 117.08 34.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.473 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.794 HG22 HD21 ' A' ' 578' ' ' LEU . 1.8 t -81.75 121.44 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.499 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.12 111.73 13.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 705' ' ' GLU . 13.7 mt -88.22 106.96 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.568 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.44 -45.2 9.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.164 0.507 . . . . 0.0 109.878 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.9 OUTLIER -110.69 141.07 44.45 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.213 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.2 OUTLIER -113.4 98.02 6.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 596' ' ' GLN . 3.3 t -63.95 64.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.897 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 55.72 46.01 83.74 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.933 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' A' ' 705' ' ' GLU . 0.5 OUTLIER -114.68 169.26 9.2 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.16 0.48 . . . . 0.0 110.573 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.585 ' O ' ' C ' ' A' ' 704' ' ' ASN . 0.1 OUTLIER -59.05 -159.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.585 ' C ' ' O ' ' A' ' 703' ' ' PHE . 10.5 t30 -16.65 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.991 0.424 . . . . 0.0 111.091 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.704 ' O ' HD13 ' A' ' 696' ' ' ILE . 2.5 pt-20 157.96 -28.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.763 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 157.28 -21.35 0.42 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.738 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.632 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -87.13 9.75 18.95 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 703' ' ' PHE . . . -90.54 131.81 10.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.647 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.568 ' SD ' HD23 ' A' ' 671' ' ' LEU . 0.4 OUTLIER -159.06 123.71 4.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.906 0.384 . . . . 0.0 110.821 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -79.23 -162.05 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.508 ' C ' ' O ' ' A' ' 710' ' ' LEU . 16.0 mt-30 -7.02 -66.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 710' ' ' LEU . 4.8 pt-20 -63.15 129.16 39.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.971 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.93 97.89 6.35 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.359 0.599 . . . . 0.0 110.45 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.827 ' NH2' HD22 ' A' ' 659' ' ' LEU . 7.0 mmm-85 50.97 79.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.824 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.415 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 8.4 m -124.32 141.52 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.945 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 663' ' ' ARG . 84.1 t -79.57 129.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -114.43 170.96 7.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.699 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -103.23 151.67 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -91.92 160.24 15.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.743 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.3 p -122.26 -176.53 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.57 -28.91 34.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.524 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.3 tm-20 -61.42 -52.7 63.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.528 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.42 -44.93 93.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.326 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -56.84 -32.31 65.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.423 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.49 -46.93 87.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.711 HD23 ' HG3' ' A' ' 600' ' ' PRO . 3.1 mp -55.49 -46.46 76.92 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 111.074 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.959 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.79 -29.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.587 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -64.84 -30.38 71.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -100.47 10.11 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.905 HD13 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.612 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.803 0.335 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -152.6 108.92 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.01 152.72 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -163.51 99.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.783 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 76.8 mt -93.76 116.07 28.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.988 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.642 -0.183 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -91.06 -22.36 20.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.926 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -159.21 65.21 0.29 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.049 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.414 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 54.9 ttp180 -86.43 105.11 16.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.121 0.486 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.655 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -93.31 -49.38 5.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.095 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.05 HD22 HD12 ' A' ' 594' ' ' ILE . 7.3 tt -113.21 142.83 45.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.811 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.829 ' N ' HD23 ' A' ' 578' ' ' LEU . 17.3 m -123.3 114.59 20.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.423 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.73 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.9 mt -98.72 109.91 22.6 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.757 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -115.39 101.35 54.32 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.994 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.05 121.81 10.58 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.379 1.386 . . . . 0.0 109.157 176.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.44 159.69 34.59 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 52.1 Cg_exo -52.78 -32.11 54.35 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.337 3.358 . . . . 0.0 113.261 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.45 -28.59 69.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.067 0.46 . . . . 0.0 109.778 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.708 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 1.8 p -96.54 153.44 17.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.345 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 690' ' ' ILE . 26.2 pt -50.2 -20.78 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.179 0.514 . . . . 0.0 110.561 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.75 ' CD1' HG23 ' A' ' 613' ' ' ILE . 2.1 mt -94.63 150.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.595 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.1 mp0 -154.37 57.61 0.7 Allowed 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.994 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.1 mm-40 -126.74 175.08 8.26 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.269 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -134.07 116.96 16.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.46 178.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 592' ' ' LEU . 0.9 OUTLIER -112.37 145.35 40.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 0.0 OUTLIER -124.96 125.34 43.75 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.05 HD12 HD22 ' A' ' 578' ' ' LEU . 11.0 mt -85.36 115.18 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.924 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.7 mm-40 -74.29 141.0 45.31 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.646 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -48.25 -29.91 4.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.11 55.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 114.777 -1.101 . . . . 0.0 113.355 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.924 HG23 ' HB2' ' A' ' 595' ' ' GLN . 48.6 t -81.82 113.84 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 118.048 0.924 . . . . 0.0 111.016 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.7 t30 -147.08 122.4 5.32 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.833 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.689 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 40.5 Cg_endo -92.17 160.88 25.57 Favored 'Cis proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.868 -0.888 . . . . 0.0 110.267 -2.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.591 ' CD1' HG23 ' A' ' 594' ' ' ILE . 4.9 t80 -88.93 114.53 25.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.689 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 98.4 m-85 -90.03 138.12 31.77 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.25 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.055 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.07 135.65 56.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.552 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.513 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.42 179.92 41.05 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.634 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -56.38 -44.1 79.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.669 0.271 . . . . 0.0 111.536 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -74.64 118.94 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.814 0.34 . . . . 0.0 111.115 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 25.4 mt-10 -47.32 -21.81 0.34 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.42 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -44.72 -29.57 0.79 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 6.3 m -73.95 118.44 16.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.964 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.34 -35.23 0.11 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.234 0.54 . . . . 0.0 110.979 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.055 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.4 t -97.74 144.43 27.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.618 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.928 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -113.43 121.32 43.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.928 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.2 mm -137.93 110.52 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.904 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -97.3 98.47 10.01 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 122.19 0.995 . . . . 0.0 109.607 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.752 ' CB ' HD13 ' A' ' 618' ' ' LEU . 4.2 t70 -133.79 108.64 8.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.413 -1.721 . . . . 0.0 109.402 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -36.96 -39.05 0.21 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.49 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.02 -28.3 49.06 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.752 HD13 ' CB ' ' A' ' 615' ' ' ASP . 4.9 mp -59.33 158.64 8.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.1 m -113.84 173.94 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.842 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -50.38 -71.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 730' ' ' LEU . 16.1 t -95.24 55.35 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.996 0.903 . . . . 0.0 109.075 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.671 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 75.3 t60 -42.72 -43.02 3.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.911 -1.495 . . . . 0.0 112.703 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p -178.43 151.76 0.62 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.3 p90 -143.31 148.91 37.06 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.295 0.569 . . . . 0.0 111.051 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.73 ' CD1' HD11 ' A' ' 580' ' ' LEU . 90.6 mt -102.19 117.42 47.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 648' ' ' TRP . 4.6 t80 -109.26 152.24 25.47 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 646' ' ' ASP . 0.2 OUTLIER -117.53 137.35 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 0.0 111.278 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 1.6 tmtt? -136.22 158.91 43.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.873 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.3 tpt85 -76.57 117.53 18.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.291 0.567 . . . . 0.0 110.611 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.58 133.86 56.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.933 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -72.74 128.65 36.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.948 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -106.46 175.17 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.256 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 632' ' ' VAL . . . -134.61 -177.67 15.11 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.146 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -70.05 106.52 3.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.76 0.314 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.69 101.17 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mmm -91.82 47.74 1.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.161 0.505 . . . . 0.0 110.115 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.43 -151.3 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.481 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -114.56 100.49 8.32 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.386 0.612 . . . . 0.0 109.831 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.62 156.84 78.37 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.012 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.424 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 64.4 Cg_endo -69.68 -153.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.672 2.248 . . . . 0.0 111.641 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 69.48 -70.12 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 34.14 36.51 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.754 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.466 ' CA ' HG21 ' A' ' 632' ' ' VAL . . . 61.73 110.04 0.01 OUTLIER Glycine 0 CA--C 1.502 -0.753 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.909 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 703' ' ' PHE . 54.6 mt -151.81 -173.61 4.58 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.66 -0.77 . . . . 0.0 110.342 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.794 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.6 OUTLIER -99.19 146.21 26.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 111.979 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -124.36 160.21 28.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.179 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.011 HD13 HD12 ' A' ' 578' ' ' LEU . 1.1 pt -117.37 109.59 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.397 0.618 . . . . 0.0 112.172 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.598 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 75.6 m95 -94.45 130.69 40.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.813 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.699 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -89.24 116.89 27.81 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.453 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.1 t -110.44 111.05 22.06 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.48 ' CG ' ' HG ' ' A' ' 657' ' ' SER . 36.4 t60 -80.74 129.13 34.35 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -124.8 0.5 8.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.694 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.41 149.68 22.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.764 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 57.9 m -77.75 -24.42 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 111.042 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.698 ' OD1' HD11 ' P' ' 831' ' ' LEU . 7.0 m-80 -74.78 5.16 5.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 655' ' ' ASN . 4.2 p 50.34 155.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.566 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.48 ' HG ' ' CG ' ' A' ' 651' ' ' HIS . 79.1 p -128.2 165.46 20.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -130.55 120.29 23.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.81 0.338 . . . . 0.0 111.298 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.862 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.8 OUTLIER -113.35 107.91 16.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.625 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.83 -79.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -149.59 17.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -113.14 141.08 47.33 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.918 0.39 . . . . 0.0 111.174 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.564 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 ttm180 -77.78 141.91 38.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.572 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 656' ' ' VAL . 9.7 mmm -129.38 88.36 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.38 . . . . 0.0 111.4 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.5 pt -87.12 144.73 8.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.671 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.25 109.25 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 110.969 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.13 20.01 4.16 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.359 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 16.7 p -123.5 151.15 43.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.422 0.63 . . . . 0.0 111.135 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -122.44 131.3 53.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.02 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -129.63 143.97 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.598 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -78.01 140.72 39.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 649' ' ' TYR . 11.1 mt -110.23 144.76 38.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 111.836 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.538 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 29.0 mt-30 -124.98 140.04 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.615 ' OD1' HD12 ' A' ' 707' ' ' LEU . 17.9 p-10 -42.17 121.98 2.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.937 0.399 . . . . 0.0 111.242 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 87.63 38.16 7.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.399 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.74 119.39 35.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.679 0.276 . . . . 0.0 110.813 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.4 OUTLIER -96.22 112.09 23.94 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.677 HG23 ' HG ' ' A' ' 659' ' ' LEU . 1.8 mt -105.29 123.13 59.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 112.014 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 4.1 mmmm -89.97 115.54 27.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.738 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.71 HG23 HD11 ' A' ' 618' ' ' LEU . 0.3 OUTLIER -72.88 -39.19 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.024 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 655' ' ' ASN . 3.2 tt -155.57 135.87 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.361 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.858 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.1 t90 -135.8 114.78 12.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.358 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.41 116.81 21.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.106 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.57 -46.19 76.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.743 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -63.49 -40.25 96.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.312 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.99 -19.27 60.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 62.73 18.65 10.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 111.021 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -115.7 116.12 27.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.008 0.433 . . . . 0.0 110.06 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.858 HG12 ' CD1' ' A' ' 682' ' ' TRP . 27.5 m -120.55 138.67 50.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.271 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.643 HD11 HD11 ' A' ' 587' ' ' ILE . 10.6 mt -117.19 144.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.596 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -166.88 132.04 2.51 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.784 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.2 m-85 -114.72 141.84 47.29 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.656 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.76 116.97 33.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.734 HG22 HD21 ' A' ' 578' ' ' LEU . 2.2 t -80.78 114.76 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.563 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.41 111.66 17.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.759 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 577' ' ' PHE . 29.1 mt -86.23 105.8 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.3 -46.25 11.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.54 141.67 43.38 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.915 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 22.3 p -112.17 96.39 6.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.709 0.766 . . . . 0.0 109.233 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 596' ' ' GLN . 2.8 t -75.02 62.75 1.17 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.803 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 62.65 50.4 64.57 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.794 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -91.82 132.21 36.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.644 0.259 . . . . 0.0 111.048 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.842 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -30.17 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.971 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.568 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -169.78 29.76 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.149 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.521 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER 69.15 -57.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 673' ' ' GLN . . . 155.58 39.99 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.262 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.615 HD12 ' OD1' ' A' ' 674' ' ' ASP . 2.9 tp -94.62 8.26 42.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.057 0.428 . . . . 0.0 111.695 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.17 58.07 Favored Glycine 0 C--N 1.321 -0.256 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.642 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.441 ' HB2' ' H ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER 36.72 -145.29 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.08 0.44 . . . . 0.0 111.206 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 710' ' ' LEU . 3.7 pp -66.33 129.67 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.835 0.35 . . . . 0.0 111.35 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 45.65 95.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.34 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.55 129.58 40.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.73 97.26 6.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 110.093 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.862 ' NH2' HD22 ' A' ' 659' ' ' LEU . 5.1 mmm-85 -111.66 72.32 0.77 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.074 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.469 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 16.4 m -123.53 140.82 45.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.009 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 663' ' ' ARG . 50.5 t -80.94 130.12 36.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.944 0.402 . . . . 0.0 111.449 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.23 156.13 30.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.502 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.81 149.83 29.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.871 0.367 . . . . 0.0 111.173 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -85.37 160.29 19.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.828 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.69 -177.29 3.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.233 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.71 -28.84 36.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 726' ' ' LEU . 28.4 tt0 -62.83 -52.79 61.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.642 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.46 -43.13 98.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 3.8 ttmt -55.85 -32.33 63.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.621 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.97 -42.07 90.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.185 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.641 HD23 ' HG3' ' A' ' 600' ' ' PRO . 6.8 mp -55.25 -46.93 76.07 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.997 0.427 . . . . 0.0 111.236 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 1.034 HG23 HG11 ' A' ' 621' ' ' VAL . 7.7 p -69.96 -29.46 40.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.089 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -59.84 -25.18 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -109.4 -29.89 8.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 621' ' ' VAL . 2.5 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.649 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -110.06 136.74 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.945 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.2 pt -106.67 141.87 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.713 ' O ' HD23 ' P' ' 831' ' ' LEU . 18.8 p90 -164.18 141.86 6.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.713 HD23 ' O ' ' P' ' 830' ' ' TYR . 27.6 mt -144.59 119.27 9.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.898 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.88 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -75.09 -22.29 58.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -167.25 48.18 0.25 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.07 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.455 ' HD3' ' CB ' ' A' ' 593' ' ' GLU . 52.7 ttp85 -88.84 116.84 27.4 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 110.119 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -109.98 -46.75 3.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.31 -179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 647' ' ' ILE . 8.0 tt -116.88 142.29 47.13 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.915 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.69 ' N ' HD23 ' A' ' 578' ' ' LEU . 14.3 m -120.39 116.47 25.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.437 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.724 HD21 HG23 ' A' ' 694' ' ' VAL . 7.7 mt -102.31 108.64 20.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.758 ' O ' HD23 ' A' ' 583' ' ' LEU . 3.9 mtmt -113.0 101.87 53.98 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.942 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.7 Cg_endo -57.83 122.55 11.93 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.579 1.519 . . . . 0.0 109.753 176.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -85.46 156.2 59.4 Favored Pre-proline 0 N--CA 1.469 0.515 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -177.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.49 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 49.3 Cg_exo -54.59 -32.13 73.25 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.358 2.705 . . . . 0.0 112.581 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -63.9 -22.15 66.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.45 . . . . 0.0 110.359 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 41.4 p -95.92 154.02 17.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -47.04 -23.82 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.29 0.567 . . . . 0.0 110.039 178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.656 HD11 HG23 ' A' ' 613' ' ' ILE . 8.9 mt -104.78 151.01 7.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.52 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.49 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -150.41 57.03 0.94 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.942 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 12.4 mm-40 -126.5 176.53 7.1 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 112.747 -2.024 . . . . 0.0 109.576 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.73 116.24 17.04 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.773 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.838 HD12 ' SG ' ' A' ' 611' ' ' CYS . 6.6 mt -114.15 145.03 42.21 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.455 ' CB ' ' HD3' ' A' ' 576' ' ' ARG . 0.2 OUTLIER -124.65 127.56 47.5 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.995 HD12 HD22 ' A' ' 578' ' ' LEU . 11.2 mt -84.0 116.65 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 598' ' ' VAL . 10.9 mm100 -72.24 140.01 48.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.783 -178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.89 -29.15 3.07 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.11 -25.52 51.74 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.608 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 598' ' ' VAL . 5.2 p -83.18 113.5 22.43 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 118.641 1.221 . . . . 0.0 111.063 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.472 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.94 122.56 5.02 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.639 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.1 Cg_endo -92.01 160.9 26.13 Favored 'Cis proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.824 -0.907 . . . . 0.0 109.987 -1.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -88.96 115.54 26.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.738 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 53.8 m-85 -89.42 134.54 34.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.775 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.844 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.1 mp -132.74 138.82 51.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.991 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.61 -155.07 24.82 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.666 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.78 ' N ' HD21 ' A' ' 618' ' ' LEU . 0.5 OUTLIER -72.04 -62.86 1.27 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.422 ' H ' ' HA ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.29 120.92 10.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.729 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.2 pt-20 -48.38 -20.72 0.43 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.631 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.05 -33.02 0.75 Allowed 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.3 m -68.85 119.65 13.53 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.001 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.538 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.61 -35.05 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.357 0.599 . . . . 0.0 110.727 -179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.844 ' HB3' HG23 ' A' ' 603' ' ' ILE . 7.6 t -98.75 143.69 28.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.472 177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.93 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -109.03 119.59 40.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 612' ' ' LYS . 5.4 mm -137.77 110.87 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.64 97.81 9.03 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.523 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 2.0 m-20 -133.57 106.59 7.5 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.774 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -36.11 -48.88 0.63 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.73 ' HB2' HD11 ' A' ' 681' ' ' ILE . 4.9 mmp_? -77.39 -23.65 50.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.954 HD12 ' CD2' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -79.18 136.95 37.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.695 0.283 . . . . 0.0 110.306 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.55 178.05 8.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -61.26 -59.2 5.67 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.538 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.796 HG11 ' CG2' ' A' ' 727' ' ' VAL . 21.8 t -96.95 49.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 122.223 1.011 . . . . 0.0 108.482 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.954 ' CD2' HD12 ' A' ' 618' ' ' LEU . 16.9 t60 -41.16 -40.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.502 -1.681 . . . . 0.0 112.738 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 651' ' ' HIS . 1.7 p 176.69 149.78 0.14 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.837 ' HA ' HD12 ' A' ' 603' ' ' ILE . 42.5 p90 -139.35 151.61 46.51 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.231 0.539 . . . . 0.0 111.044 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.605 ' CD1' HD11 ' A' ' 580' ' ' LEU . 66.9 mt -101.64 122.82 54.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.7 t80 -109.64 152.74 25.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.611 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HZ3' HG21 ' A' ' 700' ' ' THR . 17.3 ttmt -116.07 133.86 55.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.21 157.32 47.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.317 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.57 126.87 31.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.98 0.419 . . . . 0.0 110.607 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.434 ' NE2' ' HE3' ' A' ' 709' ' ' MET . 6.9 t60 -80.14 132.13 35.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.231 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -127.22 105.59 8.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.406 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 633' ' ' GLY . 12.6 p -114.19 165.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.081 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -109.84 -168.5 19.98 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.674 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 67.87 89.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.882 0.372 . . . . 0.0 111.207 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.29 98.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.3 mtt -88.32 50.64 2.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.113 0.483 . . . . 0.0 110.113 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.36 -153.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.401 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -115.25 100.57 8.23 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 109.67 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 9.8 p -133.56 156.6 79.44 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 43.5 Cg_endo -64.52 -150.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.526 2.15 . . . . 0.0 111.183 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 72.78 -63.7 0.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.718 0.294 . . . . 0.0 111.083 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -81.09 98.81 8.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.986 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 119.41 5.65 11.2 Favored Glycine 0 CA--C 1.508 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.144 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.792 HD12 ' C ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -86.44 -162.95 0.82 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.18 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -122.55 147.36 46.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.143 0.496 . . . . 0.0 111.943 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.41 ' CG ' HD11 ' A' ' 671' ' ' LEU . 6.1 t0 -134.31 129.93 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.081 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.021 HD13 HD12 ' A' ' 578' ' ' LEU . 1.5 pt -91.24 115.09 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.475 0.655 . . . . 0.0 111.654 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.919 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 84.0 m95 -100.54 133.88 44.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.522 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 678' ' ' ILE . 8.5 t80 -90.12 116.57 28.23 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.437 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 42.0 t -110.82 106.16 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 43.3 t60 -76.08 130.56 38.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.494 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -125.08 4.28 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.465 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.88 149.79 19.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.448 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.425 HG22 ' O ' ' P' ' 829' ' ' PTR . 42.0 m -77.66 -25.06 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.944 0.402 . . . . 0.0 111.342 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -76.87 4.91 8.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 49.16 146.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.652 0.739 . . . . 0.0 112.81 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 679' ' ' LYS . 61.9 p -114.56 165.38 12.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.127 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 679' ' ' LYS . 40.9 m-85 -126.01 120.45 30.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.342 . . . . 0.0 111.045 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.776 HD13 HG12 ' A' ' 678' ' ' ILE . 0.7 OUTLIER -109.21 102.38 11.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.003 179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 64.47 -73.47 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 659' ' ' LEU . 81.1 m-20 -153.99 23.4 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -118.43 141.67 48.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.8 0.334 . . . . 0.0 110.967 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.92 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -102.04 126.98 49.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.525 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.547 ' O ' HG23 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -127.55 120.27 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 -179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.9 pt -87.41 163.18 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.54 104.72 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.128 0.489 . . . . 0.0 110.509 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.32 24.92 2.32 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 22.2 p -123.05 162.33 22.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.593 0.711 . . . . 0.0 111.392 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.5 ttpm? -123.48 147.49 47.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.561 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.62 ' CD1' HD23 ' A' ' 659' ' ' LEU . 8.4 t80 -147.35 144.71 28.94 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.919 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.77 133.23 44.43 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.168 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.6 mt -112.88 112.3 23.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 111.272 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 707' ' ' LEU . 10.9 mt-30 -97.23 147.78 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.58 ' OD2' HD21 ' A' ' 707' ' ' LEU . 0.8 OUTLIER -49.67 119.12 3.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 88.72 34.88 8.77 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.562 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.26 117.32 32.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.729 0.299 . . . . 0.0 110.762 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.0 tt0 -96.2 113.94 25.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.776 HG12 HD13 ' A' ' 659' ' ' LEU . 4.0 mt -105.57 137.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.203 0.525 . . . . 0.0 111.904 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 657' ' ' SER . 0.1 OUTLIER -94.8 115.75 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.339 178.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.567 ' CG2' HG21 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -83.45 -32.47 9.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.907 -178.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.73 HD11 ' HB2' ' A' ' 617' ' ' ARG . 3.5 tt -155.21 131.13 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.651 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.8 t90 -136.47 121.99 19.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 111.333 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.661 ' OD1' HD22 ' P' ' 831' ' ' LEU . 13.5 m-20 -127.13 116.89 21.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.07 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -46.2 76.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.856 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -82.19 -40.35 21.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.658 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.85 -7.06 58.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 13.3 mttt 56.3 23.35 7.12 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.753 0.311 . . . . 0.0 110.816 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -86.23 104.7 16.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.6 OUTLIER -125.59 123.25 64.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.17 0.51 . . . . 0.0 111.718 -178.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.697 ' CG1' HG22 ' A' ' 681' ' ' ILE . 22.3 mm -121.33 136.67 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.351 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -158.57 127.76 1.93 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.779 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.9 m-85 -114.5 163.12 15.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.619 0.247 . . . . 0.0 110.358 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -119.6 116.91 27.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.4 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.8 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -85.76 114.82 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.438 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.83 111.2 16.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.738 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.551 HG23 ' CD1' ' A' ' 577' ' ' PHE . 23.2 mt -89.55 105.49 16.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -89.4 -43.19 11.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.913 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.89 140.76 43.48 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.627 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.5 p -113.13 96.99 6.22 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.848 0.833 . . . . 0.0 109.089 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 700' ' ' THR . 5.0 t -66.5 68.71 0.06 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.933 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.07 44.17 98.13 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.284 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 644' ' ' LEU . 0.3 OUTLIER -93.89 152.21 19.03 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.404 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.473 ' N ' HD12 ' A' ' 644' ' ' LEU . 45.9 p90 -58.59 -29.21 66.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.762 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.594 HD21 HD23 ' A' ' 707' ' ' LEU . 4.2 t30 -157.9 -55.41 0.07 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.823 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.616 ' HA ' HD22 ' A' ' 702' ' ' LEU . 9.5 pt-20 162.47 -28.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.446 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 144.43 28.32 0.11 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.714 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 673' ' ' GLN . 3.0 mm? -82.94 9.66 9.57 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.07 0.435 . . . . 0.0 112.13 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' A' ' 671' ' ' LEU . . . 84.33 -85.42 1.55 Allowed Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.501 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.455 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 1.3 ttp 60.95 78.32 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.51 -177.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -47.06 83.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.275 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.534 ' OE1' HG23 ' A' ' 715' ' ' VAL . 39.0 mt-10 -63.91 130.96 46.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.066 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.65 97.55 6.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.095 0.474 . . . . 0.0 110.147 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.446 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 44.12 64.43 1.31 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.463 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.534 HG23 ' OE1' ' A' ' 712' ' ' GLU . 3.2 m -124.57 145.61 31.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 663' ' ' ARG . 90.7 t -77.45 126.51 37.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.964 0.411 . . . . 0.0 111.185 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.413 HD21 ' OE2' ' A' ' 712' ' ' GLU . 0.7 OUTLIER -100.59 172.44 7.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.766 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.92 155.05 18.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.846 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -93.6 160.18 14.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 1.2 p -126.35 -177.96 4.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.213 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.74 -29.22 38.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.025 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -63.2 -48.83 76.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.4 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 5.1 mp0 -65.41 -49.37 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.963 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -56.03 -33.61 65.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.194 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -68.3 -36.64 79.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.3 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.444 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.1 mt -59.3 -44.61 92.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.148 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.796 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.4 p -69.78 -8.14 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.614 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 30.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.779 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -117.68 -37.71 3.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.239 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 730' ' ' LEU . 2.3 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.824 0.345 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -100.81 101.69 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 31.4 mt -85.45 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . 0.425 ' O ' HG22 ' A' ' 654' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -178.02 116.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.982 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.661 HD22 ' OD1' ' A' ' 683' ' ' ASP . 3.1 mt -115.89 74.58 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.918 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -93.47 6.34 48.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.558 0.218 . . . . 0.0 111.393 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 133.17 51.65 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.139 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 7.3 ttm180 -87.53 112.57 22.38 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.139 0.495 . . . . 0.0 110.183 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.712 ' CE1' HD11 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -106.8 -47.56 3.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.578 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.05 142.86 45.66 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.486 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.783 ' N ' HD23 ' A' ' 578' ' ' LEU . 20.6 m -119.03 114.62 22.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.149 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 625' ' ' ILE . 10.0 mt -102.55 110.58 22.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.635 ' O ' HD23 ' A' ' 583' ' ' LEU . 22.8 mtpt -119.93 105.6 42.58 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.165 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 13.9 Cg_exo -59.58 132.34 45.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 121.597 1.531 . . . . 0.0 109.046 176.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -91.17 156.95 43.48 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -176.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 51.5 Cg_exo -52.73 -30.72 47.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.987 3.125 . . . . 0.0 113.1 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -22.54 66.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.129 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.569 ' HA ' HG23 ' A' ' 689' ' ' VAL . 2.4 p -96.45 154.38 17.3 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.818 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.619 HG21 ' CE1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.82 -25.75 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.495 0.664 . . . . 0.0 109.374 178.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 690' ' ' ILE . 3.6 mt -112.03 150.89 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.772 177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.627 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -162.08 70.52 0.31 Allowed 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.716 1.246 . . . . 0.0 108.274 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.165 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 3.8 mm-40 -125.2 178.67 5.44 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 112.338 -2.21 . . . . 0.0 108.664 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.14 115.65 17.34 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.843 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 611' ' ' CYS . 10.9 mt -114.46 145.46 41.86 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.622 ' HG3' HG23 ' A' ' 579' ' ' THR . 4.0 mp0 -124.8 129.53 50.63 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.931 HD12 HD22 ' A' ' 578' ' ' LEU . 11.6 mt -83.0 120.76 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.488 ' O ' HG12 ' A' ' 598' ' ' VAL . 2.2 mt-30 -75.16 139.03 42.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.012 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.419 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.9 -29.67 3.51 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.33 -22.75 53.52 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.668 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 598' ' ' VAL . 3.8 p -82.01 114.71 23.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 CA-C-N 118.463 1.132 . . . . 0.0 110.879 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 7.4 t30 -147.12 123.11 5.47 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.478 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.632 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 41.8 Cg_endo -92.51 160.9 24.36 Favored 'Cis proline' 0 N--CA 1.452 -0.933 0 C-N-CA 124.577 -1.01 . . . . 0.0 109.813 -2.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.6 t80 -88.77 113.38 24.26 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.664 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.48 138.17 31.69 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.157 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.003 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.1 mt -133.08 136.71 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.815 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.557 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.08 172.35 34.2 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.765 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.64 -46.73 40.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.269 . . . . 0.0 111.316 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -68.94 119.13 12.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.124 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.05 -18.36 2.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.018 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -47.92 -29.21 3.16 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.1 m -71.29 120.88 17.5 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.3 -35.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.362 0.601 . . . . 0.0 110.806 -179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.003 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.7 t -98.02 143.67 28.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.01 122.33 40.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.72 HD11 ' CZ ' ' A' ' 692' ' ' PHE . 17.0 mm -139.46 118.44 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.648 177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -94.53 98.7 11.03 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.162 0.982 . . . . 0.0 109.239 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.825 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -132.55 108.05 8.85 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.663 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -40.21 -39.36 0.91 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.733 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.405 ' NE ' ' CA ' ' A' ' 617' ' ' ARG . 0.0 OUTLIER -78.12 -26.33 47.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.94 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.848 HD11 ' CG2' ' A' ' 680' ' ' ILE . 1.0 OUTLIER -59.37 158.78 8.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.339 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.4 p -111.8 173.1 6.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.545 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.589 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.96 -67.9 0.23 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.925 HG22 HD13 ' A' ' 730' ' ' LEU . 8.9 t -96.99 53.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.125 0.964 . . . . 0.0 109.112 178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.667 ' CG ' ' HG ' ' A' ' 618' ' ' LEU . 69.9 t60 -41.64 -39.86 1.77 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.633 -1.621 . . . . 0.0 112.947 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.551 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.8 p 176.88 151.81 0.18 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.664 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 46.9 p90 -143.22 148.29 36.2 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.285 0.565 . . . . 0.0 111.011 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.789 ' CD1' HD11 ' A' ' 580' ' ' LEU . 84.3 mt -102.46 118.27 49.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.44 152.33 25.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.729 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' A' ' 700' ' ' THR . 11.8 ttmt -113.97 131.69 56.23 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.18 158.87 43.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.229 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 3.8 tpt180 -76.78 112.4 13.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.222 0.534 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.6 t60 -62.21 136.31 57.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.645 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.06 122.19 40.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.034 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 633' ' ' GLY . 12.1 p -105.96 160.66 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 0.0 111.242 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.521 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -100.62 35.36 4.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.403 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.9 tttt 56.21 -172.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 110.784 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.59 122.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.171 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.7 mmm -78.18 60.0 2.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.966 0.412 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 176.57 -156.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.374 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.74 99.72 7.72 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.358 0.599 . . . . 0.0 109.677 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 19.6 p -138.73 156.12 73.05 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.565 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 76.1 Cg_endo -72.55 -153.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.697 2.265 . . . . 0.0 111.728 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 78.85 -71.98 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.755 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 38.76 -157.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.126 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.691 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.99 114.11 3.23 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.364 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.938 HD13 ' HA ' ' A' ' 703' ' ' PHE . 1.2 mp -148.18 -161.84 1.42 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.819 -0.69 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.868 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.5 m-20 -97.51 146.59 25.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.214 0.531 . . . . 0.0 112.085 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.514 ' HA ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -131.28 156.84 44.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.579 178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.086 HD13 HD12 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -109.28 111.63 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.674 0.75 . . . . 0.0 111.564 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.565 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 89.9 m95 -97.02 128.0 43.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.186 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.446 ' CB ' HD21 ' A' ' 672' ' ' LEU . 11.1 t80 -88.87 116.77 27.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 8.7 t -109.88 105.68 14.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 37.4 t60 -77.44 126.74 31.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 110.798 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.474 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.75 0.82 9.89 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.581 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -86.46 148.32 21.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.582 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 50.7 m -76.64 -24.6 53.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' ' O ' ' A' ' 656' ' ' VAL . 5.4 m-20 -75.27 4.05 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.569 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.07 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.591 0.71 . . . . 0.0 112.585 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 60.6 p -114.46 165.38 12.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.519 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.77 120.41 31.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.785 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.829 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -113.1 109.78 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.6 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 659' ' ' LEU . 19.9 m120 -146.71 19.85 1.3 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.725 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -120.28 141.18 50.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.87 0.367 . . . . 0.0 110.977 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.927 ' O ' HG21 ' A' ' 716' ' ' VAL . 55.7 ttp180 -96.64 135.37 38.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.559 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.553 ' O ' HG23 ' A' ' 656' ' ' VAL . 4.5 mtp -123.19 113.86 19.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.946 0.403 . . . . 0.0 111.395 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.4 pt -87.28 144.45 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -44.12 107.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.162 0.506 . . . . 0.0 110.799 -179.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 119.19 22.42 3.49 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 8.6 p -121.79 159.76 26.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.319 0.58 . . . . 0.0 111.09 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.8 ttpm? -123.3 143.61 49.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.821 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -146.57 133.71 20.45 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.701 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.64 141.43 53.65 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 111.813 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 647' ' ' ILE . 5.2 mt -111.33 111.48 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.323 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 3.8 mt-30 -94.18 150.27 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.173 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 706' ' ' GLY . 14.1 p-10 -47.83 128.88 13.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.878 0.371 . . . . 0.0 111.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.23 26.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.741 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.23 115.92 28.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.818 0.342 . . . . 0.0 110.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.0 mp0 -96.38 114.47 26.15 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.78 HG22 HD21 ' A' ' 659' ' ' LEU . 4.8 pt -105.71 137.04 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 111.888 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -98.93 116.08 30.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.854 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.848 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -78.15 -41.12 26.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.958 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.706 HG21 ' OD2' ' A' ' 615' ' ' ASP . 3.6 tt -155.74 131.59 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.343 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.73 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.5 t90 -136.12 119.11 16.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.349 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.832 ' OD2' HD22 ' P' ' 831' ' ' LEU . 7.8 m-20 -127.22 116.33 20.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.09 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -66.88 -46.18 75.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.519 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -78.57 -40.08 35.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.15 -0.37 35.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.64 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt 47.73 27.19 1.02 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.81 0.338 . . . . 0.0 111.325 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.619 ' CE1' HG21 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -101.78 104.41 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.939 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.73 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.3 m -126.57 128.58 71.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.332 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.752 HD12 HD12 ' A' ' 588' ' ' ILE . 37.4 mm -128.23 120.42 53.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -137.96 140.17 10.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.57 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.72 ' CZ ' HD11 ' A' ' 613' ' ' ILE . 20.3 m-85 -114.35 167.04 11.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.687 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.13 116.31 19.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.326 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.737 HG22 HD21 ' A' ' 578' ' ' LEU . 1.9 t -87.83 114.71 27.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.754 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -124.93 110.97 14.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.564 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.48 HG23 ' CD1' ' A' ' 577' ' ' PHE . 37.5 mt -89.32 105.63 16.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -83.86 -44.54 14.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -109.94 141.47 42.64 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.344 178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 19.9 p -112.62 96.26 5.88 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.675 0.75 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.479 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.0 t -73.01 61.8 0.59 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.271 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.82 58.82 11.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.124 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.5 OUTLIER -93.42 146.35 23.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.749 0.309 . . . . 0.0 111.142 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.938 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -41.55 -31.94 0.31 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.064 179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.484 ' OD1' ' CD2' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -179.41 31.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.088 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 706' ' ' GLY . 0.4 OUTLIER 68.54 -57.38 0.5 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.963 -178.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 705' ' ' GLU . . . 147.91 63.13 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.164 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.02 8.67 36.66 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 110.92 -68.38 0.22 Allowed Glycine 0 C--N 1.321 -0.254 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.962 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.404 ' CE ' ' NE2' ' A' ' 630' ' ' HIS . 0.0 OUTLIER 67.91 119.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.853 0.359 . . . . 0.0 110.569 -179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.871 HD22 ' N ' ' A' ' 711' ' ' GLN . 0.0 OUTLIER -51.82 -172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.497 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.871 ' N ' HD22 ' A' ' 710' ' ' LEU . 0.0 OUTLIER 77.05 -62.99 0.39 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.026 0.441 . . . . 0.0 110.072 -179.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -102.11 121.57 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.603 ' O ' HG13 ' A' ' 715' ' ' VAL . 0.0 OUTLIER -115.06 97.5 6.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.289 0.566 . . . . 0.0 110.264 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.829 ' NH2' HD22 ' A' ' 659' ' ' LEU . 12.0 mmm-85 16.13 79.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.11 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 713' ' ' GLN . 3.3 m -124.48 143.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.842 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.927 HG21 ' O ' ' A' ' 663' ' ' ARG . 96.1 t -77.53 119.61 26.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.352 . . . . 0.0 111.068 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -100.1 172.44 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.9 149.23 24.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -89.25 160.19 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.186 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 68.8 p -124.29 -176.27 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.077 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.81 40.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.251 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -61.9 -52.24 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.095 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -67.1 -48.34 68.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.8 OUTLIER -58.61 -32.74 69.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.892 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.51 -36.83 83.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.235 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.445 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.09 -45.23 95.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 110.74 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.885 HG23 HG11 ' A' ' 621' ' ' VAL . 7.4 p -72.51 -30.16 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -28.58 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.725 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -102.65 9.98 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.176 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.925 HD13 HG22 ' A' ' 621' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.609 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.91 0.386 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 59.66 83.98 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.822 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.2 pt -60.47 172.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.93 162.12 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.832 HD22 ' OD2' ' A' ' 683' ' ' ASP . 0.4 OUTLIER -131.42 152.61 50.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 39.9 t0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.981 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -84.89 -22.2 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.656 0.265 . . . . 0.0 111.146 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 124.22 2.14 8.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.943 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.435 ' CG ' ' HB2' ' A' ' 593' ' ' GLU . 3.4 ttm180 -98.15 123.92 42.45 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.839 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -115.01 -46.46 2.91 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.123 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.698 HD23 HD12 ' A' ' 594' ' ' ILE . 1.2 tp -117.58 143.44 46.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.465 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 5.2 m -130.63 114.07 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.082 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.749 HD11 ' CD1' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -104.15 108.51 19.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.75 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.2 OUTLIER -108.59 102.74 48.83 Favored Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.945 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 3.2 Cg_exo -53.81 123.31 13.1 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.518 1.478 . . . . 0.0 109.591 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -93.16 158.9 36.51 Favored Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -175.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.572 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 49.7 Cg_exo -55.1 -29.88 67.84 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.337 3.358 . . . . 0.0 112.977 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -62.45 -28.45 69.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.214 0.531 . . . . 0.0 109.597 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.0 OUTLIER -96.82 153.75 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.035 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.572 HG13 HD13 ' A' ' 588' ' ' ILE . 2.4 pt -51.83 -20.72 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.414 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 582' ' ' PRO . 20.4 mm -94.37 150.49 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.509 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.8 mp0 -154.26 60.94 0.7 Allowed 'General case' 0 CA--C 1.499 -0.993 0 CA-C-O 122.538 1.161 . . . . 0.0 108.2 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.945 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -126.99 177.56 6.55 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.181 -178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.13 115.79 17.55 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.978 177.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.91 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -114.08 121.59 44.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.479 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 0.0 OUTLIER -119.28 130.1 55.24 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 625' ' ' ILE . 10.1 mt -86.68 128.64 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -80.03 137.41 36.8 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.391 -0.523 . . . . 0.0 109.659 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.21 -29.04 1.43 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.347 0.594 . . . . 0.0 109.506 178.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -85.51 -23.5 46.91 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.654 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 595' ' ' GLN . 94.3 t -83.78 113.37 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.317 1.058 . . . . 0.0 111.195 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.1 OUTLIER -147.11 123.05 5.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.384 178.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.4 Cg_endo -91.84 160.44 26.46 Favored 'Cis proline' 0 N--CA 1.45 -1.031 0 C-N-CA 124.664 -0.973 . . . . 0.0 110.357 -1.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.576 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.0 t80 -89.7 117.33 28.49 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 72.4 m-85 -89.94 137.51 32.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.947 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.862 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -133.02 136.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.834 -177.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.25 173.23 36.0 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.408 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -34.28 56.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.827 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 16.4 p -75.87 118.26 18.47 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 6.3 pt-20 -54.75 -18.94 5.32 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.606 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -49.27 -28.97 5.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.14 123.64 22.62 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.714 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.96 -32.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.333 0.587 . . . . 0.0 110.671 -179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.91 ' SG ' HD13 ' A' ' 592' ' ' LEU . 37.2 t -97.36 144.65 26.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.884 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.936 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.78 112.7 19.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.5 mm -138.62 110.91 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.629 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -92.94 100.24 12.72 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.291 1.043 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.746 ' HB3' HD13 ' A' ' 618' ' ' LEU . 23.6 t0 -131.37 108.29 9.52 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.317 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.47 -36.99 0.08 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.5 mmp_? -78.03 -30.86 50.11 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 680' ' ' ILE . 4.7 mp -59.43 158.48 9.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.844 0.354 . . . . 0.0 111.144 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 4.9 m -113.43 176.4 5.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.188 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.501 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.59 -65.67 0.55 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.993 HG22 HD21 ' A' ' 730' ' ' LEU . 40.5 t -98.54 50.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.981 0.896 . . . . 0.0 109.196 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.628 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.3 t60 -40.25 -40.5 1.14 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.756 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.7 p 179.51 153.04 0.43 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.496 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 28.5 p90 -143.96 151.06 39.27 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.281 0.562 . . . . 0.0 111.196 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.845 HD12 HD11 ' A' ' 594' ' ' ILE . 68.8 mt -101.63 119.63 50.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 648' ' ' TRP . 3.0 t80 -108.66 152.19 25.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.512 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.9 ttmt -114.69 136.08 53.46 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.047 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.452 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.63 157.36 46.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.688 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -78.52 112.85 16.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.5 t60 -71.35 123.71 22.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.246 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.371 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -136.8 -176.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.833 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.578 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -58.81 -92.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.485 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -156.98 178.15 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 110.711 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.1 92.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.221 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 31.7 mmt -87.93 51.82 2.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.243 0.544 . . . . 0.0 110.088 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.91 -149.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.479 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -112.22 97.45 6.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.594 0.711 . . . . 0.0 109.562 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.3 p -140.75 156.86 68.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.461 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.04 -157.46 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.196 1.93 . . . . 0.0 111.135 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.54 22.58 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.142 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -82.02 61.7 5.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.584 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.47 107.18 0.01 OUTLIER Glycine 0 CA--C 1.506 -0.53 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.63 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 703' ' ' PHE . 3.5 mp -144.96 -155.76 0.64 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.509 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.36 146.88 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.166 0.508 . . . . 0.0 111.9 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.403 ' OD2' ' CZ ' ' A' ' 703' ' ' PHE . 3.1 t0 -132.4 132.29 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.104 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.839 HG21 ' CZ ' ' A' ' 577' ' ' PHE . 2.9 pt -94.14 111.61 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.635 0.731 . . . . 0.0 111.876 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.944 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 76.4 m95 -96.33 134.79 39.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.465 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.586 ' CB ' HD21 ' A' ' 672' ' ' LEU . 13.9 t80 -90.09 117.68 29.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -112.56 105.96 14.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 623' ' ' CYS . 24.7 t60 -77.69 127.39 32.36 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.559 HG23 HE22 ' A' ' 719' ' ' GLN . 0.0 OUTLIER -121.7 -1.81 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.593 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -83.14 150.38 27.42 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.634 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 33.4 m -78.65 -24.87 44.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.989 0.423 . . . . 0.0 111.087 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 656' ' ' VAL . 6.0 m-80 -73.36 4.31 4.84 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 655' ' ' ASN . 7.0 p 50.22 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.504 0.669 . . . . 0.0 112.234 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.476 ' N ' HG22 ' A' ' 656' ' ' VAL . 78.8 p -130.42 165.41 22.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.412 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -124.81 120.27 31.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.784 HD22 HH21 ' A' ' 714' ' ' ARG . 0.2 OUTLIER -117.91 109.4 16.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.776 0.322 . . . . 0.0 110.742 179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -79.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -155.16 24.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 2.5 m-80 -123.13 141.49 51.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.833 0.349 . . . . 0.0 111.051 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.753 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.2 ttm105 -75.68 141.48 42.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.722 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . . . . . . . . . 9.0 mmm -126.36 87.91 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 111.133 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 43.7 pt -87.23 145.11 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -48.58 105.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.61 22.74 2.71 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 17.8 p -125.04 158.42 33.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.492 0.663 . . . . 0.0 111.476 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.1 ttpm? -123.07 144.32 49.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.049 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 0.6 OUTLIER -147.37 143.83 28.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.944 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.98 140.17 48.98 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.081 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.702 ' CD2' HD11 ' A' ' 659' ' ' LEU . 4.4 mt -113.81 99.29 7.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 111.28 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.63 ' OE1' HD23 ' A' ' 707' ' ' LEU . 6.9 mt-30 -78.42 144.26 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.408 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.607 ' OD1' HD11 ' A' ' 707' ' ' LEU . 40.4 p-10 -47.8 115.45 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 111.018 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.43 6.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.254 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.65 118.21 31.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.755 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.04 114.28 25.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.649 HG22 ' CD2' ' A' ' 659' ' ' LEU . 1.8 pt -105.26 130.15 56.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.996 0.427 . . . . 0.0 111.919 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -95.21 116.05 28.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -75.49 -39.39 40.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.759 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.439 HG12 ' CZ ' ' A' ' 688' ' ' PHE . 2.8 tt -155.46 132.8 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.8 t90 -135.78 116.38 13.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 111.516 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 688' ' ' PHE . 8.0 m-20 -127.39 116.35 20.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.284 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -46.3 72.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.412 ' ND2' ' N ' ' A' ' 686' ' ' ASN . 1.4 p-10 -62.19 -40.27 95.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.834 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 685' ' ' ASN . 5.8 m120 -84.11 -18.17 37.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.495 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.9 tttt 63.39 23.92 13.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.515 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 1.1 p90 -113.82 108.6 17.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.189 0.519 . . . . 0.0 109.979 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -121.79 139.54 48.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.741 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.511 HG12 HG12 ' A' ' 587' ' ' ILE . 14.4 mt -117.48 135.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.392 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.72 127.62 1.7 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.347 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.551 ' HZ ' HG21 ' A' ' 613' ' ' ILE . 0.3 OUTLIER -114.92 144.01 44.24 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 116.61 33.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.929 0.395 . . . . 0.0 110.994 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.731 HG22 ' HG ' ' A' ' 580' ' ' LEU . 2.4 t -78.85 116.06 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.875 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 579' ' ' THR . 1.2 mt-10 -121.16 110.4 16.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.505 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -86.31 105.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -87.08 -43.55 12.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.889 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -110.64 139.1 46.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.304 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 699' ' ' THR . 1.2 p -114.7 96.51 5.77 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 596' ' ' GLN . 70.4 m -69.76 69.47 0.29 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.688 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.17 45.66 95.62 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.64 ' C ' HD22 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -90.44 150.19 21.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 111.369 -179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.764 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.0 OUTLIER -50.92 -23.08 2.59 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.593 ' ND2' ' H ' ' A' ' 707' ' ' LEU . 1.1 p-10 -172.42 -43.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.554 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.903 ' HB2' HD12 ' A' ' 696' ' ' ILE . 0.3 OUTLIER 158.15 -29.03 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.5 179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 140.34 15.98 0.49 Allowed Glycine 0 CA--C 1.523 0.532 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.345 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.63 HD23 ' OE1' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -80.97 9.59 6.3 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 42.31 81.74 0.03 OUTLIER Glycine 0 CA--C 1.519 0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 113.502 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.439 ' HE1' ' HB2' ' A' ' 707' ' ' LEU . 0.0 OUTLIER -75.36 92.26 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.741 0.305 . . . . 0.0 110.727 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -162.12 171.08 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.099 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -28.61 68.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.029 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.699 ' HB2' HD13 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -63.59 140.23 58.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.649 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -116.15 97.52 6.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.305 0.574 . . . . 0.0 110.31 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.784 HH21 HD22 ' A' ' 659' ' ' LEU . 1.1 mmm-85 41.8 89.52 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.036 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.424 HG21 ' HG2' ' A' ' 712' ' ' GLU . 4.5 m -124.72 142.17 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.193 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.753 HG21 ' O ' ' A' ' 663' ' ' ARG . 57.8 t -83.7 130.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.856 0.36 . . . . 0.0 111.085 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.2 mp -102.74 172.49 6.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.019 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -101.75 158.08 16.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.559 HE22 HG23 ' A' ' 652' ' ' THR . 13.0 tt0 -97.05 150.05 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.934 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.1 -178.9 4.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.333 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -54.46 -32.81 58.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.063 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -52.08 66.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.536 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.2 mp0 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.45 ' O ' HG12 ' A' ' 727' ' ' VAL . 37.4 mmtt -62.0 -34.34 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -36.62 79.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.152 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.461 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.6 mt -60.72 -43.5 97.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.414 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.86 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.1 p -68.73 -12.06 15.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.404 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm -87.34 51.2 2.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.416 . . . . 0.0 110.545 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -175.11 -46.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.993 HD21 HG22 ' A' ' 621' ' ' VAL . 3.3 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.112 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.808 0.337 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 26.8 p-10 -67.86 168.43 11.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.656 ' N ' HD13 ' P' ' 828' ' ' ILE . 0.1 OUTLIER -124.67 136.56 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.074 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.29 101.52 4.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' P' ' 831' ' ' LEU . 13.5 mt -123.1 82.32 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.692 -0.163 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -86.28 -14.28 44.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 111.238 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 128.08 11.92 3.03 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.983 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.448 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.1 ttm-85 -105.4 123.6 48.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.187 0.517 . . . . 0.0 110.841 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.809 ' CE2' HD13 ' A' ' 702' ' ' LEU . 0.4 OUTLIER -115.78 -45.95 2.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.246 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.038 HD22 HD13 ' A' ' 647' ' ' ILE . 27.2 tp -122.13 143.21 49.69 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.481 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.565 ' H ' HD12 ' A' ' 578' ' ' LEU . 22.8 m -123.62 121.4 35.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.02 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.616 ' CD2' HG23 ' A' ' 694' ' ' VAL . 6.3 mt -106.57 109.98 22.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.72 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.0 OUTLIER -117.69 105.12 48.38 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -175.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.996 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.0 OUTLIER -57.38 123.96 15.03 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.821 1.681 . . . . 0.0 109.463 176.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -91.7 158.77 39.71 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 51.2 Cg_exo -53.8 -31.88 63.84 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.243 3.296 . . . . 0.0 113.304 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.15 -28.04 69.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.026 0.441 . . . . 0.0 110.224 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.739 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.33 153.52 17.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.748 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 690' ' ' ILE . 10.1 pt -48.21 -23.85 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.206 0.527 . . . . 0.0 110.266 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 613' ' ' ILE . 1.8 mt -92.31 150.74 3.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.174 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.739 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.2 mp0 -154.69 56.83 0.68 Allowed 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.431 1.11 . . . . 0.0 108.086 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.996 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.3 OUTLIER -127.59 174.95 8.64 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 113.137 -1.847 . . . . 0.0 109.55 -178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -133.87 117.1 16.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 177.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.2 mm? -110.92 146.33 36.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.5 mp0 -124.71 125.62 44.37 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.682 HD12 HD23 ' A' ' 578' ' ' LEU . 27.3 mt -85.71 119.24 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.774 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.2 mp0 -72.13 141.1 49.14 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.346 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -49.55 -27.62 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -90.15 -13.78 59.92 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.508 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.774 HG23 ' HB2' ' A' ' 595' ' ' GLN . 71.4 t -89.83 112.95 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 118.469 1.135 . . . . 0.0 110.954 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.21 122.91 5.38 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.392 178.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 45.3 Cg_endo -91.6 160.2 27.2 Favored 'Cis proline' 0 N--CA 1.45 -1.038 0 C-N-CA 124.505 -1.04 . . . . 0.0 110.29 -1.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.592 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.2 t80 -89.22 117.3 28.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.66 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 77.1 m-85 -89.47 137.24 32.5 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.495 0.664 . . . . 0.0 111.334 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.27 136.3 55.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.622 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.7 179.8 40.62 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.592 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -54.36 -45.43 72.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.631 0.253 . . . . 0.0 111.605 -179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.03 119.17 15.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.727 0.299 . . . . 0.0 110.653 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 38.3 tt0 -50.46 -20.75 1.22 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.0 -30.08 1.69 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -70.44 120.58 16.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.705 178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.9 -34.87 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.249 0.547 . . . . 0.0 110.73 -179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.03 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.5 t -99.7 143.88 29.42 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.94 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -111.77 120.11 40.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.94 HD13 ' O ' ' A' ' 612' ' ' LYS . 2.7 mm -138.02 110.49 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.959 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 99.05 9.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.205 1.002 . . . . 0.0 109.954 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.773 ' HB3' HD13 ' A' ' 618' ' ' LEU . 21.6 t0 -133.19 108.52 8.84 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.202 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -35.1 -37.38 0.07 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.3 mmp_? -78.45 -30.32 47.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.773 HD13 ' HB3' ' A' ' 615' ' ' ASP . 4.3 mp -59.0 158.76 8.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 1.5 m -113.62 176.13 5.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.515 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -53.43 -70.11 0.1 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.965 HG22 HD21 ' A' ' 730' ' ' LEU . 22.2 t -95.46 55.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.922 0.867 . . . . 0.0 109.077 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.612 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 76.2 t60 -43.55 -43.4 5.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.963 -1.472 . . . . 0.0 112.699 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.5 p -176.98 152.06 0.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 41.8 p90 -143.52 152.26 41.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.253 0.549 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.605 HD12 HD11 ' A' ' 594' ' ' ILE . 77.7 mt -101.89 122.05 53.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.459 ' N ' ' O ' ' A' ' 648' ' ' TRP . 6.3 t80 -109.95 152.68 25.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.518 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.424 ' HB2' HG22 ' A' ' 647' ' ' ILE . 2.8 ttmt -116.21 134.16 55.22 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.66 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.5 OUTLIER -136.58 158.1 45.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.505 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.691 ' NH1' ' HB2' ' A' ' 631' ' ' ALA . 0.0 OUTLIER -77.85 119.75 21.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.149 0.499 . . . . 0.0 110.457 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.7 t60 -76.21 131.44 39.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.01 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.691 ' HB2' ' NH1' ' A' ' 629' ' ' ARG . . . -111.04 119.13 38.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.238 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.5 OUTLIER -94.74 -171.26 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.781 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.602 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -88.42 49.12 3.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.736 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.96 172.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.309 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.2 106.95 3.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.017 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.4 ttt -93.41 26.96 2.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.176 0.512 . . . . 0.0 110.444 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.24 -159.58 0.86 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.067 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -103.3 96.92 7.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.723 0.773 . . . . 0.0 109.408 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 82.5 p -140.88 156.51 68.61 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.276 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.95 -158.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.15 1.9 . . . . 0.0 111.27 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 46.48 23.46 0.23 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.235 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.82 63.28 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.953 0.406 . . . . 0.0 110.555 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.453 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 58.32 116.15 0.01 OUTLIER Glycine 0 CA--C 1.508 -0.39 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.603 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 703' ' ' PHE . 93.4 mt -154.14 -144.39 0.14 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.71 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -118.35 148.51 42.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.435 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -135.9 145.18 46.03 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.675 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.038 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -103.35 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.384 0.611 . . . . 0.0 112.059 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.706 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 66.7 m95 -104.11 134.12 47.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.845 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.1 t80 -89.49 116.94 28.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 20.7 t -109.25 105.43 14.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.453 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 34.6 t60 -75.9 132.89 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.892 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.57 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.84 7.2 4.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.975 -179.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -91.82 141.58 15.69 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.574 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -70.04 -24.8 63.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.948 0.404 . . . . 0.0 111.147 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.507 ' O ' ' CG1' ' A' ' 656' ' ' VAL . 6.7 m-80 -76.73 4.65 9.12 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 655' ' ' ASN . 6.4 p 50.63 155.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.584 0.707 . . . . 0.0 112.569 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 656' ' ' VAL . 18.6 m -128.12 165.64 20.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.177 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -123.21 120.27 32.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.659 0.266 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.66 HD13 HG12 ' A' ' 678' ' ' ILE . 0.5 OUTLIER -112.73 102.32 10.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.322 . . . . 0.0 110.924 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.03 -78.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.554 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -147.0 15.52 1.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 670' ' ' PHE . 3.4 m120 -117.26 141.27 48.5 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.844 0.354 . . . . 0.0 111.207 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.758 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.5 tpp180 -77.39 141.41 39.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.656 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 95.5 mmm -121.32 88.85 3.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 45.5 pt -87.17 146.38 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.6 tt0 -50.13 100.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.262 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.24 26.57 1.47 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.38 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 11.0 p -126.93 154.86 43.95 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.56 0.695 . . . . 0.0 111.536 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 2.3 ttpt -123.03 134.19 54.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.322 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.545 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -139.3 134.84 33.12 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.706 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.8 OUTLIER -69.79 142.16 53.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.417 . . . . 0.0 111.693 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.739 HD13 HG21 ' A' ' 694' ' ' VAL . 16.1 mt -115.82 121.98 44.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.439 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.662 ' HB3' HD22 ' A' ' 707' ' ' LEU . 15.6 mt-30 -101.06 144.36 30.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.208 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.876 ' OD1' HD21 ' A' ' 707' ' ' LEU . 11.5 p-10 -45.45 107.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.159 0.504 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 104.6 30.23 5.01 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.55 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.36 114.7 27.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.651 0.263 . . . . 0.0 110.493 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.01 112.96 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.66 HG12 HD13 ' A' ' 659' ' ' LEU . 5.4 mt -105.16 126.2 60.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.246 0.546 . . . . 0.0 111.878 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 691' ' ' GLY . 0.2 OUTLIER -87.83 115.71 25.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.821 178.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 613' ' ' ILE . 1.6 mt -71.59 -43.1 71.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.494 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.634 HG21 ' CZ ' ' A' ' 688' ' ' PHE . 2.4 tt -156.1 136.27 4.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.132 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.635 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.7 t90 -135.53 118.17 15.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.912 0.387 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.691 ' OD2' HD22 ' P' ' 831' ' ' LEU . 2.3 m-20 -127.01 116.67 21.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.914 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -46.37 75.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.923 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -71.87 -40.25 69.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.601 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 1.2 m-20 -73.83 -15.16 61.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.462 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.37 26.71 11.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.994 0.426 . . . . 0.0 110.822 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -120.92 109.17 14.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.794 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.635 HG12 ' CD1' ' A' ' 682' ' ' TRP . 6.3 m -123.93 138.51 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.493 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.811 HD11 HD11 ' A' ' 587' ' ' ILE . 4.7 mt -121.97 136.09 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.678 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 679' ' ' LYS . . . -157.91 134.32 3.85 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.737 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.9 m-85 -114.74 143.09 45.62 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.618 0.247 . . . . 0.0 111.07 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -101.68 116.66 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.859 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.883 HG13 HD11 ' A' ' 578' ' ' LEU . 1.1 t -82.77 122.99 38.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.647 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.95 111.12 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.341 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.698 ' CG1' HD13 ' A' ' 578' ' ' LEU . 7.0 mt -87.04 106.03 15.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.465 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -80.94 -47.97 12.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.763 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.7 OUTLIER -111.29 140.63 45.69 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.195 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 701' ' ' GLY . 0.9 OUTLIER -115.03 97.31 6.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.794 177.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.3 t -62.46 74.0 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.7 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 699' ' ' THR . . . 57.79 30.24 62.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.103 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.809 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.1 OUTLIER -78.07 155.42 30.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 111.351 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.775 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -58.04 -15.7 10.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.109 179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.658 HD21 HD23 ' A' ' 707' ' ' LEU . 4.6 t30 -177.43 -53.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.631 ' HB2' HD13 ' A' ' 696' ' ' ILE . 2.0 pt-20 163.71 -37.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.765 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 152.16 34.72 0.03 OUTLIER Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.848 -0.691 . . . . 0.0 113.212 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.876 HD21 ' OD1' ' A' ' 674' ' ' ASP . 2.9 mm? -86.19 9.23 18.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 117.028 0.414 . . . . 0.0 112.004 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 60.46 -84.24 0.02 OUTLIER Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.569 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 29.5 mtm 59.89 83.83 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.774 0.321 . . . . 0.0 110.907 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 710' ' ' LEU . 0.2 OUTLIER -165.27 -176.68 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 65.7 mm-40 -55.21 -34.97 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.181 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.15 139.93 36.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.838 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.59 97.31 5.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.172 0.511 . . . . 0.0 110.186 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.3 mmm-85 37.96 79.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.736 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.1 m -124.16 143.49 37.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.125 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.758 HG21 ' O ' ' A' ' 663' ' ' ARG . 38.8 t -77.46 114.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.907 0.384 . . . . 0.0 111.176 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.47 170.46 9.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.839 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.08 147.66 26.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -84.26 160.09 20.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.43 -176.93 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.165 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.9 -29.33 41.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.209 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.75 -48.26 77.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.775 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -66.56 -47.46 72.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 727' ' ' VAL . 26.4 tttp -57.9 -32.74 68.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.095 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -36.56 80.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.63 -44.93 95.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.096 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.853 HG23 HG11 ' A' ' 621' ' ' VAL . 5.7 p -69.75 -28.52 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.79 -29.29 39.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -111.58 -23.95 10.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.221 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.965 HD21 HG22 ' A' ' 621' ' ' VAL . 1.3 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.742 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.8 0.333 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -107.6 127.48 53.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 28.4 mt -100.98 129.88 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 4.2 p90 -143.65 118.57 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.691 HD22 ' OD2' ' A' ' 683' ' ' ASP . 12.8 mt -104.13 103.27 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.914 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.72 -14.59 62.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.654 0.264 . . . . 0.0 111.263 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 595' ' ' GLN . . . 116.35 -42.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.467 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -111.99 135.79 52.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.403 0.62 . . . . 0.0 111.572 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.762 ' HB2' ' HB3' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -123.64 -45.13 2.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.6 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.055 HD22 HD13 ' A' ' 647' ' ' ILE . 26.1 tp -127.91 142.8 51.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.141 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.447 ' H ' HD12 ' A' ' 578' ' ' LEU . 5.3 m -131.79 126.11 33.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.024 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mt -107.71 108.69 20.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.736 ' O ' HD23 ' A' ' 583' ' ' LEU . 1.5 mttm -105.38 100.53 26.34 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.9 Cg_endo -56.07 124.04 15.3 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 121.698 1.599 . . . . 0.0 110.079 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 581' ' ' LYS . 0.1 OUTLIER -98.17 161.0 26.9 Favored Pre-proline 0 N--CA 1.471 0.594 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -176.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 589' ' ' GLN . 76.8 Cg_exo -50.7 -35.21 46.78 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 124.34 3.36 . . . . 0.0 113.112 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.36 -24.6 67.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.55 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 13.1 p -95.36 153.28 17.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.104 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.652 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -54.6 -18.32 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.105 0.478 . . . . 0.0 110.323 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.893 HG13 HG23 ' A' ' 613' ' ' ILE . 10.9 mm -103.8 151.12 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.719 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.541 ' CG ' ' HA ' ' A' ' 584' ' ' PRO . 18.9 mp0 -148.08 59.56 1.11 Allowed 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.7 mt-10 -126.06 177.48 6.34 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.637 -2.074 . . . . 0.0 109.208 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -129.85 120.65 25.3 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.267 0.556 . . . . 0.0 110.488 177.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.785 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -104.83 135.97 45.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.732 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 576' ' ' ARG . 5.2 mt-10 -124.06 112.87 17.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.024 HD11 HD11 ' A' ' 580' ' ' LEU . 16.3 mt -83.69 124.99 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.8 OUTLIER -77.58 140.76 39.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -49.81 -25.3 2.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.209 0.528 . . . . 0.0 109.782 179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -90.92 -14.55 57.72 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.436 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.795 HG23 ' HB2' ' A' ' 595' ' ' GLN . 73.7 t -87.9 112.99 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 118.328 1.064 . . . . 0.0 111.0 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.23 122.11 5.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.096 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.539 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.0 Cg_endo -91.18 160.59 28.89 Favored 'Cis proline' 0 N--CA 1.451 -1.001 0 C-N-CA 124.471 -1.054 . . . . 0.0 110.205 -1.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.625 ' CD1' HG23 ' A' ' 594' ' ' ILE . 8.9 t80 -88.62 116.68 27.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 79.4 m-85 -89.07 137.94 31.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.263 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.1 mt -132.76 135.54 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.871 -177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 168.19 172.05 34.73 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.358 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -50.54 -42.13 54.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.665 0.269 . . . . 0.0 111.288 -179.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.3 OUTLIER -71.78 118.77 15.03 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.427 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 24.9 pt-20 -52.58 -19.1 2.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.273 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -47.19 -29.87 2.59 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.6 m -71.71 123.86 23.49 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.531 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -38.79 -33.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.337 0.589 . . . . 0.0 110.63 -179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 42.8 t -95.55 144.31 26.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.747 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -120.51 113.12 19.83 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.893 HG23 HG13 ' A' ' 588' ' ' ILE . 18.0 mm -139.04 114.76 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.503 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -89.86 100.05 12.94 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.074 0.94 . . . . 0.0 108.914 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.895 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -131.51 108.32 9.49 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.143 179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -39.76 -41.11 1.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.623 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.48 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.0 OUTLIER -77.45 -28.81 52.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.558 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.895 HD13 ' CB ' ' A' ' 615' ' ' ASP . 3.0 mp -58.69 158.32 8.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.855 0.36 . . . . 0.0 110.638 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 3.5 t -113.99 175.23 5.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.269 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.608 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.6 -65.01 0.67 Allowed 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.913 HG11 HG23 ' A' ' 727' ' ' VAL . 9.4 t -100.13 50.56 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 122.012 0.91 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.82 ' CD2' HD12 ' A' ' 680' ' ' ILE . 70.2 t60 -40.39 -38.67 0.85 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.043 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.0 p 176.89 152.85 0.2 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 42.5 p90 -143.75 151.64 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.083 0.468 . . . . 0.0 111.055 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.602 HD11 HD21 ' A' ' 580' ' ' LEU . 78.6 mt -102.04 122.21 54.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 648' ' ' TRP . 7.5 t80 -110.54 152.39 26.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.8 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 15.5 ttmt -114.11 128.95 56.61 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.766 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -137.35 158.64 43.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.984 -179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -77.63 122.27 25.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 110.605 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 644' ' ' LEU . 4.0 t60 -76.24 129.66 37.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.945 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.26 129.04 52.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.511 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -97.41 159.96 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.955 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.511 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -74.52 170.01 53.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.498 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.35 90.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.38 109.93 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.02 35.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 -152.14 0.17 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.423 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -114.51 100.31 8.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.394 0.616 . . . . 0.0 109.751 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 p -137.28 156.68 75.18 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.753 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.555 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 65.2 Cg_endo -69.64 -153.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.687 2.258 . . . . 0.0 111.737 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 77.98 -70.38 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 37.61 35.08 0.06 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.581 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 62.0 125.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.743 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.4 mt -155.88 -147.0 0.19 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.123 -0.538 . . . . 0.0 110.177 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.853 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -113.39 147.54 37.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.163 0.506 . . . . 0.0 112.364 -179.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -141.34 135.0 30.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.881 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.055 HD13 HD22 ' A' ' 578' ' ' LEU . 2.1 pt -89.25 119.21 35.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 111.936 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.969 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 85.4 m95 -103.33 132.46 49.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.647 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.2 t80 -90.52 117.21 29.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 9.1 t -109.49 115.29 29.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.472 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 40.4 t60 -84.13 132.55 34.68 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.557 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -130.29 8.72 5.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.472 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -97.5 143.09 16.51 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.433 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 28.4 m -67.78 -22.84 65.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.074 0.464 . . . . 0.0 111.127 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.575 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -73.35 3.56 5.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.2 OUTLIER 50.68 153.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.312 0.577 . . . . 0.0 112.048 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 680' ' ' ILE . 9.0 t -125.99 165.99 17.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.083 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -130.81 120.77 24.21 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.859 HD12 ' CE1' ' A' ' 670' ' ' PHE . 0.6 OUTLIER -115.12 121.72 43.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.197 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD13 ' A' ' 659' ' ' LEU . 3.3 m-80 56.56 -82.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 659' ' ' LEU . 29.9 p30 -139.4 -1.14 1.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.668 ' HB3' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -110.66 141.07 44.4 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.603 -179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.894 ' O ' HG21 ' A' ' 716' ' ' VAL . 3.9 ttp180 -93.42 137.77 32.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.798 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.455 ' HE1' ' CD2' ' A' ' 649' ' ' TYR . 0.6 OUTLIER -122.53 137.21 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.134 0.492 . . . . 0.0 111.796 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.43 165.17 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.627 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 652' ' ' THR . 7.3 tt0 -58.68 97.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.833 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 127.52 31.07 0.74 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 9.4 p -128.0 163.5 24.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.443 0.64 . . . . 0.0 111.6 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.9 ttpt -122.21 146.52 47.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.402 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.859 ' CE1' HD12 ' A' ' 659' ' ' LEU . 7.3 t80 -147.56 145.23 28.98 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.969 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -77.64 138.55 39.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.106 179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.596 HD13 HG21 ' A' ' 694' ' ' VAL . 2.6 mt -115.39 114.07 24.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.07 0.462 . . . . 0.0 110.929 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 5.5 mt-30 -93.24 136.93 33.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.841 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.698 ' OD1' HD11 ' A' ' 707' ' ' LEU . 1.1 p-10 -48.04 118.16 2.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.978 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 90.12 33.87 8.57 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.877 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -105.76 134.5 48.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 111.19 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -96.34 113.52 25.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.754 HG22 HD21 ' A' ' 659' ' ' LEU . 0.9 OUTLIER -104.91 127.93 59.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 0.0 111.634 -178.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.11 116.55 32.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.816 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.82 HD12 ' CD2' ' A' ' 622' ' ' HIS . 23.6 pt -85.27 -18.41 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.841 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 617' ' ' ARG . 16.2 tt -155.75 131.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.798 0.332 . . . . 0.0 111.262 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.697 ' CD1' HG12 ' A' ' 689' ' ' VAL . 10.0 t90 -136.47 120.54 17.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.688 ' OD1' HD13 ' P' ' 831' ' ' LEU . 36.2 m-20 -126.81 116.36 20.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.207 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -46.66 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.085 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -72.33 -40.32 67.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.711 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 -8.95 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm 50.84 27.96 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.05 0.453 . . . . 0.0 110.649 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.457 ' CZ ' HD13 ' A' ' 681' ' ' ILE . 0.0 OUTLIER -123.61 105.66 9.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.949 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.697 HG12 ' CD1' ' A' ' 682' ' ' TRP . 15.4 m -118.85 139.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.434 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.652 ' CD1' HG22 ' A' ' 587' ' ' ILE . 34.2 mm -105.76 155.34 6.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -179.22 120.24 0.69 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.073 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 613' ' ' ILE . 1.8 m-30 -114.27 148.34 37.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -100.71 116.93 33.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.98 0.419 . . . . 0.0 110.524 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 1.006 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -79.77 126.32 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -133.02 110.3 10.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.896 HG12 HD13 ' A' ' 578' ' ' LEU . 54.3 mt -89.92 104.88 15.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.183 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -82.72 -43.36 16.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.205 0.526 . . . . 0.0 109.842 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.467 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -109.66 141.06 42.77 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.679 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 1.9 p -113.47 96.31 5.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.746 HG22 ' CE2' ' A' ' 577' ' ' PHE . 2.9 t -66.82 73.22 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 59.99 29.32 67.74 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.735 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.853 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -76.25 136.14 39.67 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.922 0.391 . . . . 0.0 111.178 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.859 ' HA ' HD12 ' A' ' 644' ' ' LEU . 0.1 OUTLIER -50.21 -24.81 3.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.247 0.546 . . . . 0.0 110.417 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 707' ' ' LEU . 9.1 t30 -160.24 -56.78 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.492 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 5.6 pt-20 161.67 -30.74 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.13 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 142.49 33.11 0.11 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.662 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.698 HD11 ' OD1' ' A' ' 674' ' ' ASP . 8.4 mp -88.29 8.37 27.72 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 33.16 71.16 0.11 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.571 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.496 ' HE3' ' H ' ' A' ' 709' ' ' MET . 0.0 OUTLIER -79.13 118.95 21.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.102 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 712' ' ' GLU . 0.3 OUTLIER 178.74 170.23 0.85 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.756 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -31.05 66.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 710' ' ' LEU . 1.3 mt-10 -63.68 141.16 58.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -113.77 97.17 6.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.291 0.567 . . . . 0.0 110.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.736 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 4.7 mmm180 28.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.946 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.06 144.14 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.048 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.894 HG21 ' O ' ' A' ' 663' ' ' ARG . 95.9 t -79.19 130.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.31 172.33 7.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.61 158.22 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.405 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 11.5 tt0 -91.98 151.12 20.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.819 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 48.6 p -125.52 -177.83 4.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.273 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.42 -30.23 64.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.52 -52.33 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.794 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.405 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 3.8 mp0 -68.24 -40.41 82.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.763 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.01 -33.42 74.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -67.99 -36.88 80.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.07 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 600' ' ' PRO . 2.7 mt -61.03 -45.02 96.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.77 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.913 HG23 HG11 ' A' ' 621' ' ' VAL . 7.6 p -75.04 -30.29 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.751 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -60.38 -26.74 66.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.444 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -91.47 -16.83 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.075 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.884 HD13 HG22 ' A' ' 621' ' ' VAL . 5.2 tt . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.961 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.755 0.312 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -161.82 126.63 3.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 13.8 pt -73.68 148.15 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.114 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.51 116.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.834 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.718 ' O ' HD12 ' P' ' 831' ' ' LEU . 0.6 OUTLIER -147.92 89.1 1.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.978 -179.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -92.42 8.82 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.661 0.267 . . . . 0.0 111.273 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -137.64 -36.98 0.16 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.657 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 tmm_? -96.9 134.89 39.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.134 0.493 . . . . 0.0 110.017 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -126.23 -44.55 1.73 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.634 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.015 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -122.56 143.5 49.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.871 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.809 ' N ' HD23 ' A' ' 578' ' ' LEU . 9.3 m -131.0 117.19 18.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.95 HD11 HD11 ' A' ' 594' ' ' ILE . 1.1 mp -102.59 108.77 20.17 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.641 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -106.63 100.96 33.69 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.901 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.8 Cg_endo -56.33 124.75 17.01 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 121.589 1.526 . . . . 0.0 109.281 176.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -75.85 158.62 82.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -176.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 589' ' ' GLN . 43.2 Cg_endo -69.96 -24.03 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.019 2.479 . . . . 0.0 112.153 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.25 -21.03 66.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 110.251 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.515 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.3 OUTLIER -96.44 153.25 17.94 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 587' ' ' ILE . 0.2 OUTLIER -44.38 -25.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 121.099 0.475 . . . . 0.0 110.368 178.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 583' ' ' LEU . 3.7 tt -106.02 151.48 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.643 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.596 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -151.89 71.4 0.97 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.901 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 8.1 mm-40 -126.63 175.93 7.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 112.884 -1.962 . . . . 0.0 110.068 -177.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -130.81 116.92 18.61 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.552 177.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -102.05 131.98 48.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.434 179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.614 ' HG2' HG23 ' A' ' 579' ' ' THR . 9.5 mt-10 -124.36 112.46 16.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.95 HD11 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -81.32 136.57 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.6 mp0 -89.18 137.09 32.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.017 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -46.37 -29.31 1.63 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 109.66 179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.62 55.18 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.614 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.729 HG23 ' HB2' ' A' ' 595' ' ' GLN . 88.0 t -86.2 113.59 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.115 0.957 . . . . 0.0 111.472 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.04 123.1 5.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.064 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 48.0 Cg_endo -91.2 160.36 28.69 Favored 'Cis proline' 0 N--CA 1.452 -0.912 0 C-N-CA 124.638 -0.984 . . . . 0.0 110.479 -1.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.723 ' CD1' HG23 ' A' ' 594' ' ' ILE . 5.5 t80 -89.76 118.78 29.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 67.0 m-85 -90.49 137.79 32.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.011 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.9 mt -133.37 136.72 54.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.961 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.45 175.1 38.38 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.254 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 616' ' ' ASN . 0.0 OUTLIER -55.47 -41.81 73.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.994 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.577 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -72.75 119.24 16.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -51.02 -19.77 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.21 -30.59 1.23 Allowed 'General case' 0 C--N 1.34 0.161 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.9 m -72.6 120.73 18.63 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.566 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.602 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.8 OUTLIER -38.69 -33.37 0.11 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.359 0.6 . . . . 0.0 110.766 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.011 ' HB3' HG23 ' A' ' 603' ' ' ILE . 1.6 t -95.43 144.32 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.68 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -120.83 116.18 24.7 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.536 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 9.9 mm -138.13 114.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.625 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -94.16 99.65 11.88 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 122.322 1.058 . . . . 0.0 109.806 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.802 ' HB3' HD13 ' A' ' 618' ' ' LEU . 47.9 t0 -132.13 108.38 9.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.431 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 605' ' ' ARG . 15.1 m120 -36.84 -37.79 0.16 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.963 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.487 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 5.7 mmp_? -78.51 -27.56 46.09 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.992 HD11 ' CG2' ' A' ' 680' ' ' ILE . 3.7 mp -59.26 158.72 8.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.85 0.357 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 58.8 m -113.53 176.33 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.273 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.25 -68.19 0.2 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.742 0.306 . . . . 0.0 110.188 179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.871 HG11 ' CG2' ' A' ' 727' ' ' VAL . 19.0 t -98.61 54.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.021 0.915 . . . . 0.0 108.836 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.59 ' NE2' HG23 ' A' ' 680' ' ' ILE . 76.7 t60 -42.86 -41.62 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.864 -1.516 . . . . 0.0 113.032 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.563 ' O ' ' N ' ' A' ' 603' ' ' ILE . 3.8 p -178.59 152.89 0.66 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 10.3 p90 -143.61 149.9 38.02 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.598 ' CD1' HD21 ' A' ' 580' ' ' LEU . 20.3 mt -101.89 121.44 52.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 5.7 t80 -109.92 152.88 25.27 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.721 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.503 ' NZ ' HG21 ' A' ' 700' ' ' THR . 16.6 ttmt -117.16 135.28 53.88 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.825 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.12 157.98 45.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.267 -178.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 2.6 tpt180 -77.87 115.06 17.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.479 ' CE1' ' CE2' ' A' ' 703' ' ' PHE . 1.7 t60 -61.98 134.39 56.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.406 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -134.52 126.05 28.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 642' ' ' GLN . 0.4 OUTLIER -114.69 -175.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.037 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.574 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -56.92 -168.17 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.563 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -74.25 133.9 42.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.885 0.374 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.41 119.58 35.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.7 mmm -94.38 28.4 2.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.121 0.486 . . . . 0.0 110.568 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.77 -163.86 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.779 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -114.6 99.49 7.57 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.398 0.618 . . . . 0.0 109.676 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.402 ' HB2' ' HD2' ' A' ' 640' ' ' PRO . 92.0 p -138.88 156.36 72.7 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.797 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.547 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.6 Cg_endo -67.46 -151.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.534 2.156 . . . . 0.0 111.178 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 75.39 -62.18 0.45 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.721 0.296 . . . . 0.0 111.2 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.789 ' HB2' HG12 ' A' ' 632' ' ' VAL . 63.5 tt0 -98.61 93.16 5.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 111.38 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 146.47 -6.36 1.24 Allowed Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.828 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 703' ' ' PHE . 2.8 mp -106.54 -164.87 1.03 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.219 -0.49 . . . . 0.0 110.76 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.872 ' O ' HD13 ' A' ' 702' ' ' LEU . 8.4 m-20 -122.45 147.35 46.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.4 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 4.1 t0 -123.01 139.74 53.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.681 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 578' ' ' LEU . 4.0 pt -95.74 115.86 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.633 0.73 . . . . 0.0 111.752 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.557 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 98.1 m95 -103.69 128.12 51.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.477 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.646 ' CB ' HD21 ' A' ' 672' ' ' LEU . 15.8 t80 -89.29 118.52 29.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 624' ' ' PHE . 1.5 t -108.97 117.42 34.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.456 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -86.51 131.56 34.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.597 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -129.29 5.56 5.26 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.8 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.85 140.88 15.29 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.387 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.1 m -66.8 -23.91 66.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.973 0.416 . . . . 0.0 111.391 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.81 ' OD1' HD12 ' P' ' 831' ' ' LEU . 5.0 m-80 -76.55 4.57 9.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.546 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.5 p 48.32 157.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.438 0.637 . . . . 0.0 112.295 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.453 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 96.3 p -133.15 165.41 24.84 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.5 137.9 53.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.832 HD21 ' CD2' ' A' ' 672' ' ' LEU . 0.2 OUTLIER -134.66 112.61 10.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.19 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.507 ' N ' HD12 ' A' ' 659' ' ' LEU . 30.6 m120 60.5 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.685 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 11.3 p-10 -145.21 0.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.632 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -113.84 141.56 47.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.956 -179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.89 ' O ' HG21 ' A' ' 716' ' ' VAL . 1.5 ttp-105 -87.78 141.74 28.36 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.094 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.427 ' HE3' ' CE2' ' A' ' 649' ' ' TYR . 0.0 OUTLIER -127.58 109.77 12.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.046 0.45 . . . . 0.0 112.144 -178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 29.0 pt -87.81 165.28 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.469 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 652' ' ' THR . 8.9 tt0 -57.81 103.05 0.12 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 111.149 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 124.8 24.01 1.76 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.552 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.6 p -129.84 162.57 28.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.416 0.626 . . . . 0.0 111.274 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 7.0 ttpm? -124.1 143.17 50.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.893 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 649' ' ' TYR . 3.3 t80 -147.03 135.55 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.557 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.05 141.77 54.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 112.267 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.93 HD13 HG21 ' A' ' 694' ' ' VAL . 2.9 mt -106.21 99.72 9.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.144 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.588 ' HB3' HD12 ' A' ' 707' ' ' LEU . 9.6 mt-30 -79.37 134.06 36.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.304 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.457 ' OD2' HD13 ' A' ' 707' ' ' LEU . 2.8 p30 -35.95 121.09 0.65 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.021 0.439 . . . . 0.0 110.923 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 79.68 40.11 15.9 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.434 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -93.67 113.78 25.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.491 -0.355 . . . . 0.0 111.162 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.608 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.36 114.19 25.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.811 HG22 HD13 ' A' ' 659' ' ' LEU . 33.7 pt -105.22 137.14 36.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -95.35 115.88 28.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.302 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.992 ' CG2' HD11 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -89.44 -31.46 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.212 -178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.678 HG21 ' OD2' ' A' ' 615' ' ' ASP . 1.2 tp -154.28 130.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.996 0.427 . . . . 0.0 111.059 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -137.16 117.4 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.422 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.9 m-20 -124.2 116.57 22.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.4 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.2 -46.52 73.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.523 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -82.14 -40.44 21.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.341 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.5 OUTLIER -74.97 -14.64 60.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.989 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.78 29.87 19.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 110.736 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.424 ' CE1' ' CD1' ' A' ' 587' ' ' ILE . 1.3 t80 -101.69 104.44 15.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.591 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 689' ' ' VAL . 3.7 m -126.74 124.37 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.065 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 586' ' ' SER . 1.1 tt -125.59 141.44 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.3 . . . . 0.0 110.901 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -163.2 133.87 3.21 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.174 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.743 ' CE2' HD12 ' A' ' 680' ' ' ILE . 0.1 OUTLIER -115.48 144.39 43.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -101.58 117.33 34.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.87 0.367 . . . . 0.0 111.142 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.93 HG21 HD13 ' A' ' 672' ' ' LEU . 1.6 t -77.62 114.73 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.698 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.09 111.18 17.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.34 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 705' ' ' GLU . 5.5 mt -91.82 105.72 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.181 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -86.35 -44.85 11.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.593 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.32 140.34 44.6 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.111 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 5.8 p -113.55 96.51 5.91 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.696 0.76 . . . . 0.0 109.045 178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.503 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 3.5 t -71.7 74.61 0.83 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.71 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 60.27 43.99 97.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.28 130.48 37.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.655 0.264 . . . . 0.0 110.968 -179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.734 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.2 p90 -44.3 -31.3 0.99 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.358 0.599 . . . . 0.0 110.486 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 5.8 t30 -149.06 -55.9 0.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.065 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 696' ' ' ILE . 11.5 pt-20 156.51 -27.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.402 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 141.24 -9.36 2.71 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.481 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 673' ' ' GLN . 3.0 tt -94.58 9.84 37.08 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.996 0.427 . . . . 0.0 111.904 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . -79.44 126.98 7.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 5.8 mmt -148.66 134.28 18.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 0.0 110.96 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -140.51 138.41 34.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.854 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 69.35 -64.43 0.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.711 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 140.67 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.706 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -115.78 97.5 6.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.397 0.617 . . . . 0.0 110.078 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.651 ' NE ' ' HA ' ' A' ' 714' ' ' ARG . 5.0 mmm180 35.89 89.16 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.12 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.409 ' HA ' ' OD1' ' A' ' 662' ' ' ASN . 3.9 m -124.72 142.12 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.049 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 663' ' ' ARG . 91.4 t -83.26 128.2 38.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.013 0.435 . . . . 0.0 111.716 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mp -108.97 170.43 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.531 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 136.32 43.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -76.31 160.21 29.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.672 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.4 p -122.01 -173.88 2.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.279 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -28.82 37.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.152 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.34 -48.86 79.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.729 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -46.9 70.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.739 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.1 OUTLIER -58.02 -32.78 68.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.014 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.19 -36.75 80.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.436 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 1.8 mt -59.78 -44.72 93.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.871 ' CG2' HG11 ' A' ' 621' ' ' VAL . 4.0 p -69.13 -22.68 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.976 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -57.66 -25.42 60.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.859 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm -100.17 -43.26 6.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.726 HD21 HG22 ' A' ' 621' ' ' VAL . 2.0 mt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.339 -0.839 . . . . 0.0 110.754 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.873 0.368 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . 0.543 ' C ' HD13 ' P' ' 828' ' ' ILE . 47.7 m-20 -147.6 80.39 1.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.543 HD13 ' C ' ' P' ' 827' ' ' ASP . 0.7 OUTLIER -113.26 80.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.111 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' P' ' 830' ' ' TYR . 2.7 m-85 -113.0 -163.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.887 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.81 HD12 ' OD1' ' A' ' 655' ' ' ASN . 18.3 mt 69.51 63.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.25 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.8 10.15 41.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.282 . . . . 0.0 111.403 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 116.55 -4.85 19.37 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.948 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 3.6 ttm180 -95.63 124.32 39.6 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.229 0.537 . . . . 0.0 110.255 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.1 OUTLIER -117.56 -45.12 2.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.361 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.023 HD12 HD13 ' A' ' 647' ' ' ILE . 6.9 tt -124.94 143.2 51.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.746 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.82 ' N ' HD23 ' A' ' 578' ' ' LEU . 33.8 m -124.17 120.9 33.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 625' ' ' ILE . 9.0 mt -103.4 108.8 20.19 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 579' ' ' THR . 1.8 mttp -113.03 102.76 55.25 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.885 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 12.2 Cg_endo -64.34 110.94 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.655 1.57 . . . . 0.0 109.515 176.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.72 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -75.36 157.36 84.8 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.462 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 51.4 Cg_exo -53.02 -30.41 48.93 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.906 3.071 . . . . 0.0 112.702 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.52 -22.23 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.199 0.523 . . . . 0.0 109.778 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.54 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -95.38 153.54 17.64 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.945 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -46.81 -26.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-O 121.292 0.568 . . . . 0.0 109.68 178.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.542 HD13 HG23 ' A' ' 587' ' ' ILE . 18.8 mm -97.92 149.82 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.327 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -148.91 49.22 0.99 Allowed 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.643 1.211 . . . . 0.0 108.137 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.885 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.4 mm-40 -125.06 176.16 6.87 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 112.676 -2.057 . . . . 0.0 109.035 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -131.29 123.46 28.4 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.736 0.303 . . . . 0.0 111.082 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.5 mm? -112.68 148.65 34.23 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 20.1 mt-10 -125.17 124.46 41.82 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.964 HD12 HD22 ' A' ' 578' ' ' LEU . 17.4 mt -88.37 121.25 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.841 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.3 mp0 -78.72 141.14 38.12 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.437 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.666 ' HB2' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.94 -29.07 3.06 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.58 -24.94 52.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.404 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.841 HG23 ' HB2' ' A' ' 595' ' ' GLN . 60.1 t -84.06 112.81 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 118.272 1.036 . . . . 0.0 111.131 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.42 122.4 5.19 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.196 178.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.7 Cg_endo -91.25 160.46 28.58 Favored 'Cis proline' 0 N--CA 1.451 -0.992 0 C-N-CA 124.515 -1.035 . . . . 0.0 110.12 -1.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.551 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.1 t80 -88.9 117.13 27.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.701 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 76.4 m-85 -89.43 137.47 32.29 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.409 -176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.008 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -133.4 136.38 54.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.763 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 169.92 -179.28 42.35 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.693 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -57.52 -42.48 82.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.719 0.295 . . . . 0.0 111.609 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.2 OUTLIER -76.42 119.11 19.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 110.792 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.47 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -47.62 -21.91 0.42 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.337 179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -44.5 -30.43 0.88 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.8 m -72.34 120.54 18.1 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.802 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -36.89 -34.71 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.267 0.556 . . . . 0.0 110.969 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.008 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.9 t -99.12 143.95 28.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.846 ' C ' HD13 ' A' ' 613' ' ' ILE . 0.4 OUTLIER -112.62 119.28 37.6 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 1.008 HD12 ' CZ ' ' A' ' 692' ' ' PHE . 0.5 OUTLIER -137.48 110.76 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.63 179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -97.57 99.02 10.41 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 122.225 1.012 . . . . 0.0 109.794 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.901 ' OD2' HG21 ' A' ' 681' ' ' ILE . 2.6 t70 -133.3 108.41 8.72 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.287 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -35.94 -40.74 0.21 Allowed 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 5.5 mmp_? -77.75 -30.15 51.4 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.824 HD13 ' CG ' ' A' ' 615' ' ' ASP . 5.7 mp -58.5 158.55 7.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.582 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.78 172.53 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.466 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -51.0 -66.93 0.3 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.334 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 730' ' ' LEU . 42.4 t -97.68 54.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.981 0.896 . . . . 0.0 108.99 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 77.2 t60 -43.06 -44.09 4.65 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.9 -1.5 . . . . 0.0 112.723 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.6 p -177.76 151.81 0.74 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.9 p90 -143.68 152.69 41.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.163 0.506 . . . . 0.0 110.971 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.722 ' CD1' HD11 ' A' ' 580' ' ' LEU . 97.0 mt -102.01 119.94 50.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 8.1 t80 -109.27 152.91 24.59 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.012 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 647' ' ' ILE . 15.7 ttmt -116.83 131.71 56.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.139 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.3 OUTLIER -137.65 157.34 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.922 -179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 4.7 tpt180 -77.52 116.54 18.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.265 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -61.3 134.26 56.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.27 116.51 29.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.545 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 633' ' ' GLY . 8.1 p -107.87 161.24 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.983 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -82.25 148.55 26.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.447 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.94 91.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.16 115.74 28.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.132 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.99 29.44 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.104 0.478 . . . . 0.0 110.25 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.09 -159.81 1.04 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.885 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.77 99.78 7.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.593 0.711 . . . . 0.0 109.732 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 17.4 p -138.7 156.58 72.9 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.461 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 57.5 Cg_endo -67.67 -153.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.414 2.076 . . . . 0.0 111.394 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 71.91 -68.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.822 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.433 ' HB2' HD11 ' A' ' 644' ' ' LEU . 7.1 mm-40 43.99 -164.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.964 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.612 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -123.31 119.46 3.86 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.647 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.693 HD13 ' HA ' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -150.24 -162.04 1.47 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.77 -0.715 . . . . 0.0 109.97 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.537 ' O ' ' HA ' ' A' ' 702' ' ' LEU . 0.2 OUTLIER -95.35 142.98 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.34 0.59 . . . . 0.0 111.717 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 627' ' ' LYS . 3.7 t0 -126.06 155.28 41.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.631 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.023 HD13 HD12 ' A' ' 578' ' ' LEU . 3.0 pt -111.67 113.02 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.53 0.681 . . . . 0.0 111.732 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 1.002 ' CH2' HD22 ' A' ' 671' ' ' LEU . 72.3 m95 -100.34 136.88 39.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.295 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.669 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.5 t80 -89.84 117.2 28.5 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -108.59 105.54 15.21 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -177.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.418 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 31.7 t60 -79.31 125.84 30.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.442 178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -121.58 3.22 10.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.834 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -94.49 150.95 19.96 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.581 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 31.0 m -77.73 -22.29 50.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.045 0.45 . . . . 0.0 110.775 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.552 ' O ' ' O ' ' A' ' 656' ' ' VAL . 0.7 OUTLIER -72.52 2.91 5.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.47 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.552 ' O ' ' O ' ' A' ' 655' ' ' ASN . 2.1 p 47.83 153.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.592 0.71 . . . . 0.0 112.725 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 656' ' ' VAL . 60.8 p -126.35 165.44 19.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.16 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -129.54 120.7 25.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.309 . . . . 0.0 111.432 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.859 ' HG ' HG22 ' A' ' 678' ' ' ILE . 2.0 tt -118.54 116.22 26.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.998 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.19 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -151.21 14.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.685 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 670' ' ' PHE . 8.2 m-80 -114.16 135.45 54.03 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.905 ' O ' HG21 ' A' ' 716' ' ' VAL . 37.2 ttt-85 -90.92 137.89 32.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.06 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.447 ' HA ' HG11 ' A' ' 716' ' ' VAL . 1.2 mtp -127.71 118.81 24.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.967 0.413 . . . . 0.0 111.64 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 25.1 pt -87.77 148.08 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.389 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -47.56 109.56 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.448 . . . . 0.0 111.0 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.49 21.25 4.42 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 19.5 p -120.97 162.22 20.26 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.433 0.635 . . . . 0.0 111.18 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpt -123.44 149.84 44.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.943 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.5 OUTLIER -147.18 141.81 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.883 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 1.002 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.1 OUTLIER -77.69 130.69 37.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.95 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 649' ' ' TYR . 4.4 mt -107.05 144.91 33.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.34 0.591 . . . . 0.0 112.26 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -130.27 130.79 45.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.285 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.655 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.0 p30 -39.74 120.47 1.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.075 0.464 . . . . 0.0 111.276 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 98.06 36.16 4.8 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.671 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -109.33 120.99 44.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 111.496 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 16.2 tt0 -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.859 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -105.36 125.65 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 112.112 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 116.05 22.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.767 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.682 HG23 HD11 ' A' ' 618' ' ' LEU . 0.1 OUTLIER -79.83 -39.93 20.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.729 -179.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.901 HG21 ' OD2' ' A' ' 615' ' ' ASP . 4.2 tt -155.57 131.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.3 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.698 ' CD1' HG12 ' A' ' 689' ' ' VAL . 12.0 t90 -136.04 121.47 19.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.173 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.1 116.91 21.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.42 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 685' ' ' ASN . 0.5 OUTLIER -67.13 -41.68 85.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.71 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . 0.517 ' N ' ' HG2' ' A' ' 684' ' ' LYS . 39.4 m-20 -83.33 -40.36 19.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.491 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.09 -7.24 55.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.269 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.9 tptp 54.28 25.28 5.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 110.876 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.57 ' CD1' HD13 ' A' ' 587' ' ' ILE . 1.1 t80 -104.51 105.56 15.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.794 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.698 HG12 ' CD1' ' A' ' 682' ' ' TRP . 5.3 m -124.21 133.68 68.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.7 mt -125.7 156.35 35.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.395 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -176.09 142.2 5.92 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.832 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 1.008 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 4.0 m-85 -129.4 141.5 51.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 110.669 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -104.58 116.66 32.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.889 0.376 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.78 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -78.52 119.99 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.489 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 111.49 18.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.47 HD12 ' HB3' ' A' ' 674' ' ' ASP . 27.0 mt -93.61 105.41 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -86.74 -44.98 11.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.564 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -110.37 141.01 44.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.009 179.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.6 p -113.11 96.16 5.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.658 0.742 . . . . 0.0 109.02 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 596' ' ' GLN . 4.2 t -80.24 63.6 4.78 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.5 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 74.51 53.49 6.62 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.714 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 645' ' ' ASP . 0.9 OUTLIER -81.06 137.52 36.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.693 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.8 p90 -45.1 -32.91 1.94 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.489 0.661 . . . . 0.0 110.328 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 0.2 OUTLIER -141.75 -44.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.59 -179.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.549 ' CB ' ' O ' ' A' ' 704' ' ' ASN . 17.1 pt-20 137.31 -22.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.302 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.655 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 100.71 20.75 13.8 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.414 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.554 HD22 ' OD2' ' A' ' 674' ' ' ASP . 0.1 OUTLIER -82.83 8.02 13.55 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 41.14 97.75 0.01 OUTLIER Glycine 0 CA--C 1.519 0.321 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.206 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.448 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -41.83 97.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.739 0.304 . . . . 0.0 111.642 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.5 OUTLIER 35.95 82.84 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.163 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 40.77 88.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.971 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.64 141.31 36.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.49 . . . . 0.0 111.7 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -113.4 99.61 7.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.443 ' HB2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -73.33 -151.45 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.15 -178.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.92 142.36 17.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.391 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.905 HG21 ' O ' ' A' ' 663' ' ' ARG . 76.9 t -77.66 113.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.079 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.13 169.82 9.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -98.17 145.52 26.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 723' ' ' GLU . 6.7 pt20 -84.81 160.14 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.7 p -118.53 -173.84 2.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.207 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.85 30.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -59.1 -50.68 73.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.455 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 719' ' ' GLN . 17.5 mm-40 -67.45 -44.9 77.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.73 69.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -36.74 81.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.424 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -62.08 -44.49 96.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.883 HG23 HG11 ' A' ' 621' ' ' VAL . 5.9 p -72.84 -8.04 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.475 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -90.34 42.84 1.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.319 . . . . 0.0 111.223 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.07 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.536 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 621' ' ' VAL . 4.9 mt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.32 -0.847 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.873 0.368 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.32 165.27 22.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.839 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . 0.619 HD12 ' CB ' ' P' ' 830' ' ' TYR . 10.9 pt -96.05 176.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . 0.619 ' CB ' HD12 ' P' ' 828' ' ' ILE . 4.0 t80 -92.78 133.31 36.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.959 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 7.2 mt -96.12 122.49 39.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.767 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -83.46 -22.56 32.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.82 50.75 0.85 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.642 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 593' ' ' GLU . 27.3 ttp180 -85.28 107.23 17.21 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.128 0.49 . . . . 0.0 109.77 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.583 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -100.43 -48.0 4.71 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.563 -179.353 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.062 HD12 HD13 ' A' ' 647' ' ' ILE . 7.6 tt -113.17 142.4 45.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.053 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.805 ' N ' HD23 ' A' ' 578' ' ' LEU . 29.1 m -120.54 115.97 24.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.447 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.814 HD11 HD12 ' A' ' 625' ' ' ILE . 10.9 mt -102.74 109.58 21.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.726 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -114.58 101.98 54.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.962 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.6 Cg_endo -55.94 122.03 11.04 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.429 1.419 . . . . 0.0 109.42 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -83.46 155.91 65.85 Favored Pre-proline 0 N--CA 1.47 0.548 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -176.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.444 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 31.9 Cg_exo -56.9 -28.76 79.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.522 2.815 . . . . 0.0 112.814 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.78 -25.62 68.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 67.8 p -95.9 154.16 17.38 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.098 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 690' ' ' ILE . 32.4 pt -45.98 -25.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 613' ' ' ILE . 15.7 mt -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.22 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.531 178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.459 ' HG2' ' C ' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -155.61 58.96 0.62 Allowed 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.962 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.1 OUTLIER -126.53 176.32 7.26 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 112.795 -2.002 . . . . 0.0 109.516 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 592' ' ' LEU . 0.0 OUTLIER -131.91 116.38 17.09 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 123.437 0.461 . . . . 0.0 110.906 177.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.88 HD12 ' SG ' ' A' ' 611' ' ' CYS . 1.5 mt -113.56 143.53 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.416 ' HG2' ' CD ' ' A' ' 576' ' ' ARG . 0.1 OUTLIER -124.17 126.4 46.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.044 HD12 HD22 ' A' ' 578' ' ' LEU . 8.0 mt -84.47 119.26 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.488 ' N ' HG12 ' A' ' 598' ' ' VAL . 4.6 mt-30 -74.71 140.63 44.29 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.771 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -47.72 -29.85 3.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -82.67 -23.97 54.64 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.612 -1.176 . . . . 0.0 113.646 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 598' ' ' VAL . 3.4 p -84.18 113.78 23.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-N 118.681 1.24 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.8 123.19 5.21 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.537 179.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 42.2 Cg_endo -92.11 160.47 25.54 Favored 'Cis proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.647 -0.981 . . . . 0.0 110.2 -1.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.541 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 6.0 t80 -89.52 115.69 27.12 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 84.5 m-85 -89.86 137.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 611' ' ' CYS . 1.7 mt -133.28 135.77 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.74 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 167.49 176.33 38.14 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.803 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.32 -46.52 62.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.481 -179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -70.73 118.76 13.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.568 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.468 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -50.58 -20.36 1.16 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -46.07 -29.74 1.61 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 2.3 m -71.91 117.98 14.2 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.72 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.541 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -35.99 -36.51 0.09 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.376 0.608 . . . . 0.0 110.753 -179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.036 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.5 t -98.54 143.57 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.899 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -114.11 123.37 49.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -178.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 612' ' ' LYS . 3.1 mm -138.48 110.44 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.499 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.64 99.09 10.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.193 0.997 . . . . 0.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.871 ' HB3' HD13 ' A' ' 618' ' ' LEU . 5.3 t70 -133.33 108.61 8.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.402 -1.726 . . . . 0.0 109.312 178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -36.74 -35.57 0.09 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.679 0.276 . . . . 0.0 111.645 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.0 mmp_? -78.09 -32.83 50.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.791 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.871 HD13 ' HB3' ' A' ' 615' ' ' ASP . 5.1 mp -58.26 158.79 6.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.561 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.26 176.6 4.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.578 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.19 -67.69 0.25 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.951 ' CG2' HD11 ' A' ' 730' ' ' LEU . 26.0 t -95.93 53.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.919 0.866 . . . . 0.0 109.042 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.663 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 73.3 t60 -41.52 -43.92 2.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.996 -1.456 . . . . 0.0 112.525 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' A' ' 680' ' ' ILE . 1.6 p -178.44 151.25 0.59 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.672 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 43.4 p90 -143.53 149.95 38.2 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.29 0.567 . . . . 0.0 111.104 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.814 HD12 HD11 ' A' ' 580' ' ' LEU . 87.2 mt -101.68 119.2 49.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 3.8 t80 -109.02 152.39 25.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.786 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 14.5 ttmt -114.1 134.45 54.87 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.873 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.71 157.57 46.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.144 -179.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.8 tpt180 -77.94 123.88 27.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.167 0.508 . . . . 0.0 110.35 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 644' ' ' LEU . 1.6 t60 -61.07 140.54 57.84 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.42 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.449 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -56.0 -162.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.334 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.4 OUTLIER 65.13 179.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.639 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.64 ' N ' HG13 ' A' ' 632' ' ' VAL . . . 140.22 163.68 9.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.406 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp 56.67 83.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.369 . . . . 0.0 110.814 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 2.2 p -119.44 133.08 55.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.8 tpt -97.24 27.27 4.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.596 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -145.0 -159.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.617 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -114.44 98.99 7.23 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.417 0.627 . . . . 0.0 109.898 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 36.8 p -139.47 156.54 71.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.504 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 72.1 Cg_endo -72.82 -156.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.384 2.056 . . . . 0.0 111.482 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 67.65 -67.76 0.17 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 34.4 36.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 57.77 114.37 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.726 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 701' ' ' GLY . 91.7 mt -155.31 -166.07 2.17 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.287 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.848 ' O ' HD23 ' A' ' 702' ' ' LEU . 4.1 m-20 -104.55 145.82 29.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.209 0.528 . . . . 0.0 112.065 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 4.8 t0 -129.34 143.86 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.555 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.062 HD13 HD12 ' A' ' 578' ' ' LEU . 1.2 pt -101.45 113.56 38.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.49 0.662 . . . . 0.0 112.114 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.932 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 68.5 m95 -100.27 134.15 43.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.373 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.62 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.0 t80 -89.98 117.04 28.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.443 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.3 105.7 14.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 657' ' ' SER . 67.1 t60 -76.57 130.36 37.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.48 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -127.19 3.71 6.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.896 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -92.65 152.05 20.89 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.697 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 66.9 m -77.73 -22.72 49.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 110.97 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.525 ' O ' ' O ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -71.49 3.13 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.508 -179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.525 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.1 OUTLIER 46.61 124.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.491 0.717 . . . . 0.0 112.925 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.443 ' N ' ' CE1' ' A' ' 651' ' ' HIS . 78.8 p -97.3 165.28 12.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.341 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.4 ' N ' ' CD1' ' A' ' 658' ' ' TYR . 5.3 m-85 -131.83 120.5 22.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.054 HD13 HG22 ' A' ' 678' ' ' ILE . 0.3 OUTLIER -102.2 100.08 10.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.124 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' N ' HD12 ' A' ' 659' ' ' LEU . 0.5 OUTLIER 63.13 -78.26 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -143.38 14.33 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.362 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.04 134.32 54.57 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.865 0.365 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.589 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -91.78 139.6 30.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.449 ' O ' HG12 ' A' ' 656' ' ' VAL . 0.0 OUTLIER -134.52 121.35 20.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.973 -179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 41.1 pt -87.78 147.87 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.325 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -47.77 104.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.205 0.526 . . . . 0.0 110.597 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.12 23.86 2.36 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 6.2 p -120.65 162.23 20.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.437 0.637 . . . . 0.0 111.2 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.461 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.7 ttpt -123.74 147.84 47.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.372 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.733 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -147.41 144.22 28.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.932 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -71.78 135.05 46.55 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.966 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.4 mt -114.76 115.21 26.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.065 0.46 . . . . 0.0 111.279 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 14.5 mt-30 -101.93 134.86 44.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 706' ' ' GLY . 4.6 p-10 -37.17 124.56 0.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 111.453 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.631 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.07 120.8 41.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.059 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.701 ' OE2' HD11 ' A' ' 583' ' ' LEU . 0.0 OUTLIER -96.45 109.93 22.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.054 HG22 HD13 ' A' ' 659' ' ' LEU . 18.8 pt -105.28 129.13 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.917 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 657' ' ' SER . 12.8 mtpt -87.41 115.43 24.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.543 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' A' ' 623' ' ' CYS . 0.4 OUTLIER -75.99 -41.22 38.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.558 HD11 HD21 ' P' ' 831' ' ' LEU . 6.6 tt -155.65 131.31 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.535 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.873 ' CD1' HG12 ' A' ' 689' ' ' VAL . 13.0 t90 -136.66 115.65 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.431 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.489 ' CB ' ' CE1' ' A' ' 688' ' ' PHE . 15.4 t0 -127.72 116.2 19.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.945 0.402 . . . . 0.0 110.596 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -30.52 69.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.565 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -58.64 -40.61 83.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.856 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.27 -8.34 18.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.492 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.3 13.54 9.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.385 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.489 ' CE1' ' CB ' ' A' ' 683' ' ' ASP . 7.9 p90 -90.09 111.1 22.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.076 0.465 . . . . 0.0 110.164 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.873 HG12 ' CD1' ' A' ' 682' ' ' TRP . 16.2 m -118.37 137.99 50.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.963 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 1.037 HD11 HD11 ' A' ' 587' ' ' ILE . 9.9 mt -126.2 135.89 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -157.52 135.26 4.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.446 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 613' ' ' ILE . 3.6 m-85 -114.56 141.73 47.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.673 0.273 . . . . 0.0 110.661 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.81 117.05 34.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.355 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 578' ' ' LEU . 2.4 t -80.0 124.43 38.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.481 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.01 111.2 11.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.52 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 705' ' ' GLU . 39.5 mt -84.01 105.45 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.182 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -77.09 -47.26 20.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -111.03 143.84 41.1 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.851 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 73.0 p -113.86 96.33 5.78 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.839 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 700' ' ' THR . 8.2 t -76.6 60.59 1.67 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.721 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.832 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 57.08 58.87 12.32 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.769 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 645' ' ' ASP . 0.3 OUTLIER -87.23 136.94 32.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.632 ' HA ' HD12 ' A' ' 644' ' ' LEU . 4.4 p90 -28.34 -42.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.412 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.6 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.6 OUTLIER -133.29 -47.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.518 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 17.0 pt-20 133.14 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.349 1.031 . . . . 0.0 109.359 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.36 10.74 4.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.111 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 9.73 8.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 117.19 -135.55 11.98 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 1.9 ttm 179.06 -140.69 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.387 -0.407 . . . . 0.0 109.999 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -163.46 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -44.61 -93.26 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.605 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -115.02 99.47 7.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.716 0.293 . . . . 0.0 111.569 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 714' ' ' ARG . 43.8 tp60 -117.16 96.93 5.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 713' ' ' GLN . 6.0 mmm-85 -162.93 69.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.71 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.427 ' N ' ' HE1' ' A' ' 670' ' ' PHE . 3.8 m -123.69 141.25 44.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 663' ' ' ARG . 78.8 t -82.64 130.11 36.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.04 172.06 7.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -95.48 139.94 31.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.893 0.377 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.97 153.41 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.666 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.44 -177.68 3.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.83 -29.1 39.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.981 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -60.52 -51.37 69.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 15.3 mp0 -67.14 -45.65 76.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.7 mttt -58.28 -33.56 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.083 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.49 -36.52 79.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.448 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 2.0 mt -58.87 -44.46 91.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.224 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.844 ' CG2' HG11 ' A' ' 621' ' ' VAL . 3.7 p -69.45 -26.51 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.956 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -62.3 -21.05 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.842 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -56.87 16.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.03 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.951 HD11 ' CG2' ' A' ' 621' ' ' VAL . 3.4 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.831 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -68.42 74.38 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 1.4 pt -107.27 98.58 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -165.89 132.97 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.558 HD21 HD11 ' A' ' 681' ' ' ILE . 63.7 mt -103.3 156.79 17.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -70.47 -19.39 62.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.656 0.265 . . . . 0.0 111.22 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 123.67 11.48 4.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.797 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.454 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 1.2 ttm180 -104.98 125.78 51.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.339 0.59 . . . . 0.0 110.707 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -114.5 -46.2 2.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.183 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.987 HD12 HD13 ' A' ' 647' ' ' ILE . 7.2 tt -121.04 142.47 49.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.132 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.799 ' N ' HD23 ' A' ' 578' ' ' LEU . 21.0 m -125.42 113.85 18.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.942 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.74 ' CD1' HD11 ' A' ' 594' ' ' ILE . 0.4 OUTLIER -99.5 108.79 21.32 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.619 ' O ' HD13 ' A' ' 583' ' ' LEU . 1.2 mtpt -109.27 100.94 43.4 Favored Pre-proline 0 C--N 1.318 -0.777 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.954 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.5 Cg_endo -59.05 108.01 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.598 1.532 . . . . 0.0 109.496 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.627 HD22 ' H ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.11 159.8 56.17 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 72.6 Cg_exo -50.25 -27.83 18.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.452 3.435 . . . . 0.0 113.52 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -28.34 69.74 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.661 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 0.1 OUTLIER -96.59 153.62 17.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.204 178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.717 HG22 HG12 ' A' ' 690' ' ' ILE . 0.1 OUTLIER -52.15 -21.16 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.069 0.461 . . . . 0.0 110.436 178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.674 ' CD1' HG23 ' A' ' 613' ' ' ILE . 12.8 mm -93.15 151.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.625 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.661 ' NE2' ' O ' ' A' ' 586' ' ' SER . 19.4 mp0 -150.94 53.16 0.86 Allowed 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.6 1.191 . . . . 0.0 108.745 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.954 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 0.9 OUTLIER -125.23 177.4 6.14 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 112.802 -1.999 . . . . 0.0 108.764 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.32 124.56 34.63 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.303 0.573 . . . . 0.0 110.253 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.79 HD13 ' SG ' ' A' ' 611' ' ' CYS . 0.0 OUTLIER -112.13 135.97 52.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.722 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.454 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 3.9 mt-10 -124.4 114.04 18.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.727 -0.389 . . . . 0.0 112.04 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 580' ' ' LEU . 43.9 mt -81.71 119.65 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.785 ' HB2' HG23 ' A' ' 598' ' ' VAL . 1.4 mp0 -73.85 137.22 43.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.898 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -46.73 -28.59 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.515 178.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -86.8 -21.54 50.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.556 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 595' ' ' GLN . 76.8 t -79.95 114.26 20.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.334 1.067 . . . . 0.0 110.939 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 9.2 t30 -146.86 121.44 5.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.744 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 43.6 Cg_endo -91.89 161.3 26.69 Favored 'Cis proline' 0 N--CA 1.451 -0.986 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.037 -2.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.529 ' CG ' HG12 ' A' ' 594' ' ' ILE . 7.3 t80 -88.15 115.74 25.85 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.661 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 66.0 m-85 -89.14 137.98 31.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.027 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -132.96 136.86 54.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.08 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 165.93 172.91 33.85 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.306 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -51.76 -40.35 60.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 110.909 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 620' ' ' ARG . 18.6 p -70.6 118.75 13.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -54.7 -18.06 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.718 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.81 -28.53 3.76 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.8 m -73.36 122.59 22.29 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.894 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -38.88 -33.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.258 0.552 . . . . 0.0 110.816 -179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 41.3 t -95.37 142.73 27.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.773 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -122.36 113.99 20.14 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.674 HG23 ' CD1' ' A' ' 588' ' ' ILE . 3.7 mp -140.18 120.46 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.653 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.94 99.99 12.23 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 122.278 1.037 . . . . 0.0 109.66 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.847 ' CB ' HD13 ' A' ' 618' ' ' LEU . 0.2 OUTLIER -131.32 107.58 9.06 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.451 -1.704 . . . . 0.0 109.726 178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -39.93 -37.25 0.55 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.922 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.427 ' NE ' ' HA ' ' A' ' 617' ' ' ARG . 6.1 mmp_? -77.57 -31.91 53.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -59.59 158.5 9.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.676 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 7.1 t -112.12 174.55 5.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.756 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 606' ' ' SER . 0.0 OUTLIER -55.16 -67.58 0.26 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.908 HG22 HD21 ' A' ' 730' ' ' LEU . 42.3 t -97.68 51.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.957 0.884 . . . . 0.0 109.057 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 68.8 t60 -41.35 -38.17 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 113.907 -1.497 . . . . 0.0 112.991 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.564 ' O ' ' N ' ' A' ' 603' ' ' ILE . 2.3 p 175.57 153.64 0.16 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.661 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 44.2 p90 -143.29 149.66 38.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.225 0.536 . . . . 0.0 110.897 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.71 ' CD1' HD11 ' A' ' 580' ' ' LEU . 69.3 mt -102.02 119.16 49.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 648' ' ' TRP . 9.1 t80 -109.71 152.46 25.6 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.507 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.431 ' NZ ' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER -118.69 137.17 53.51 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.702 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.21 158.12 45.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.856 -178.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.6 tpt85 -77.38 119.74 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.396 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 13.5 t60 -61.19 136.33 58.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.723 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.452 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -50.58 -176.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.762 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.4 OUTLIER 57.77 -179.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.511 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.632 ' N ' HG13 ' A' ' 632' ' ' VAL . . . 119.65 32.37 1.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.582 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -131.53 60.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.73 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 20.1 p -102.47 141.59 35.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.086 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.44 31.83 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.483 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.93 -153.48 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.401 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -114.4 99.72 7.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.511 0.672 . . . . 0.0 109.891 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.7 p -138.72 156.63 72.86 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.512 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 642' ' ' GLN . 74.0 Cg_endo -71.55 -156.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.562 2.174 . . . . 0.0 111.74 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 65.04 -71.87 0.07 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.771 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 640' ' ' PRO . 0.2 OUTLIER 41.12 -164.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -112.51 118.26 4.59 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.083 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.728 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.1 mp -143.88 -154.97 0.56 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.766 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.833 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -118.42 147.47 43.53 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.5 OUTLIER -127.29 160.2 32.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.339 178.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.987 HD13 HD12 ' A' ' 578' ' ' LEU . 1.3 pt -116.51 114.77 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.521 0.677 . . . . 0.0 112.068 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.67 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 82.7 m95 -101.82 131.96 47.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.375 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.576 ' HB2' HD11 ' A' ' 672' ' ' LEU . 10.4 t80 -89.36 117.18 28.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.445 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.5 OUTLIER -109.93 105.78 15.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.44 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 42.2 t60 -76.63 128.65 35.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.003 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.511 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -123.34 0.77 8.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.622 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -87.12 150.3 22.74 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.538 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 47.5 m -76.57 -24.72 53.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.856 0.36 . . . . 0.0 111.306 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 656' ' ' VAL . 9.9 m-20 -74.73 4.15 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 655' ' ' ASN . 1.4 p 48.2 145.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.636 0.731 . . . . 0.0 112.681 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 651' ' ' HIS . 14.3 m -113.83 165.72 12.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 679' ' ' LYS . 19.0 m-85 -128.06 120.79 28.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 111.192 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.931 HD22 ' NH2' ' A' ' 714' ' ' ARG . 0.2 OUTLIER -114.09 118.26 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.194 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.25 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.3 m-80 -143.28 12.24 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.489 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.418 ' ND2' HG23 ' A' ' 716' ' ' VAL . 0.1 OUTLIER -113.9 141.16 47.7 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.048 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.928 ' O ' HG21 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -93.34 140.43 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.388 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.538 ' O ' HG23 ' A' ' 656' ' ' VAL . 1.8 mtp -127.2 114.56 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 111.302 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.47 147.43 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -45.44 105.7 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 110.742 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.51 21.64 3.27 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 18.0 p -118.68 159.74 23.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.529 0.68 . . . . 0.0 111.256 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 4.8 ttpm? -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.451 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 649' ' ' TYR . 0.4 OUTLIER -147.13 130.85 16.95 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.67 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.6 OUTLIER -68.53 141.99 55.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.026 0.441 . . . . 0.0 111.154 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.831 ' CD2' HD11 ' A' ' 659' ' ' LEU . 12.3 mt -110.65 115.16 29.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.627 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.469 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 7.6 mt-30 -86.87 149.71 24.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.411 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.511 ' OD1' HD22 ' A' ' 707' ' ' LEU . 5.7 p-10 -47.8 124.08 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 76.49 42.72 21.61 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.399 -0.905 . . . . 0.0 110.857 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -94.05 120.12 33.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.447 -0.377 . . . . 0.0 111.396 -179.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.1 OUTLIER -96.61 108.78 21.44 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.901 HG22 HD21 ' A' ' 659' ' ' LEU . 2.6 pt -104.33 120.88 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.59 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 658' ' ' TYR . 0.1 OUTLIER -77.94 115.97 18.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.748 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 692' ' ' PHE . 2.0 mm -73.13 -40.22 57.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.923 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . . . . . . . . . 17.3 tt -155.3 133.38 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.325 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.444 ' HA ' ' O ' ' A' ' 688' ' ' PHE . 10.8 t90 -135.2 118.1 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 111.093 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -127.09 117.2 21.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.099 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -66.49 -46.29 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.702 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -73.62 -40.2 63.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.344 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -7.94 57.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.518 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt 55.38 24.11 6.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 587' ' ' ILE . 0.1 OUTLIER -84.06 104.99 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 0.7 OUTLIER -126.54 123.8 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.083 0.468 . . . . 0.0 111.884 -178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 587' ' ' ILE . 19.9 mt -128.21 157.03 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.313 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.52 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 172.07 133.89 1.71 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.065 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.581 ' CE2' HD11 ' A' ' 680' ' ' ILE . 0.2 OUTLIER -116.95 153.38 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -101.41 117.67 35.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.825 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.7 HG22 HD21 ' A' ' 578' ' ' LEU . 2.1 t -76.18 114.71 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.754 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -121.77 111.62 17.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.308 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 705' ' ' GLU . 10.6 mt -90.09 110.67 22.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -88.9 -45.3 9.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 2.2 m-20 -110.87 141.42 44.28 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.067 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 10.2 p -113.12 96.47 5.94 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.622 0.725 . . . . 0.0 109.055 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 700' ' ' THR . 5.1 t -68.91 69.39 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.777 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 644' ' ' LEU . . . 58.74 47.73 88.76 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.951 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -91.24 139.58 30.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.0 111.225 -179.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.728 ' HA ' HD13 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -49.06 -29.44 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.395 0.617 . . . . 0.0 110.103 178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 705' ' ' GLU . 3.6 t30 -150.96 -58.29 0.17 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.906 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 696' ' ' ILE . 5.8 pt-20 159.59 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.447 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.36 -10.9 2.0 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.661 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 707' ' ' LEU . 0.1 OUTLIER -87.94 9.34 22.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 703' ' ' PHE . . . 65.78 -167.08 34.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.757 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.77 30.85 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.809 0.338 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.698 HD12 ' N ' ' A' ' 711' ' ' GLN . 3.4 pp -127.89 -169.7 2.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.698 ' N ' HD12 ' A' ' 710' ' ' LEU . 1.1 mp0 -63.96 -99.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.046 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.8 102.58 10.14 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.684 ' CD ' HD21 ' A' ' 710' ' ' LEU . 38.6 tt0 -116.55 97.51 6.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.173 0.511 . . . . 0.0 109.91 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.931 ' NH2' HD22 ' A' ' 659' ' ' LEU . 16.0 mmm-85 -157.07 77.02 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.036 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.42 142.04 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.391 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.928 HG21 ' O ' ' A' ' 663' ' ' ARG . 89.1 t -78.0 124.56 36.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.071 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.26 172.57 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.85 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -102.71 151.85 21.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.05 160.18 14.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 18.6 p -123.63 -175.16 3.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.3 35.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -59.27 -51.57 69.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.38 -45.1 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.605 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -58.9 -32.92 69.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.021 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -36.63 81.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.425 ' CB ' ' HG3' ' A' ' 600' ' ' PRO . 3.0 mt -59.67 -45.03 93.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.734 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.85 ' CG2' HG11 ' A' ' 621' ' ' VAL . 5.4 p -72.38 -27.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.62 -29.45 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.177 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -114.3 -24.38 8.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.908 HD21 HG22 ' A' ' 621' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -133.93 91.69 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 2.4 pt -86.54 169.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -61.9 157.49 18.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . . . . . . . . . 15.5 mt -124.76 119.6 29.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.918 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.016 -0.434 . . . . 4.5199999999999996 112.016 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -69.48 -19.41 63.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.284 . . . . 3.7599999999999998 111.277 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -144.42 -17.09 0.21 Allowed Glycine 0 C--O 1.225 -0.42 0 C-N-CA 120.454 -0.879 . . . . 0.66000000000000003 113.64 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 593' ' ' GLU . 30.8 ttp180 -92.98 130.29 38.61 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 117.447 0.624 . . . . 1.6699999999999999 110.677 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.65 ' CZ ' HG21 ' A' ' 647' ' ' ILE . 0.0 OUTLIER -121.69 -46.9 2.22 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.92000000000000004 110.052 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.952 HD12 HD13 ' A' ' 647' ' ' ILE . 7.9 tt -114.81 143.07 45.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.56 -1.2 . . . . 0.93000000000000005 110.748 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 578' ' ' LEU . 24.5 m -118.67 117.28 28.5 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.246 0.461 . . . . 0.40000000000000002 112.246 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.754 ' CD2' HG23 ' A' ' 694' ' ' VAL . 11.0 mt -105.64 109.28 21.19 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.591 -1.633 . . . . 0.83999999999999997 106.591 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.732 ' O ' HD23 ' A' ' 583' ' ' LEU . 11.2 ptpt -113.98 103.11 55.28 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 114.887 1.44 . . . . 1.6699999999999999 114.887 -175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.941 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 1.2 Cg_endo -56.77 122.15 11.3 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.601 1.534 . . . . 0.29999999999999999 109.633 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.743 HD23 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -85.6 156.84 58.77 Favored Pre-proline 0 N--CA 1.47 0.555 0 N-CA-C 113.843 1.053 . . . . 1.1699999999999999 113.843 -177.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.452 ' HA ' ' CD ' ' A' ' 589' ' ' GLN . 48.5 Cg_exo -54.91 -29.8 65.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.596 2.864 . . . . 0.62 113.032 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.2 -23.72 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.001 0.429 . . . . 1.6699999999999999 110.32 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 97.4 p -95.71 153.71 17.59 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.845 -0.616 . . . . 1.0700000000000001 110.692 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.691 HD11 HD11 ' A' ' 690' ' ' ILE . 10.7 pt -48.15 -24.19 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.325 0.583 . . . . 1.9199999999999999 109.713 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.597 ' CD1' HG23 ' A' ' 613' ' ' ILE . 14.3 mt -100.18 150.57 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.266 -0.879 . . . . 1.3899999999999999 109.198 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.452 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -153.84 59.98 0.73 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 107.379 -1.341 . . . . 1.49 107.379 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.941 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 28.8 mt-10 -126.51 176.08 7.44 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.798 -2.001 . . . . 2.1099999999999999 109.403 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -131.84 115.92 16.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.131 -0.486 . . . . 0.54000000000000004 110.809 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.792 HD12 ' SG ' ' A' ' 611' ' ' CYS . 3.2 mt -114.12 141.77 47.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 1.98 109.292 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 579' ' ' THR . 1.1 mp0 -124.46 124.9 43.31 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.441 -0.504 . . . . 1.5 112.203 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.721 HD12 HD22 ' A' ' 578' ' ' LEU . 54.4 mt -72.75 136.01 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.377 -0.972 . . . . 0.32000000000000001 108.377 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.1 mp0 -84.81 136.55 33.63 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.268 -0.573 . . . . 1.6599999999999999 110.914 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -48.65 -29.2 4.11 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.084 -0.71 . . . . 1.1100000000000001 109.084 178.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -87.83 -22.51 42.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 113.177 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 595' ' ' GLN . 56.6 t -85.47 113.08 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 CA-C-N 118.071 0.935 . . . . 0.81999999999999995 111.136 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.1 OUTLIER -147.33 122.54 5.26 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 114.773 -1.103 . . . . 1.8799999999999999 109.815 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 44.9 Cg_endo -90.51 160.78 32.03 Favored 'Cis proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.534 -1.027 . . . . 0.29999999999999999 110.412 -0.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.63 ' CD1' HG23 ' A' ' 594' ' ' ILE . 6.5 t80 -88.42 117.35 27.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.593 -1.262 . . . . 0.26000000000000001 107.593 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 624' ' ' PHE . 69.4 m-85 -89.27 137.34 32.41 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.519 0.676 . . . . 0.23999999999999999 111.218 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 1.014 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.3 mt -133.21 136.74 54.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.584 -1.189 . . . . 0.45000000000000001 111.775 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 622' ' ' HIS . . . 166.91 177.89 38.98 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.29999999999999999 112.673 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 0.0 OUTLIER -52.39 -47.44 66.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.659 0.266 . . . . 1.02 111.523 -179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 620' ' ' ARG . 0.1 OUTLIER -69.47 119.29 13.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.712 0.292 . . . . 1.3200000000000001 110.366 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -19.34 1.7 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.396 -0.365 . . . . 2.3700000000000001 110.888 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -46.85 -29.8 2.17 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.038 -0.727 . . . . 1.8799999999999999 109.038 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 1.7 m -70.61 121.05 17.16 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 109.696 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.5 OUTLIER -37.05 -34.89 0.09 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.334 0.588 . . . . 1.24 110.814 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 1.014 ' HB3' HG23 ' A' ' 603' ' ' ILE . 5.1 t -98.69 143.9 28.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.432 -0.951 . . . . 0.5 108.432 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.852 ' O ' HD13 ' A' ' 613' ' ' ILE . 0.0 OUTLIER -114.07 123.04 48.7 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.095 0.776 . . . . 2.0699999999999998 113.095 -178.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 612' ' ' LYS . 8.3 mm -138.24 110.62 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.171 -0.922 . . . . 1.1100000000000001 110.225 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -91.3 97.81 11.33 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.169 0.985 . . . . 2.75 108.37 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.97 ' CB ' HD13 ' A' ' 618' ' ' LEU . 1.8 m-20 -133.56 107.33 7.93 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 113.447 -1.706 . . . . 1.6100000000000001 109.631 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -41.93 -37.62 1.37 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.306 -0.406 . . . . 1.8899999999999999 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.437 ' HB3' ' ND2' ' A' ' 655' ' ' ASN . 6.2 mmp_? -78.24 -29.94 48.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.286 -0.415 . . . . 0.68000000000000005 112.001 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.97 HD13 ' CB ' ' A' ' 615' ' ' ASP . 5.7 mp -59.69 158.66 9.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.377 -0.374 . . . . 0.71999999999999997 111.646 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 25.5 m -110.48 176.24 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 110.579 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' A' ' 606' ' ' SER . 0.0 OUTLIER -54.81 -69.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.171 -0.307 . . . . 0.91000000000000003 110.171 179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.854 HG11 ' CG2' ' A' ' 727' ' ' VAL . 25.0 t -96.01 54.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.928 0.871 . . . . 0.26000000000000001 109.105 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 618' ' ' LEU . 70.3 t60 -42.12 -41.78 2.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.962 -1.472 . . . . 0.28000000000000003 112.85 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.539 ' O ' ' N ' ' A' ' 603' ' ' ILE . 1.8 p 179.71 152.96 0.45 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.388 -0.597 . . . . 0.23999999999999999 109.388 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.682 ' HB3' ' HA ' ' A' ' 602' ' ' PHE . 39.4 p90 -143.3 152.1 41.28 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.22 0.533 . . . . 0.29999999999999999 111.017 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 580' ' ' LEU . 83.2 mt -101.73 122.16 53.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.794 -1.188 . . . . 0.76000000000000001 107.794 177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 7.0 t80 -109.71 152.61 25.41 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.006 -0.543 . . . . 0.29999999999999999 109.752 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.455 ' NZ ' HG21 ' A' ' 700' ' ' THR . 21.3 ttmt -116.22 133.57 55.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.771 -0.65 . . . . 0.91000000000000003 110.731 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 2.5 tmtt? -136.35 157.83 45.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.948 -0.569 . . . . 1.8 111.897 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.1 tpt180 -78.12 113.01 15.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.075 -0.511 . . . . 2.29 110.269 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 644' ' ' LEU . 6.0 t60 -64.02 126.34 27.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.741 -0.663 . . . . 0.98999999999999999 111.302 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.87 31.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.1799999999999999 111.298 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.531 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.1 p -102.55 160.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.514 . . . . 2.3399999999999999 111.103 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -66.1 165.47 38.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 2.8599999999999999 112.422 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -58.51 130.22 45.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 4.7999999999999998 110.831 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.44 112.93 20.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 2.46 111.142 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 20.1 mtp -97.9 30.86 2.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 4.7000000000000002 110.337 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.29 -153.69 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.777 -0.647 . . . . 6.29 110.506 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 100.22 8.13 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.375 0.607 . . . . 3.8599999999999999 109.733 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 11.5 p -138.24 156.9 73.51 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 115.003 -0.999 . . . . 2.3599999999999999 110.704 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 58.6 Cg_endo -67.97 -153.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.567 2.178 . . . . 2.2999999999999998 111.514 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 703' ' ' PHE . . . 68.62 -70.87 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.278 -0.419 . . . . 1.49 110.758 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 34.37 37.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.906 -0.588 . . . . 4.1200000000000001 111.531 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 60.56 115.38 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.081 -0.58 . . . . 0.91000000000000003 112.303 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.925 HD12 ' HA ' ' A' ' 703' ' ' PHE . 92.0 mt -151.63 -152.45 0.43 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.814 -0.693 . . . . 1.25 110.253 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' O ' HD22 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -107.41 147.16 30.74 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.32 0.859 . . . . 1.52 113.32 -178.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -133.3 145.93 50.9 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 114.804 -1.089 . . . . 1.3600000000000001 109.621 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.952 HD13 HD12 ' A' ' 578' ' ' LEU . 2.6 pt -105.55 116.24 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.465 0.65 . . . . 0.34999999999999998 112.031 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.965 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 61.9 m95 -104.35 133.64 48.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.827 -1.079 . . . . 0.42999999999999999 111.507 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.58 ' CB ' HD21 ' A' ' 672' ' ' LEU . 10.1 t80 -89.84 117.08 28.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.039 -1.097 . . . . 0.34000000000000002 108.039 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 624' ' ' PHE . 0.1 OUTLIER -111.41 105.9 14.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.349 0.5 . . . . 0.44 112.349 -177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 656' ' ' VAL . 44.1 t60 -75.11 131.62 40.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.25 110.865 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.473 ' O ' ' NE2' ' A' ' 666' ' ' GLN . 0.0 OUTLIER -126.54 6.16 6.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 111.5 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -93.7 149.09 19.29 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.964 -0.562 . . . . 0.26000000000000001 112.615 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 73.9 m -75.88 -24.98 55.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.805 0.336 . . . . 0.33000000000000002 111.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.547 ' O ' ' O ' ' A' ' 656' ' ' VAL . 14.8 m-20 -77.53 4.51 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.716 0.635 . . . . 1.8300000000000001 112.716 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 664' ' ' MET . 1.9 p 48.57 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.725 0.774 . . . . 0.97999999999999998 112.823 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . . . . . . . . . 87.5 p -114.83 165.58 12.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.036 -0.984 . . . . 1.1599999999999999 110.025 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 679' ' ' LYS . 66.2 m-85 -122.3 145.39 48.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.586 -0.279 . . . . 1.22 110.972 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.104 HD13 HG22 ' A' ' 678' ' ' ILE . 1.1 tp -135.66 100.71 4.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.482 -0.326 . . . . 1.29 111.115 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.82 -79.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.101 -0.5 . . . . 2.1499999999999999 110.697 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -144.91 16.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 2.4199999999999999 111.322 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.561 HD22 HG23 ' A' ' 716' ' ' VAL . 2.2 m120 -117.19 141.09 48.72 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.923 0.392 . . . . 1.8999999999999999 111.096 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.886 ' O ' HG21 ' A' ' 716' ' ' VAL . 9.5 ttp180 -101.52 141.05 34.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 2.6400000000000001 110.324 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 656' ' ' VAL . 3.0 ptm -139.94 118.15 11.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.97999999999999998 111.24 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 34.2 pt -87.5 165.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.02 -0.537 . . . . 0.64000000000000001 110.873 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 652' ' ' THR . 0.0 OUTLIER -56.73 104.65 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.114 0.483 . . . . 0.81999999999999995 110.493 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 122.55 23.45 2.33 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.798 -0.715 . . . . 0.44 111.439 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 15.6 p -122.98 159.75 27.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.513 0.673 . . . . 0.44 111.394 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.405 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.6 ttpm? -123.02 145.48 48.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.794 -1.094 . . . . 0.81999999999999995 109.157 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.783 ' CD2' HD23 ' A' ' 659' ' ' LEU . 1.1 t80 -147.37 144.5 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.848 0.684 . . . . 0.80000000000000004 112.848 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.965 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -72.72 136.56 45.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.028 -0.533 . . . . 1.5 110.922 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.58 HD21 ' CB ' ' A' ' 649' ' ' TYR . 2.9 mt -110.7 102.0 10.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.068 0.461 . . . . 0.63 110.733 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.498 ' CB ' ' HA ' ' A' ' 707' ' ' LEU . 13.8 mt-30 -81.92 147.15 29.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.665 -0.698 . . . . 0.54000000000000004 110.987 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.672 ' OD2' HD13 ' A' ' 707' ' ' LEU . 2.2 p30 -48.82 122.31 5.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 1.4099999999999999 110.844 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 79.85 37.67 21.98 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.552 -0.833 . . . . 0.42999999999999999 111.391 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.63 121.08 35.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 1.3100000000000001 110.7 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.676 ' CD ' HD11 ' A' ' 583' ' ' LEU . 0.6 OUTLIER -96.3 114.16 25.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.316 -0.402 . . . . 2.4300000000000002 110.151 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.104 HG22 HD13 ' A' ' 659' ' ' LEU . 19.7 pt -105.32 125.29 60.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.07 0.462 . . . . 1.3400000000000001 111.869 -178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 658' ' ' TYR . 1.2 mttt -88.27 116.18 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.769 -0.65 . . . . 2.04 109.66 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 618' ' ' LEU . 7.5 mt -78.34 -36.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.048 -0.524 . . . . 1.7 111.554 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.537 HG21 ' OD2' ' A' ' 615' ' ' ASP . 2.9 tt -154.88 131.8 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.955 0.407 . . . . 0.62 111.694 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . 0.652 ' CD1' HG12 ' A' ' 689' ' ' VAL . 11.2 t90 -136.37 116.36 13.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.521 . . . . 0.91000000000000003 111.14 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -127.14 116.08 20.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 1.75 109.973 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -67.27 -46.28 74.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.042 -0.527 . . . . 3.4399999999999999 111.761 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -73.97 -40.39 63.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.307 -0.406 . . . . 2.1400000000000001 111.355 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.66 -6.63 59.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 1.8400000000000001 111.178 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.4 tttt 56.23 23.95 7.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.335 . . . . 3.1400000000000001 111.195 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 587' ' ' ILE . 0.6 OUTLIER -92.14 103.86 16.3 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.729 -0.471 . . . . 2.1800000000000002 109.729 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.652 HG12 ' CD1' ' A' ' 682' ' ' TRP . 13.1 m -126.69 125.54 67.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.416 -0.356 . . . . 1.3799999999999999 111.307 -179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.783 HD12 ' OD2' ' A' ' 615' ' ' ASP . 4.8 mt -128.11 152.48 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.82999999999999996 110.765 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -169.75 131.93 2.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.629 -0.796 . . . . 0.33000000000000002 112.735 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 3.6 m-85 -114.68 141.41 47.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.465 -0.198 . . . . 1.3500000000000001 110.465 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -101.72 116.93 33.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.949 0.404 . . . . 1.8700000000000001 110.31 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.754 HG23 ' CD2' ' A' ' 580' ' ' LEU . 1.0 OUTLIER -81.87 118.9 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.31 111.04 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.86 111.12 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.984 -0.553 . . . . 1.9199999999999999 110.569 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 705' ' ' GLU . 14.8 mt -83.63 110.96 19.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.46999999999999997 111.17 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.86 -43.95 13.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.231 0.539 . . . . 1.24 109.631 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.4 141.97 42.74 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.359 -0.837 . . . . 1.28 110.919 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 701' ' ' GLY . 19.1 p -113.07 96.73 6.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.835 -0.802 . . . . 0.55000000000000004 108.835 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 700' ' ' THR . 7.1 t -67.06 66.52 0.06 Allowed 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.697 -1.138 . . . . 0.98999999999999999 110.765 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 644' ' ' LEU . . . 55.23 38.42 67.67 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.793 -0.717 . . . . 0.79000000000000004 112.094 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 645' ' ' ASP . 2.7 mt -78.42 138.96 38.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 1.4199999999999999 111.054 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.925 ' HA ' HD12 ' A' ' 644' ' ' LEU . 39.4 p90 -43.25 -34.72 1.23 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.654 0.74 . . . . 1.3200000000000001 109.862 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 3.9 t30 -145.63 -59.93 0.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.504 -1.225 . . . . 1.8600000000000001 108.865 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 696' ' ' ILE . 5.8 pt-20 161.24 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.684 -1.144 . . . . 1.9399999999999999 109.593 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . . . . . . . . . . . 144.02 -9.11 2.0 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.745 -0.661 . . . . 1.6000000000000001 112.765 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.672 HD13 ' OD2' ' A' ' 674' ' ' ASP . 1.0 OUTLIER -86.57 9.15 19.37 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 112.293 0.479 . . . . 1.9399999999999999 112.293 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 50.2 -160.76 1.19 Allowed Glycine 0 C--N 1.319 -0.362 0 C-N-CA 120.805 -0.712 . . . . 2.5099999999999998 112.662 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.05 40.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.67 0.271 . . . . 3.2000000000000002 110.933 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.417 HD13 ' CB ' ' A' ' 712' ' ' GLU . 0.2 OUTLIER -132.72 -172.8 3.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.864 0.364 . . . . 4.1900000000000004 111.306 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -62.81 -17.95 62.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 6.0599999999999996 112.047 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.417 ' CB ' HD13 ' A' ' 710' ' ' LEU . 1.1 tm-20 -63.39 120.82 12.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 6.04 110.773 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -116.45 97.18 5.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.152 0.501 . . . . 4.6399999999999997 110.605 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.3 OUTLIER 30.75 89.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.028 -0.987 . . . . 2.5 112.856 179.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.65 140.9 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.58999999999999997 109.971 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.886 HG21 ' O ' ' A' ' 663' ' ' ARG . 46.1 t -85.11 130.28 36.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.826 0.346 . . . . 0.71999999999999997 111.113 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.1 mp -110.9 172.3 6.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 1.6899999999999999 110.693 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.35 156.46 17.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 2.4700000000000002 111.108 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.09 160.27 14.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.01 110.851 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 62.7 p -124.92 -175.09 3.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.346 -0.388 . . . . 0.81999999999999995 111.172 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.64 -29.58 38.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.69999999999999996 111.077 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.57 -49.19 78.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 2.2599999999999998 110.584 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.429 ' HA ' ' HG ' ' A' ' 726' ' ' LEU . 1.0 OUTLIER -67.41 -46.97 71.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 1.6499999999999999 110.863 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.9 OUTLIER -57.01 -33.67 67.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 2.6800000000000002 111.155 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -36.58 79.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 1.6100000000000001 111.109 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 723' ' ' GLU . 3.0 mt -58.61 -44.91 90.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 1.23 111.184 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.854 ' CG2' HG11 ' A' ' 621' ' ' VAL . 6.0 p -69.41 -25.18 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.66000000000000003 111.063 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -25.83 53.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.339 -0.392 . . . . 2.75 110.993 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -106.15 -35.51 7.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 2.8300000000000001 110.988 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.752 HD21 HG22 ' A' ' 621' ' ' VAL . 1.8 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.184 -0.912 . . . . 2.6899999999999999 110.879 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 826' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.795 0.331 . . . . 7.0300000000000002 111.159 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 827' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -88.9 106.14 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 5.4000000000000004 110.924 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 828' ' ' ILE . . . . . . . . . . . . . 8.1 pt -108.51 93.43 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 2.9500000000000002 110.961 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 829' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 830' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -109.27 153.96 23.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 5.79 110.945 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 831' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' P' ' 831' ' ' LEU . 22.0 mt -154.75 148.04 24.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 2.5600000000000001 110.884 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 832' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.195 -0.907 . . . . 4.8700000000000001 110.91 -179.979 . . . . . . . . 1 1 . 1 stop_ save_